<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006958</article-id><article-id pub-id-type="pmc">PMC11860391</article-id><article-id pub-id-type="doi">10.3390/v17020203</article-id><article-id pub-id-type="publisher-id">viruses-17-00203</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Viruses and the Brain&#x02014;A Relationship Prone to Trouble</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mielcarska</surname><given-names>Matylda Barbara</given-names></name><xref rid="af1-viruses-17-00203" ref-type="aff">1</xref><xref rid="c1-viruses-17-00203" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Rouse</surname><given-names>Barry T.</given-names></name><xref rid="af2-viruses-17-00203" ref-type="aff">2</xref><xref rid="c1-viruses-17-00203" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Liang</surname><given-names>Bo</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-17-00203"><label>1</label>Department of Preclinical Sciences, Institute of Veterinary Sciences, Warsaw University of Life Sciences&#x02013;SGGW, Jana Ciszewskiego 8, 02-786 Warsaw, Poland</aff><aff id="af2-viruses-17-00203"><label>2</label>College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA</aff><author-notes><corresp id="c1-viruses-17-00203"><label>*</label>Correspondence: <email>matylda_mielcarska@sggw.edu.pl</email> (M.B.M.); <email>btr@utk.edu</email> (B.T.R.)</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>203</elocation-id><history><date date-type="received"><day>06</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>23</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Neurological disorders, some of which are associated with viral infections, are growing due to the aging and expanding population. Despite strong defenses of the central nervous system, some viruses have evolved ways to breach them, which often result in dire consequences. In this review, we recount the various ways by which different viruses can enter the CNS, and we describe the consequences of such invasions. Consequences may manifest as acute disease, such as encephalitis, meningitis, or result in long-term effects, such as neuromuscular dysfunction, as occurs in poliomyelitis. We discuss evidence for viral involvement in the causation of well-known chronic neurodegenerative diseases, such as Alzheimer&#x02019;s disease, Parkinson&#x02019;s disease, amyotrophic lateral sclerosis, multiple sclerosis, as well as vascular dementia in the elderly. We also describe the approaches currently available to control a few of the neural viral infections. These include antivirals that are effective against human immunodeficiency virus and herpes simplex virus, as well as vaccines valuable for controlling rabies virus, poliomyelitis virus, and some flavivirus infections. There is an urgent need to better understand, at a molecular level, how viruses contribute to acute and, especially, chronic neurological diseases and to develop more precise and effective vaccines and therapies.</p></abstract><kwd-group><kwd>CNS</kwd><kwd>BBB</kwd><kwd>viral encephalitis</kwd><kwd>flaviviruses</kwd><kwd>Alzheimer&#x02019;s disease</kwd><kwd>dementia</kwd><kwd>Parkinson&#x02019;s disease</kwd><kwd>amyotrophic lateral sclerosis</kwd><kwd>multiple sclerosis</kwd></kwd-group><funding-group><funding-statement>This work received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-17-00203"><title>1. Introduction</title><p>Characteristically, the brain of vertebrates is highly protected from invasion by viruses and other factors that could damage its function. Indeed, getting into the brain is no easy task, and few exogenous viral agents can achieve success. There are two highly specialized multicellular obstacles that must be crossed by the virus present in tissues prior its entry to the brain. These are the blood&#x02013;brain barrier (BBB) and the blood&#x02013;cerebrospinal fluid (BCSF) barrier. By separating the bloodstream and cerebrospinal fluid (CSF) from the brain&#x02019;s own cerebral extracellular fluid, the BBB and BCSF barriers secure the brain from invasion by viruses and other potential hazards such as foreign cells, toxins, and inflammatory factors [<xref rid="B1-viruses-17-00203" ref-type="bibr">1</xref>,<xref rid="B2-viruses-17-00203" ref-type="bibr">2</xref>]. Nevertheless, some viruses do succeed, and, when this happens, the consequences can be dire.</p><p>With some infections, severe damaging consequences rapidly occur, and these are highly disruptive to the brain&#x02019;s function and are often terminal. Several insect-borne infections within the <italic toggle="yes">Flaviviridae</italic> family represent examples causing encephalitis [<xref rid="B3-viruses-17-00203" ref-type="bibr">3</xref>]. However, some viral infections cause minimal overt damage, and the agents can persist in brain tissues for prolonged periods of time before being associated with lesions. One such example is amyotrophic lateral sclerosis (ALS), which is associated with an enterovirus that can invade motor neurons and maintain persistent infection in the central nervous system (CNS) [<xref rid="B4-viruses-17-00203" ref-type="bibr">4</xref>]. In some viral infections, chronic sequelae can occur, which sometimes involve the immune system reactivity. Thus, viruses may trigger autoimmune lesions such as multiple sclerosis (MS), although its mechanisms are still unresolved. There is also evidence that viruses can participate in physical and mental decline, although associating these chronic consequences to direct effects of the infection is yet to be substantiated. For example, several viral types that achieve brain access, perhaps accidentally, could act as triggers for the initiation or acceleration of neurodegenerative syndromes such as Alzheimer&#x02019;s disease (AD). Furthermore, there is now evidence that endogenous retroviruses, which represent up to 8% of the human genome, sometimes can be precipitated by environmental and perhaps other factors, can get involved in the etiopathogenesis of some inflammatory and neurodegenerative diseases (NDs), which include MS and ALS [<xref rid="B5-viruses-17-00203" ref-type="bibr">5</xref>], as well as mental disorders. It is not uncommon to find the footprints of many different viruses in normal as well as diseased brain tissues, but linking the presence of these agents to the cause of either subtle or evident neurological events is highly problematic.</p><p>In this review, we describe the numerous mechanisms employed by viruses that permit entrance into the brain and mention the viral properties that can result in neuroinvasive disorders such as encephalitis, meningitis, as well as chronic damage to the brain. We also describe conditions where viruses are not overtly tissue damaging, but can persist in brain tissues and may act as primary or contributary causes of ND. These include AD, Parkinson&#x02019;s disease (PD), MS, and ALS, together with vascular dementia (VaD), the second most common cause of dementia in the elderly people. During such evaluation, we comment on the value of current diagnostic and therapeutic procedures and suggest improvements that are still needed to clarify this confusing situation. Finally, we deal briefly with the contention that endogenous retroviruses may, in some instances, contribute to degenerative neurological diseases and that retrotransposons may affect motor neuron functioning. We take most of our viral-associated neuro-damaging examples from natural infections of humans and from animal models of infection, the latter of which can often reveal a misleading picture.</p></sec><sec id="sec2-viruses-17-00203"><title>2. Getting into the Brain Is Not So Easy</title><p>The brain is well protected against invasion, and few viruses have achieved success at gaining entry. Thus, in addition to the hard-to-penetrate bones of the skull, there are two highly specialized multicellular defense walls, the blood&#x02013;brain barrier (BBB) and the blood&#x02013;cerebrospinal fluid barrier (BCSF) that must be crossed if a virus or other factor such as a toxin or drug is to pass from a systemic location and enter brain tissue. The BBB is composed of non-fenestrated vessels comprising polarized endothelial cells connected by tight and adherent junctions, the capillary basement membrane, pericytes, and astrocyte endfeet, which provide an effective separation between blood and perivascular spaces [<xref rid="B6-viruses-17-00203" ref-type="bibr">6</xref>] (see <xref rid="viruses-17-00203-f001" ref-type="fig">Figure 1</xref>).</p><p>The functions of endothelial cells, the central component of the BBB, are dependent on the interactions with pericytes and astrocytes as well as factors circulating in the CNS microenvironment such as cytokines and other soluble molecules [<xref rid="B2-viruses-17-00203" ref-type="bibr">2</xref>,<xref rid="B7-viruses-17-00203" ref-type="bibr">7</xref>].</p><p>One of the most prominent roles of the BBB is the precise regulation of paracellular, and thus vascular, permeability, which is attained with junction complexes that include tight, adherens, and gap junctions connecting endothelial cells [<xref rid="B8-viruses-17-00203" ref-type="bibr">8</xref>,<xref rid="B9-viruses-17-00203" ref-type="bibr">9</xref>]. Tight junctions (TJs) consist of integral membrane proteins such as occludins and claudins, with claudin-5 being the major constitutive claudin of the BBB. The TJ also comprise additional junctional adhesion molecules, cytoplasmic accessory zonula occludens phosphoproteins, and others [<xref rid="B10-viruses-17-00203" ref-type="bibr">10</xref>]. The TJs provide low paracellular permeability to ions and small molecules and are major contributors to BBB properties [<xref rid="B11-viruses-17-00203" ref-type="bibr">11</xref>]. The adherens junctions present a similar organization to the TJ and consist of cadherins and supporting catenins, and these regulate signaling processes as well as secure cell&#x02013;cell adhesion [<xref rid="B8-viruses-17-00203" ref-type="bibr">8</xref>]. Gap junctions consist of proteins from the connexin family [<xref rid="B12-viruses-17-00203" ref-type="bibr">12</xref>], and play a role in cell proliferation and migration beyond intercellular communication [<xref rid="B13-viruses-17-00203" ref-type="bibr">13</xref>]. The cytoskeleton linked to junction scaffolding proteins is also an indispensable component of intercellular connections. The types of junctions between BBB endothelial cells are depicted in <xref rid="viruses-17-00203-f002" ref-type="fig">Figure 2</xref>.</p><p>Vascular endothelial cells of the BBB are dynamic, semipermeable, and extremely selective and serve to regulate what can access and pass through the barrier. However, the BBB can be subjected to damage, and its permeability may increase as a person ages, accounting for the onset of age-related syndromes, some of which could be associated with opportunist viral infections, as discussed by Noe and colleagues [<xref rid="B14-viruses-17-00203" ref-type="bibr">14</xref>]. Furthermore, some infections may accelerate NDs [<xref rid="B15-viruses-17-00203" ref-type="bibr">15</xref>], and some have speculated that this happens in some survivors of COVID-19 [<xref rid="B16-viruses-17-00203" ref-type="bibr">16</xref>].</p><p>The BCSF barrier is formed by a pair of membranes&#x02014;one, composed of choroid plexus epithelial cells, and the second, the arachnoid membrane, composed of several layers of fibroblasts [<xref rid="B17-viruses-17-00203" ref-type="bibr">17</xref>], that envelops the brain [<xref rid="B18-viruses-17-00203" ref-type="bibr">18</xref>]. The choroid plexus-derived membrane consists of a layer of specialized ciliated glial cells that form the ependymal epithelium, which lines the ventricles of the brain and produces CSF on one side and surrounds capillaries on the other side. In comparison to the BBB, the BSCF barrier blood vessels are fenestrated, and astrocytes are not involved in the barrier structure. The BCSF barrier is a critical determinant of brain homeostasis and has several functions. These include secreting and regulating the ionic and nutrient composition of CSF, which provides a route for signal transduction between the choroid plexus and the brain via CSF [<xref rid="B19-viruses-17-00203" ref-type="bibr">19</xref>]. This also limits the access of potentially neurotoxic compounds to the CNS [<xref rid="B20-viruses-17-00203" ref-type="bibr">20</xref>]. Moreover, the BCSF barrier participates in the recruitment, skewing, and suppression of immune cells from the bloodstream into the CNS [<xref rid="B21-viruses-17-00203" ref-type="bibr">21</xref>]. The BCSF likely prevents most viruses from accessing the brain, although how this is accomplished has received minimal investigation in comparison to the BBB. Several BCSF barrier models have now been developed so further understanding of the consequences of virus&#x02013;BCSF interaction is anticipated [<xref rid="B22-viruses-17-00203" ref-type="bibr">22</xref>]. Other recent studies indicate that aging is associated with morphological and molecular changes in the BCSF barrier, as well as altered CSF production and turnover. These changes may contribute to age-related cognitive decline and neurodegenerative disorders and perhaps to susceptibility to viruses that could help cause some of these lesions [<xref rid="B21-viruses-17-00203" ref-type="bibr">21</xref>,<xref rid="B23-viruses-17-00203" ref-type="bibr">23</xref>].</p><p>The protection of the CNS has been suggested to reflect the defense of a medieval castle [<xref rid="B24-viruses-17-00203" ref-type="bibr">24</xref>,<xref rid="B25-viruses-17-00203" ref-type="bibr">25</xref>]. The castle is surrounded by two walls bordering a moat, located behind a closed gate, hidden, but in plain sight [<xref rid="B26-viruses-17-00203" ref-type="bibr">26</xref>,<xref rid="B27-viruses-17-00203" ref-type="bibr">27</xref>]. However, despite these protective barriers, castles like the brain were never invincible, and some viruses do achieve neuroinvasion. We next describe the different strategies that viruses employ to achieve this maneuver.</p></sec><sec id="sec3-viruses-17-00203"><title>3. What Makes a Virus Capable of Neuroinvasion?</title><p>There are basically two main avenues for a virus to enter the undamaged CNS: passage by way of nerve axons that synapse in the CNS or traversing the protective BBB and BCSF barriers. Those human infecting viral pathogens that take the former route include rabies virus (RABV), poliovirus (PV), and alpha herpesviruses. Curiously, with the latter virus infections, when the agent is not a specific pathogen of the species, oftentimes the virus transports to the brain to cause lethal encephalitis, which is an uncommon outcome in the natural host. An example is human infection with Herpes B, an insignificant pathogen in some primate species [<xref rid="B28-viruses-17-00203" ref-type="bibr">28</xref>] but often causing lethal encephalitis if humans are infected. Moreover, although, immunologically, normal humans rarely suffer encephalitis following herpes simplex virus (HSV) infection, some primate relatives infected with HSV are highly prone to develop encephalitis [<xref rid="B29-viruses-17-00203" ref-type="bibr">29</xref>]. A similar example occurs with alphaviruses in some domestic animals [<xref rid="B30-viruses-17-00203" ref-type="bibr">30</xref>]. Thus, Pseudorabies virus (PRV) usually causes a peripheral infection in its natural host, the pig, but it is apt to result in encephalitis if cattle, feline, or canine species are infected [<xref rid="B31-viruses-17-00203" ref-type="bibr">31</xref>,<xref rid="B32-viruses-17-00203" ref-type="bibr">32</xref>]. The reasons for these differences in viral tropism are not fully understood, but herpesviruses always establish a second lifestyle in animals they infect, referred to as latency. With alpha herpesviruses, latency is established and maintained in the peripheral nervous system but is subject to reversal from time to time. When this occurs, the pathogen commonly passes anterogradely via sensory nerves to peripheral sites where recurrent lesions may occur [<xref rid="B33-viruses-17-00203" ref-type="bibr">33</xref>]. During reactivation, the pathogen may also disseminate via neuronal projections from the latency site to the CNS, causing severe encephalitis or raising no symptoms, but the frequency of the latter phenomenon occurrence remains unknown. There is some evidence that HSV can persist in the CNS and perhaps be a cause of neurodegenerative disorders, although this remains an area of controversy [<xref rid="B34-viruses-17-00203" ref-type="bibr">34</xref>]. There is also evidence that some of the flaviviruses may access the CNS by infecting olfactory neurons or peripheral nerves and exploit retrograde axonal transport [<xref rid="B35-viruses-17-00203" ref-type="bibr">35</xref>,<xref rid="B36-viruses-17-00203" ref-type="bibr">36</xref>], although it is not known how often this route occurs compared to crossing the BBB.</p><sec id="sec3dot1-viruses-17-00203"><title>3.1. Neuronal Route of Infection</title><p>An example of a virus using the axonal transport route to invade the CNS is RABV, and this usually ends in fatal encephalomyelitis [<xref rid="B37-viruses-17-00203" ref-type="bibr">37</xref>]. After inoculation by a bite or scratch from an infected animal, the virus enters a motor neuron of the PNS via receptor-mediated endocytosis at the neuromuscular junction [<xref rid="B38-viruses-17-00203" ref-type="bibr">38</xref>,<xref rid="B39-viruses-17-00203" ref-type="bibr">39</xref>]. RABV retrogradely traverses the neuron by hijacking the microtubule transport machinery [<xref rid="B40-viruses-17-00203" ref-type="bibr">40</xref>,<xref rid="B41-viruses-17-00203" ref-type="bibr">41</xref>]. After reaching the cell soma, the virus replicates and spreads trans-synaptically to subsequent neurons to ultimately disseminate in the CNS to culminate in death of the host [<xref rid="B42-viruses-17-00203" ref-type="bibr">42</xref>]. Once in the CNS, the virus encounters scanty obstacles to its spread since neuronal cells have few, if any, immune defenses, and the virus produces multifunctional proteins that further inhibit the extent of any innate immune reactions, for example, RABV P [<xref rid="B43-viruses-17-00203" ref-type="bibr">43</xref>,<xref rid="B44-viruses-17-00203" ref-type="bibr">44</xref>]. This occurs by mechanisms that include the production of proteins that arrest interferon signaling, inhibit inflammatory cell infiltration to the CNS, and induce apoptosis in infiltrating T cells [<xref rid="B45-viruses-17-00203" ref-type="bibr">45</xref>,<xref rid="B46-viruses-17-00203" ref-type="bibr">46</xref>].</p><p>Once within neurons, RABV induces major alterations in gene expression [<xref rid="B47-viruses-17-00203" ref-type="bibr">47</xref>], in axon and dendrite degeneration [<xref rid="B48-viruses-17-00203" ref-type="bibr">48</xref>,<xref rid="B49-viruses-17-00203" ref-type="bibr">49</xref>], as well as neurotransmitter dysregulation [<xref rid="B37-viruses-17-00203" ref-type="bibr">37</xref>,<xref rid="B50-viruses-17-00203" ref-type="bibr">50</xref>]. Interestingly, in some instances, the brain of RABV-infected animals contains a small number of necrotic neurons without evidence of inflammation, yet animals still suffer from lethal consequences [<xref rid="B51-viruses-17-00203" ref-type="bibr">51</xref>,<xref rid="B52-viruses-17-00203" ref-type="bibr">52</xref>]. This likely happens because the field strain of RABV primarily infects and damages astrocytes, with neuronal dysfunction as a secondary effect of astrocyte infection. In fact, highly virulent field RABV strains exhibit high tropism for non-neuronal cells in the CNS, with astrocytic infection frequencies far exceeding neuron infection [<xref rid="B53-viruses-17-00203" ref-type="bibr">53</xref>,<xref rid="B54-viruses-17-00203" ref-type="bibr">54</xref>].</p><p>Alpha herpesviruses can also invade the CNS via the neuronal route and exploit the nerve axon transport system. In the case of HSV-1, cellular entry requires the use of specific cellular receptors, which is a key factor determining tissue and cell-specific susceptibility to virus infection. Viral nucleocapsids traffic along microtubules to reach the trigeminal ganglia (TG) and the brainstem by afferent inputs from the TG, where latency is established [<xref rid="B55-viruses-17-00203" ref-type="bibr">55</xref>]. Occasionally, primary HSV infection or reactivation from latency may turn into severe acute inflammation, resulting in potentially fatal necrotizing meningoencephalitis [<xref rid="B56-viruses-17-00203" ref-type="bibr">56</xref>,<xref rid="B57-viruses-17-00203" ref-type="bibr">57</xref>]. Although a rare disorder, herpes simplex encephalitis (HSE), is the most common sporadic infectious encephalitis in humans [<xref rid="B58-viruses-17-00203" ref-type="bibr">58</xref>]. One of the determinants of HSV neurovirulence includes the extent of the type I IFN response that limits virus replication, spread, and cytopathic effect in the brain [<xref rid="B59-viruses-17-00203" ref-type="bibr">59</xref>]. Mutations that reduce the CNS-intrinsic IFN production in response to HSV-1 may predispose to HSE [<xref rid="B60-viruses-17-00203" ref-type="bibr">60</xref>,<xref rid="B61-viruses-17-00203" ref-type="bibr">61</xref>]. A comparison of two different viruses using retrograde axonal transport to reach the CNS: RABV and HSV-1 is summarized in <xref rid="viruses-17-00203-t001" ref-type="table">Table 1</xref>.</p><p>In the past decades, a frequent cause of neurological lesions was poliomyelitis virus, (PV), now almost eliminated by effective vaccines and the WHO eradication and endgame program. PV infections are mostly asymptomatic, with viral replication largely confined to the tissues of the oropharynx and gastrointestinal tract, typically accompanied with a brief period of viremia [<xref rid="B70-viruses-17-00203" ref-type="bibr">70</xref>,<xref rid="B71-viruses-17-00203" ref-type="bibr">71</xref>]. However, in some individuals, the circulating virus may access the CNS either via the BBB or be retrogradely transported along the axons of peripheral nerves. In the latter process, virions undergo endocytosis at synapses, and virus-containing endosomes are transported along the axon, from peripheral regions to the neuronal cell body [<xref rid="B72-viruses-17-00203" ref-type="bibr">72</xref>]. Once there, viral particles are uncoated and virus replicates. Interestingly, the pathway of PV dissemination depends on the virus strain [<xref rid="B73-viruses-17-00203" ref-type="bibr">73</xref>]. CNS invasion by PV can lead to non-paralytic, aseptic meningitis in a small proportion of cases, or to the infectious destruction of alpha motor neurons located in the anterior horns of the spinal cord, as well as cranial nerve nuclei in the medulla oblongata, pons, and midbrain, resulting in characteristic paralytic poliomyelitis [<xref rid="B71-viruses-17-00203" ref-type="bibr">71</xref>]. Surprisingly, most sensory neurons and much of the brain, aside from the brainstem, remain unaffected during the disease. The pattern of viral localization may be attributed to the intrinsic differences in the susceptibility of various neuronal cell types, host genetic variants in the innate immune defenses and cell death pathways, as well as and possibly the route of viral spread [<xref rid="B73-viruses-17-00203" ref-type="bibr">73</xref>,<xref rid="B74-viruses-17-00203" ref-type="bibr">74</xref>]. The relationship between the latter and the disease&#x02019;s clinical form, severity, and eventual pattern of paralysis awaits to be determined.</p><p>Another route of neuroinvasion that bypasses the CNS barrier defenses is anterograde transport through olfactory sensory neurons. Such cells have their cell bodies in the olfactory epithelium, and their axons pass from the nasal to the cranial cavity to terminate in the olfactory bulb (OB). This makes them the only CNS cells exposed directly to the external environment [<xref rid="B51-viruses-17-00203" ref-type="bibr">51</xref>,<xref rid="B75-viruses-17-00203" ref-type="bibr">75</xref>]. Various DNA and RNA viruses are initially detected within the OB during neuroinvasive infection, which include herpesviruses, some neurotropic flaviviruses, measles virus (MeV), influenza A virus, and others, as reviewed by Durrant et al. [<xref rid="B75-viruses-17-00203" ref-type="bibr">75</xref>].</p><p>Interestingly, retinal cells of the eye were recently suggested as another entry point for virus neuroinvasion [<xref rid="B76-viruses-17-00203" ref-type="bibr">76</xref>]. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can exhibit ocular tropism, permissively infect, and therefore replicate in retinal cells in vitro [<xref rid="B77-viruses-17-00203" ref-type="bibr">77</xref>]. However, if and how the virus may spread into adjacent neurons, such as the neighboring optic nerve constituting the extension of the retina, remains to be clarified.</p></sec><sec id="sec3dot2-viruses-17-00203"><title>3.2. Hematogenous Route of Infection</title><p>The more common route of entry for neurotropic viruses, as well as for most accidental viral invaders, is from the bloodstream and crossing either the BBB or BCSF barriers. As mentioned before, in normal circumstances, these barriers are difficult to transverse as the membrane cells are tightly attached to each other, and the defense of the site is assisted also by innate immune activities. Those viruses that do succeed have developed a number of strategies. Many of these are listed in <xref rid="viruses-17-00203-t002" ref-type="table">Table 2</xref>, along with examples of viruses that use the specific strategy.</p><p>The mechanisms used to cross the barriers vary, with some viruses passing with no or minimal damage to the barrier cells and junctions between them, whereas others pass by, causing notable damage. Some viruses are only able to pass if the barriers are made more permeable, such as by exposure to pro-inflammatory factors and mediators. The increase in barrier permeability can also occur under the sole influence of some proteins derived from viruses themselves. Finally, passage can be achieved by the so-called Trojan horse mechanism, which is a combination process that we further describe in a separate section.</p><sec id="sec3dot2dot1-viruses-17-00203"><title>3.2.1. Neuroinvasion from the Blood Stream</title><p>The most prevalent agents that can enter and infect brain cells are insect-transmitted members of the Flavivirus and Togavirus families, which initiate the infection at an extraneural site. Many of these viruses achieve passage into the CNS by the binding of a surface viral glycoprotein to a receptor on BBB endothelial cells, after which cell entry occurs by exploiting clathrin-coated or caveolae-mediated endocytosis. The virus is then released into the CNS tissue without causing overt damage to the endothelial layer. Traversing BBB may occur with or without replication [<xref rid="B78-viruses-17-00203" ref-type="bibr">78</xref>], and, once in the CNS, flaviviruses primarily target differentiated neurons [<xref rid="B79-viruses-17-00203" ref-type="bibr">79</xref>,<xref rid="B80-viruses-17-00203" ref-type="bibr">80</xref>] but also can infect neural progenitor cells (NPCs) [<xref rid="B81-viruses-17-00203" ref-type="bibr">81</xref>], astrocytes, and microglia [<xref rid="B82-viruses-17-00203" ref-type="bibr">82</xref>,<xref rid="B83-viruses-17-00203" ref-type="bibr">83</xref>]. Research on WNV, JEV, TBEV, and ZIKV in vitro and ZIKV-infected animal models has also demonstrated that the transcytotic crossing of endothelial cells caused no changes in BBB overall permeability or integrity [<xref rid="B84-viruses-17-00203" ref-type="bibr">84</xref>,<xref rid="B85-viruses-17-00203" ref-type="bibr">85</xref>,<xref rid="B86-viruses-17-00203" ref-type="bibr">86</xref>,<xref rid="B87-viruses-17-00203" ref-type="bibr">87</xref>,<xref rid="B88-viruses-17-00203" ref-type="bibr">88</xref>]. Similarly, other arboviruses, such as Venezuelan and Western equine encephalitis viruses (VEEV and WEEV, respectively) from the <italic toggle="yes">Togaviridae</italic> family, transcytose through brain microvascular endothelial cells without damaging the BBB, as shown by in vitro studies with BBB cultures [<xref rid="B89-viruses-17-00203" ref-type="bibr">89</xref>]. However, further research is necessary to verify if these findings hold true in vivo in humans.</p><p>A different scenario ensues when viruses that encounter the barrier cells infect and damage the barrier function, and this is often followed by wide scale invasion of the CNS. This situation happens with <italic toggle="yes">Paramyxoviridae</italic> pathogens such as Hendra virus (HeV) and Nipah virus (NiV) infections [<xref rid="B90-viruses-17-00203" ref-type="bibr">90</xref>]. The major characteristic of infections by HeV or NiV is an acute, severe respiratory illness and a widespread endothelial infection in the CNS that rapidly progresses to an often fatal encephalitis [<xref rid="B90-viruses-17-00203" ref-type="bibr">90</xref>]. With both pathogens, after a respiratory phase, viremia occurs, and the virus in free form, or bound to host leukocytes, makes contact with BBB endothelial cells as well as choroid plexus blood vessels [<xref rid="B91-viruses-17-00203" ref-type="bibr">91</xref>,<xref rid="B92-viruses-17-00203" ref-type="bibr">92</xref>]. Cell fusion and syncytium formation mediated by viral envelope glycoproteins, e.g., Nipah virus F envelope glycoprotein (NiF) and NiG then occur, and this results in extensive damage and ready access to cells in the CNS [<xref rid="B93-viruses-17-00203" ref-type="bibr">93</xref>]. At the same time, an excessive induction of inflammatory cytokines may occur that further facilitates access to brain tissues [<xref rid="B94-viruses-17-00203" ref-type="bibr">94</xref>,<xref rid="B95-viruses-17-00203" ref-type="bibr">95</xref>].</p><p>In some instances, viral proteins alone also have the potential to substantially disrupt the barrier structure. This can occur with Human Immunodeficiency Virus (HIV-1) and some flavivirus infections [<xref rid="B96-viruses-17-00203" ref-type="bibr">96</xref>,<xref rid="B97-viruses-17-00203" ref-type="bibr">97</xref>,<xref rid="B98-viruses-17-00203" ref-type="bibr">98</xref>]. In the case of HIV-1, the Tat, gp120, and Nef proteins can damage the BBB, causing apoptosis and oxidative stress as well as changing the adhesiveness of endothelial cells [<xref rid="B99-viruses-17-00203" ref-type="bibr">99</xref>,<xref rid="B100-viruses-17-00203" ref-type="bibr">100</xref>,<xref rid="B101-viruses-17-00203" ref-type="bibr">101</xref>]. These proteins also hijack membrane trafficking to degrade or displace host antiviral proteins and activate cytokine secretion, all of which can profoundly affect the endothelium and other BBB components [<xref rid="B102-viruses-17-00203" ref-type="bibr">102</xref>,<xref rid="B103-viruses-17-00203" ref-type="bibr">103</xref>]. In addition, some flavivirus proteins also have been linked to causing increased endothelial permeability, as detected by some in vitro and in vivo studies [<xref rid="B104-viruses-17-00203" ref-type="bibr">104</xref>,<xref rid="B105-viruses-17-00203" ref-type="bibr">105</xref>]. For example, the nonstructural protein 1 (NS1) from DENV, ZIKV, WNV, and JEV can bind to the endothelial glycocalyx layer, disrupting its integrity and inducing breakdown [<xref rid="B106-viruses-17-00203" ref-type="bibr">106</xref>], as well as contributing to endothelial cells&#x02019; apoptosis or lysis [<xref rid="B107-viruses-17-00203" ref-type="bibr">107</xref>]. When injected into animals, the DENV NS1 alone can induce the production of key inflammatory cytokines, leading to brain endothelium dysfunction [<xref rid="B108-viruses-17-00203" ref-type="bibr">108</xref>,<xref rid="B109-viruses-17-00203" ref-type="bibr">109</xref>]. Other flavivirus nonstructural proteins, such as NS2A and NS2B, were shown to act as viroporins and alter membrane permeability in different models [<xref rid="B110-viruses-17-00203" ref-type="bibr">110</xref>,<xref rid="B111-viruses-17-00203" ref-type="bibr">111</xref>]. However, their role in crossing brain barriers in vivo in human systems awaits exploration [<xref rid="B112-viruses-17-00203" ref-type="bibr">112</xref>].</p><p>Other viruses that infect the brain mediate the changes they cause indirectly by inducing various cytokines, chemokines, and other protein mediators that in turn increase their access to the brain. Such effects have been observed with some flaviviruses, HIV-1, SARS-CoV-2, and a few other infections [<xref rid="B113-viruses-17-00203" ref-type="bibr">113</xref>,<xref rid="B114-viruses-17-00203" ref-type="bibr">114</xref>,<xref rid="B115-viruses-17-00203" ref-type="bibr">115</xref>]. The effects of these mediators set the scene for the disease pattern that follows [<xref rid="B116-viruses-17-00203" ref-type="bibr">116</xref>]. In some cases, induced factors, such as interferons, can act to minimize or even terminate the infection. However, other mediators function to increase the permeability of the brain barriers and hence increase the likelihood of spreading infection, and additional mediators may contribute to the severity of damage once the barrier is crossed [<xref rid="B83-viruses-17-00203" ref-type="bibr">83</xref>,<xref rid="B96-viruses-17-00203" ref-type="bibr">96</xref>,<xref rid="B117-viruses-17-00203" ref-type="bibr">117</xref>]. In some conditions, the virus may not enter the CNS, but central neuroinflammatory effects still occur, likely attributed to mediators. This scenario has been advocated to occur occasionally when SARS-CoV-2 infection results in a &#x0201c;cytokine storm&#x0201d;, a state of hyperinflammation that may lead to neurological lesions [<xref rid="B118-viruses-17-00203" ref-type="bibr">118</xref>,<xref rid="B119-viruses-17-00203" ref-type="bibr">119</xref>,<xref rid="B120-viruses-17-00203" ref-type="bibr">120</xref>]. Pro-inflammatory cytokines and other mediators released during this phenomenon activate barrier endothelial cells and astrocytes and further microglia. These effects induce and amplify neuroinflammation and destabilize and damage the BBB [<xref rid="B120-viruses-17-00203" ref-type="bibr">120</xref>,<xref rid="B121-viruses-17-00203" ref-type="bibr">121</xref>]. Finally, at times, the induction of brain-damaging mediators has been attributed to the effects of viral components inducing them within the CNS rather than the result of actual CNS infection [<xref rid="B104-viruses-17-00203" ref-type="bibr">104</xref>,<xref rid="B122-viruses-17-00203" ref-type="bibr">122</xref>]. This may be occurring in some cases of neural problems associated with HIV and perhaps DENV infections [<xref rid="B123-viruses-17-00203" ref-type="bibr">123</xref>].</p><p>Among the pro-inflammatory mediators that may weaken guard barriers, the tumor necrosis factor (TNF) and interleukin (IL)-1&#x003b2; are the most prominent. In vitro studies have shown these to alter the organization of junctional complexes and transcellular trafficking [<xref rid="B124-viruses-17-00203" ref-type="bibr">124</xref>]. In addition, IL-6 reduces the expression of a variety of intercellular junction proteins [<xref rid="B125-viruses-17-00203" ref-type="bibr">125</xref>], and interferon-&#x003b3; (IFN-&#x003b3;), secreted by activated leukocytes, can cause the redistribution of TJ and AJ proteins in culture systems. Additionally, high IFN-&#x003b3; and TNF concentrations may induce endothelial apoptosis [<xref rid="B126-viruses-17-00203" ref-type="bibr">126</xref>], and elevated plasma IL-8 and transforming growth factor-&#x003b2; (TGF-&#x003b2;) levels have been advocated to be associated with BBB disruption and increased BBB permeability [<xref rid="B118-viruses-17-00203" ref-type="bibr">118</xref>,<xref rid="B123-viruses-17-00203" ref-type="bibr">123</xref>,<xref rid="B127-viruses-17-00203" ref-type="bibr">127</xref>]. All these pro-inflammatory effects may be counterbalanced, to a varying extent, by the inhibitory activity of the type I IFN response that the viruses induce. Thus, the overall outcome of neural infection by virus is hard to predict in individual infections, and far more studies are warranted, especially using human systems.</p></sec><sec id="sec3dot2dot2-viruses-17-00203"><title>3.2.2. Trojan Horse Delivery</title><p>The intriguing Trojan horse idea that a virus might succeed in entering the brain hidden within cells that can cross barriers was proposed by Ashley Haase and Bill Narayan to explain how the lentivirus Visna achieved brain access [<xref rid="B128-viruses-17-00203" ref-type="bibr">128</xref>,<xref rid="B129-viruses-17-00203" ref-type="bibr">129</xref>]. This idea was later extended to explain how mouse cytomegalovirus gets into the brain, and it has been advocated too as a major way that HIV-1 and HCMV gain brain access [<xref rid="B130-viruses-17-00203" ref-type="bibr">130</xref>,<xref rid="B131-viruses-17-00203" ref-type="bibr">131</xref>,<xref rid="B132-viruses-17-00203" ref-type="bibr">132</xref>]. The essence of the Trojan horse concept is that the virus can only access the brain within a cell such as a monocyte, dendritic cell, or lymphocyte, which remains unchanged and may be endowed with heightened mobility and other activities to achieve such passage. Another required step may be that the barrier itself usually needs to be made more receptive by exposure to inflammatory cytokines and chemokines such as the TNF and/or IL-1&#x003b2;, and monocyte chemoattractant protein-1. The Trojan horse idea has been pursued largely by in vitro studies that have focused particularly on HIV-1, HCMV, and, more recently, SARS-CoV-2 [<xref rid="B133-viruses-17-00203" ref-type="bibr">133</xref>]. However, proving that the mechanism is a major brain access portal in vivo is problematic, and how such knowledge can influence the selection of protective therapies needs be explored.</p></sec><sec id="sec3dot2dot3-viruses-17-00203"><title>3.2.3. Hematogenous Route of Neuroinvasion, Conclusions</title><p>In summary, from using in vitro models and some animal models of virus infection, numerous routes have been identified by which a virus can pass from the bloodstream to infect the cells of the CNS [<xref rid="B134-viruses-17-00203" ref-type="bibr">134</xref>,<xref rid="B135-viruses-17-00203" ref-type="bibr">135</xref>]. Well-studied flaviviruses, such as WNV, can penetrate the CNS through multiple mechanisms, and almost certainly there could be several alternative ways for any particular virus to achieve entry. Furthermore, the pathway employed could vary, depending on the circumstances of infection, genetics of the host, and the past disease history [<xref rid="B136-viruses-17-00203" ref-type="bibr">136</xref>]. Sorting out what actually occurs could be highly relevant, especially if the therapies available were more effective against one mechanism than against another. Alas at present, successfully preventing and controlling most acute and particularly chronic viral-associated neurological diseases is not usually a practical procedure, but this scenario is likely to be clarified by further studies.</p></sec></sec></sec><sec id="sec4-viruses-17-00203"><title>4. Once the Barriers Protecting the CNS Have Been Breached</title><sec id="sec4dot1-viruses-17-00203"><title>4.1. The Disease Scenario When Viruses Infect the Human Brain</title><p>Should they succeed in gaining entrance to the CNS, several types of viruses cause neural damage. We have already described some examples in the previous sections, and <xref rid="viruses-17-00203-t003" ref-type="table">Table 3</xref> lists the main named viruses that, in humans, cause neuropathologies of clinical consequences.</p><p>The outcome of neural invasion can occur quickly after infection, as happens with several flaviviruses, or may take a prolonged time period (up to years) to become manifested. In the latter scenarios, the role of the virus infection, especially as a sole cause of the clinical syndromes, is debatable, as will be mentioned in the sections describing those diseases. The CNS infection outcome is closely linked to the extent of cellular damage that it induces. Already during the viral crossing of the CNS barriers, immune and barrier endothelial cells can undergo activation and release pro-inflammatory factors, which in turn can lead to reactive astrogliosis and microglial activation [<xref rid="B198-viruses-17-00203" ref-type="bibr">198</xref>]. Inflammatory cytokines, mediators, and neurotransmitters released by activated glial cells may potentiate the neuroinflammatory state and lead to neurotoxicity and ultimate cell death. CNS cell death may occur via apoptosis; for example, viral proteins may disrupt the equilibrium of various Bcl-2 (B-cell lymphoma 2) family members, leading to the execution of this death pathway. Inflammation can elicit cell death by necroptosis or pyroptosis, mediated by the activation of the TNF receptor or receptors and proteins recognizing viral PAMPs, or by different inflammasome pathways, respectively [<xref rid="B199-viruses-17-00203" ref-type="bibr">199</xref>]. Necrotic cells or focal necrotic lesions may also be observed, where severe cellular damage was irreparable, and cells died as a result of necrosis [<xref rid="B200-viruses-17-00203" ref-type="bibr">200</xref>].</p><p>Perhaps the most famous infectious agents that cause damage to the CNS are prions, which lack nucleic acids but are self-replicating proteins. These are chronic, usually lethal infections that primarily damage the CNS. Examples in humans are Kuru, Creutzfeldt&#x02013;Jakob syndrome, and, occasionally, infections transmitted from prion-infected animals such as bovine spongiform encephalopathy, also called &#x0201c;mad cow disease&#x0201d;, chronic wasting disease affecting cervids throughout North America, and scrapie affecting sheep and goats [<xref rid="B201-viruses-17-00203" ref-type="bibr">201</xref>]. Finally, there is evidence that, under some circumstances, endogenous retroviruses, which account for up to 8% of the human genome, may become activated and act as, at least, a cofactor in the expression of some neurological syndromes. This issue is briefly discussed in a later section. The descriptions that follow cover the agents that can cause mainly acute damage to the CNS and that were not described in the section on how viruses enter the CNS.</p><sec id="sec4dot1dot1-viruses-17-00203"><title>4.1.1. Flavivirus Infections of the CNS</title><p>Several members of the insect-transmitted Flavivirus family can invade the CNS in humans and also domestic animals, leading to severe and sometimes long-lasting neurological disorders and even to death. However, most infections caused by these viruses in humans are asymptomatic or result in mild clinical signs often confused with influenza, but some become febrile and develop acute neurological signs that can progress to encephalitis, and some infected patients suffer long-term neurological complications and lasting disabilities. The outcome of infection with four of the most common flavivirus agents that affect humans is summarized in <xref rid="viruses-17-00203-t004" ref-type="table">Table 4</xref>.</p><p>Not all members of the <italic toggle="yes">Flaviviridae</italic> family are regular causes of neurological problems, with hepatitis C virus (HCV), YFV, and dengue viruses as notable examples. In addition, some, such as ZIKV, are primarily neural pathogens when they infect the fetus or newborn. Additionally, some flavivirus infections have been associated with subsequent chronic syndromes, such as autoimmune-related disorders and systemic or metabolic disturbances, which may contribute to neurological outcomes.</p><p>In order to cause neural lesions, flaviviruses must pass from the blood and enter the CNS, which requires passage across the BBB. Once within the CNS, the outcome depends on the cell type, location, and extent of the infection and, in some instances, the ability of the virus to manage the extent of the host response to infection. JEV, WNV, and TBEV are considered to cause some of the most severe neuroinfections and can present as acute and fulminant encephalitic syndromes with a high mortality rate (see <xref rid="viruses-17-00203-t003" ref-type="table">Table 3</xref>). Among them, JEV causes severe neurological symptoms, and they are followed by a greater loss of disability-adjusted life years than any other virus transmitted by arthropods [<xref rid="B208-viruses-17-00203" ref-type="bibr">208</xref>]. Flaviviral acute encephalitis is accompanied by high viral titers within the brain, elevated levels of inflammatory cytokines and chemokines, disruption of the BBB, and other vascular damage, resulting in increased intracranial pressure and significant swelling in the CNS [<xref rid="B235-viruses-17-00203" ref-type="bibr">235</xref>]. Additionally, lesions and necrotic areas are observed in various brain regions, with the specific locations depending on the flavivirus involved [<xref rid="B236-viruses-17-00203" ref-type="bibr">236</xref>]. Patients may present behavioral and movement abnormalities, spastic paralysis, and cognitive disorders. Many survivors of the acute illness develop post-encephalitic syndrome and/or suffer from a wide array of long-term or permanent neurological sequelae involving the CNS, PNS, or both [<xref rid="B237-viruses-17-00203" ref-type="bibr">237</xref>,<xref rid="B238-viruses-17-00203" ref-type="bibr">238</xref>]. JEV, in particular, has the potential to recur months after primary acute encephalitis [<xref rid="B239-viruses-17-00203" ref-type="bibr">239</xref>].</p><p>With flavivirus infections, neurons are the primary target cell type infected, and such cells may be killed directly by the virus or damaged indirectly by immune-mediated mechanisms. Non-neuronal cells susceptible to infection by selected flaviviruses are listed in <xref rid="viruses-17-00203-t005" ref-type="table">Table 5</xref>.</p><p>The question of whether WNV infects microglia remains contentious, as these cells fail to support viral replication [<xref rid="B242-viruses-17-00203" ref-type="bibr">242</xref>]. Glial cells, BMECs, and even some inflammatory cells may serve as potential reservoirs for flaviviruses, allowing for prolonged viral persistence within the host [<xref rid="B252-viruses-17-00203" ref-type="bibr">252</xref>,<xref rid="B253-viruses-17-00203" ref-type="bibr">253</xref>,<xref rid="B254-viruses-17-00203" ref-type="bibr">254</xref>,<xref rid="B255-viruses-17-00203" ref-type="bibr">255</xref>] and contributing to the nature of the clinical signs. There is evidence that viral RNA and perhaps complete virions can remain in the CNS for extended periods of time [<xref rid="B202-viruses-17-00203" ref-type="bibr">202</xref>,<xref rid="B256-viruses-17-00203" ref-type="bibr">256</xref>,<xref rid="B257-viruses-17-00203" ref-type="bibr">257</xref>]. In fact, the diseases caused by flaviviruses can present with a wide spectrum of consequences. This likely reflects the distinct cellular and tissue tropism of each virus, variations in their ability to evade or counteract host immunity, and the interplay between pathogenic effects of infection and damage resulting from the host response [<xref rid="B3-viruses-17-00203" ref-type="bibr">3</xref>,<xref rid="B258-viruses-17-00203" ref-type="bibr">258</xref>]. Indeed, we need to fully understand what factors account for the variable outcome of flavivirus infections with a view to provide useful clues to control these troublesome agents that are of increasing relevance in many locations [<xref rid="B259-viruses-17-00203" ref-type="bibr">259</xref>,<xref rid="B260-viruses-17-00203" ref-type="bibr">260</xref>,<xref rid="B261-viruses-17-00203" ref-type="bibr">261</xref>].</p><p>Evidence accumulates showing that some flavivirus infections could be involved either as causes or at least cofactors in the outcome of some chronic neurodegenerative disorders. Some of these disorders are considered primarily as autoimmune lesions (see <xref rid="viruses-17-00203-t004" ref-type="table">Table 4</xref> and <xref rid="viruses-17-00203-t006" ref-type="table">Table 6</xref>).</p><p>For example, approximately 45% of Japanese encephalitis survivors suffer from Parkinsonism [<xref rid="B274-viruses-17-00203" ref-type="bibr">274</xref>], the term encompassing multiple neurodegenerative disorders characterized by motor dysfunction and unstable posture [<xref rid="B275-viruses-17-00203" ref-type="bibr">275</xref>]. In addition, chronic tick-borne encephalitis can present with a number of neurological conditions, which include a disease resembling PD [<xref rid="B276-viruses-17-00203" ref-type="bibr">276</xref>], and survivors of WNV infection can experience depression, memory loss, as well as motor dysfunction [<xref rid="B277-viruses-17-00203" ref-type="bibr">277</xref>]. Systemic DENV infection that affects the neuroaxis is also indicated as a potential risk factor for developing NDs [<xref rid="B278-viruses-17-00203" ref-type="bibr">278</xref>]. Notably, within the <italic toggle="yes">Flaviviridae</italic> family, DENV accounts for the highest number of annual infections, estimated at 100&#x02013;400 million cases worldwide, with up to 20% of these cases considered to involve the CNS [<xref rid="B279-viruses-17-00203" ref-type="bibr">279</xref>,<xref rid="B280-viruses-17-00203" ref-type="bibr">280</xref>]. Abundant studies using animal models of flavivirus infections also have revealed similarities between persistent viral lesions and changes observed in AD, PD, Huntington&#x02019;s disease (HD), or multiple sclerosis (MS) [<xref rid="B277-viruses-17-00203" ref-type="bibr">277</xref>,<xref rid="B281-viruses-17-00203" ref-type="bibr">281</xref>]. Even if the solid evidence that flaviviruses are the causes of chronic neurodegenerative diseases in humans is not available, their acting as cofactors in some cases would seem a likely event. Moreover, in situations where a flavivirus is implicated as a cause of either acute or chronic neurodegenerative syndrome, there is the possibility of control by using vaccines. Successful vaccines are available for several flaviviruses, especially to control animal diseases.</p></sec><sec id="sec4dot1dot2-viruses-17-00203"><title>4.1.2. HIV Infection of the CNS</title><p>HIV primarily targets helper T-lymphocytes and macrophages that express the CD4 molecule, the main cellular receptor for this virus [<xref rid="B282-viruses-17-00203" ref-type="bibr">282</xref>]. As early as 1&#x02013;2 weeks after the primary infection, the virus can gain access to the CNS and is transported there mainly by being present within transmigrating cells, such as monocytes, macrophages, and T-lymphocytes, the often-called Trojan horse infection mechanism, or on the surface of DCs [<xref rid="B283-viruses-17-00203" ref-type="bibr">283</xref>,<xref rid="B284-viruses-17-00203" ref-type="bibr">284</xref>,<xref rid="B285-viruses-17-00203" ref-type="bibr">285</xref>]. The early neuroinvasion by HIV triggers inflammation in the brain, but neurological symptoms are scarce, and only 1&#x02013;4% of patients develop acute neurological disease. The HIV-infected cells accumulate within the brain parenchyma, where the virus replicates and is released, leading to infection of other CNS cells. The virus may persist in the brain throughout the individual&#x02019;s lifetime [<xref rid="B286-viruses-17-00203" ref-type="bibr">286</xref>] and, in the early phase, this occurs mainly in T cell populations. However, over time, the virus targets perivascular macrophages and microglia, which become the primary sites for HIV replication [<xref rid="B287-viruses-17-00203" ref-type="bibr">287</xref>,<xref rid="B288-viruses-17-00203" ref-type="bibr">288</xref>,<xref rid="B289-viruses-17-00203" ref-type="bibr">289</xref>]. The virus also infects astrocytes, of which up to 20% can harbor a DNA copy of the HIV RNA genome, as they often bear latent and nonproductive viruses [<xref rid="B290-viruses-17-00203" ref-type="bibr">290</xref>,<xref rid="B291-viruses-17-00203" ref-type="bibr">291</xref>]. Interestingly, HIV-infected macrophages, microglia, and astrocytes are unlikely to undergo apoptosis and can maintain viral infection despite antiretroviral therapy (ART) [<xref rid="B195-viruses-17-00203" ref-type="bibr">195</xref>,<xref rid="B292-viruses-17-00203" ref-type="bibr">292</xref>,<xref rid="B293-viruses-17-00203" ref-type="bibr">293</xref>]. This likely contributes to virus persistence in the CNS [<xref rid="B294-viruses-17-00203" ref-type="bibr">294</xref>]. The presence of a viral reservoir in the CNS is recognized as a major challenge to eradicating HIV using ART [<xref rid="B295-viruses-17-00203" ref-type="bibr">295</xref>].</p><p>Although HIV does not directly infect neurons, infected individuals experience neuronal injuries, such as synaptodendritic damage, the dysregulation of myelination, and axonal damage. The ensuing neuronal loss may result in cognitive difficulties [<xref rid="B294-viruses-17-00203" ref-type="bibr">294</xref>,<xref rid="B296-viruses-17-00203" ref-type="bibr">296</xref>]. However, the actual causes of neuronal damage and loss are multifaceted and can be attributed in part to the production of neurotoxic viral proteins derived from productively infected non-neuronal cells but, in some cases, even from latently infected cells following low-level transcription [<xref rid="B297-viruses-17-00203" ref-type="bibr">297</xref>]. The other cause of neuronal damage is a bystander consequence of an immune reaction triggered in response to viral replication or viral persistence in brain cells [<xref rid="B298-viruses-17-00203" ref-type="bibr">298</xref>,<xref rid="B299-viruses-17-00203" ref-type="bibr">299</xref>].</p><p>Over the course of infection in non-neuronal brain cells, various HIV-encoded proteins may be released that can have a range of effects on nearby cells that include the direct toxic damage of neurons (see <xref rid="viruses-17-00203-t007" ref-type="table">Table 7</xref>).</p><p>Several HIV proteins mediate such paracrine effects, with Tat, gp120, and Nef the most prominent. Additionally, these proteins can induce the expression of various pro-inflammatory cytokines in neurons or activate other types of CNS resident cells [<xref rid="B122-viruses-17-00203" ref-type="bibr">122</xref>,<xref rid="B304-viruses-17-00203" ref-type="bibr">304</xref>,<xref rid="B307-viruses-17-00203" ref-type="bibr">307</xref>]. HIV proteins exhibit both proapoptotic and antiapoptotic properties [<xref rid="B321-viruses-17-00203" ref-type="bibr">321</xref>,<xref rid="B322-viruses-17-00203" ref-type="bibr">322</xref>] and alter intracellular ionic homeostasis, entailing dysregulation, injury, and death of neurons or non-neuronal cells [<xref rid="B326-viruses-17-00203" ref-type="bibr">326</xref>,<xref rid="B327-viruses-17-00203" ref-type="bibr">327</xref>,<xref rid="B328-viruses-17-00203" ref-type="bibr">328</xref>]. These effects may result in excitotoxic damage to neurons, potentially contributing to neurodegenerative processes [<xref rid="B346-viruses-17-00203" ref-type="bibr">346</xref>]. Additional changes include inflammatory cytokine induction, changes in cell-to-cell communication [<xref rid="B334-viruses-17-00203" ref-type="bibr">334</xref>], migration patterns, and the propagation of toxic signals to neighboring cells [<xref rid="B359-viruses-17-00203" ref-type="bibr">359</xref>]. This functional diversity underscores the critical role of HIV proteins in the development of HIV-associated neurocognitive disorders.</p><p>During CNS invasion, HIV-infected monocytes present in the CNS, along with macrophages, microglia, and astrocytes, release inflammatory mediators such as the TNF, IL-1&#x003b2;, IL-6, IFN-&#x003b3;, IL-8, CCL2, CCL5, CXCL10, as well as the platelet-activating factor (PAF), nitric oxide, matrix metalloproteases (MMPs), and arachidonic acid [<xref rid="B294-viruses-17-00203" ref-type="bibr">294</xref>,<xref rid="B360-viruses-17-00203" ref-type="bibr">360</xref>]. These factors disrupt neuronal homeostasis and metabolism, causing neuronal injury and BBB damage, allowing a greater leakage of serum proteins and other substances into the brain. Additionally, the release of pro-inflammatory factors in the brain of patients with neural signs was shown to dysregulate levels of neurogranin, a protein essential for maintaining synaptic integrity and function [<xref rid="B361-viruses-17-00203" ref-type="bibr">361</xref>]. Furthermore, the pro-inflammatory cytokines activate uninfected cells and facilitate the recruitment of infected cells from the bloodstream to the CNS [<xref rid="B362-viruses-17-00203" ref-type="bibr">362</xref>]. This exacerbates the cascade of neuroinflammation triggered originally by a small number of transmigrated cells [<xref rid="B294-viruses-17-00203" ref-type="bibr">294</xref>]. These consequences of HIV brain infection are highly variable both in terms of the damaging events that occur, their location within the CNS, and the time after infection that lesions become clinically significant.</p><p>In high-income countries, most patients diagnosed as HIV-infected are treated with antiviral drugs, and these can be extraordinarily effective at controlling acute disease manifestations, but none succeed in removing the virus from the body, especially when the virus is present in the brain. Many patients infected with HIV eventually develop neurological problems, and these are less prevalent in patients treated with ART [<xref rid="B363-viruses-17-00203" ref-type="bibr">363</xref>].</p><p>The most common neurological outcome is termed HIV-associated neurocognitive disorders (HANDs), and this has dropped from affecting about 20% prior to ART to around 2&#x02013;5% today [<xref rid="B364-viruses-17-00203" ref-type="bibr">364</xref>]. While treatment reduces neuronal breakdown, patients on therapy continue to experience ongoing direct virus-related damage or aging-like repercussions attributable to HIV infection [<xref rid="B365-viruses-17-00203" ref-type="bibr">365</xref>]. Notably, even in the ART era, the virus persists within the brain, and this could contribute, along with other comorbidities such as age, diabetes, hypertension, and hypercholesterolemia, to the onset of cognitive impairments that often occur in HIV patients [<xref rid="B366-viruses-17-00203" ref-type="bibr">366</xref>]. As individuals with HIV age, they face increasing risk of the accelerated onset of other neurodegenerative disorders, particularly AD [<xref rid="B367-viruses-17-00203" ref-type="bibr">367</xref>,<xref rid="B368-viruses-17-00203" ref-type="bibr">368</xref>,<xref rid="B369-viruses-17-00203" ref-type="bibr">369</xref>,<xref rid="B370-viruses-17-00203" ref-type="bibr">370</xref>], AD precursor, amnestic mild cognitive impairment (aMCI) [<xref rid="B371-viruses-17-00203" ref-type="bibr">371</xref>], Parkinsonism [<xref rid="B372-viruses-17-00203" ref-type="bibr">372</xref>,<xref rid="B373-viruses-17-00203" ref-type="bibr">373</xref>,<xref rid="B374-viruses-17-00203" ref-type="bibr">374</xref>,<xref rid="B375-viruses-17-00203" ref-type="bibr">375</xref>,<xref rid="B376-viruses-17-00203" ref-type="bibr">376</xref>], vascular dementia [<xref rid="B297-viruses-17-00203" ref-type="bibr">297</xref>,<xref rid="B377-viruses-17-00203" ref-type="bibr">377</xref>], rarely ALS-like symptoms [<xref rid="B378-viruses-17-00203" ref-type="bibr">378</xref>,<xref rid="B379-viruses-17-00203" ref-type="bibr">379</xref>], and others. The topic of HIV is complex and fascinating but has received some excellent reviews worth consulting for details [<xref rid="B380-viruses-17-00203" ref-type="bibr">380</xref>,<xref rid="B381-viruses-17-00203" ref-type="bibr">381</xref>,<xref rid="B382-viruses-17-00203" ref-type="bibr">382</xref>,<xref rid="B383-viruses-17-00203" ref-type="bibr">383</xref>,<xref rid="B384-viruses-17-00203" ref-type="bibr">384</xref>].</p></sec><sec id="sec4dot1dot3-viruses-17-00203"><title>4.1.3. SARS-CoV-2 Infection of the CNS</title><p>The SARS-CoV-2 pandemic has profoundly affected human health and the public&#x02019;s opinions about the value of vaccines. The virus can infect many locations, with the occurrence of encephalitis as a complication in severely ill COVID-19 patients, around 7% [<xref rid="B385-viruses-17-00203" ref-type="bibr">385</xref>,<xref rid="B386-viruses-17-00203" ref-type="bibr">386</xref>]. Many survivors, including those with mild symptoms, continue to suffer from a debilitating post-viral condition known as LC/PASC (long COVID/post-acute sequelae of SARS-CoV-2) [<xref rid="B387-viruses-17-00203" ref-type="bibr">387</xref>]. PASC may share features with myalgic encephalomyelitis and chronic fatigue syndrome. It includes cognitive deficits, the loss of smell, muscle pain, and autonomic dysregulation, as reviewed by Pandya [<xref rid="B388-viruses-17-00203" ref-type="bibr">388</xref>]. The potential factors contributing to PASC are viral persistence, activation of the immune responses and autoimmune processes [<xref rid="B389-viruses-17-00203" ref-type="bibr">389</xref>]. These consequences are potentially involved in long-term neurological disorders that appear after SARS-CoV-2 infection. Although SARS-CoV-2 is associated with acute encephalitis and neurological signs in some patients with LC, whether such signs result from a replicating virus present in the brain is uncertain. However, SARS-CoV-2 antigens and RNA were reported post-mortem in the brain parenchyma of some victims [<xref rid="B390-viruses-17-00203" ref-type="bibr">390</xref>,<xref rid="B391-viruses-17-00203" ref-type="bibr">391</xref>], but the findings have not been widely supported. Suggestive features such as neuroinflammation, gliosis, vascular, and BBB damage were observed in the brains of some COVID-19 patients [<xref rid="B392-viruses-17-00203" ref-type="bibr">392</xref>,<xref rid="B393-viruses-17-00203" ref-type="bibr">393</xref>], and others reported extensive neuronal degeneration and morphological changes in glial cells, particularly in the hippocampus of affected individuals [<xref rid="B394-viruses-17-00203" ref-type="bibr">394</xref>].</p><p>It is conceivable that the neurodegenerative consequences of SARS-CoV-2 could be an indirect result of infection, such as the induction of a cytokine storm that occurs in some patients [<xref rid="B395-viruses-17-00203" ref-type="bibr">395</xref>]. In fact, the occurrence of cytokines and chemokines in the CSF, as well as in the circulation, has been documented [<xref rid="B396-viruses-17-00203" ref-type="bibr">396</xref>]. Currently, we must conclude that evidence linking SARS-CoV-2 infection directly or indirectly to neurodegeneration remains equivocal and whether SARS-CoV-2 infection alone is sufficient to initiate neurodegeneration remains to be firmly established, as should happen with further research.</p></sec></sec><sec id="sec4dot2-viruses-17-00203"><title>4.2. Chronic Neurodegenerative Diseases and Viral Infections</title><p>The burden of disability and deaths due to neurological disorders is increasingly recognized as a global health challenge [<xref rid="B397-viruses-17-00203" ref-type="bibr">397</xref>]. Neurological disorders are the main cause of human physical and cognitive disability worldwide and the second leading cause of death according to a study analyzing data from 195 countries over 30 years [<xref rid="B398-viruses-17-00203" ref-type="bibr">398</xref>]. The burden of NDs, a neurological disorder subset, is expected to at least double in the coming twenty years, giving rise to a significant challenge to keep neurological care accessible to everyone [<xref rid="B399-viruses-17-00203" ref-type="bibr">399</xref>]. NDs are diverse in pathophysiology, and multiple risk factors underlie their development, such as genetic makeup, environment, infections, as well as age, which appears to be the most consistent determinant [<xref rid="B400-viruses-17-00203" ref-type="bibr">400</xref>].</p><p>Senescence entails a multitude of changes across the spectrum of body systems [<xref rid="B401-viruses-17-00203" ref-type="bibr">401</xref>], and the brain deteriorates with age in parallel with other organs. Aging causes a decline in cognitive functioning, which is related to brain atrophy and significant changes to the brain&#x02019;s vascular structure and function [<xref rid="B402-viruses-17-00203" ref-type="bibr">402</xref>,<xref rid="B403-viruses-17-00203" ref-type="bibr">403</xref>] at varying extents in different brain regions. Further, with increasing age, innate and adaptive immune systems undergo senescence, and increasing inflammatory functions entail chronic low-grade inflammation that could contribute to ND [<xref rid="B404-viruses-17-00203" ref-type="bibr">404</xref>]. NDs have increased rapidly in incidence in recent years along with the expansion and aging of the human population [<xref rid="B405-viruses-17-00203" ref-type="bibr">405</xref>] and are a common cause of cognitive impairment and morbidity in older people [<xref rid="B406-viruses-17-00203" ref-type="bibr">406</xref>].</p><p>There are numerous chronic neurodegenerative syndromes, many given a name where one of the likely causes could be a virus infection. In this section, we describe many of these focusing on the role that a virus infection might be playing in their cause and expression.</p><sec id="sec4dot2dot1-viruses-17-00203"><title>4.2.1. Parkinson&#x02019;s Disease (PD)</title><p>PD is primarily a disease of older people. It affects approximately 1&#x02013;2% of individuals over 65 and increases to 4&#x02013;5% in those reaching 85 [<xref rid="B407-viruses-17-00203" ref-type="bibr">407</xref>]. While genetic susceptibility factors explain 10&#x02013;20% of PD cases, the vast majority have no clear underlying cause identified. The disease is marked by the presence of abnormal intracellular aggregates known as Lewy bodies, Lewy neurites, and cytoplasmic inclusions in glial cells that are primarily composed of &#x003b1;-synuclein proteins [<xref rid="B408-viruses-17-00203" ref-type="bibr">408</xref>]. Key pathological features of PD include progressive degeneration and the loss of dopaminergic neurons, particularly in the <italic toggle="yes">substantia nigra pars compacta</italic> of the midbrain, basal ganglia, and other brain regions, along with a corresponding reduction in dopamine in the striatum [<xref rid="B409-viruses-17-00203" ref-type="bibr">409</xref>]. The PD clinical signs encompass motor features such as resting tremors, postural instability, bradykinesia and muscle rigidity, along with non-motor symptoms such as cognitive decline and dementia [<xref rid="B410-viruses-17-00203" ref-type="bibr">410</xref>]. Disease manifestations arise when approximately 60% of neurons within the nigrostriatal pathway die [<xref rid="B411-viruses-17-00203" ref-type="bibr">411</xref>]. Without the Lewy bodies and other PD pathological hallmarks that characterize primary PD, secondary Parkinsonism may appear, which is similar in clinical presentation [<xref rid="B412-viruses-17-00203" ref-type="bibr">412</xref>]. An unresolved question is do virus infections either help set off or contribute to the pathogenesis of PD? Several clues suggest this could occur.</p><p>For example, following the 1918 H1N1 influenza A pandemic, cases of post-encephalitic Parkinsonism became a more common occurrence [<xref rid="B413-viruses-17-00203" ref-type="bibr">413</xref>], but later H1N1 flu pandemics did not find a similar association, and the virus was not detected in brain of the victims. Moreover, the infection of mice with neurogenic strains of influenza mimics PD [<xref rid="B414-viruses-17-00203" ref-type="bibr">414</xref>]. By meta-analysis, infections with HSV, MuV, HBV, and HCV have been associated with an increased risk of PD [<xref rid="B415-viruses-17-00203" ref-type="bibr">415</xref>,<xref rid="B416-viruses-17-00203" ref-type="bibr">416</xref>], and successful HCV drug therapy was associated with a reduced risk of subsequent PD [<xref rid="B415-viruses-17-00203" ref-type="bibr">415</xref>,<xref rid="B417-viruses-17-00203" ref-type="bibr">417</xref>]. Infections with Saint Louis encephalitis virus, JEV, WNV, Coxsackie virus and HIV can all produce some core motor symptoms characteristic of PD and were associated with postencephalitic Parkinsonism [<xref rid="B418-viruses-17-00203" ref-type="bibr">418</xref>]. Other viruses associated with Parkinsonism include Echovirus, PV, MeV, HSV, EBV, CMV, VZV, Borna disease virus, and WEEV [<xref rid="B193-viruses-17-00203" ref-type="bibr">193</xref>,<xref rid="B418-viruses-17-00203" ref-type="bibr">418</xref>]. However, in the case of PD, there are some data consistent with the notion that exposure to some viruses protects a person against subsequently developing PD [<xref rid="B419-viruses-17-00203" ref-type="bibr">419</xref>].</p><p>We conclude that the case for any virus causing or contributing to the expression of PD is very weak, but it does not exclude several virus infections acting as cofactors in PD pathogenesis. We can also surmise that exposure to an infected colleague is highly unlikely to cause PD in the exposed person.</p></sec><sec id="sec4dot2dot2-viruses-17-00203"><title>4.2.2. Alzheimer&#x02019;s Disease (AD) and Other Major Neurocognitive Disorders (MNDs)</title><p>Dementia, now referred to as major neurocognitive disorder (MND), is characterized by a progressive and persistent decline in memory and cognitive functions. It is recognized as the fifth leading global cause of death [<xref rid="B420-viruses-17-00203" ref-type="bibr">420</xref>]. The most prevalent forms of MNDs include AD, which affects approximately 25 million individuals worldwide and accounts for 60&#x02013;80% of all cases and vascular dementia (VaD) constituting around 15% of cases [<xref rid="B421-viruses-17-00203" ref-type="bibr">421</xref>,<xref rid="B422-viruses-17-00203" ref-type="bibr">422</xref>,<xref rid="B423-viruses-17-00203" ref-type="bibr">423</xref>]. Familial cases of AD account for only 1&#x02013;5% of the total [<xref rid="B422-viruses-17-00203" ref-type="bibr">422</xref>]. In the case of VaD, a long list of risk factors has been documented [<xref rid="B424-viruses-17-00203" ref-type="bibr">424</xref>], but the underlying causes of MNDs continue to impede the effective prevention of these diseases.</p><p>The majority of MNDs, including AD, are proteopathies defined by the accumulation of native proteins within the brain, which are considered key mediators of the disease pathology [<xref rid="B425-viruses-17-00203" ref-type="bibr">425</xref>]. Surprisingly, the deposition of amyloid-beta (A&#x003b2;), an AD hallmark observed in the brain of patients, may be the brain&#x02019;s physiological solution to its need to suppress the effects of an invader [<xref rid="B426-viruses-17-00203" ref-type="bibr">426</xref>]. VaD is characterized by impaired cerebral blood flow leading to small and microscopic infarcts that collectively contribute to vascular brain damage, a key pathological feature of this syndrome [<xref rid="B427-viruses-17-00203" ref-type="bibr">427</xref>]. Notably, this type of pathology also can be observed in other types of dementia. The amyloid and vascular theories are central frameworks that attempt to explain AD and VaD origins [<xref rid="B428-viruses-17-00203" ref-type="bibr">428</xref>]. However, aggravating the complexity of causation and diagnosis is the frequent occurrence and coexistence of AD and VaD, making the pathological expression variable and changeable [<xref rid="B428-viruses-17-00203" ref-type="bibr">428</xref>].</p><p>A feature playing a prominent role in the pathogenesis and progression of almost all MNDs is a persistent inflammatory response in the CNS that represents a reaction of glial cells to injurious signals that need to be repaired [<xref rid="B429-viruses-17-00203" ref-type="bibr">429</xref>]. The root cause of chronic neural inflammatory reactions may be a persistent stimulus that eventually results in neurodegeneration [<xref rid="B429-viruses-17-00203" ref-type="bibr">429</xref>,<xref rid="B430-viruses-17-00203" ref-type="bibr">430</xref>], and such stimuli could include pathogens, notably viruses. In particular, when exposed to infection, microglia become more responsive to stimuli, a phenomenon known as microglial priming. The cells can serve as a major source of inflammatory cytokines, thereby exacerbating brain inflammation [<xref rid="B431-viruses-17-00203" ref-type="bibr">431</xref>].</p><p>In fact, several named viruses have been implicated as having a potential role in the etiology of MNDs. These include members of the <italic toggle="yes">Picornaviridae</italic> family [<xref rid="B432-viruses-17-00203" ref-type="bibr">432</xref>,<xref rid="B433-viruses-17-00203" ref-type="bibr">433</xref>], ZIKV, HIV, MeV, IAV, HCV [<xref rid="B434-viruses-17-00203" ref-type="bibr">434</xref>], as well as at least six members of the <italic toggle="yes">Herpesviridae</italic> family, some of which can be detected in AD patients&#x02019; brain [<xref rid="B435-viruses-17-00203" ref-type="bibr">435</xref>]. Scrutinous observations have focused on a role for HSV-1 cerebral infection but so far without convincing evidence. The issue is made complicated by the high positive seroprevalence of HSV-1 in the general population, as well as some studies that showed that 65&#x02013;75% of otherwise healthy, deceased individuals carried HSV-1 in their brain [<xref rid="B34-viruses-17-00203" ref-type="bibr">34</xref>]. Similar findings are claimed for HHV-6, with its presence detected in the brain of up to 87.5% of people with no clinical signs of active infection or neurological disease [<xref rid="B145-viruses-17-00203" ref-type="bibr">145</xref>]. Curiously, one study showed that around 1% of the population had the HHV-6 genome present in all nucleated cells of the body, attributed to infection and integration into progenitor germinal cells [<xref rid="B157-viruses-17-00203" ref-type="bibr">157</xref>].</p><p>We must conclude that an abundance of circumstantial but rarely confirmed information implicates herpesviruses as involved in any neurodegenerative syndrome. However, the issue is far from settled. Conceivably, MDNs could be caused by the cumulative impact of multiple infections or exposure to a high virus dose to set off such lesions. The results of ongoing studies examining large cohorts with long follow-up periods and multiple infections might solve the dilemma. For instance, an analysis of exposure to 925 infectious diseases before dementia onset in hundreds of thousands of people concluded that dementia risk was associated with the number of episodes of hospital-treated infections [<xref rid="B436-viruses-17-00203" ref-type="bibr">436</xref>]. The greatest risk was seen for CNS infections, but complicating the issue was the observation that extra-CNS infections also made dementia more likely. Another study examining hundreds of thousands of people and 45 viral exposures showed a strong association between viral encephalitis, or viral infections of other organs, with dementia [<xref rid="B437-viruses-17-00203" ref-type="bibr">437</xref>]. Interestingly, the greatest likelihood of diagnosing the dementia existed in the first year after encephalitis, but a significantly elevated risk of ND was observed even 15 years after viral exposure.</p><p>Other data supporting the possible causality of viruses in dementia include post-vaccination reduceddementia risk. For instance, the nationwide shingles vaccination program against VZV in Wales has been associated with the decreased incidence of dementia in the immunized, particularly VaD and AD [<xref rid="B438-viruses-17-00203" ref-type="bibr">438</xref>]. Interestingly, the reduction was linked to improved vascular health rather than a decreased incidence of shingles. Additionally, vaccinations against polio and influenza were associated with a 25&#x02013;60% reduction in the later development of AD [<xref rid="B439-viruses-17-00203" ref-type="bibr">439</xref>]. These findings indicate that vaccines targeting shingles, along with other vaccines for older adults, could play a role in mitigating dementia risk. However, these intriguing observations require independent verification before we rewrite the rulebook.</p><p>Assuredly, some viral infections, and particularly those related to the CNS, are linked to a sustained elevation in dementia risk. Notably, this relationship is also valid for infections outside the CNS, which implies their role in influencing brain health. Moreover, the interplay of viral infections with other factors, such as genetics, could be driving the elevated dementia incidence. Conceivably, the increased dementia risk also could be driven more by a generalized inflammatory state than by any specific or multiple infections.</p></sec><sec id="sec4dot2dot3-viruses-17-00203"><title>4.2.3. Multiple Sclerosis (MS) and Other Demyelinating Diseases</title><p>Among human demyelinating diseases with direct viral involvement, two prominent examples are progressive multifocal leukoencephalopathy (PML) and subacute sclerosing panencephalitis (SSPE). PML is caused by reactivation of the John Cunningham virus from a latent state, particularly in the individuals with immune deficiencies. The productive polyomavirus lytically infects oligodendrocytes, resulting in the formation of demyelinated lesions [<xref rid="B440-viruses-17-00203" ref-type="bibr">440</xref>]. Patients experience neurological symptoms, such as cognitive impairment, motor weakness, and paralysis, and the disease generally follows a relentless progression, leading to death within several months [<xref rid="B441-viruses-17-00203" ref-type="bibr">441</xref>].</p><p>Another virus-caused demyelinating disorder is SSPE, a devastating disease primarily affecting children, generally appearing 7&#x02013;10 years post-measles infection. SSPE is characterized by progressive cognitive decline, behavioral changes, motor dysfunction, and seizures, ultimately leading to a fatal outcome [<xref rid="B442-viruses-17-00203" ref-type="bibr">442</xref>,<xref rid="B443-viruses-17-00203" ref-type="bibr">443</xref>].</p><p>A third disease where viruses are implicated, so far without solid evidence, is MS. This syndrome is a leading cause of long-term disability in young adults [<xref rid="B444-viruses-17-00203" ref-type="bibr">444</xref>]. Usually starting at the age 20 to 40 and occurring more frequently in women, the condition is characterized by the degeneration of myelin sheaths around axons in optic nerves, as well as nerve cells in the brain and spinal cord. This leads to diffuse neurodegeneration, as the protective and trophic functions of oligodendrocytes towards neurons cease being produced. The consequence is the production of focal demyelinating plaques associated with varying levels of inflammatory cells within the brain, which in turn lead to progressive, physical and cognitive impairment [<xref rid="B445-viruses-17-00203" ref-type="bibr">445</xref>]. The diversity of demyelination patterns observed in MS suggests variability in the mechanisms that contribute to lesion formation [<xref rid="B446-viruses-17-00203" ref-type="bibr">446</xref>].</p><p>It is hypothesized that the pathogenesis of MS involves an autoimmune process primarily driven by myelin-reactive T cells, but this still remains an unproven concept. Antibodies targeting myelin components also have been observed in MS patients, but their role in causing lesions has not been substantiated. In addition, there is uncertainty as to the role of virus infections as causes or triggers in the development of MS [<xref rid="B447-viruses-17-00203" ref-type="bibr">447</xref>]. Many different, named viruses have been suggested to cause MS, particularly by the late flamboyant and clever investigator Hilary Koprowski [<xref rid="B448-viruses-17-00203" ref-type="bibr">448</xref>,<xref rid="B449-viruses-17-00203" ref-type="bibr">449</xref>], but the strongest case that viruses might cause MS comes from studies in animal models of MS such as EAE. However, the EAE models only partially resemble MS. The most valuable study of such models uses Theiler&#x02019;s virus in susceptible mouse strains, and these studies have been invaluable to identify how a virus infection could cause demyelinating lesions and set off an autoimmune reaction but also to learn how some viruses might even contribute to controlling such lesions [<xref rid="B450-viruses-17-00203" ref-type="bibr">450</xref>]. MS is strongly suspected to represent an autoimmune lesion with myelin components as the antigen source, but the changing disease presentation typical of MS is difficult to comprehend and is not replicated by most EAE models used to study MS. Recently, based on longitudinal studies, a strong case was made that infection with the gamma herpesvirus EBV was correlated with the subsequent development of MS [<xref rid="B451-viruses-17-00203" ref-type="bibr">451</xref>]. The study involved over 10 million active military personnel and identified 955 individuals who later or after their service developed MS.</p><p>In this comprehensive study, EBV infection was found to increase the risk of MS in the analyzed individuals by 32-fold, and EBV seroconversion occurred in MS patients who were seronegative at the beginning of the study. The effect also happened before elevation of the early marker of preclinical MS in their blood, the serum neurofilament light chain (sNfL). Moreover, the risk of developing MS turned out to be extremely low in those individuals who had not been infected with EBV. These studies were persuasive, but not entirely convincing, and obviously have not been duplicated by an independent study. In addition, and of interest, those who contracted EBV-caused infectious mononucleosis also had an increased risk of developing MS [<xref rid="B452-viruses-17-00203" ref-type="bibr">452</xref>], and the presence of antibodies against Epstein&#x02013;Barr nuclear antigens acted as a strong predictor of MS risk up to 20 years after their appearance [<xref rid="B453-viruses-17-00203" ref-type="bibr">453</xref>]. Nevertheless, up to 90% of individuals worldwide are infected with EBV, but only a small minority develop MS, indicating that many other factors are involved in development of the disease. The studies implicating EBV as a cause of MS make a strong case, but the jury is still deliberating. Moreover, were EBV to be a significant causative factor, no way currently exists to prevent the infection or to modulate its infection process.</p></sec><sec id="sec4dot2dot4-viruses-17-00203"><title>4.2.4. Amyotrophic Lateral Sclerosis (ALS)</title><p>One tragic, invariably lethal, rare, neurodegenerative disorder of the nervous system that possibly involves viruses is ALS. During ALS progression, the degeneration and rapid loss of motor neurons occur in the motor cortex, brainstem, and anterior horns of the spinal cord [<xref rid="B454-viruses-17-00203" ref-type="bibr">454</xref>]. This motor neuron loss results in muscle atrophy with progressive muscle weakness that leads to paralysis, respiratory failure, and, ultimately, death, which typically occurs within 3 to 5 years following onset [<xref rid="B455-viruses-17-00203" ref-type="bibr">455</xref>].</p><p>Interestingly, up to 50% of ALS patients experience varying levels of cognitive impairment, indicating the additional potential involvement of systems beyond the motor pathways in the disease pathogenesis. ALS can present in either familial or sporadic forms, the latter accounting for about 90&#x02013;95% of cases [<xref rid="B456-viruses-17-00203" ref-type="bibr">456</xref>,<xref rid="B457-viruses-17-00203" ref-type="bibr">457</xref>]. The evidence that some virus acts as a cofactor in the cause or expression of ALS remains a debated possibility. The favored candidates for involvement are enteroviruses [<xref rid="B4-viruses-17-00203" ref-type="bibr">4</xref>]. These agents are advocated to cause RNA-processing abnormalities, disrupted nucleocytoplasmic transport and consequent protein aggregation, neuroinflammation, deficits in protein quality control mechanisms, as well as the TAR DNA-binding protein 43 (TDP-43) expression observed in motor neurons and glial cells of around 97% ALS patients [<xref rid="B458-viruses-17-00203" ref-type="bibr">458</xref>]. The involvement of PV, coxsackievirus, echovirus, enterovirus-A71 (EV-A71), as well as enterovirus-D68, in the development of ALS, also has been hypothesized [<xref rid="B457-viruses-17-00203" ref-type="bibr">457</xref>]. However, the causative role of a known virus remains debatable, which is fortunate since it means that ALS patients are not an infectious danger to others. Investigating the possible role of viruses in ALS is also made problematic by the lack of good animal models to study the issue.</p></sec><sec id="sec4dot2dot5-viruses-17-00203"><title>4.2.5. Human Endogenous Retroviruses and Their Association with Neurodegenerative Syndromes</title><p>Human endogenous retroviruses (HERVs) constitute around 8% of the human genome and are dormant remnants of exogenous retroviruses that incorporated into germline DNA in the distant past and are now vertically transmitted [<xref rid="B459-viruses-17-00203" ref-type="bibr">459</xref>]. In addition to their high copy numbers contributing to genomic variation [<xref rid="B460-viruses-17-00203" ref-type="bibr">460</xref>,<xref rid="B461-viruses-17-00203" ref-type="bibr">461</xref>], the set of HERVs integrated at identified genomic sites can differ among individuals [<xref rid="B461-viruses-17-00203" ref-type="bibr">461</xref>,<xref rid="B462-viruses-17-00203" ref-type="bibr">462</xref>]. Most open reading frames of HERVs are mutated, rendering them incapable of producing functional proteins or virions, or they are silenced through epigenetic mechanisms [<xref rid="B463-viruses-17-00203" ref-type="bibr">463</xref>,<xref rid="B464-viruses-17-00203" ref-type="bibr">464</xref>]. Nevertheless, endogenous retroviruses can still influence nearby genes by serving as alternative promoters, or by modifying chromatin structure [<xref rid="B465-viruses-17-00203" ref-type="bibr">465</xref>]. Additionally, aging may promote the loss of heterochromatin, and this could result in the transcriptional activation of these normally silenced elements [<xref rid="B466-viruses-17-00203" ref-type="bibr">466</xref>]. Moreover, infections with several human viruses, which include HIV-1, HTLV-1, HBV, IAV, and some herpes viruses, can act as triggers of HERV expression [<xref rid="B464-viruses-17-00203" ref-type="bibr">464</xref>]. Under favorable physiological or pathological conditions, some endogenous retroviruses may contribute to the onset of neurodegenerative disorders and other syndromes (see <xref rid="viruses-17-00203-t008" ref-type="table">Table 8</xref>).</p><p>However, the mechanistic circumstance that precipitates such events is poorly understood. Nevertheless, evidence continues to accumulate that links endogenous retroviruses to MS, ALS, and other chronic neurodegenerative syndromes [<xref rid="B471-viruses-17-00203" ref-type="bibr">471</xref>]. Moreover, endogenous retroviruses are known to influence several aspects of innate immune responsiveness that, in turn, could affect the pathogenesis of neurodegenerative disorders. Furthermore, the increased expression of HERV genes or levels of antibodies against particular HERV peptide fragments could serve as possible biomarkers in patients with MS or ALS [<xref rid="B469-viruses-17-00203" ref-type="bibr">469</xref>,<xref rid="B473-viruses-17-00203" ref-type="bibr">473</xref>]. In fact, clinical trials have already been initiated in treating diseases where HERVs are implicated [<xref rid="B5-viruses-17-00203" ref-type="bibr">5</xref>]. Moreover, in this age where removing or modifying HERVs is becoming feasible, the prospect of the management of chronic neural lesions could become realistic. The topic of how different endogenous retroviruses could play a role in the causation and outcome of various neurological and other chronic diseases, as well as in aging, has been covered in detail in other reviews [<xref rid="B5-viruses-17-00203" ref-type="bibr">5</xref>,<xref rid="B464-viruses-17-00203" ref-type="bibr">464</xref>,<xref rid="B474-viruses-17-00203" ref-type="bibr">474</xref>,<xref rid="B475-viruses-17-00203" ref-type="bibr">475</xref>].</p></sec></sec></sec><sec sec-type="conclusions" id="sec5-viruses-17-00203"><title>5. Conclusions</title><p>The brain is the body&#x02019;s sanctuary. This delicate and essential organ is highly protected against infectious violators since, when this happens, usually a high price must be paid. However, viral invasions do happen, and we describe the circumstances wherein this occurs. We then portray the acute consequences of invasions by several known viruses, after which we discuss the many instances of usually chronic neurodegenerative syndromes where viral involvement is advocated but most often not substantiated. However, with these chronic diseases, which include some common named syndromes such as AD, PD and MS, rarely, if ever, is a single named virus the sole cause of damage to the brain&#x02019;s function. Instead, viruses are but one of many cofactors that can contribute to the syndromes.</p><p>Few viruses have the properties that permit their access to the CNS. To get there from an initial extraneural infection site, they must either transport along nerves that enter the CNS or cross membrane barriers that act as significant obstacles to the passage. Those able to achieve CNS access express several strategies that allow passage, and these activities could be inhibited by therapeutic procedures that strengthen the barrier function. This strategy should be achievable with anti-inflammatory drugs in situations where barrier permeability is increased by inflammatory factors derived from the virus or the host itself. In other circumstances, vaccines against the causative viruses can be effective, but, except for Rabies virus with its often extraordinarily long incubation time after infection before it expresses lesions and perhaps shingles, vaccines must be used prior to infection to be effective against neural consequences. Some prophylactic vaccines have been extraordinarily efficacious, most notable those against polioviruses, but few viral neuropathogens are currently controllable with vaccines. We expect this situation to change when more is known about the molecular events involved during infection and disease along with the application of new developments in vaccine design that can target critical events in viral pathogenesis and are less toxic. Accordingly, effective vaccines would be useful to minimize the impact of Nipah viral infection, as well as some human flavivirus infections that currently lack vaccines. Vaccines are used effectively to control several encephalitides of veterinary relevance; for example, VEE and an attenuated VEE vaccine are used by special groups, such as the US military, and they have side effects that the general public would not accept.</p><p>Another control measure to protect the brain would be to use antiviral drugs and perhaps biologicals. Alas, this approach is currently used against very few viruses that infect the brain. Antivirals are valuable to counteract the severe consequences of HSV and HIV infections, although, in most instances, they do not succeed in removing the virus from the brain or some other locations. Other neural infections potentially controllable by antiviral therapy include infections that are caused by some of the flaviviruses and togaviruses, since effective antivirals are used against similar viruses that mainly cause non-neural diseases. Most notable are the highly effective antivirals used against the hepatitis C flavivirus.</p><p>While it seems fair to expect that the future will see therapies and vaccines that effectively manage some acute viral neural diseases, controlling chronic ND syndromes by targeting the putative viral involvement will remain far more problematic. Thus, although viruses are advocated to cause, or at least contribute, to the development and course of several major ND diseases, which include AD, MS, PD and several others, controlling them by targeting viruses seems implausible. Moreover, any role for a virus in those major ND diseases is likely to be as a cofactor amongst many others. Thus, targeting viruses to control such diseases will be futile. With some chronic NDs, such as ALS, the evidence for viral involvement is stronger, but controlling ALS by therapies that target a virus are ineffective at present. Nevertheless, the good news with most if not all chronic ND syndromes is that the affected person is unlikely to be an infectious source of danger to others. With some chronic NDs, a case linking them to a named virus, such as EBV with MS, has strong circumstantial support, but, even if substantiated, effective vaccines or antivirals currently are lacking to control the possible viral cause. We can conclude that much has been learned, but more needs to be known before we solve the problems that viruses cause when they access the brain. Stay tuned.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors extend heartfelt gratitude to Ada Schollenberger for critical suggestions during writing the manuscript and for the valuable inputs of colleagues during discussions on the topic. Considering the vast and dynamic scope of the discussed field, we apologize to authors whose work could not be cited due to space limitations. <xref rid="viruses-17-00203-f001" ref-type="fig">Figure 1</xref> and <xref rid="viruses-17-00203-f002" ref-type="fig">Figure 2</xref> were created with <uri>Biorender.Com</uri>.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>M.B.M. and B.T.R. wrote, reviewed, and edited the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-17-00203"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daneman</surname><given-names>R.</given-names></name>
<name><surname>Prat</surname><given-names>A.</given-names></name>
</person-group><article-title>The Blood-Brain Barrier</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2015</year><volume>7</volume><elocation-id>a020412</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a020412</pub-id><pub-id pub-id-type="pmid">25561720</pub-id>
</element-citation></ref><ref id="B2-viruses-17-00203"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alahmari</surname><given-names>A.</given-names></name>
</person-group><article-title>Blood-Brain Barrier Overview: Structural and Functional Correlation</article-title><source>Neural Plast.</source><year>2021</year><volume>2021</volume><fpage>6564585</fpage><pub-id pub-id-type="doi">10.1155/2021/6564585</pub-id><pub-id pub-id-type="pmid">34912450</pub-id>
</element-citation></ref><ref id="B3-viruses-17-00203"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pierson</surname><given-names>T.C.</given-names></name>
<name><surname>Diamond</surname><given-names>M.S.</given-names></name>
</person-group><article-title>The Continued Threat of Emerging Flaviviruses</article-title><source>Nat. Microbiol.</source><year>2020</year><volume>5</volume><fpage>796</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-0714-0</pub-id><pub-id pub-id-type="pmid">32367055</pub-id>
</element-citation></ref><ref id="B4-viruses-17-00203"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xue</surname><given-names>Y.C.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Mohamud</surname><given-names>Y.</given-names></name>
<name><surname>Bahreyni</surname><given-names>A.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Cashman</surname><given-names>N.R.</given-names></name>
<name><surname>Luo</surname><given-names>H.</given-names></name>
</person-group><article-title>Sublethal Enteroviral Infection Exacerbates Disease Progression in an ALS Mouse Model</article-title><source>J. Neuroinflammation</source><year>2022</year><volume>19</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/s12974-022-02380-7</pub-id><pub-id pub-id-type="pmid">35022041</pub-id>
</element-citation></ref><ref id="B5-viruses-17-00203"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adler</surname><given-names>G.L.</given-names></name>
<name><surname>Le</surname><given-names>K.</given-names></name>
<name><surname>Fu</surname><given-names>Y.H.</given-names></name>
<name><surname>Kim</surname><given-names>W.S.</given-names></name>
</person-group><article-title>Human Endogenous Retroviruses in Neurodegenerative Diseases</article-title><source>Genes</source><year>2024</year><volume>15</volume><elocation-id>745</elocation-id><pub-id pub-id-type="doi">10.3390/genes15060745</pub-id><pub-id pub-id-type="pmid">38927681</pub-id>
</element-citation></ref><ref id="B6-viruses-17-00203"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Dotiwala</surname><given-names>A.K.</given-names></name>
<name><surname>McCausland</surname><given-names>C.</given-names></name>
<name><surname>Samra</surname><given-names>N.S.</given-names></name>
</person-group><source>Anatomy, Head and Neck: Blood Brain Barrier</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B7-viruses-17-00203"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
</person-group><article-title>Immune Response and Blood&#x02013;Brain Barrier Dysfunction during Viral Neuroinvasion</article-title><source>Innate Immun.</source><year>2021</year><volume>27</volume><fpage>109</fpage><pub-id pub-id-type="doi">10.1177/1753425920954281</pub-id><pub-id pub-id-type="pmid">32903111</pub-id>
</element-citation></ref><ref id="B8-viruses-17-00203"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stamatovic</surname><given-names>S.M.</given-names></name>
<name><surname>Johnson</surname><given-names>A.M.</given-names></name>
<name><surname>Keep</surname><given-names>R.F.</given-names></name>
<name><surname>Andjelkovic</surname><given-names>A.V.</given-names></name>
</person-group><article-title>Junctional Proteins of the Blood-Brain Barrier: New Insights into Function and Dysfunction</article-title><source>Tissue Barriers</source><year>2016</year><volume>4</volume><fpage>e1154641</fpage><pub-id pub-id-type="doi">10.1080/21688370.2016.1154641</pub-id><pub-id pub-id-type="pmid">27141427</pub-id>
</element-citation></ref><ref id="B9-viruses-17-00203"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duong</surname><given-names>C.N.</given-names></name>
<name><surname>Vestweber</surname><given-names>D.</given-names></name>
</person-group><article-title>Mechanisms Ensuring Endothelial Junction Integrity Beyond VE-Cadherin</article-title><source>Front. Physiol.</source><year>2020</year><volume>11</volume><elocation-id>519</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2020.00519</pub-id><pub-id pub-id-type="pmid">32670077</pub-id>
</element-citation></ref><ref id="B10-viruses-17-00203"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>W.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Wei</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
</person-group><article-title>Tight Junction in Blood-Brain Barrier: An Overview of Structure, Regulation, and Regulator Substances</article-title><source>CNS Neurosci. Ther.</source><year>2012</year><volume>18</volume><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1111/j.1755-5949.2012.00340.x</pub-id><pub-id pub-id-type="pmid">22686334</pub-id>
</element-citation></ref><ref id="B11-viruses-17-00203"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lochhead</surname><given-names>J.J.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Ronaldson</surname><given-names>P.T.</given-names></name>
<name><surname>Davis</surname><given-names>T.P.</given-names></name>
</person-group><article-title>Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders</article-title><source>Front. Physiol.</source><year>2020</year><volume>11</volume><elocation-id>914</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2020.00914</pub-id><pub-id pub-id-type="pmid">32848858</pub-id>
</element-citation></ref><ref id="B12-viruses-17-00203"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Bock</surname><given-names>M.</given-names></name>
<name><surname>De Smet</surname><given-names>M.</given-names></name>
<name><surname>Verwaerde</surname><given-names>S.</given-names></name>
<name><surname>Tahiri</surname><given-names>H.</given-names></name>
<name><surname>Schumacher</surname><given-names>S.</given-names></name>
<name><surname>Van Haver</surname><given-names>V.</given-names></name>
<name><surname>Witschas</surname><given-names>K.</given-names></name>
<name><surname>Steinh&#x000e4;user</surname><given-names>C.</given-names></name>
<name><surname>Rouach</surname><given-names>N.</given-names></name>
<name><surname>Vandenbroucke</surname><given-names>R.E.</given-names></name>
<etal/>
</person-group><article-title>Targeting Gliovascular Connexins Prevents Inflammatory Blood-Brain Barrier Leakage and Astrogliosis</article-title><source>JCI Insight</source><year>2022</year><volume>7</volume><fpage>e135263</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.135263</pub-id><pub-id pub-id-type="pmid">35881483</pub-id>
</element-citation></ref><ref id="B13-viruses-17-00203"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kameritsch</surname><given-names>P.</given-names></name>
<name><surname>Pogoda</surname><given-names>K.</given-names></name>
<name><surname>Pohl</surname><given-names>U.</given-names></name>
</person-group><article-title>Channel-Independent Influence of Connexin 43 on Cell Migration</article-title><source>Biochim. Biophys. Acta</source><year>2012</year><volume>1818</volume><fpage>1993</fpage><lpage>2001</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2011.11.016</pub-id><pub-id pub-id-type="pmid">22155212</pub-id>
</element-citation></ref><ref id="B14-viruses-17-00203"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noe</surname><given-names>C.R.</given-names></name>
<name><surname>Noe-Letschnig</surname><given-names>M.</given-names></name>
<name><surname>Handschuh</surname><given-names>P.</given-names></name>
<name><surname>Noe</surname><given-names>C.A.</given-names></name>
<name><surname>Lanzenberger</surname><given-names>R.</given-names></name>
</person-group><article-title>Dysfunction of the Blood-Brain Barrier&#x02014;A Key Step in Neurodegeneration and Dementia</article-title><source>Front. Aging Neurosci.</source><year>2020</year><volume>12</volume><elocation-id>185</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2020.00185</pub-id><pub-id pub-id-type="pmid">32848697</pub-id>
</element-citation></ref><ref id="B15-viruses-17-00203"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Vlieger</surname><given-names>L.</given-names></name>
<name><surname>Vandenbroucke</surname><given-names>R.E.</given-names></name>
<name><surname>Van Hoecke</surname><given-names>L.</given-names></name>
</person-group><article-title>Recent Insights into Viral Infections as a Trigger and Accelerator in Alzheimer&#x02019;s Disease</article-title><source>Drug Discov. Today</source><year>2022</year><volume>27</volume><fpage>103340</fpage><pub-id pub-id-type="doi">10.1016/j.drudis.2022.103340</pub-id><pub-id pub-id-type="pmid">35987492</pub-id>
</element-citation></ref><ref id="B16-viruses-17-00203"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krey</surname><given-names>L.</given-names></name>
<name><surname>Huber</surname><given-names>M.K.</given-names></name>
<name><surname>H&#x000f6;glinger</surname><given-names>G.U.</given-names></name>
<name><surname>Wegner</surname><given-names>F.</given-names></name>
</person-group><article-title>Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson&#x02019;s Disease?</article-title><source>Brain Sci.</source><year>2021</year><volume>11</volume><elocation-id>1654</elocation-id><pub-id pub-id-type="doi">10.3390/brainsci11121654</pub-id><pub-id pub-id-type="pmid">34942956</pub-id>
</element-citation></ref><ref id="B17-viruses-17-00203"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saboori</surname><given-names>P.</given-names></name>
<name><surname>Sadegh</surname><given-names>A.</given-names></name>
</person-group><article-title>Histology and Morphology of the Brain Subarachnoid Trabeculae</article-title><source>Anat. Res. Int.</source><year>2015</year><volume>2015</volume><fpage>279814</fpage><pub-id pub-id-type="doi">10.1155/2015/279814</pub-id><pub-id pub-id-type="pmid">26090230</pub-id>
</element-citation></ref><ref id="B18-viruses-17-00203"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Laterra</surname><given-names>J.</given-names></name>
<name><surname>Keep</surname><given-names>R.</given-names></name>
<name><surname>Betz</surname><given-names>L.A.</given-names></name>
<name><surname>Goldstein</surname><given-names>G.W.</given-names></name>
</person-group><article-title>Blood&#x02014;Brain&#x02014;Cerebrospinal Fluid Barriers</article-title><source>Basic Neurochemistry: Molecular, Cellular and Medical Aspects</source><edition>6th ed.</edition><publisher-name>Lippincott-Raven</publisher-name><publisher-loc>Philadelphia, PA, USA</publisher-loc><year>1999</year></element-citation></ref><ref id="B19-viruses-17-00203"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaiser</surname><given-names>K.</given-names></name>
<name><surname>Bryja</surname><given-names>V.</given-names></name>
</person-group><article-title>Choroid Plexus: The Orchestrator of Long-Range Signalling Within the CNS</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4760</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21134760</pub-id><pub-id pub-id-type="pmid">32635478</pub-id>
</element-citation></ref><ref id="B20-viruses-17-00203"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanchez-Covarrubias</surname><given-names>L.</given-names></name>
<name><surname>Slosky</surname><given-names>L.M.</given-names></name>
<name><surname>Thompson</surname><given-names>B.J.</given-names></name>
<name><surname>Davis</surname><given-names>T.P.</given-names></name>
<name><surname>Ronaldson</surname><given-names>P.T.</given-names></name>
</person-group><article-title>Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?</article-title><source>Curr. Pharm. Des.</source><year>2014</year><volume>20</volume><fpage>1422</fpage><pub-id pub-id-type="doi">10.2174/13816128113199990463</pub-id><pub-id pub-id-type="pmid">23789948</pub-id>
</element-citation></ref><ref id="B21-viruses-17-00203"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ayub</surname><given-names>M.</given-names></name>
<name><surname>Jin</surname><given-names>H.K.</given-names></name>
<name><surname>Bae</surname><given-names>J.-S.</given-names></name>
</person-group><article-title>The Blood Cerebrospinal Fluid Barrier Orchestrates Immunosurveillance, Immunoprotection, and Immunopathology in the Central Nervous System</article-title><source>BMB Rep.</source><year>2021</year><volume>54</volume><fpage>196</fpage><pub-id pub-id-type="doi">10.5483/BMBRep.2021.54.4.205</pub-id><pub-id pub-id-type="pmid">33298242</pub-id>
</element-citation></ref><ref id="B22-viruses-17-00203"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dabbagh</surname><given-names>F.</given-names></name>
<name><surname>Schroten</surname><given-names>H.</given-names></name>
<name><surname>Schwerk</surname><given-names>C.</given-names></name>
</person-group><article-title>In Vitro Models of the Blood&#x02013;Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals</article-title><source>Pharmaceutics</source><year>2022</year><volume>14</volume><elocation-id>1729</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics14081729</pub-id><pub-id pub-id-type="pmid">36015358</pub-id>
</element-citation></ref><ref id="B23-viruses-17-00203"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>R.L.</given-names></name>
<name><surname>Kassem</surname><given-names>N.A.</given-names></name>
<name><surname>Redzic</surname><given-names>Z.B.</given-names></name>
<name><surname>Chen</surname><given-names>C.P.C.</given-names></name>
<name><surname>Segal</surname><given-names>M.B.</given-names></name>
<name><surname>Preston</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Age-Related Changes in Choroid Plexus and Blood-Cerebrospinal Fluid Barrier Function in the Sheep</article-title><source>Exp. Gerontol.</source><year>2009</year><volume>44</volume><fpage>289</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2008.12.004</pub-id><pub-id pub-id-type="pmid">19133323</pub-id>
</element-citation></ref><ref id="B24-viruses-17-00203"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Proulx</surname><given-names>S.T.</given-names></name>
<name><surname>Engelhardt</surname><given-names>B.</given-names></name>
</person-group><article-title>Central Nervous System Zoning: How Brain Barriers Establish Subdivisions for CNS Immune Privilege and Immune Surveillance</article-title><source>J. Intern. Med.</source><year>2022</year><volume>292</volume><fpage>47</fpage><pub-id pub-id-type="doi">10.1111/joim.13469</pub-id><pub-id pub-id-type="pmid">35184353</pub-id>
</element-citation></ref><ref id="B25-viruses-17-00203"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muldoon</surname><given-names>L.L.</given-names></name>
<name><surname>Alvarez</surname><given-names>J.I.</given-names></name>
<name><surname>Begley</surname><given-names>D.J.</given-names></name>
<name><surname>Boado</surname><given-names>R.J.</given-names></name>
<name><surname>Del Zoppo</surname><given-names>G.J.</given-names></name>
<name><surname>Doolittle</surname><given-names>N.D.</given-names></name>
<name><surname>Engelhardt</surname><given-names>B.</given-names></name>
<name><surname>Hallenbeck</surname><given-names>J.M.</given-names></name>
<name><surname>Lonser</surname><given-names>R.R.</given-names></name>
<name><surname>Ohlfest</surname><given-names>J.R.</given-names></name>
<etal/>
</person-group><article-title>Immunologic Privilege in the Central Nervous System and the Blood&#x02013;Brain Barrier</article-title><source>J. Cereb. Blood Flow Metab.</source><year>2012</year><volume>33</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1038/jcbfm.2012.153</pub-id><pub-id pub-id-type="pmid">23072749</pub-id>
</element-citation></ref><ref id="B26-viruses-17-00203"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carson</surname><given-names>M.J.</given-names></name>
<name><surname>Doose</surname><given-names>J.M.</given-names></name>
<name><surname>Melchior</surname><given-names>B.</given-names></name>
<name><surname>Schmid</surname><given-names>C.D.</given-names></name>
<name><surname>Ploix</surname><given-names>C.C.</given-names></name>
</person-group><article-title>CNS Immune Privilege: Hiding in Plain Sight</article-title><source>Immunol. Rev.</source><year>2006</year><volume>213</volume><fpage>48</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2006.00441.x</pub-id><pub-id pub-id-type="pmid">16972896</pub-id>
</element-citation></ref><ref id="B27-viruses-17-00203"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daniels</surname><given-names>B.P.</given-names></name>
<name><surname>Klein</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System</article-title><source>PLoS Pathog.</source><year>2015</year><volume>11</volume><elocation-id>e1005096</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005096</pub-id><pub-id pub-id-type="pmid">26379171</pub-id>
</element-citation></ref><ref id="B28-viruses-17-00203"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>J.</given-names></name>
<name><surname>Long</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Gong</surname><given-names>L.</given-names></name>
</person-group><article-title>Towards a Comprehensive View of the Herpes B Virus</article-title><source>Front. Immunol.</source><year>2023</year><volume>14</volume><elocation-id>1281384</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1281384</pub-id><pub-id pub-id-type="pmid">38035092</pub-id>
</element-citation></ref><ref id="B29-viruses-17-00203"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakulwira</surname><given-names>K.</given-names></name>
<name><surname>Theamboonlers</surname><given-names>A.</given-names></name>
<name><surname>Charoonrut</surname><given-names>P.</given-names></name>
<name><surname>Ratanakorn</surname><given-names>P.</given-names></name>
<name><surname>Poovorawan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Serological Evidence of Herpesvirus Infection in Gibbons</article-title><source>BMC Microbiol.</source><year>2002</year><volume>2</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-2-11</pub-id><pub-id pub-id-type="pmid">12038968</pub-id>
</element-citation></ref><ref id="B30-viruses-17-00203"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Matos</surname><given-names>R.</given-names></name>
<name><surname>Russell</surname><given-names>D.</given-names></name>
<name><surname>Van Alstine</surname><given-names>W.</given-names></name>
<name><surname>Miller</surname><given-names>A.</given-names></name>
</person-group><article-title>Spontaneous Fatal Human Herpesvirus 1 Encephalitis in Two Domestic Rabbits (<italic toggle="yes">Oryctolagus cuniculus</italic>)</article-title><source>J. Vet. Diagn. Investig.</source><year>2014</year><volume>26</volume><fpage>689</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1177/1040638714545111</pub-id><pub-id pub-id-type="pmid">25085871</pub-id>
</element-citation></ref><ref id="B31-viruses-17-00203"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>A.</given-names></name>
<name><surname>Xue</surname><given-names>T.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
<name><surname>Zou</surname><given-names>J.</given-names></name>
<name><surname>Pu</surname><given-names>H.</given-names></name>
<name><surname>Hu</surname><given-names>X.</given-names></name>
<name><surname>Tian</surname><given-names>Z.</given-names></name>
</person-group><article-title>Pseudorabies Virus Associations in Wild Animals: Review of Potential Reservoirs for Cross-Host Transmission</article-title><source>Viruses</source><year>2022</year><volume>14</volume><elocation-id>2254</elocation-id><pub-id pub-id-type="doi">10.3390/v14102254</pub-id><pub-id pub-id-type="pmid">36298809</pub-id>
</element-citation></ref><ref id="B32-viruses-17-00203"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sehl</surname><given-names>J.</given-names></name>
<name><surname>Teifke</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Comparative Pathology of Pseudorabies in Different Naturally and Experimentally Infected Species-A Review</article-title><source>Pathogens</source><year>2020</year><volume>9</volume><elocation-id>633</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens9080633</pub-id><pub-id pub-id-type="pmid">32759704</pub-id>
</element-citation></ref><ref id="B33-viruses-17-00203"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wisner</surname><given-names>T.W.</given-names></name>
<name><surname>Sugimoto</surname><given-names>K.</given-names></name>
<name><surname>Howard</surname><given-names>P.W.</given-names></name>
<name><surname>Kawaguchi</surname><given-names>Y.</given-names></name>
<name><surname>Johnson</surname><given-names>D.C.</given-names></name>
</person-group><article-title>Anterograde Transport of Herpes Simplex Virus Capsids in Neurons by Both Separate and Married Mechanisms</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>5919</fpage><pub-id pub-id-type="doi">10.1128/JVI.00116-11</pub-id><pub-id pub-id-type="pmid">21450818</pub-id>
</element-citation></ref><ref id="B34-viruses-17-00203"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duarte</surname><given-names>L.F.</given-names></name>
<name><surname>Far&#x000ed;as</surname><given-names>M.A.</given-names></name>
<name><surname>&#x000c1;lvarez</surname><given-names>D.M.</given-names></name>
<name><surname>Bueno</surname><given-names>S.M.</given-names></name>
<name><surname>Riedel</surname><given-names>C.A.</given-names></name>
<name><surname>Gonz&#x000e1;lez</surname><given-names>P.A.</given-names></name>
</person-group><article-title>Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights into Proposed Interrelationships with Neurodegenerative Disorders</article-title><source>Front. Cell Neurosci.</source><year>2019</year><volume>13</volume><elocation-id>46</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2019.00046</pub-id><pub-id pub-id-type="pmid">30863282</pub-id>
</element-citation></ref><ref id="B35-viruses-17-00203"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bai</surname><given-names>F.</given-names></name>
<name><surname>Ashley Thompson</surname><given-names>E.</given-names></name>
<name><surname>Vig</surname><given-names>P.J.S.</given-names></name>
<name><surname>Arturo Leis</surname><given-names>A.</given-names></name>
</person-group><article-title>Current Understanding of West Nile Virus Clinical Manifestations, Immune Responses, Neuroinvasion, and Immunotherapeutic Implications</article-title><source>Pathogens</source><year>2019</year><volume>8</volume><elocation-id>193</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens8040193</pub-id><pub-id pub-id-type="pmid">31623175</pub-id>
</element-citation></ref><ref id="B36-viruses-17-00203"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Samuel</surname><given-names>M.A.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Siddharthan</surname><given-names>V.</given-names></name>
<name><surname>Morrey</surname><given-names>J.D.</given-names></name>
<name><surname>Diamond</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Axonal Transport Mediates West Nile Virus Entry into the Central Nervous System and Induces Acute Flaccid Paralysis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>17140</fpage><lpage>17145</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705837104</pub-id><pub-id pub-id-type="pmid">17939996</pub-id>
</element-citation></ref><ref id="B37-viruses-17-00203"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fooks</surname><given-names>A.R.</given-names></name>
<name><surname>Cliquet</surname><given-names>F.</given-names></name>
<name><surname>Finke</surname><given-names>S.</given-names></name>
<name><surname>Freuling</surname><given-names>C.</given-names></name>
<name><surname>Hemachudha</surname><given-names>T.</given-names></name>
<name><surname>Mani</surname><given-names>R.S.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>T.</given-names></name>
<name><surname>Nadin-Davis</surname><given-names>S.</given-names></name>
<name><surname>Picard-Meyer</surname><given-names>E.</given-names></name>
<name><surname>Wilde</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Rabies</article-title><source>Nat. Rev. Dis. Primers</source><year>2017</year><volume>3</volume><fpage>17091</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2017.91</pub-id><pub-id pub-id-type="pmid">29188797</pub-id>
</element-citation></ref><ref id="B38-viruses-17-00203"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le Blanc</surname><given-names>I.</given-names></name>
<name><surname>Luyet</surname><given-names>P.P.</given-names></name>
<name><surname>Pons</surname><given-names>V.</given-names></name>
<name><surname>Ferguson</surname><given-names>C.</given-names></name>
<name><surname>Emans</surname><given-names>N.</given-names></name>
<name><surname>Petiot</surname><given-names>A.</given-names></name>
<name><surname>Mayran</surname><given-names>N.</given-names></name>
<name><surname>Demaurex</surname><given-names>N.</given-names></name>
<name><surname>Faur&#x000e9;</surname><given-names>J.</given-names></name>
<name><surname>Sadoul</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Endosome-to-Cytosol Transport of Viral Nucleocapsids</article-title><source>Nat. Cell Biol.</source><year>2005</year><volume>7</volume><elocation-id>653</elocation-id><pub-id pub-id-type="doi">10.1038/ncb1269</pub-id><pub-id pub-id-type="pmid">15951806</pub-id>
</element-citation></ref><ref id="B39-viruses-17-00203"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Piccinotti</surname><given-names>S.</given-names></name>
<name><surname>Kirchhausen</surname><given-names>T.</given-names></name>
<name><surname>Whelan</surname><given-names>S.P.J.</given-names></name>
</person-group><article-title>Uptake of Rabies Virus into Epithelial Cells by Clathrin-Mediated Endocytosis Depends upon Actin</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>11637</fpage><pub-id pub-id-type="doi">10.1128/JVI.01648-13</pub-id><pub-id pub-id-type="pmid">23966407</pub-id>
</element-citation></ref><ref id="B40-viruses-17-00203"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsiang</surname><given-names>H.</given-names></name>
<name><surname>Ceccaldi</surname><given-names>P.E.</given-names></name>
<name><surname>Lycke</surname><given-names>E.</given-names></name>
</person-group><article-title>Rabies Virus Infection and Transport in Human Sensory Dorsal Root Ganglia Neurons</article-title><source>J. Gen. Virol.</source><year>1991</year><volume>72</volume><fpage>1191</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-72-5-1191</pub-id><pub-id pub-id-type="pmid">2033395</pub-id>
</element-citation></ref><ref id="B41-viruses-17-00203"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bauer</surname><given-names>A.</given-names></name>
<name><surname>Nolden</surname><given-names>T.</given-names></name>
<name><surname>Nemitz</surname><given-names>S.</given-names></name>
<name><surname>Perlson</surname><given-names>E.</given-names></name>
<name><surname>Finke</surname><given-names>S.</given-names></name>
</person-group><article-title>A Dynein Light Chain 1 Binding Motif in Rabies Virus Polymerase L Protein Plays a Role in Microtubule Reorganization and Viral Primary Transcription</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>9591</fpage><pub-id pub-id-type="doi">10.1128/JVI.01298-15</pub-id><pub-id pub-id-type="pmid">26157129</pub-id>
</element-citation></ref><ref id="B42-viruses-17-00203"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chailangkarn</surname><given-names>T.</given-names></name>
<name><surname>Tanwattana</surname><given-names>N.</given-names></name>
<name><surname>Jaemthaworn</surname><given-names>T.</given-names></name>
<name><surname>Sriswasdi</surname><given-names>S.</given-names></name>
<name><surname>Wanasen</surname><given-names>N.</given-names></name>
<name><surname>Tangphatsornruang</surname><given-names>S.</given-names></name>
<name><surname>Leetanasaksakul</surname><given-names>K.</given-names></name>
<name><surname>Jantraphakorn</surname><given-names>Y.</given-names></name>
<name><surname>Nawae</surname><given-names>W.</given-names></name>
<name><surname>Chankeeree</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Establishment of Human-Induced Pluripotent Stem Cell-Derived Neurons&#x02014;A Promising in Vitro Model for a Molecular Study of Rabies Virus and Host Interaction</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>11986</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222111986</pub-id><pub-id pub-id-type="pmid">34769416</pub-id>
</element-citation></ref><ref id="B43-viruses-17-00203"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rieder</surname><given-names>M.</given-names></name>
<name><surname>Conzelmann</surname><given-names>K.K.</given-names></name>
</person-group><article-title>Interferon in Rabies Virus Infection</article-title><source>Adv. Virus Res.</source><year>2011</year><volume>79</volume><fpage>91</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-387040-7.00006-8</pub-id><pub-id pub-id-type="pmid">21601044</pub-id>
</element-citation></ref><ref id="B44-viruses-17-00203"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brz&#x000f3;zka</surname><given-names>K.</given-names></name>
<name><surname>Finke</surname><given-names>S.</given-names></name>
<name><surname>Conzelmann</surname><given-names>K.-K.</given-names></name>
</person-group><article-title>Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3</article-title><source>J. Virol.</source><year>2005</year><volume>79</volume><fpage>7673</fpage><pub-id pub-id-type="doi">10.1128/JVI.79.12.7673-7681.2005</pub-id><pub-id pub-id-type="pmid">15919920</pub-id>
</element-citation></ref><ref id="B45-viruses-17-00203"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kiflu</surname><given-names>A.B.</given-names></name>
</person-group><article-title>The Immune Escape Strategy of Rabies Virus and Its Pathogenicity Mechanisms</article-title><source>Viruses</source><year>2024</year><volume>16</volume><elocation-id>1774</elocation-id><pub-id pub-id-type="doi">10.3390/v16111774</pub-id><pub-id pub-id-type="pmid">39599888</pub-id>
</element-citation></ref><ref id="B46-viruses-17-00203"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ito</surname><given-names>N.</given-names></name>
<name><surname>Moseley</surname><given-names>G.W.</given-names></name>
<name><surname>Sugiyama</surname><given-names>M.</given-names></name>
</person-group><article-title>The Importance of Immune Evasion in the Pathogenesis of Rabies Virus: Veterinary Science Award Winner&#x02019;s (No.116) Commemorative Review</article-title><source>J. Vet. Med. Sci.</source><year>2016</year><volume>78</volume><fpage>1089</fpage><pub-id pub-id-type="doi">10.1292/jvms.16-0092</pub-id><pub-id pub-id-type="pmid">27041139</pub-id>
</element-citation></ref><ref id="B47-viruses-17-00203"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Korie</surname><given-names>G.C.</given-names></name>
<name><surname>Sallau</surname><given-names>A.B.</given-names></name>
<name><surname>Kanu</surname><given-names>B.</given-names></name>
<name><surname>Kia</surname><given-names>G.S.N.</given-names></name>
<name><surname>Kwaga</surname><given-names>J.K.P.</given-names></name>
</person-group><article-title>Rabies Virus Infection Is Associated with Variations in Calbindin D-28K and Calretinin MRNA Expression Levels in Mouse Brain Tissue</article-title><source>Arch. Virol.</source><year>2023</year><volume>168</volume><fpage>143</fpage><pub-id pub-id-type="doi">10.1007/s00705-023-05753-2</pub-id><pub-id pub-id-type="pmid">37069450</pub-id>
</element-citation></ref><ref id="B48-viruses-17-00203"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sundaramoorthy</surname><given-names>V.</given-names></name>
<name><surname>Green</surname><given-names>D.</given-names></name>
<name><surname>Locke</surname><given-names>K.</given-names></name>
<name><surname>O&#x02019;Brien</surname><given-names>C.M.</given-names></name>
<name><surname>Dearnley</surname><given-names>M.</given-names></name>
<name><surname>Bingham</surname><given-names>J.</given-names></name>
</person-group><article-title>Novel Role of SARM1 Mediated Axonal Degeneration in the Pathogenesis of Rabies</article-title><source>PLoS Pathog.</source><year>2020</year><volume>16</volume><elocation-id>e1008343</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008343</pub-id><pub-id pub-id-type="pmid">32069324</pub-id>
</element-citation></ref><ref id="B49-viruses-17-00203"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Nawaz</surname><given-names>Z.</given-names></name>
<name><surname>Guo</surname><given-names>C.</given-names></name>
<name><surname>Ali</surname><given-names>S.</given-names></name>
<name><surname>Naeem</surname><given-names>M.A.</given-names></name>
<name><surname>Jamil</surname><given-names>T.</given-names></name>
<name><surname>Ahmad</surname><given-names>W.</given-names></name>
<name><surname>Siddiq</surname><given-names>M.U.</given-names></name>
<name><surname>Ahmed</surname><given-names>S.</given-names></name>
<name><surname>Asif Idrees</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Rabies Virus Exploits Cytoskeleton Network to Cause Early Disease Progression and Cellular Dysfunction</article-title><source>Front. Vet. Sci.</source><year>2022</year><volume>9</volume><elocation-id>889873</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2022.889873</pub-id><pub-id pub-id-type="pmid">35685339</pub-id>
</element-citation></ref><ref id="B50-viruses-17-00203"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Larrous</surname><given-names>F.</given-names></name>
<name><surname>Varet</surname><given-names>H.</given-names></name>
<name><surname>Legendre</surname><given-names>R.</given-names></name>
<name><surname>Feige</surname><given-names>L.</given-names></name>
<name><surname>Dumas</surname><given-names>G.</given-names></name>
<name><surname>Matsas</surname><given-names>R.</given-names></name>
<name><surname>Kouroupi</surname><given-names>G.</given-names></name>
<name><surname>Grailhe</surname><given-names>R.</given-names></name>
<name><surname>Bourhy</surname><given-names>H.</given-names></name>
</person-group><article-title>Early Transcriptional Changes in Rabies Virus-Infected Neurons and Their Impact on Neuronal Functions</article-title><source>Front. Microbiol.</source><year>2021</year><volume>12</volume><elocation-id>730892</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.730892</pub-id><pub-id pub-id-type="pmid">34970230</pub-id>
</element-citation></ref><ref id="B51-viruses-17-00203"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davis</surname><given-names>B.M.</given-names></name>
<name><surname>Rall</surname><given-names>G.F.</given-names></name>
<name><surname>Schnell</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Everything You Always Wanted to Know about Rabies Virus (but Were Afraid to Ask)</article-title><source>Annu. Rev. Virol.</source><year>2015</year><volume>2</volume><fpage>451</fpage><pub-id pub-id-type="doi">10.1146/annurev-virology-100114-055157</pub-id><pub-id pub-id-type="pmid">26958924</pub-id>
</element-citation></ref><ref id="B52-viruses-17-00203"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feige</surname><given-names>L.</given-names></name>
<name><surname>Zaeck</surname><given-names>L.M.</given-names></name>
<name><surname>Sehl-Ewert</surname><given-names>J.</given-names></name>
<name><surname>Finke</surname><given-names>S.</given-names></name>
<name><surname>Bourhy</surname><given-names>H.</given-names></name>
</person-group><article-title>Innate Immune Signaling and Role of Glial Cells in Herpes Simplex Virus- and Rabies Virus-Induced Encephalitis</article-title><source>Viruses</source><year>2021</year><volume>13</volume><elocation-id>2364</elocation-id><pub-id pub-id-type="doi">10.3390/v13122364</pub-id><pub-id pub-id-type="pmid">34960633</pub-id>
</element-citation></ref><ref id="B53-viruses-17-00203"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Potratz</surname><given-names>M.</given-names></name>
<name><surname>Zaeck</surname><given-names>L.</given-names></name>
<name><surname>Christen</surname><given-names>M.</given-names></name>
<name><surname>Te Kamp</surname><given-names>V.</given-names></name>
<name><surname>Klein</surname><given-names>A.</given-names></name>
<name><surname>Nolden</surname><given-names>T.</given-names></name>
<name><surname>Freuling</surname><given-names>C.M.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>T.</given-names></name>
<name><surname>Finke</surname><given-names>S.</given-names></name>
</person-group><article-title>Astrocyte Infection during Rabies Encephalitis Depends on the Virus Strain and Infection Route as Demonstrated by Novel Quantitative 3D Analysis of Cell Tropism</article-title><source>Cells</source><year>2020</year><volume>9</volume><elocation-id>412</elocation-id><pub-id pub-id-type="doi">10.3390/cells9020412</pub-id><pub-id pub-id-type="pmid">32053954</pub-id>
</element-citation></ref><ref id="B54-viruses-17-00203"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Potratz</surname><given-names>M.</given-names></name>
<name><surname>Zaeck</surname><given-names>L.M.</given-names></name>
<name><surname>Weigel</surname><given-names>C.</given-names></name>
<name><surname>Klein</surname><given-names>A.</given-names></name>
<name><surname>Freuling</surname><given-names>C.M.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>T.</given-names></name>
<name><surname>Finke</surname><given-names>S.</given-names></name>
</person-group><article-title>Neuroglia Infection by Rabies Virus after Anterograde Virus Spread in Peripheral Neurons</article-title><source>Acta Neuropathol. Commun.</source><year>2020</year><volume>8</volume><fpage>199</fpage><pub-id pub-id-type="doi">10.1186/s40478-020-01074-6</pub-id><pub-id pub-id-type="pmid">33228789</pub-id>
</element-citation></ref><ref id="B55-viruses-17-00203"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sivasubramanian</surname><given-names>M.K.</given-names></name>
<name><surname>Monteiro</surname><given-names>R.</given-names></name>
<name><surname>Harrison</surname><given-names>K.S.</given-names></name>
<name><surname>Plakkot</surname><given-names>B.</given-names></name>
<name><surname>Subramanian</surname><given-names>M.</given-names></name>
<name><surname>Jones</surname><given-names>C.</given-names></name>
</person-group><article-title>Herpes Simplex Virus Type 1 Preferentially Enhances Neuro-Inflammation and Senescence in Brainstem of Female Mice</article-title><source>J. Virol.</source><year>2022</year><volume>96</volume><fpage>e0108122</fpage><pub-id pub-id-type="doi">10.1128/jvi.01081-22</pub-id><pub-id pub-id-type="pmid">35975996</pub-id>
</element-citation></ref><ref id="B56-viruses-17-00203"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gnann</surname><given-names>J.W.</given-names></name>
<name><surname>Whitley</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Herpes Simplex Encephalitis: An Update</article-title><source>Curr. Infect. Dis. Rep.</source><year>2017</year><volume>19</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1007/s11908-017-0568-7</pub-id><pub-id pub-id-type="pmid">28251511</pub-id>
</element-citation></ref><ref id="B57-viruses-17-00203"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rohani</surname><given-names>H.</given-names></name>
<name><surname>Arjmand</surname><given-names>R.</given-names></name>
<name><surname>Mozhgani</surname><given-names>S.H.</given-names></name>
<name><surname>Shafiee</surname><given-names>A.</given-names></name>
<name><surname>Javad Amini</surname><given-names>M.</given-names></name>
<name><surname>Forghani-Ramandi</surname><given-names>M.M.</given-names></name>
</person-group><article-title>The Worldwide Prevalence of Herpes Simplex Virus Encephalitis and Meningitis: A Systematic Review and Meta-Analysis</article-title><source>Turk. Arch. Pediatr.</source><year>2023</year><volume>58</volume><fpage>580</fpage><pub-id pub-id-type="doi">10.5152/TurkArchPediatr.2023.23007</pub-id><pub-id pub-id-type="pmid">37553966</pub-id>
</element-citation></ref><ref id="B58-viruses-17-00203"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quist-Paulsen</surname><given-names>E.</given-names></name>
<name><surname>Kran</surname><given-names>A.M.B.</given-names></name>
<name><surname>Lindland</surname><given-names>E.S.</given-names></name>
<name><surname>Ellefsen</surname><given-names>K.</given-names></name>
<name><surname>Sandvik</surname><given-names>L.</given-names></name>
<name><surname>Dunlop</surname><given-names>O.</given-names></name>
<name><surname>Ormaasen</surname><given-names>V.</given-names></name>
</person-group><article-title>To What Extent Can Clinical Characteristics Be Used to Distinguish Encephalitis from Encephalopathy of Other Causes? Results from a Prospective Observational Study</article-title><source>BMC Infect. Dis.</source><year>2019</year><volume>19</volume><elocation-id>80</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-018-3570-2</pub-id><pub-id pub-id-type="pmid">30669985</pub-id>
</element-citation></ref><ref id="B59-viruses-17-00203"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verzosa</surname><given-names>A.L.</given-names></name>
<name><surname>McGeever</surname><given-names>L.A.</given-names></name>
<name><surname>Bhark</surname><given-names>S.J.</given-names></name>
<name><surname>Delgado</surname><given-names>T.</given-names></name>
<name><surname>Salazar</surname><given-names>N.</given-names></name>
<name><surname>Sanchez</surname><given-names>E.L.</given-names></name>
</person-group><article-title>Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.644664</pub-id><pub-id pub-id-type="pmid">34135889</pub-id>
</element-citation></ref><ref id="B60-viruses-17-00203"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>H.K.</given-names></name>
<name><surname>Sepp&#x000e4;nen</surname><given-names>M.</given-names></name>
<name><surname>Hautala</surname><given-names>T.</given-names></name>
<name><surname>Ciancanelli</surname><given-names>M.J.</given-names></name>
<name><surname>Itan</surname><given-names>Y.</given-names></name>
<name><surname>Lafaille</surname><given-names>F.G.</given-names></name>
<name><surname>Dell</surname><given-names>W.</given-names></name>
<name><surname>Lorenzo</surname><given-names>L.</given-names></name>
<name><surname>Byun</surname><given-names>M.</given-names></name>
<name><surname>Pauwels</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>TLR3 Deficiency in Herpes Simplex Encephalitis: High Allelic Heterogeneity and Recurrence Risk</article-title><source>Neurology</source><year>2014</year><volume>83</volume><fpage>1888</fpage><lpage>1897</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000999</pub-id><pub-id pub-id-type="pmid">25339207</pub-id>
</element-citation></ref><ref id="B61-viruses-17-00203"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Casanova</surname><given-names>J.L.</given-names></name>
<name><surname>Abel</surname><given-names>L.</given-names></name>
</person-group><article-title>From Rare Disorders of Immunity to Common Determinants of Infection: Following the Mechanistic Thread</article-title><source>Cell</source><year>2022</year><volume>185</volume><fpage>3086</fpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.07.004</pub-id><pub-id pub-id-type="pmid">35985287</pub-id>
</element-citation></ref><ref id="B62-viruses-17-00203"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schnell</surname><given-names>M.J.</given-names></name>
<name><surname>McGettigan</surname><given-names>J.P.</given-names></name>
<name><surname>Wirblich</surname><given-names>C.</given-names></name>
<name><surname>Papaneri</surname><given-names>A.</given-names></name>
</person-group><article-title>The Cell Biology of Rabies Virus: Using Stealth to Reach the Brain</article-title><source>Nat. Rev. Microbiol.</source><year>2009</year><volume>8</volume><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2260</pub-id><pub-id pub-id-type="pmid">19946287</pub-id>
</element-citation></ref><ref id="B63-viruses-17-00203"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weed</surname><given-names>D.J.</given-names></name>
<name><surname>Nicola</surname><given-names>A.V.</given-names></name>
</person-group><article-title>Herpes Simplex Virus Membrane Fusion</article-title><source>Adv. Anat. Embryol. Cell Biol.</source><year>2017</year><volume>223</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1007/978-3-319-53168-7_2</pub-id><pub-id pub-id-type="pmid">28528438</pub-id>
</element-citation></ref><ref id="B64-viruses-17-00203"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaudin</surname><given-names>Y.</given-names></name>
<name><surname>Ruigrok</surname><given-names>R.W.H.</given-names></name>
<name><surname>Tuffereau</surname><given-names>C.</given-names></name>
<name><surname>Knossow</surname><given-names>M.</given-names></name>
<name><surname>Flamand</surname><given-names>A.</given-names></name>
</person-group><article-title>Rabies Virus Glycoprotein Is a Trimer</article-title><source>Virology</source><year>2004</year><volume>187</volume><fpage>627</fpage><pub-id pub-id-type="doi">10.1016/0042-6822(92)90465-2</pub-id></element-citation></ref><ref id="B65-viruses-17-00203"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Etessami</surname><given-names>R.</given-names></name>
<name><surname>Conzelmann</surname><given-names>K.K.</given-names></name>
<name><surname>Fadai-Ghotbi</surname><given-names>B.</given-names></name>
<name><surname>Natelson</surname><given-names>B.</given-names></name>
<name><surname>Tsiang</surname><given-names>H.</given-names></name>
<name><surname>Ceccaldi</surname><given-names>P.E.</given-names></name>
</person-group><article-title>Spread and Pathogenic Characteristics of a G-Deficient Rabies Virus Recombinant: An in Vitro and in Vivo Study</article-title><source>J. Gen. Virol.</source><year>2000</year><volume>81</volume><fpage>2147</fpage><lpage>2153</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-81-9-2147</pub-id><pub-id pub-id-type="pmid">10950970</pub-id>
</element-citation></ref><ref id="B66-viruses-17-00203"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madavaraju</surname><given-names>K.</given-names></name>
<name><surname>Koganti</surname><given-names>R.</given-names></name>
<name><surname>Volety</surname><given-names>I.</given-names></name>
<name><surname>Yadavalli</surname><given-names>T.</given-names></name>
<name><surname>Shukla</surname><given-names>D.</given-names></name>
</person-group><article-title>Herpes Simplex Virus Cell Entry Mechanisms: An Update</article-title><source>Front. Cell Infect. Microbiol.</source><year>2020</year><volume>10</volume><elocation-id>617578</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2020.617578</pub-id><pub-id pub-id-type="pmid">33537244</pub-id>
</element-citation></ref><ref id="B67-viruses-17-00203"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Gao</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<name><surname>Duan</surname><given-names>M.</given-names></name>
<name><surname>Guan</surname><given-names>Z.</given-names></name>
<name><surname>Guo</surname><given-names>Y.</given-names></name>
</person-group><article-title>Dynein- and Kinesin- Mediated Intracellular Transport on Microtubules Facilitates RABV Infection</article-title><source>Vet. Microbiol.</source><year>2021</year><volume>262</volume><elocation-id>109241</elocation-id><pub-id pub-id-type="doi">10.1016/j.vetmic.2021.109241</pub-id><pub-id pub-id-type="pmid">34555731</pub-id>
</element-citation></ref><ref id="B68-viruses-17-00203"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miranda-Saksena</surname><given-names>M.</given-names></name>
<name><surname>Denes</surname><given-names>C.E.</given-names></name>
<name><surname>Diefenbach</surname><given-names>R.J.</given-names></name>
<name><surname>Cunningham</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Infection and Transport of Herpes Simplex Virus Type 1 in Neurons: Role of the Cytoskeleton</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>92</elocation-id><pub-id pub-id-type="doi">10.3390/v10020092</pub-id><pub-id pub-id-type="pmid">29473915</pub-id>
</element-citation></ref><ref id="B69-viruses-17-00203"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Piret</surname><given-names>J.</given-names></name>
<name><surname>Boivin</surname><given-names>G.</given-names></name>
</person-group><article-title>Innate Immune Response during Herpes Simplex Virus Encephalitis and Development of Immunomodulatory Strategies</article-title><source>Rev. Med. Virol.</source><year>2015</year><volume>25</volume><fpage>300</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1002/rmv.1848</pub-id><pub-id pub-id-type="pmid">26205506</pub-id>
</element-citation></ref><ref id="B70-viruses-17-00203"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Devaux</surname><given-names>C.A.</given-names></name>
<name><surname>Pontarotti</surname><given-names>P.</given-names></name>
<name><surname>Levasseur</surname><given-names>A.</given-names></name>
<name><surname>Colson</surname><given-names>P.</given-names></name>
<name><surname>Raoult</surname><given-names>D.</given-names></name>
</person-group><article-title>Is It Time to Switch to a Formulation Other than the Live Attenuated Poliovirus Vaccine to Prevent Poliomyelitis?</article-title><source>Front. Public Health</source><year>2023</year><volume>11</volume><elocation-id>1284337</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2023.1284337</pub-id><pub-id pub-id-type="pmid">38259741</pub-id>
</element-citation></ref><ref id="B71-viruses-17-00203"><label>71.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Wolbert</surname><given-names>J.G.</given-names></name>
<name><surname>Rajnik</surname><given-names>M.</given-names></name>
<name><surname>Swinkels</surname><given-names>H.M.</given-names></name>
<name><surname>Higginbotham</surname><given-names>K.</given-names></name>
</person-group><source>Poliomyelitis</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2024</year></element-citation></ref><ref id="B72-viruses-17-00203"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ohka</surname><given-names>S.</given-names></name>
<name><surname>Nihei</surname><given-names>C.I.</given-names></name>
<name><surname>Yamazaki</surname><given-names>M.</given-names></name>
<name><surname>Nomoto</surname><given-names>A.</given-names></name>
</person-group><article-title>Poliovirus Trafficking toward Central Nervous System via Human Poliovirus Receptor-Dependent and -Independent Pathway</article-title><source>Front. Microbiol.</source><year>2012</year><volume>3</volume><elocation-id>147</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2012.00147</pub-id><pub-id pub-id-type="pmid">22529845</pub-id>
</element-citation></ref><ref id="B73-viruses-17-00203"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nathanson</surname><given-names>N.</given-names></name>
</person-group><article-title>Chapter 1 The Pathogenesis of Poliomyelitis: What We Don&#x02019;t Know</article-title><source>Adv. Virus Res.</source><year>2008</year><volume>71</volume><fpage>1</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/S0065-3527(08)00001-8</pub-id><pub-id pub-id-type="pmid">18585526</pub-id>
</element-citation></ref><ref id="B74-viruses-17-00203"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andersen</surname><given-names>N.S.B.</given-names></name>
<name><surname>Larsen</surname><given-names>S.M.</given-names></name>
<name><surname>Nissen</surname><given-names>S.K.</given-names></name>
<name><surname>J&#x000f8;rgensen</surname><given-names>S.E.</given-names></name>
<name><surname>Mardahl</surname><given-names>M.</given-names></name>
<name><surname>Christiansen</surname><given-names>M.</given-names></name>
<name><surname>Kay</surname><given-names>L.</given-names></name>
<name><surname>Mogensen</surname><given-names>T.H.</given-names></name>
</person-group><article-title>Host Genetics, Innate Immune Responses, and Cellular Death Pathways in Poliomyelitis Patients</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><elocation-id>455664</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.01495</pub-id></element-citation></ref><ref id="B75-viruses-17-00203"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Durrant</surname><given-names>D.M.</given-names></name>
<name><surname>Ghosh</surname><given-names>S.</given-names></name>
<name><surname>Klein</surname><given-names>R.S.</given-names></name>
</person-group><article-title>The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections</article-title><source>ACS Chem. Neurosci.</source><year>2016</year><volume>7</volume><fpage>464</fpage><pub-id pub-id-type="doi">10.1021/acschemneuro.6b00043</pub-id><pub-id pub-id-type="pmid">27058872</pub-id>
</element-citation></ref><ref id="B76-viruses-17-00203"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pacheco-Herrero</surname><given-names>M.</given-names></name>
<name><surname>Soto-Rojas</surname><given-names>L.O.</given-names></name>
<name><surname>Harrington</surname><given-names>C.R.</given-names></name>
<name><surname>Flores-Martinez</surname><given-names>Y.M.</given-names></name>
<name><surname>Villegas-Rojas</surname><given-names>M.M.</given-names></name>
<name><surname>Le&#x000f3;n-Aguilar</surname><given-names>A.M.</given-names></name>
<name><surname>Mart&#x000ed;nez-G&#x000f3;mez</surname><given-names>P.A.</given-names></name>
<name><surname>Campa-C&#x000f3;rdoba</surname><given-names>B.B.</given-names></name>
<name><surname>Ap&#x000e1;tiga-P&#x000e9;rez</surname><given-names>R.</given-names></name>
<name><surname>Corniel-Taveras</surname><given-names>C.N.</given-names></name>
<etal/>
</person-group><article-title>Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection</article-title><source>Front. Neurol.</source><year>2021</year><volume>12</volume><elocation-id>660087</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2021.660087</pub-id><pub-id pub-id-type="pmid">33912129</pub-id>
</element-citation></ref><ref id="B77-viruses-17-00203"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monu</surname><given-names>M.</given-names></name>
<name><surname>Ahmad</surname><given-names>F.</given-names></name>
<name><surname>Olson</surname><given-names>R.M.</given-names></name>
<name><surname>Balendiran</surname><given-names>V.</given-names></name>
<name><surname>Singh</surname><given-names>P.K.</given-names></name>
</person-group><article-title>SARS-CoV-2 Infects Cells Lining the Blood-Retinal Barrier and Induces a Hyperinflammatory Immune Response in the Retina via Systemic Exposure</article-title><source>PLoS Pathog.</source><year>2024</year><volume>20</volume><elocation-id>e1012156</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1012156</pub-id><pub-id pub-id-type="pmid">38598560</pub-id>
</element-citation></ref><ref id="B78-viruses-17-00203"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiu</surname><given-names>C.F.</given-names></name>
<name><surname>Chu</surname><given-names>L.W.</given-names></name>
<name><surname>Liao</surname><given-names>I.C.</given-names></name>
<name><surname>Simanjuntak</surname><given-names>Y.</given-names></name>
<name><surname>Lin</surname><given-names>Y.L.</given-names></name>
<name><surname>Juan</surname><given-names>C.C.</given-names></name>
<name><surname>Ping</surname><given-names>Y.H.</given-names></name>
</person-group><article-title>The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><elocation-id>214</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.00214</pub-id><pub-id pub-id-type="pmid">32153526</pub-id>
</element-citation></ref><ref id="B79-viruses-17-00203"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Marle</surname><given-names>G.</given-names></name>
<name><surname>Antony</surname><given-names>J.</given-names></name>
<name><surname>Ostermann</surname><given-names>H.</given-names></name>
<name><surname>Dunham</surname><given-names>C.</given-names></name>
<name><surname>Hunt</surname><given-names>T.</given-names></name>
<name><surname>Halliday</surname><given-names>W.</given-names></name>
<name><surname>Maingat</surname><given-names>F.</given-names></name>
<name><surname>Urbanowski</surname><given-names>M.D.</given-names></name>
<name><surname>Hobman</surname><given-names>T.</given-names></name>
<name><surname>Peeling</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>West Nile Virus-Induced Neuroinflammation: Glial Infection and Capsid Protein-Mediated Neurovirulence</article-title><source>J. Virol.</source><year>2007</year><volume>81</volume><fpage>10933</fpage><pub-id pub-id-type="doi">10.1128/JVI.02422-06</pub-id><pub-id pub-id-type="pmid">17670819</pub-id>
</element-citation></ref><ref id="B80-viruses-17-00203"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marinho</surname><given-names>P.E.S.</given-names></name>
<name><surname>Kroon</surname><given-names>E.G.</given-names></name>
</person-group><article-title>Flaviviruses as Agents of Childhood Central Nervous System Infections in Brazil</article-title><source>New Microbes New Infect.</source><year>2019</year><volume>31</volume><fpage>100572</fpage><pub-id pub-id-type="doi">10.1016/j.nmni.2019.100572</pub-id><pub-id pub-id-type="pmid">31312458</pub-id>
</element-citation></ref><ref id="B81-viruses-17-00203"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Das</surname><given-names>S.</given-names></name>
<name><surname>Basu</surname><given-names>A.</given-names></name>
</person-group><article-title>Japanese Encephalitis Virus Infects Neural Progenitor Cells and Decreases Their Proliferation</article-title><source>J. Neurochem.</source><year>2008</year><volume>106</volume><fpage>1624</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05511.x</pub-id><pub-id pub-id-type="pmid">18540995</pub-id>
</element-citation></ref><ref id="B82-viruses-17-00203"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Potokar</surname><given-names>M.</given-names></name>
<name><surname>Jorga&#x0010d;evski</surname><given-names>J.</given-names></name>
<name><surname>Zorec</surname><given-names>R.</given-names></name>
</person-group><article-title>Astrocytes in Flavivirus Infections</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>691</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20030691</pub-id><pub-id pub-id-type="pmid">30736273</pub-id>
</element-citation></ref><ref id="B83-viruses-17-00203"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Vries</surname><given-names>L.</given-names></name>
<name><surname>Harding</surname><given-names>A.T.</given-names></name>
</person-group><article-title>Mechanisms of Neuroinvasion and Neuropathogenesis by Pathologic Flaviviruses</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>261</elocation-id><pub-id pub-id-type="doi">10.3390/v15020261</pub-id><pub-id pub-id-type="pmid">36851477</pub-id>
</element-citation></ref><ref id="B84-viruses-17-00203"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alimonti</surname><given-names>J.B.</given-names></name>
<name><surname>Ribecco-Lutkiewicz</surname><given-names>M.</given-names></name>
<name><surname>Sodja</surname><given-names>C.</given-names></name>
<name><surname>Jezierski</surname><given-names>A.</given-names></name>
<name><surname>Stanimirovic</surname><given-names>D.B.</given-names></name>
<name><surname>Liu</surname><given-names>Q.</given-names></name>
<name><surname>Haqqani</surname><given-names>A.S.</given-names></name>
<name><surname>Conlan</surname><given-names>W.</given-names></name>
<name><surname>Bani-Yaghoub</surname><given-names>M.</given-names></name>
</person-group><article-title>Zika Virus Crosses an in Vitro Human Blood Brain Barrier Model</article-title><source>Fluids Barriers CNS</source><year>2018</year><volume>15</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s12987-018-0100-y</pub-id><pub-id pub-id-type="pmid">29759080</pub-id>
</element-citation></ref><ref id="B85-viruses-17-00203"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papa</surname><given-names>M.P.</given-names></name>
<name><surname>Meuren</surname><given-names>L.M.</given-names></name>
<name><surname>Coelho</surname><given-names>S.V.A.</given-names></name>
<name><surname>de Oliveira Lucas</surname><given-names>C.G.</given-names></name>
<name><surname>Mustaf&#x000e1;</surname><given-names>Y.M.</given-names></name>
<name><surname>Matassoli</surname><given-names>F.L.</given-names></name>
<name><surname>Silveira</surname><given-names>P.P.</given-names></name>
<name><surname>Frost</surname><given-names>P.S.</given-names></name>
<name><surname>Pezzuto</surname><given-names>P.</given-names></name>
<name><surname>Ribeiro</surname><given-names>M.R.</given-names></name>
<etal/>
</person-group><article-title>Zika Virus Infects, Activates, and Crosses Brain Microvascular Endothelial Cells, without Barrier Disruption</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><elocation-id>2557</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.02557</pub-id><pub-id pub-id-type="pmid">29312238</pub-id>
</element-citation></ref><ref id="B86-viruses-17-00203"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verma</surname><given-names>S.</given-names></name>
<name><surname>Lo</surname><given-names>Y.</given-names></name>
<name><surname>Chapagain</surname><given-names>M.</given-names></name>
<name><surname>Lum</surname><given-names>S.</given-names></name>
<name><surname>Kumar</surname><given-names>M.</given-names></name>
<name><surname>Gurjav</surname><given-names>U.</given-names></name>
<name><surname>Luo</surname><given-names>H.</given-names></name>
<name><surname>Nakatsuka</surname><given-names>A.</given-names></name>
<name><surname>Nerurkar</surname><given-names>V.R.</given-names></name>
</person-group><article-title>West Nile Virus Infection Modulates Human Brain Microvascular Endothelial Cells Tight Junction Proteins and Cell Adhesion Molecules: Transmigration across the in Vitro Blood-Brain Barrier</article-title><source>Virology</source><year>2009</year><volume>385</volume><fpage>425</fpage><pub-id pub-id-type="doi">10.1016/j.virol.2008.11.047</pub-id><pub-id pub-id-type="pmid">19135695</pub-id>
</element-citation></ref><ref id="B87-viruses-17-00203"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agrawal</surname><given-names>T.</given-names></name>
<name><surname>Sharvani</surname><given-names>V.</given-names></name>
<name><surname>Nair</surname><given-names>D.</given-names></name>
<name><surname>Medigeshi</surname><given-names>G.R.</given-names></name>
</person-group><article-title>Japanese Encephalitis Virus Disrupts Cell-Cell Junctions and Affects the Epithelial Permeability Barrier Functions</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>69465</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0069465</pub-id></element-citation></ref><ref id="B88-viruses-17-00203"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palus</surname><given-names>M.</given-names></name>
<name><surname>Vancova</surname><given-names>M.</given-names></name>
<name><surname>Sirmarova</surname><given-names>J.</given-names></name>
<name><surname>Elsterova</surname><given-names>J.</given-names></name>
<name><surname>Perner</surname><given-names>J.</given-names></name>
<name><surname>Ruzek</surname><given-names>D.</given-names></name>
</person-group><article-title>Tick-Borne Encephalitis Virus Infects Human Brain Microvascular Endothelial Cells without Compromising Blood-Brain Barrier Integrity</article-title><source>Virology</source><year>2017</year><volume>507</volume><fpage>110</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2017.04.012</pub-id><pub-id pub-id-type="pmid">28432926</pub-id>
</element-citation></ref><ref id="B89-viruses-17-00203"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salimi</surname><given-names>H.</given-names></name>
<name><surname>Cain</surname><given-names>M.D.</given-names></name>
<name><surname>Jiang</surname><given-names>X.</given-names></name>
<name><surname>Roth</surname><given-names>R.A.</given-names></name>
<name><surname>Beatty</surname><given-names>W.L.</given-names></name>
<name><surname>Sun</surname><given-names>C.</given-names></name>
<name><surname>Klimstra</surname><given-names>W.B.</given-names></name>
<name><surname>Hou</surname><given-names>J.</given-names></name>
<name><surname>Klein</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry</article-title><source>mBio</source><year>2020</year><volume>11</volume><fpage>02731-19</fpage><pub-id pub-id-type="doi">10.1128/mBio.02731-19</pub-id></element-citation></ref><ref id="B90-viruses-17-00203"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alam</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Nipah Virus, an Emerging Zoonotic Disease Causing Fatal Encephalitis</article-title><source>Clin. Med.</source><year>2022</year><volume>22</volume><fpage>348</fpage><pub-id pub-id-type="doi">10.7861/clinmed.2022-0166</pub-id><pub-id pub-id-type="pmid">35760448</pub-id>
</element-citation></ref><ref id="B91-viruses-17-00203"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Escaffre</surname><given-names>O.</given-names></name>
<name><surname>Borisevich</surname><given-names>V.</given-names></name>
<name><surname>Rockx</surname><given-names>B.</given-names></name>
</person-group><article-title>Pathogenesis of Hendra and Nipah Virus Infection in Humans</article-title><source>J. Infect. Dev. Ctries.</source><year>2013</year><volume>7</volume><fpage>308</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.3855/jidc.3648</pub-id><pub-id pub-id-type="pmid">23592639</pub-id>
</element-citation></ref><ref id="B92-viruses-17-00203"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bruno</surname><given-names>L.</given-names></name>
<name><surname>Nappo</surname><given-names>M.A.</given-names></name>
<name><surname>Ferrari</surname><given-names>L.</given-names></name>
<name><surname>Di Lecce</surname><given-names>R.</given-names></name>
<name><surname>Guarnieri</surname><given-names>C.</given-names></name>
<name><surname>Cantoni</surname><given-names>A.M.</given-names></name>
<name><surname>Corradi</surname><given-names>A.</given-names></name>
</person-group><article-title>Nipah Virus Disease: Epidemiological, Clinical, Diagnostic and Legislative Aspects of This Unpredictable Emerging Zoonosis</article-title><source>Animals</source><year>2022</year><volume>13</volume><elocation-id>159</elocation-id><pub-id pub-id-type="doi">10.3390/ani13010159</pub-id><pub-id pub-id-type="pmid">36611767</pub-id>
</element-citation></ref><ref id="B93-viruses-17-00203"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Contreras</surname><given-names>E.M.</given-names></name>
<name><surname>Johnston</surname><given-names>G.P.</given-names></name>
<name><surname>Buchholz</surname><given-names>D.W.</given-names></name>
<name><surname>Ortega</surname><given-names>V.</given-names></name>
<name><surname>Monreal</surname><given-names>I.A.</given-names></name>
<name><surname>Zamora</surname><given-names>J.L.R.</given-names></name>
<name><surname>Cheung</surname><given-names>T.</given-names></name>
<name><surname>Aguilar</surname><given-names>H.C.</given-names></name>
</person-group><article-title>Roles of Cholesterol in Early and Late Steps of the Nipah Virus Membrane Fusion Cascade</article-title><source>J. Virol.</source><year>2021</year><volume>95</volume><fpage>2323</fpage><lpage>2343</lpage><pub-id pub-id-type="doi">10.1128/JVI.02323-20</pub-id></element-citation></ref><ref id="B94-viruses-17-00203"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aditi</surname></name>
<name><surname>Shariff</surname><given-names>M.</given-names></name>
</person-group><article-title>Nipah Virus Infection: A Review</article-title><source>Epidemiol. Infect.</source><year>2019</year><volume>147</volume><fpage>e95</fpage><pub-id pub-id-type="doi">10.1017/S0950268819000086</pub-id><pub-id pub-id-type="pmid">30869046</pub-id>
</element-citation></ref><ref id="B95-viruses-17-00203"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Salimi</surname><given-names>H.</given-names></name>
<name><surname>Klein</surname><given-names>R.S.</given-names></name>
<name><surname>Salimi</surname><given-names>H.</given-names></name>
<name><surname>Klein</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Disruption of the Blood-Brain Barrier During Neuroinflammatory and Neuroinfectious Diseases</article-title><source>Neuroimmune Diseases</source><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2019</year><volume>Volume 195</volume><pub-id pub-id-type="doi">10.1007/978-3-030-19515-1_7</pub-id></element-citation></ref><ref id="B96-viruses-17-00203"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mustaf&#x000e1;</surname><given-names>Y.M.</given-names></name>
<name><surname>Meuren</surname><given-names>L.M.</given-names></name>
<name><surname>Coelho</surname><given-names>S.V.A.</given-names></name>
<name><surname>De Arruda</surname><given-names>L.B.</given-names></name>
</person-group><article-title>Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier and Invade the Central Nervous System</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><elocation-id>525</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.00525</pub-id><pub-id pub-id-type="pmid">30984122</pub-id>
</element-citation></ref><ref id="B97-viruses-17-00203"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lorin</surname><given-names>V.</given-names></name>
<name><surname>Danckaert</surname><given-names>A.</given-names></name>
<name><surname>Porrot</surname><given-names>F.</given-names></name>
<name><surname>Schwartz</surname><given-names>O.</given-names></name>
<name><surname>Afonso</surname><given-names>P.V.</given-names></name>
<name><surname>Mouqueta</surname><given-names>H.</given-names></name>
</person-group><article-title>Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier</article-title><source>mBio</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1128/mBio.02424-20</pub-id><pub-id pub-id-type="pmid">33082263</pub-id>
</element-citation></ref><ref id="B98-viruses-17-00203"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blackhurst</surname><given-names>B.M.</given-names></name>
<name><surname>Funk</surname><given-names>K.E.</given-names></name>
</person-group><article-title>Molecular and Cellular Mechanisms Underlying Neurologic Manifestations of Mosquito-Borne Flavivirus Infections</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>2200</elocation-id><pub-id pub-id-type="doi">10.3390/v15112200</pub-id><pub-id pub-id-type="pmid">38005878</pub-id>
</element-citation></ref><ref id="B99-viruses-17-00203"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbita</surname><given-names>Z.</given-names></name>
<name><surname>Hull</surname><given-names>R.</given-names></name>
<name><surname>Dlamini</surname><given-names>Z.</given-names></name>
</person-group><article-title>Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets</article-title><source>Viruses</source><year>2014</year><volume>6</volume><elocation-id>3181</elocation-id><pub-id pub-id-type="doi">10.3390/v6083181</pub-id><pub-id pub-id-type="pmid">25196285</pub-id>
</element-citation></ref><ref id="B100-viruses-17-00203"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ivanov</surname><given-names>A.V.</given-names></name>
<name><surname>Valuev-Elliston</surname><given-names>V.T.</given-names></name>
<name><surname>Ivanova</surname><given-names>O.N.</given-names></name>
<name><surname>Kochetkov</surname><given-names>S.N.</given-names></name>
<name><surname>Starodubova</surname><given-names>E.S.</given-names></name>
<name><surname>Bartosch</surname><given-names>B.</given-names></name>
<name><surname>Isaguliants</surname><given-names>M.G.</given-names></name>
</person-group><article-title>Oxidative Stress during HIV Infection: Mechanisms and Consequences</article-title><source>Oxid. Med. Cell Longev.</source><year>2016</year><volume>2016</volume><fpage>8910396</fpage><pub-id pub-id-type="doi">10.1155/2016/8910396</pub-id><pub-id pub-id-type="pmid">27829986</pub-id>
</element-citation></ref><ref id="B101-viruses-17-00203"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Landi</surname><given-names>A.</given-names></name>
<name><surname>Iannucci</surname><given-names>V.</given-names></name>
<name><surname>Van Nuffel</surname><given-names>A.</given-names></name>
<name><surname>Meuwissen</surname><given-names>P.</given-names></name>
<name><surname>Verhasselt</surname><given-names>B.</given-names></name>
</person-group><article-title>One Protein to Rule Them All: Modulation of Cell Surface Receptors and Molecules by HIV Nef</article-title><source>Curr. HIV Res.</source><year>2011</year><volume>9</volume><fpage>496</fpage><pub-id pub-id-type="doi">10.2174/157016211798842116</pub-id><pub-id pub-id-type="pmid">22103833</pub-id>
</element-citation></ref><ref id="B102-viruses-17-00203"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anand</surname><given-names>A.R.</given-names></name>
<name><surname>Rachel</surname><given-names>G.</given-names></name>
<name><surname>Parthasarathy</surname><given-names>D.</given-names></name>
</person-group><article-title>HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease</article-title><source>Front. Cardiovasc. Med.</source><year>2018</year><volume>5</volume><elocation-id>425638</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2018.00185</pub-id></element-citation></ref><ref id="B103-viruses-17-00203"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iwamoto</surname><given-names>Y.</given-names></name>
<name><surname>Ye</surname><given-names>A.A.</given-names></name>
<name><surname>Shirazinejad</surname><given-names>C.</given-names></name>
<name><surname>Hurley</surname><given-names>J.H.</given-names></name>
<name><surname>Drubin</surname><given-names>D.G.</given-names></name>
</person-group><article-title>Kinetic Investigation Reveals an HIV-1 Nef-Dependent Increase in AP-2 Recruitment and Productivity at Endocytic Sites</article-title><source>Mol. Biol. Cell</source><year>2024</year><volume>35</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.1091/mbc.E23-04-0126</pub-id></element-citation></ref><ref id="B104-viruses-17-00203"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Modhiran</surname><given-names>N.</given-names></name>
<name><surname>Watterson</surname><given-names>D.</given-names></name>
<name><surname>Muller</surname><given-names>D.A.</given-names></name>
<name><surname>Panetta</surname><given-names>A.K.</given-names></name>
<name><surname>Sester</surname><given-names>D.P.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Hume</surname><given-names>D.A.</given-names></name>
<name><surname>Stacey</surname><given-names>K.J.</given-names></name>
<name><surname>Young</surname><given-names>P.R.</given-names></name>
</person-group><article-title>Dengue Virus NS1 Protein Activates Cells via Toll-like Receptor 4 and Disrupts Endothelial Cell Monolayer Integrity</article-title><source>Sci. Transl. Med.</source><year>2015</year><volume>7</volume><fpage>304ra142</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aaa3863</pub-id></element-citation></ref><ref id="B105-viruses-17-00203"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Puerta-Guardo</surname><given-names>H.</given-names></name>
<name><surname>Glasner</surname><given-names>D.R.</given-names></name>
<name><surname>Espinosa</surname><given-names>D.A.</given-names></name>
<name><surname>Biering</surname><given-names>S.B.</given-names></name>
<name><surname>Patana</surname><given-names>M.</given-names></name>
<name><surname>Ratnasiri</surname><given-names>K.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Beatty</surname><given-names>P.R.</given-names></name>
<name><surname>Harris</surname><given-names>E.</given-names></name>
</person-group><article-title>Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism</article-title><source>Cell Rep.</source><year>2019</year><volume>26</volume><fpage>1598</fpage><lpage>1613.e8</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.036</pub-id><pub-id pub-id-type="pmid">30726741</pub-id>
</element-citation></ref><ref id="B106-viruses-17-00203"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Puerta-Guardo</surname><given-names>H.</given-names></name>
<name><surname>Glasner</surname><given-names>D.R.</given-names></name>
<name><surname>Harris</surname><given-names>E.</given-names></name>
</person-group><article-title>Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability</article-title><source>PLoS Pathog.</source><year>2016</year><volume>12</volume><elocation-id>e1005738</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005738</pub-id><pub-id pub-id-type="pmid">27416066</pub-id>
</element-citation></ref><ref id="B107-viruses-17-00203"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>C.-F.</given-names></name>
<name><surname>Lei</surname><given-names>H.-Y.</given-names></name>
<name><surname>Shiau</surname><given-names>A.-L.</given-names></name>
<name><surname>Liu</surname><given-names>H.-S.</given-names></name>
<name><surname>Yeh</surname><given-names>T.-M.</given-names></name>
<name><surname>Chen</surname><given-names>S.-H.</given-names></name>
<name><surname>Liu</surname><given-names>C.-C.</given-names></name>
<name><surname>Chiu</surname><given-names>S.-C.</given-names></name>
<name><surname>Lin</surname><given-names>Y.-S.</given-names></name>
</person-group><article-title>Endothelial Cell Apoptosis Induced by Antibodies against Dengue Virus Nonstructural Protein 1 via Production of Nitric Oxide</article-title><source>J. Immunol.</source><year>2002</year><volume>169</volume><fpage>657</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.2.657</pub-id><pub-id pub-id-type="pmid">12097367</pub-id>
</element-citation></ref><ref id="B108-viruses-17-00203"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beatty</surname><given-names>P.R.</given-names></name>
<name><surname>Puerta-Guardo</surname><given-names>H.</given-names></name>
<name><surname>Killingbeck</surname><given-names>S.S.</given-names></name>
<name><surname>Glasner</surname><given-names>D.R.</given-names></name>
<name><surname>Hopkins</surname><given-names>K.</given-names></name>
<name><surname>Harris</surname><given-names>E.</given-names></name>
</person-group><article-title>Dengue Virus NS1 Triggers Endothelial Permeability and Vascular Leak That Is Prevented by NS1 Vaccination</article-title><source>Sci. Transl. Med.</source><year>2015</year><volume>7</volume><fpage>304ra141</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aaa3787</pub-id></element-citation></ref><ref id="B109-viruses-17-00203"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Hao</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>B.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
</person-group><article-title>Making Sense of Flavivirus Non-Strctural Protein 1 in Innate Immune Evasion and Inducing Tissue-Specific Damage</article-title><source>Virus Res.</source><year>2023</year><volume>336</volume><fpage>199222</fpage><pub-id pub-id-type="doi">10.1016/j.virusres.2023.199222</pub-id><pub-id pub-id-type="pmid">37716670</pub-id>
</element-citation></ref><ref id="B110-viruses-17-00203"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shrivastava</surname><given-names>G.</given-names></name>
<name><surname>Garc&#x000ed;a-Cordero</surname><given-names>J.</given-names></name>
<name><surname>Le&#x000f3;n-Ju&#x000e1;rez</surname><given-names>M.</given-names></name>
<name><surname>Oza</surname><given-names>G.</given-names></name>
<name><surname>Tapia-Ram&#x000ed;rez</surname><given-names>J.</given-names></name>
<name><surname>Villegas-Sepulveda</surname><given-names>N.</given-names></name>
<name><surname>Cedillo-Barr&#x000f3;n</surname><given-names>L.</given-names></name>
</person-group><article-title>NS2A Comprises a Putative Viroporin of Dengue Virus 2</article-title><source>Virulence</source><year>2017</year><volume>8</volume><fpage>1450</fpage><pub-id pub-id-type="doi">10.1080/21505594.2017.1356540</pub-id><pub-id pub-id-type="pmid">28723277</pub-id>
</element-citation></ref><ref id="B111-viruses-17-00203"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shrivastava</surname><given-names>G.</given-names></name>
<name><surname>Visoso-Carvajal</surname><given-names>G.</given-names></name>
<name><surname>Garcia-Cordero</surname><given-names>J.</given-names></name>
<name><surname>Leon-Juarez</surname><given-names>M.</given-names></name>
<name><surname>Chavez-Munguia</surname><given-names>B.</given-names></name>
<name><surname>Lopez</surname><given-names>T.</given-names></name>
<name><surname>Nava</surname><given-names>P.</given-names></name>
<name><surname>Villegas-Sepulveda</surname><given-names>N.</given-names></name>
<name><surname>Cedillo-Barron</surname><given-names>L.</given-names></name>
</person-group><article-title>Dengue Virus Serotype 2 and Its Non-Structural Proteins 2A and 2B Activate NLRP3 Inflammasome</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>469220</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00352</pub-id><pub-id pub-id-type="pmid">32210961</pub-id>
</element-citation></ref><ref id="B112-viruses-17-00203"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Latanova</surname><given-names>A.</given-names></name>
<name><surname>Starodubova</surname><given-names>E.</given-names></name>
<name><surname>Karpov</surname><given-names>V.</given-names></name>
</person-group><article-title>Flaviviridae Nonstructural Proteins: The Role in Molecular Mechanisms of Triggering Inflammation</article-title><source>Viruses</source><year>2022</year><volume>14</volume><elocation-id>1808</elocation-id><pub-id pub-id-type="doi">10.3390/v14081808</pub-id><pub-id pub-id-type="pmid">36016430</pub-id>
</element-citation></ref><ref id="B113-viruses-17-00203"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Almeida</surname><given-names>S.M.</given-names></name>
<name><surname>Rotta</surname><given-names>I.</given-names></name>
<name><surname>Ribeiro</surname><given-names>C.E.</given-names></name>
<name><surname>Smith</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Judicello</surname><given-names>J.</given-names></name>
<name><surname>Potter</surname><given-names>M.</given-names></name>
<name><surname>Vaida</surname><given-names>F.</given-names></name>
<name><surname>Letendre</surname><given-names>S.</given-names></name>
<name><surname>Ellis</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Blood-CSF Barrier and Compartmentalization of CNS Cellular Immune Response in HIV Infection</article-title><source>J. Neuroimmunol.</source><year>2016</year><volume>301</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2016.10.009</pub-id><pub-id pub-id-type="pmid">27836178</pub-id>
</element-citation></ref><ref id="B114-viruses-17-00203"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pokorna Formanova</surname><given-names>P.</given-names></name>
<name><surname>Palus</surname><given-names>M.</given-names></name>
<name><surname>Salat</surname><given-names>J.</given-names></name>
<name><surname>H&#x000f6;nig</surname><given-names>V.</given-names></name>
<name><surname>Stefanik</surname><given-names>M.</given-names></name>
<name><surname>Svoboda</surname><given-names>P.</given-names></name>
<name><surname>Ruzek</surname><given-names>D.</given-names></name>
</person-group><article-title>Changes in Cytokine and Chemokine Profiles in Mouse Serum and Brain, and in Human Neural Cells, upon Tick-Borne Encephalitis Virus Infection</article-title><source>J. Neuroinflammation</source><year>2019</year><volume>16</volume><fpage>205</fpage><pub-id pub-id-type="doi">10.1186/s12974-019-1596-z</pub-id><pub-id pub-id-type="pmid">31699097</pub-id>
</element-citation></ref><ref id="B115-viruses-17-00203"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costela-Ruiz</surname><given-names>V.J.</given-names></name>
<name><surname>Illescas-Montes</surname><given-names>R.</given-names></name>
<name><surname>Puerta-Puerta</surname><given-names>J.M.</given-names></name>
<name><surname>Ruiz</surname><given-names>C.</given-names></name>
<name><surname>Melguizo-Rodr&#x000ed;guez</surname><given-names>L.</given-names></name>
</person-group><article-title>SARS-CoV-2 Infection: The Role of Cytokines in COVID-19 Disease</article-title><source>Cytokine Growth Factor Rev.</source><year>2020</year><volume>54</volume><fpage>62</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2020.06.001</pub-id><pub-id pub-id-type="pmid">32513566</pub-id>
</element-citation></ref><ref id="B116-viruses-17-00203"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zidovec-Lepej</surname><given-names>S.</given-names></name>
<name><surname>Vilibic-Cavlek</surname><given-names>T.</given-names></name>
<name><surname>Barbic</surname><given-names>L.</given-names></name>
<name><surname>Ilic</surname><given-names>M.</given-names></name>
<name><surname>Savic</surname><given-names>V.</given-names></name>
<name><surname>Tabain</surname><given-names>I.</given-names></name>
<name><surname>Ferenc</surname><given-names>T.</given-names></name>
<name><surname>Grgic</surname><given-names>I.</given-names></name>
<name><surname>Gorenec</surname><given-names>L.</given-names></name>
<name><surname>Bogdanic</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Antiviral Cytokine Response in Neuroinvasive and Non-Neuroinvasive West Nile Virus Infection</article-title><source>Viruses</source><year>2021</year><volume>13</volume><elocation-id>342</elocation-id><pub-id pub-id-type="doi">10.3390/v13020342</pub-id><pub-id pub-id-type="pmid">33671821</pub-id>
</element-citation></ref><ref id="B117-viruses-17-00203"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eugenin</surname><given-names>E.A.</given-names></name>
<name><surname>Berman</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Chemokine-Dependent Mechanisms of Leukocyte Trafficking across a Model of the Blood&#x02013;Brain Barrier</article-title><source>Methods</source><year>2003</year><volume>29</volume><fpage>351</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/S1046-2023(02)00359-6</pub-id><pub-id pub-id-type="pmid">12725802</pub-id>
</element-citation></ref><ref id="B118-viruses-17-00203"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Greene</surname><given-names>C.</given-names></name>
<name><surname>Connolly</surname><given-names>R.</given-names></name>
<name><surname>Brennan</surname><given-names>D.</given-names></name>
<name><surname>Laffan</surname><given-names>A.</given-names></name>
<name><surname>O&#x02019;Keeffe</surname><given-names>E.</given-names></name>
<name><surname>Zaporojan</surname><given-names>L.</given-names></name>
<name><surname>O&#x02019;Callaghan</surname><given-names>J.</given-names></name>
<name><surname>Thomson</surname><given-names>B.</given-names></name>
<name><surname>Connolly</surname><given-names>E.</given-names></name>
<name><surname>Argue</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Blood&#x02013;Brain Barrier Disruption and Sustained Systemic Inflammation in Individuals with Long COVID-Associated Cognitive Impairment</article-title><source>Nat. Neurosci.</source><year>2024</year><volume>27</volume><fpage>421</fpage><pub-id pub-id-type="doi">10.1038/s41593-024-01576-9</pub-id><pub-id pub-id-type="pmid">38388736</pub-id>
</element-citation></ref><ref id="B119-viruses-17-00203"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rhea</surname><given-names>E.M.</given-names></name>
<name><surname>Logsdon</surname><given-names>A.F.</given-names></name>
<name><surname>Hansen</surname><given-names>K.M.</given-names></name>
<name><surname>Williams</surname><given-names>L.M.</given-names></name>
<name><surname>Reed</surname><given-names>M.J.</given-names></name>
<name><surname>Baumann</surname><given-names>K.K.</given-names></name>
<name><surname>Holden</surname><given-names>S.J.</given-names></name>
<name><surname>Raber</surname><given-names>J.</given-names></name>
<name><surname>Banks</surname><given-names>W.A.</given-names></name>
<name><surname>Erickson</surname><given-names>M.A.</given-names></name>
</person-group><article-title>The S1 Protein of SARS-CoV-2 Crosses the Blood&#x02013;Brain Barrier in Mice</article-title><source>Nat. Neurosci.</source><year>2020</year><volume>24</volume><fpage>368</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00771-8</pub-id><pub-id pub-id-type="pmid">33328624</pub-id>
</element-citation></ref><ref id="B120-viruses-17-00203"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hern&#x000e1;ndez-Parra</surname><given-names>H.</given-names></name>
<name><surname>Reyes-Hern&#x000e1;ndez</surname><given-names>O.D.</given-names></name>
<name><surname>Figueroa-Gonz&#x000e1;lez</surname><given-names>G.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Del Carmen</surname><given-names>M.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Torres</surname><given-names>M.</given-names></name>
<name><surname>Pe&#x000f1;a-Corona</surname><given-names>S.I.</given-names></name>
<name><surname>Flor&#x000e1;n</surname><given-names>B.</given-names></name>
<name><surname>Cort&#x000e9;s</surname><given-names>H.</given-names></name>
<name><surname>Leyva-G&#x000f3;mez</surname><given-names>G.</given-names></name>
</person-group><article-title>Alteration of the Blood-Brain Barrier by COVID-19 and Its Implication in the Permeation of Drugs into the Brain</article-title><source>Front. Cell Neurosci.</source><year>2023</year><volume>17</volume><elocation-id>1125109</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2023.1125109</pub-id><pub-id pub-id-type="pmid">36998270</pub-id>
</element-citation></ref><ref id="B121-viruses-17-00203"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Tan</surname><given-names>R.</given-names></name>
<name><surname>Mo</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
</person-group><article-title>The Blood-Brain Barrier in Health, Neurological Diseases, and COVID-19</article-title><source>Fundam. Res.</source><year>2022</year><volume>2</volume><fpage>817</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1016/j.fmre.2022.03.003</pub-id></element-citation></ref><ref id="B122-viruses-17-00203"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Levast</surname><given-names>B.</given-names></name>
<name><surname>Barblu</surname><given-names>L.</given-names></name>
<name><surname>Coutu</surname><given-names>M.</given-names></name>
<name><surname>Pr&#x000e9;vost</surname><given-names>J.</given-names></name>
<name><surname>Brassard</surname><given-names>N.</given-names></name>
<name><surname>Peres</surname><given-names>A.</given-names></name>
<name><surname>Stegen</surname><given-names>C.</given-names></name>
<name><surname>Madrenas</surname><given-names>J.</given-names></name>
<name><surname>Kaufmann</surname><given-names>D.E.</given-names></name>
<name><surname>Finzi</surname><given-names>A.</given-names></name>
</person-group><article-title>HIV-1 Gp120 Envelope Glycoprotein Determinants for Cytokine Burst in Human Monocytes</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0174550</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0174550</pub-id><pub-id pub-id-type="pmid">28346521</pub-id>
</element-citation></ref><ref id="B123-viruses-17-00203"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pandey</surname><given-names>N.</given-names></name>
<name><surname>Jain</surname><given-names>A.</given-names></name>
<name><surname>Garg</surname><given-names>R.K.</given-names></name>
<name><surname>Kumar</surname><given-names>R.</given-names></name>
<name><surname>Agrawal</surname><given-names>O.P.</given-names></name>
<name><surname>Lakshmana Rao</surname><given-names>P.V.</given-names></name>
</person-group><article-title>Serum Levels of IL-8, IFN&#x003b3;, IL-10, and TGF &#x003b2; and Their Gene Expression Levels in Severe and Non-Severe Cases of Dengue Virus Infection</article-title><source>Arch. Virol.</source><year>2015</year><volume>160</volume><fpage>1463</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.1007/s00705-015-2410-6</pub-id><pub-id pub-id-type="pmid">25860648</pub-id>
</element-citation></ref><ref id="B124-viruses-17-00203"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Versele</surname><given-names>R.</given-names></name>
<name><surname>Sevin</surname><given-names>E.</given-names></name>
<name><surname>Gosselet</surname><given-names>F.</given-names></name>
<name><surname>Fenart</surname><given-names>L.</given-names></name>
<name><surname>Candela</surname><given-names>P.</given-names></name>
</person-group><article-title>TNF-&#x003b1; and IL-1&#x003b2; Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-&#x003b2; Peptide Efflux in a Human Blood-Brain Barrier Model</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>10235</elocation-id><pub-id pub-id-type="doi">10.3390/ijms231810235</pub-id><pub-id pub-id-type="pmid">36142143</pub-id>
</element-citation></ref><ref id="B125-viruses-17-00203"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blecharz-Lang</surname><given-names>K.G.</given-names></name>
<name><surname>Wagner</surname><given-names>J.</given-names></name>
<name><surname>Fries</surname><given-names>A.</given-names></name>
<name><surname>Nieminen-Kelh&#x000e4;</surname><given-names>M.</given-names></name>
<name><surname>R&#x000f6;sner</surname><given-names>J.</given-names></name>
<name><surname>Schneider</surname><given-names>U.C.</given-names></name>
<name><surname>Vajkoczy</surname><given-names>P.</given-names></name>
</person-group><article-title>Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells</article-title><source>Transl. Stroke Res.</source><year>2018</year><volume>9</volume><fpage>631</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1007/s12975-018-0614-2</pub-id><pub-id pub-id-type="pmid">29429002</pub-id>
</element-citation></ref><ref id="B126-viruses-17-00203"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopez-Ramirez</surname><given-names>M.A.</given-names></name>
<name><surname>Fischer</surname><given-names>R.</given-names></name>
<name><surname>Torres-Badillo</surname><given-names>C.C.</given-names></name>
<name><surname>Davies</surname><given-names>H.A.</given-names></name>
<name><surname>Logan</surname><given-names>K.</given-names></name>
<name><surname>Pfizenmaier</surname><given-names>K.</given-names></name>
<name><surname>Male</surname><given-names>D.K.</given-names></name>
<name><surname>Sharrack</surname><given-names>B.</given-names></name>
<name><surname>Romero</surname><given-names>I.A.</given-names></name>
</person-group><article-title>Role of Caspases in Cytokine-Induced Barrier Breakdown in Human Brain Endothelial Cells</article-title><source>J. Immunol.</source><year>2012</year><volume>189</volume><fpage>3130</fpage><lpage>3139</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1103460</pub-id><pub-id pub-id-type="pmid">22896632</pub-id>
</element-citation></ref><ref id="B127-viruses-17-00203"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Veldhuis</surname><given-names>W.B.</given-names></name>
<name><surname>Floris</surname><given-names>S.</given-names></name>
<name><surname>Van der Meide</surname><given-names>P.H.</given-names></name>
<name><surname>Vos</surname><given-names>I.M.P.</given-names></name>
<name><surname>De Vries</surname><given-names>H.E.</given-names></name>
<name><surname>Dijkstra</surname><given-names>C.D.</given-names></name>
<name><surname>B&#x000e4;r</surname><given-names>P.R.</given-names></name>
<name><surname>Nicolay</surname><given-names>K.</given-names></name>
</person-group><article-title>Interferon-Beta Prevents Cytokine-Induced Neutrophil Infiltration and Attenuates Blood-Brain Barrier Disruption</article-title><source>J. Cereb. Blood Flow Metab.</source><year>2003</year><volume>23</volume><fpage>1060</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1097/01.WCB.0000080701.47016.24</pub-id><pub-id pub-id-type="pmid">12973022</pub-id>
</element-citation></ref><ref id="B128-viruses-17-00203"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haase</surname><given-names>A.T.</given-names></name>
<name><surname>Stowring</surname><given-names>L.</given-names></name>
<name><surname>Narayan</surname><given-names>O.</given-names></name>
<name><surname>Griffin</surname><given-names>D.</given-names></name>
<name><surname>Price</surname><given-names>D.</given-names></name>
</person-group><article-title>Slow Persistent Infection Caused by Visna Virus: Role of Host Restriction</article-title><source>Science</source><year>1977</year><volume>195</volume><fpage>175</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1126/science.188133</pub-id><pub-id pub-id-type="pmid">188133</pub-id>
</element-citation></ref><ref id="B129-viruses-17-00203"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Narayan</surname><given-names>O.</given-names></name>
<name><surname>Wolinsky</surname><given-names>J.S.</given-names></name>
<name><surname>Clements</surname><given-names>J.E.</given-names></name>
<name><surname>Strandberg</surname><given-names>J.D.</given-names></name>
<name><surname>Griffin</surname><given-names>D.E.</given-names></name>
<name><surname>Cork</surname><given-names>L.C.</given-names></name>
</person-group><article-title>Slow Virus Replication: The Role of Macrophages in the Persistence and Expression of Visna Viruses of Sheep and Goats</article-title><source>J. Gen. Virol.</source><year>1982</year><volume>59</volume><fpage>345</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-59-2-345</pub-id><pub-id pub-id-type="pmid">6281373</pub-id>
</element-citation></ref><ref id="B130-viruses-17-00203"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meltzer</surname><given-names>M.S.</given-names></name>
<name><surname>Skillman</surname><given-names>D.R.</given-names></name>
<name><surname>Gomatos</surname><given-names>P.J.</given-names></name>
<name><surname>Kalter</surname><given-names>D.C.</given-names></name>
<name><surname>Gendelman</surname><given-names>H.E.</given-names></name>
</person-group><article-title>Role of Mononuclear Phagocytes in the Pathogenesis of Human Immunodeficiency Virus Infection</article-title><source>Annu. Rev. Immunol.</source><year>1990</year><volume>8</volume><fpage>169</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1146/annurev.iy.08.040190.001125</pub-id><pub-id pub-id-type="pmid">2188662</pub-id>
</element-citation></ref><ref id="B131-viruses-17-00203"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pulliam</surname><given-names>L.</given-names></name>
</person-group><article-title>Cytomegalovirus Preferentially Infects a Monocyte Derived Macrophage/Microglial Cell in Human Brain Cultures: Neuropathology Differs between Strains</article-title><source>J. Neuropathol. Exp. Neurol.</source><year>1991</year><volume>50</volume><fpage>432</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1097/00005072-199107000-00004</pub-id><pub-id pub-id-type="pmid">1648122</pub-id>
</element-citation></ref><ref id="B132-viruses-17-00203"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daley-Bauer</surname><given-names>L.P.</given-names></name>
<name><surname>Roback</surname><given-names>L.J.</given-names></name>
<name><surname>Wynn</surname><given-names>G.M.</given-names></name>
<name><surname>Mocarski</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Cytomegalovirus Hijacks CX3CR1hi Patrolling Monocytes as Immune-Privileged Vehicles for Dissemination in Mice</article-title><source>Cell Host Microbe</source><year>2014</year><volume>15</volume><fpage>351</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.02.002</pub-id><pub-id pub-id-type="pmid">24629341</pub-id>
</element-citation></ref><ref id="B133-viruses-17-00203"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Percivalle</surname><given-names>E.</given-names></name>
<name><surname>Sammartino</surname><given-names>J.C.</given-names></name>
<name><surname>Cassaniti</surname><given-names>I.</given-names></name>
<name><surname>Arbustini</surname><given-names>E.</given-names></name>
<name><surname>Urtis</surname><given-names>M.</given-names></name>
<name><surname>Smirnova</surname><given-names>A.</given-names></name>
<name><surname>Concardi</surname><given-names>M.</given-names></name>
<name><surname>Belgiovine</surname><given-names>C.</given-names></name>
<name><surname>Ferrari</surname><given-names>A.</given-names></name>
<name><surname>Lilleri</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Macrophages and Monocytes: &#x0201c;Trojan Horses&#x0201d; in COVID-19</article-title><source>Viruses</source><year>2021</year><volume>13</volume><elocation-id>2178</elocation-id><pub-id pub-id-type="doi">10.3390/v13112178</pub-id><pub-id pub-id-type="pmid">34834984</pub-id>
</element-citation></ref><ref id="B134-viruses-17-00203"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koyuncu</surname><given-names>O.O.</given-names></name>
<name><surname>Hogue</surname><given-names>I.B.</given-names></name>
<name><surname>Enquist</surname><given-names>L.W.</given-names></name>
</person-group><article-title>Virus Infections in the Nervous System</article-title><source>Cell Host Microbe</source><year>2013</year><volume>13</volume><fpage>379</fpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.03.010</pub-id><pub-id pub-id-type="pmid">23601101</pub-id>
</element-citation></ref><ref id="B135-viruses-17-00203"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ayala-Nunez</surname><given-names>N.V.</given-names></name>
<name><surname>Gaudin</surname><given-names>R.</given-names></name>
</person-group><article-title>A Viral Journey to the Brain: Current Considerations and Future Developments</article-title><source>PLoS Pathog.</source><year>2020</year><volume>16</volume><elocation-id>e1008434</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008434</pub-id><pub-id pub-id-type="pmid">32437459</pub-id>
</element-citation></ref><ref id="B136-viruses-17-00203"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rouse</surname><given-names>B.T.</given-names></name>
<name><surname>Sehrawat</surname><given-names>S.</given-names></name>
</person-group><article-title>Immunity and Immunopathology to Viruses: What Decides the Outcome?</article-title><source>Nat. Rev. Immunol.</source><year>2010</year><volume>10</volume><fpage>514</fpage><pub-id pub-id-type="doi">10.1038/nri2802</pub-id><pub-id pub-id-type="pmid">20577268</pub-id>
</element-citation></ref><ref id="B137-viruses-17-00203"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bearer</surname><given-names>E.L.</given-names></name>
</person-group><article-title>HSV, Axonal Transport and Alzheimer&#x02019;s Disease: In Vitro and in Vivo Evidence for Causal Relationships</article-title><source>Future Virol.</source><year>2012</year><volume>7</volume><fpage>885</fpage><pub-id pub-id-type="doi">10.2217/fvl.12.81</pub-id><pub-id pub-id-type="pmid">23335944</pub-id>
</element-citation></ref><ref id="B138-viruses-17-00203"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Esiri</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Herpes Simplex Encephalitis. An Immunohistological Study of the Distribution of Viral Antigen within the Brain</article-title><source>J. Neurol. Sci.</source><year>1982</year><volume>54</volume><fpage>209</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/0022-510X(82)90183-6</pub-id><pub-id pub-id-type="pmid">6284882</pub-id>
</element-citation></ref><ref id="B139-viruses-17-00203"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McMahon</surname><given-names>A.</given-names></name>
<name><surname>Conrick-Martin</surname><given-names>I.</given-names></name>
</person-group><article-title>Commonly Encountered Central Nervous System Infections in the Intensive Care Unit</article-title><source>BJA Educ.</source><year>2023</year><volume>23</volume><fpage>212</fpage><pub-id pub-id-type="doi">10.1016/j.bjae.2023.02.003</pub-id><pub-id pub-id-type="pmid">37223692</pub-id>
</element-citation></ref><ref id="B140-viruses-17-00203"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Doll</surname><given-names>J.R.</given-names></name>
<name><surname>Thompson</surname><given-names>R.L.</given-names></name>
<name><surname>Sawtell</surname><given-names>N.M.</given-names></name>
</person-group><article-title>Infectious Herpes Simplex Virus in the Brain Stem Is Correlated with Reactivation in the Trigeminal Ganglia</article-title><source>J. Virol.</source><year>2019</year><volume>93</volume><fpage>e02209-18</fpage><pub-id pub-id-type="doi">10.1128/JVI.02209-18</pub-id><pub-id pub-id-type="pmid">30728262</pub-id>
</element-citation></ref><ref id="B141-viruses-17-00203"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mielcarska</surname><given-names>M.B.</given-names></name>
<name><surname>Skowro&#x00144;ska</surname><given-names>K.</given-names></name>
<name><surname>Wy&#x0017c;ewski</surname><given-names>Z.</given-names></name>
<name><surname>Toka</surname><given-names>F.N.</given-names></name>
</person-group><article-title>Disrupting Neurons and Glial Cells Oneness in the Brain&#x02014;The Possible Causal Role of Herpes Simplex Virus Type 1 (HSV-1) in Alzheimer&#x02019;s Disease</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>23</volume><elocation-id>242</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23010242</pub-id><pub-id pub-id-type="pmid">35008671</pub-id>
</element-citation></ref><ref id="B142-viruses-17-00203"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pahud</surname><given-names>B.A.</given-names></name>
<name><surname>Glaser</surname><given-names>C.A.</given-names></name>
<name><surname>Dekker</surname><given-names>C.L.</given-names></name>
<name><surname>Arvin</surname><given-names>A.M.</given-names></name>
<name><surname>Schmid</surname><given-names>D.S.</given-names></name>
</person-group><article-title>Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine</article-title><source>J. Infect. Dis.</source><year>2011</year><volume>203</volume><fpage>316</fpage><pub-id pub-id-type="doi">10.1093/infdis/jiq066</pub-id><pub-id pub-id-type="pmid">21177308</pub-id>
</element-citation></ref><ref id="B143-viruses-17-00203"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yakovenko</surname><given-names>V.</given-names></name>
<name><surname>Ciobotaro</surname><given-names>P.</given-names></name>
<name><surname>Bardenstein</surname><given-names>R.</given-names></name>
<name><surname>Zusev</surname><given-names>M.</given-names></name>
<name><surname>Zimhony</surname><given-names>O.</given-names></name>
</person-group><article-title>The Role of Varicella Zoster Virus (VZV) in Central Nervous System Infectious Syndromes</article-title><source>Can. J. Infect. Dis. Med. Microbiol.</source><year>2024</year><volume>2024</volume><elocation-id>6664417</elocation-id><pub-id pub-id-type="doi">10.1155/cjid/6664417</pub-id><pub-id pub-id-type="pmid">39624438</pub-id>
</element-citation></ref><ref id="B144-viruses-17-00203"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liedtke</surname><given-names>W.</given-names></name>
<name><surname>Opalka</surname><given-names>B.</given-names></name>
<name><surname>Zimmermann</surname><given-names>C.W.</given-names></name>
<name><surname>Lignitz</surname><given-names>E.</given-names></name>
</person-group><article-title>Age Distribution of Latent Herpes Simplex Virus 1 and Varicella-Zoster Virus Genome in Human Nervous Tissue</article-title><source>J. Neurol. Sci.</source><year>1993</year><volume>116</volume><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/0022-510X(93)90082-A</pub-id><pub-id pub-id-type="pmid">8389816</pub-id>
</element-citation></ref><ref id="B145-viruses-17-00203"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hemling</surname><given-names>N.</given-names></name>
<name><surname>R&#x000f6;ytt&#x000e4;</surname><given-names>M.</given-names></name>
<name><surname>Rinne</surname><given-names>J.</given-names></name>
<name><surname>P&#x000f6;ll&#x000e4;nen</surname><given-names>P.</given-names></name>
<name><surname>Broberg</surname><given-names>E.</given-names></name>
<name><surname>Tapio</surname><given-names>V.</given-names></name>
<name><surname>Vahlberg</surname><given-names>T.</given-names></name>
<name><surname>Hukkanen</surname><given-names>V.</given-names></name>
</person-group><article-title>Herpesviruses in Brains in Alzheimer&#x02019;s and Parkinson&#x02019;s Diseases</article-title><source>Ann. Neurol.</source><year>2003</year><volume>54</volume><fpage>267</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1002/ana.10662</pub-id><pub-id pub-id-type="pmid">12891684</pub-id>
</element-citation></ref><ref id="B146-viruses-17-00203"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bubak</surname><given-names>A.N.</given-names></name>
<name><surname>Como</surname><given-names>C.N.</given-names></name>
<name><surname>Blackmon</surname><given-names>A.M.</given-names></name>
<name><surname>Jones</surname><given-names>D.</given-names></name>
<name><surname>Nagel</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Varicella Zoster Virus Differentially Alters Morphology and Suppresses Proinflammatory Cytokines in Primary Human Spinal Cord and Hippocampal Astrocytes</article-title><source>J. Neuroinflammation</source><year>2018</year><volume>15</volume><fpage>318</fpage><pub-id pub-id-type="doi">10.1186/s12974-018-1360-9</pub-id><pub-id pub-id-type="pmid">30442152</pub-id>
</element-citation></ref><ref id="B147-viruses-17-00203"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleinschmidt-DeMasters</surname><given-names>B.K.</given-names></name>
<name><surname>Gilden</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Varicella-Zoster Virus Infections of the Nervous SystemClinical and Pathologic Correlates</article-title><source>Arch. Pathol. Lab. Med.</source><year>2001</year><volume>125</volume><fpage>770</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.5858/2001-125-0770-VZVIOT</pub-id><pub-id pub-id-type="pmid">11371229</pub-id>
</element-citation></ref><ref id="B148-viruses-17-00203"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chijioke</surname><given-names>O.</given-names></name>
<name><surname>Azzi</surname><given-names>T.</given-names></name>
<name><surname>Nadal</surname><given-names>D.</given-names></name>
<name><surname>M&#x000fc;nz</surname><given-names>C.</given-names></name>
</person-group><article-title>Innate Immune Responses against Epstein Barr Virus Infection</article-title><source>J. Leukoc. Biol.</source><year>2013</year><volume>94</volume><elocation-id>1185</elocation-id><pub-id pub-id-type="doi">10.1189/jlb.0313173</pub-id><pub-id pub-id-type="pmid">23812328</pub-id>
</element-citation></ref><ref id="B149-viruses-17-00203"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soldan</surname><given-names>S.S.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Epstein-Barr Virus Infection in the Development of Neurological Disorders</article-title><source>Drug Discov. Today Dis. Models</source><year>2020</year><volume>32</volume><fpage>35</fpage><pub-id pub-id-type="doi">10.1016/j.ddmod.2020.01.001</pub-id><pub-id pub-id-type="pmid">33897799</pub-id>
</element-citation></ref><ref id="B150-viruses-17-00203"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>N.</given-names></name>
<name><surname>Zuo</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>L.</given-names></name>
<name><surname>Peng</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>X.</given-names></name>
<name><surname>Zuo</surname><given-names>L.</given-names></name>
</person-group><article-title>Epstein-Barr Virus and Neurological Diseases</article-title><source>Front. Mol. Biosci.</source><year>2022</year><volume>8</volume><elocation-id>816098</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2021.816098</pub-id><pub-id pub-id-type="pmid">35083281</pub-id>
</element-citation></ref><ref id="B151-viruses-17-00203"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tyler</surname><given-names>K.L.</given-names></name>
</person-group><article-title>The Enigmatic Links between Epstein-Barr Virus Infection and Multiple Sclerosis</article-title><source>J. Clin. Investig.</source><year>2022</year><volume>132</volume><fpage>e160468</fpage><pub-id pub-id-type="doi">10.1172/JCI160468</pub-id><pub-id pub-id-type="pmid">35499072</pub-id>
</element-citation></ref><ref id="B152-viruses-17-00203"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>H.</given-names></name>
<name><surname>Savitz</surname><given-names>J.</given-names></name>
</person-group><article-title>Effect of Cytomegalovirus Infection on the Central Nervous System: Implications for Psychiatric Disorders</article-title><source>Curr. Top. Behav. Neurosci.</source><year>2023</year><volume>61</volume><fpage>215</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1007/7854_2022_361</pub-id><pub-id pub-id-type="pmid">35505056</pub-id>
</element-citation></ref><ref id="B153-viruses-17-00203"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adelman</surname><given-names>J.W.</given-names></name>
<name><surname>Rosas-Rogers</surname><given-names>S.</given-names></name>
<name><surname>Schumacher</surname><given-names>M.L.</given-names></name>
<name><surname>Mokry</surname><given-names>R.L.</given-names></name>
<name><surname>Terhune</surname><given-names>S.S.</given-names></name>
<name><surname>Ebert</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Human Cytomegalovirus Induces Significant Structural and Functional Changes in Terminally Differentiated Human Cortical Neurons</article-title><source>mBio</source><year>2023</year><volume>14</volume><fpage>e02251-23</fpage><pub-id pub-id-type="doi">10.1128/mbio.02251-23</pub-id><pub-id pub-id-type="pmid">37966250</pub-id>
</element-citation></ref><ref id="B154-viruses-17-00203"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harberts</surname><given-names>E.</given-names></name>
<name><surname>Yao</surname><given-names>K.</given-names></name>
<name><surname>Wohler</surname><given-names>J.E.</given-names></name>
<name><surname>Maric</surname><given-names>D.</given-names></name>
<name><surname>Ohayon</surname><given-names>J.</given-names></name>
<name><surname>Henkin</surname><given-names>R.</given-names></name>
<name><surname>Jacobson</surname><given-names>S.</given-names></name>
</person-group><article-title>Human Herpesvirus-6 Entry into the Central Nervous System through the Olfactory Pathway</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>13734</fpage><pub-id pub-id-type="doi">10.1073/pnas.1105143108</pub-id><pub-id pub-id-type="pmid">21825120</pub-id>
</element-citation></ref><ref id="B155-viruses-17-00203"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chapenko</surname><given-names>S.</given-names></name>
<name><surname>Roga</surname><given-names>S.</given-names></name>
<name><surname>Skuja</surname><given-names>S.</given-names></name>
<name><surname>Rasa</surname><given-names>S.</given-names></name>
<name><surname>Cistjakovs</surname><given-names>M.</given-names></name>
<name><surname>Svirskis</surname><given-names>S.</given-names></name>
<name><surname>Zaserska</surname><given-names>Z.</given-names></name>
<name><surname>Groma</surname><given-names>V.</given-names></name>
<name><surname>Murovska</surname><given-names>M.</given-names></name>
</person-group><article-title>Detection Frequency of Human Herpesviruses-6A, -6B, and -7 Genomic Sequences in Central Nervous System DNA Samples from Post-Mortem Individuals with Unspecified Encephalopathy</article-title><source>J. Neurovirol.</source><year>2016</year><volume>22</volume><fpage>488</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1007/s13365-015-0417-0</pub-id><pub-id pub-id-type="pmid">26727906</pub-id>
</element-citation></ref><ref id="B156-viruses-17-00203"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Skuja</surname><given-names>S.</given-names></name>
<name><surname>Svirskis</surname><given-names>S.</given-names></name>
<name><surname>Murovska</surname><given-names>M.</given-names></name>
</person-group><article-title>Human Herpesvirus-6 and -7 in the Brain Microenvironment of Persons with Neurological Pathology and Healthy People</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>2364</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22052364</pub-id><pub-id pub-id-type="pmid">33673426</pub-id>
</element-citation></ref><ref id="B157-viruses-17-00203"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Santpere</surname><given-names>G.</given-names></name>
<name><surname>Telford</surname><given-names>M.</given-names></name>
<name><surname>Andr&#x000e9;s-Benito</surname><given-names>P.</given-names></name>
<name><surname>Navarro</surname><given-names>A.</given-names></name>
<name><surname>Ferrer</surname><given-names>I.</given-names></name>
</person-group><article-title>The Presence of Human Herpesvirus 6 in the Brain in Health and Disease</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>1520</elocation-id><pub-id pub-id-type="doi">10.3390/biom10111520</pub-id><pub-id pub-id-type="pmid">33172107</pub-id>
</element-citation></ref><ref id="B158-viruses-17-00203"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bahramian</surname><given-names>E.</given-names></name>
<name><surname>Furr</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>J.T.</given-names></name>
<name><surname>Ceballos</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Differential Impacts of HHV-6A versus HHV-6B Infection in Differentiated Human Neural Stem Cells</article-title><source>Front. Immunol.</source><year>2022</year><volume>13</volume><elocation-id>847106</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.847106</pub-id><pub-id pub-id-type="pmid">35911725</pub-id>
</element-citation></ref><ref id="B159-viruses-17-00203"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bortolotti</surname><given-names>D.</given-names></name>
<name><surname>Gentili</surname><given-names>V.</given-names></name>
<name><surname>Rotola</surname><given-names>A.</given-names></name>
<name><surname>Caselli</surname><given-names>E.</given-names></name>
<name><surname>Rizzo</surname><given-names>R.</given-names></name>
</person-group><article-title>HHV-6A Infection Induces Amyloid-Beta Expression and Activation of Microglial Cells</article-title><source>Alzheimers Res. Ther.</source><year>2019</year><volume>11</volume><fpage>104</fpage><pub-id pub-id-type="doi">10.1186/s13195-019-0552-6</pub-id><pub-id pub-id-type="pmid">31831060</pub-id>
</element-citation></ref><ref id="B160-viruses-17-00203"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grut</surname><given-names>V.</given-names></name>
<name><surname>Bistr&#x000f6;m</surname><given-names>M.</given-names></name>
<name><surname>Salzer</surname><given-names>J.</given-names></name>
<name><surname>Stridh</surname><given-names>P.</given-names></name>
<name><surname>Jons</surname><given-names>D.</given-names></name>
<name><surname>Gustafsson</surname><given-names>R.</given-names></name>
<name><surname>Fogdell-Hahn</surname><given-names>A.</given-names></name>
<name><surname>Huang</surname><given-names>J.</given-names></name>
<name><surname>Butt</surname><given-names>J.</given-names></name>
<name><surname>Lindam</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Human Herpesvirus 6A and Axonal Injury before the Clinical Onset of Multiple Sclerosis</article-title><source>Brain</source><year>2024</year><volume>147</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1093/brain/awad374</pub-id><pub-id pub-id-type="pmid">37930324</pub-id>
</element-citation></ref><ref id="B161-viruses-17-00203"><label>161.</label><element-citation publication-type="webpage"><article-title>Poliomyelitis</article-title><comment>Available online: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/poliomyelitis" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/poliomyelitis</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-21">(accessed on 21 December 2024)</date-in-citation></element-citation></ref><ref id="B162-viruses-17-00203"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pavio</surname><given-names>N.</given-names></name>
<name><surname>Buc-Caron</surname><given-names>M.H.</given-names></name>
<name><surname>Colb&#x000e8;re-Garapin</surname><given-names>F.</given-names></name>
</person-group><article-title>Persistent Poliovirus Infection of Human Fetal Brain Cells</article-title><source>J. Virol.</source><year>1996</year><volume>70</volume><fpage>6395</fpage><pub-id pub-id-type="doi">10.1128/jvi.70.9.6395-6401.1996</pub-id><pub-id pub-id-type="pmid">8709269</pub-id>
</element-citation></ref><ref id="B163-viruses-17-00203"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Sun</surname><given-names>Z.</given-names></name>
<name><surname>Ma</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
</person-group><article-title>Enterovirus A71 Capsid Protein VP1 Increases Blood&#x02013;Brain Barrier Permeability and Virus Receptor Vimentin on the Brain Endothelial Cells</article-title><source>J. Neurovirol.</source><year>2019</year><volume>26</volume><fpage>84</fpage><pub-id pub-id-type="doi">10.1007/s13365-019-00800-8</pub-id><pub-id pub-id-type="pmid">31512144</pub-id>
</element-citation></ref><ref id="B164-viruses-17-00203"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>L.Y.</given-names></name>
<name><surname>Lin</surname><given-names>H.Y.</given-names></name>
<name><surname>Gau</surname><given-names>S.S.F.</given-names></name>
<name><surname>Lu</surname><given-names>C.Y.</given-names></name>
<name><surname>Hsia</surname><given-names>S.H.</given-names></name>
<name><surname>Huang</surname><given-names>Y.C.</given-names></name>
<name><surname>Huang</surname><given-names>L.M.</given-names></name>
<name><surname>Lin</surname><given-names>T.Y.</given-names></name>
</person-group><article-title>Enterovirus A71 Neurologic Complications and Long-Term Sequelae</article-title><source>J. Biomed. Sci.</source><year>2019</year><volume>26</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.1186/s12929-019-0552-7</pub-id><pub-id pub-id-type="pmid">31395054</pub-id>
</element-citation></ref><ref id="B165-viruses-17-00203"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>L.Y.</given-names></name>
<name><surname>Lin</surname><given-names>T.Y.</given-names></name>
<name><surname>Hsu</surname><given-names>K.H.</given-names></name>
<name><surname>Huang</surname><given-names>Y.C.</given-names></name>
<name><surname>Lin</surname><given-names>K.L.</given-names></name>
<name><surname>Hsueh</surname><given-names>C.</given-names></name>
<name><surname>Shih</surname><given-names>S.R.</given-names></name>
<name><surname>Ning</surname><given-names>H.C.</given-names></name>
<name><surname>Hwang</surname><given-names>M.S.</given-names></name>
<name><surname>Wang</surname><given-names>H.S.</given-names></name>
<etal/>
</person-group><article-title>Clinical Features and Risk Factors of Pulmonary Oedema after Enterovirus-71-Related Hand, Foot, and Mouth Disease</article-title><source>Lancet</source><year>1999</year><volume>354</volume><fpage>1682</fpage><lpage>1686</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(99)04434-7</pub-id><pub-id pub-id-type="pmid">10568570</pub-id>
</element-citation></ref><ref id="B166-viruses-17-00203"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tee</surname><given-names>H.K.</given-names></name>
<name><surname>Zainol</surname><given-names>M.I.</given-names></name>
<name><surname>Sam</surname><given-names>I.C.</given-names></name>
<name><surname>Chan</surname><given-names>Y.F.</given-names></name>
</person-group><article-title>Recent Advances in the Understanding of Enterovirus A71 Infection: A Focus on Neuropathogenesis</article-title><source>Expert. Rev. Anti Infect. Ther.</source><year>2021</year><volume>19</volume><fpage>733</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1080/14787210.2021.1851194</pub-id><pub-id pub-id-type="pmid">33183118</pub-id>
</element-citation></ref><ref id="B167-viruses-17-00203"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>M.</given-names></name>
<name><surname>Liao</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Fan</surname><given-names>S.</given-names></name>
<name><surname>Xu</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
</person-group><article-title>Mechanism for the Lethal Effect of Enterovirus A71 Intracerebral Injection in Neonatal Mice</article-title><source>Lab. Investig.</source><year>2019</year><volume>100</volume><fpage>596</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/s41374-019-0351-5</pub-id><pub-id pub-id-type="pmid">31857694</pub-id>
</element-citation></ref><ref id="B168-viruses-17-00203"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>P.</given-names></name>
<name><surname>Ji</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>F.</given-names></name>
<name><surname>Sun</surname><given-names>T.</given-names></name>
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Jin</surname><given-names>Y.</given-names></name>
<name><surname>Duan</surname><given-names>G.</given-names></name>
</person-group><article-title>The Activation of Complement C5a-C5aR1 Axis in Astrocytes Facilitates the Neuropathogenesis Due to EV-A71 Infection by Upregulating CXCL1</article-title><source>J. Virol.</source><year>2024</year><fpage>e0151424</fpage><pub-id pub-id-type="doi">10.1128/jvi.01514-24</pub-id><pub-id pub-id-type="pmid">39679722</pub-id>
</element-citation></ref><ref id="B169-viruses-17-00203"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Majde</surname><given-names>J.A.</given-names></name>
<name><surname>Bohnet</surname><given-names>S.G.</given-names></name>
<name><surname>Ellis</surname><given-names>G.A.</given-names></name>
<name><surname>Churchill</surname><given-names>L.</given-names></name>
<name><surname>Leyva-Grado</surname><given-names>V.</given-names></name>
<name><surname>Wu</surname><given-names>M.</given-names></name>
<name><surname>Szentirmai</surname><given-names>E.</given-names></name>
<name><surname>Rehman</surname><given-names>A.</given-names></name>
<name><surname>Krueger</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Detection of Mouse-Adapted Human Influenza Virus in the Olfactory Bulbs of Mice within Hours after Intranasal Infection</article-title><source>J. Neurovirol.</source><year>2007</year><volume>13</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1080/13550280701427069</pub-id><pub-id pub-id-type="pmid">17994424</pub-id>
</element-citation></ref><ref id="B170-viruses-17-00203"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shinya</surname><given-names>K.</given-names></name>
<name><surname>Makino</surname><given-names>A.</given-names></name>
<name><surname>Hatta</surname><given-names>M.</given-names></name>
<name><surname>Watanabe</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>J.H.</given-names></name>
<name><surname>Hatta</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>P.</given-names></name>
<name><surname>Ozawa</surname><given-names>M.</given-names></name>
<name><surname>Le</surname><given-names>Q.M.</given-names></name>
<name><surname>Kawaoka</surname><given-names>Y.</given-names></name>
</person-group><article-title>Subclinical Brain Injury Caused by H5N1 Influenza Virus Infection</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>5202</fpage><pub-id pub-id-type="doi">10.1128/JVI.00239-11</pub-id><pub-id pub-id-type="pmid">21389133</pub-id>
</element-citation></ref><ref id="B171-viruses-17-00203"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Riel</surname><given-names>D.</given-names></name>
<name><surname>Leijten</surname><given-names>L.M.</given-names></name>
<name><surname>Verdijk</surname><given-names>R.M.</given-names></name>
<name><surname>GeurtsvanKessel</surname><given-names>C.</given-names></name>
<name><surname>Van Der Vries</surname><given-names>E.</given-names></name>
<name><surname>Van Rossum</surname><given-names>A.M.C.</given-names></name>
<name><surname>Osterhaus</surname><given-names>A.D.M.E.</given-names></name>
<name><surname>Kuiken</surname><given-names>T.</given-names></name>
</person-group><article-title>Evidence for Influenza Virus CNS Invasion along the Olfactory Route in an Immunocompromised Infant</article-title><source>J. Infect. Dis.</source><year>2014</year><volume>210</volume><fpage>419</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiu097</pub-id><pub-id pub-id-type="pmid">24550441</pub-id>
</element-citation></ref><ref id="B172-viruses-17-00203"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siegers</surname><given-names>J.Y.</given-names></name>
<name><surname>van de Bildt</surname><given-names>M.W.G.</given-names></name>
<name><surname>Lin</surname><given-names>Z.</given-names></name>
<name><surname>Leijten</surname><given-names>L.M.</given-names></name>
<name><surname>Lavrijssen</surname><given-names>R.A.M.</given-names></name>
<name><surname>Bestebroer</surname><given-names>T.</given-names></name>
<name><surname>Spronken</surname><given-names>M.I.J.</given-names></name>
<name><surname>De Zeeuw</surname><given-names>C.I.</given-names></name>
<name><surname>Gao</surname><given-names>Z.</given-names></name>
<name><surname>Schrauwen</surname><given-names>E.J.A.</given-names></name>
<etal/>
</person-group><article-title>Viral Factors Important for Efficient Replication of Influenza A Viruses in Cells of the Central Nervous System</article-title><source>J. Virol.</source><year>2019</year><volume>93</volume><fpage>e02273-18</fpage><pub-id pub-id-type="doi">10.1128/JVI.02273-18</pub-id><pub-id pub-id-type="pmid">30867311</pub-id>
</element-citation></ref><ref id="B173-viruses-17-00203"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura-Ohba</surname><given-names>S.</given-names></name>
<name><surname>Kitamura</surname><given-names>M.</given-names></name>
<name><surname>Tsukamoto</surname><given-names>Y.</given-names></name>
<name><surname>Kogaki</surname><given-names>S.</given-names></name>
<name><surname>Sakai</surname><given-names>S.</given-names></name>
<name><surname>Fushimi</surname><given-names>H.</given-names></name>
<name><surname>Matsuoka</surname><given-names>K.</given-names></name>
<name><surname>Takeuchi</surname><given-names>M.</given-names></name>
<name><surname>Itoh</surname><given-names>K.</given-names></name>
<name><surname>Ueda</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Viral Entry and Translation in Brain Endothelia Provoke Influenza-Associated Encephalopathy</article-title><source>Acta Neuropathol.</source><year>2024</year><volume>147</volume><fpage>77</fpage><pub-id pub-id-type="doi">10.1007/s00401-024-02723-z</pub-id><pub-id pub-id-type="pmid">38687393</pub-id>
</element-citation></ref><ref id="B174-viruses-17-00203"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jang</surname><given-names>H.</given-names></name>
<name><surname>Boltz</surname><given-names>D.</given-names></name>
<name><surname>Sturm-Ramirez</surname><given-names>K.</given-names></name>
<name><surname>Shepherd</surname><given-names>K.R.</given-names></name>
<name><surname>Jiao</surname><given-names>Y.</given-names></name>
<name><surname>Webster</surname><given-names>R.</given-names></name>
<name><surname>Smeyne</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Highly Pathogenic H5N1 Influenza Virus Can Enter the Central Nervous System and Induce Neuroinflammation and Neurodegeneration</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>14063</fpage><lpage>14068</lpage><pub-id pub-id-type="doi">10.1073/pnas.0900096106</pub-id><pub-id pub-id-type="pmid">19667183</pub-id>
</element-citation></ref><ref id="B175-viruses-17-00203"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ng</surname><given-names>Y.P.</given-names></name>
<name><surname>Yip</surname><given-names>T.F.</given-names></name>
<name><surname>Peiris</surname><given-names>J.S.M.</given-names></name>
<name><surname>Ip</surname><given-names>N.Y.</given-names></name>
<name><surname>Lee</surname><given-names>S.M.Y.</given-names></name>
</person-group><article-title>Avian Influenza A H7N9 Virus Infects Human Astrocytes and Neuronal Cells and Induces Inflammatory Immune Responses</article-title><source>J. Neurovirol.</source><year>2018</year><volume>24</volume><fpage>752</fpage><pub-id pub-id-type="doi">10.1007/s13365-018-0659-8</pub-id><pub-id pub-id-type="pmid">29987581</pub-id>
</element-citation></ref><ref id="B176-viruses-17-00203"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Libbey</surname><given-names>J.E.</given-names></name>
<name><surname>Fujinami</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Adaptive Immune Response to Viral Infections in the Central Nervous System</article-title><source>Handb. Clin. Neurol.</source><year>2014</year><volume>123</volume><fpage>225</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-53488-0.00010-9</pub-id><pub-id pub-id-type="pmid">25015488</pub-id>
</element-citation></ref><ref id="B177-viruses-17-00203"><label>177.</label><element-citation publication-type="webpage"><article-title>Mumps</article-title><comment>Available online: <ext-link xlink:href="https://www.ecdc.europa.eu/en/mumps" ext-link-type="uri">https://www.ecdc.europa.eu/en/mumps</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-21">(accessed on 21 December 2024)</date-in-citation></element-citation></ref><ref id="B178-viruses-17-00203"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rubin</surname><given-names>S.</given-names></name>
<name><surname>Eckhaus</surname><given-names>M.</given-names></name>
<name><surname>Rennick</surname><given-names>L.J.</given-names></name>
<name><surname>Bamford</surname><given-names>C.G.G.</given-names></name>
<name><surname>Duprex</surname><given-names>W.P.</given-names></name>
</person-group><article-title>Molecular Biology, Pathogenesis and Pathology of Mumps Virus</article-title><source>J. Pathol.</source><year>2015</year><volume>235</volume><fpage>242</fpage><pub-id pub-id-type="doi">10.1002/path.4445</pub-id><pub-id pub-id-type="pmid">25229387</pub-id>
</element-citation></ref><ref id="B179-viruses-17-00203"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Julkunen</surname><given-names>I.</given-names></name>
<name><surname>Lehtokoski-Lehtiniemi</surname><given-names>E.</given-names></name>
<name><surname>Koskiniemi</surname><given-names>M.</given-names></name>
<name><surname>Vaheri</surname><given-names>A.</given-names></name>
</person-group><article-title>Elevated Mumps Antibody Titers in the Cerebrospinal Fluid Suggesting Chronic Mumps Virus Infection in the Central Nervous System</article-title><source>Pediatr. Infect. Dis.</source><year>1985</year><volume>4</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.1097/00006454-198501000-00023</pub-id><pub-id pub-id-type="pmid">3969368</pub-id>
</element-citation></ref><ref id="B180-viruses-17-00203"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haginoya</surname><given-names>K.</given-names></name>
<name><surname>Ike</surname><given-names>K.</given-names></name>
<name><surname>Linuma</surname><given-names>K.</given-names></name>
<name><surname>Yagi</surname><given-names>T.</given-names></name>
<name><surname>Kon</surname><given-names>K.</given-names></name>
<name><surname>Yokoyama</surname><given-names>H.</given-names></name>
<name><surname>Numazaki</surname><given-names>Y.</given-names></name>
</person-group><article-title>Chronic Progressive Mumps Virus Encephalitis in a Child</article-title><source>Lancet</source><year>1995</year><volume>346</volume><fpage>50</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(95)92678-X</pub-id></element-citation></ref><ref id="B181-viruses-17-00203"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rubin</surname><given-names>S.A.</given-names></name>
<name><surname>Amexis</surname><given-names>G.</given-names></name>
<name><surname>Pletnikov</surname><given-names>M.</given-names></name>
<name><surname>Vanderzanden</surname><given-names>J.</given-names></name>
<name><surname>Mauldin</surname><given-names>J.</given-names></name>
<name><surname>Sauder</surname><given-names>C.</given-names></name>
<name><surname>Malik</surname><given-names>T.</given-names></name>
<name><surname>Chumakov</surname><given-names>K.</given-names></name>
<name><surname>Carbone</surname><given-names>K.M.</given-names></name>
</person-group><article-title>Changes in Mumps Virus Gene Sequence Associated with Variability in Neurovirulent Phenotype</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>11616</fpage><pub-id pub-id-type="doi">10.1128/JVI.77.21.11616-11624.2003</pub-id><pub-id pub-id-type="pmid">14557647</pub-id>
</element-citation></ref><ref id="B182-viruses-17-00203"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Esolen</surname><given-names>L.M.</given-names></name>
<name><surname>Takahashi</surname><given-names>K.</given-names></name>
<name><surname>Johnson</surname><given-names>R.T.</given-names></name>
<name><surname>Vaisberg</surname><given-names>A.</given-names></name>
<name><surname>Moench</surname><given-names>T.R.</given-names></name>
<name><surname>Wesselingh</surname><given-names>S.L.</given-names></name>
<name><surname>Griffin</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Brain Endothelial Cell Infection in Children with Acute Fatal Measles</article-title><source>J. Clin. Investig.</source><year>1995</year><volume>96</volume><fpage>2478</fpage><pub-id pub-id-type="doi">10.1172/JCI118306</pub-id><pub-id pub-id-type="pmid">7593637</pub-id>
</element-citation></ref><ref id="B183-viruses-17-00203"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Young</surname><given-names>V.A.</given-names></name>
<name><surname>Rall</surname><given-names>G.F.</given-names></name>
</person-group><article-title>Making It to the Synapse: Measles Virus Spread in and among Neurons</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2009</year><volume>330</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1007/978-3-540-70617-5_1</pub-id><pub-id pub-id-type="pmid">19203102</pub-id>
</element-citation></ref><ref id="B184-viruses-17-00203"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonthius</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Measles Virus and the Central Nervous System: An Update</article-title><source>Semin. Pediatr. Neurol.</source><year>2023</year><volume>47</volume><fpage>101078</fpage><pub-id pub-id-type="doi">10.1016/j.spen.2023.101078</pub-id><pub-id pub-id-type="pmid">37919033</pub-id>
</element-citation></ref><ref id="B185-viruses-17-00203"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schneider-Schaulies</surname><given-names>J.</given-names></name>
<name><surname>Niewiesk</surname><given-names>S.</given-names></name>
<name><surname>Schneider-Schaulies</surname><given-names>S.</given-names></name>
<name><surname>Ter Meulen</surname><given-names>V.</given-names></name>
</person-group><article-title>Measles Virus in the CNS: The Role of Viral and Host Factors for the Establishment and Maintenance of a Persistent Infection</article-title><source>J. Neurovirol.</source><year>1999</year><volume>5</volume><fpage>613</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.3109/13550289909021290</pub-id><pub-id pub-id-type="pmid">10602402</pub-id>
</element-citation></ref><ref id="B186-viruses-17-00203"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dando</surname><given-names>S.J.</given-names></name>
<name><surname>Mackay-Sim</surname><given-names>A.</given-names></name>
<name><surname>Norton</surname><given-names>R.</given-names></name>
<name><surname>Currie</surname><given-names>B.J.</given-names></name>
<name><surname>St. John</surname><given-names>J.A.</given-names></name>
<name><surname>Ekberg</surname><given-names>J.A.K.</given-names></name>
<name><surname>Batzloff</surname><given-names>M.</given-names></name>
<name><surname>Ulett</surname><given-names>G.C.</given-names></name>
<name><surname>Beacham</surname><given-names>I.R.</given-names></name>
</person-group><article-title>Pathogens Penetrating the Central Nervous System: Infection Pathways and the Cellular and Molecular Mechanisms of Invasion</article-title><source>Clin. Microbiol. Rev.</source><year>2014</year><volume>27</volume><elocation-id>691</elocation-id><pub-id pub-id-type="doi">10.1128/CMR.00118-13</pub-id><pub-id pub-id-type="pmid">25278572</pub-id>
</element-citation></ref><ref id="B187-viruses-17-00203"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zacks</surname><given-names>M.A.</given-names></name>
<name><surname>Paessler</surname><given-names>S.</given-names></name>
</person-group><article-title>Encephalitic alphaviruses</article-title><source>Vet. Microbiol.</source><year>2009</year><volume>140</volume><elocation-id>281</elocation-id><pub-id pub-id-type="doi">10.1016/j.vetmic.2009.08.023</pub-id><pub-id pub-id-type="pmid">19775836</pub-id>
</element-citation></ref><ref id="B188-viruses-17-00203"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>K.T.</given-names></name>
<name><surname>Robertson</surname><given-names>T.</given-names></name>
<name><surname>Ong</surname><given-names>B.B.</given-names></name>
<name><surname>Chong</surname><given-names>J.W.</given-names></name>
<name><surname>Yaiw</surname><given-names>K.C.</given-names></name>
<name><surname>Wang</surname><given-names>L.F.</given-names></name>
<name><surname>Ansford</surname><given-names>A.J.</given-names></name>
<name><surname>Tannenberg</surname><given-names>A.</given-names></name>
</person-group><article-title>Human Hendra Virus Infection Causes Acute and Relapsing Encephalitis</article-title><source>Neuropathol. Appl. Neurobiol.</source><year>2009</year><volume>35</volume><fpage>296</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2990.2008.00991.x</pub-id><pub-id pub-id-type="pmid">19473296</pub-id>
</element-citation></ref><ref id="B189-viruses-17-00203"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meier</surname><given-names>K.</given-names></name>
<name><surname>Olejnik</surname><given-names>J.</given-names></name>
<name><surname>Hume</surname><given-names>A.J.</given-names></name>
<name><surname>M&#x000fc;hlberger</surname><given-names>E.</given-names></name>
</person-group><article-title>A Comparative Assessment of the Pathogenic Potential of Newly Discovered Henipaviruses</article-title><source>Pathogens</source><year>2024</year><volume>13</volume><elocation-id>587</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens13070587</pub-id><pub-id pub-id-type="pmid">39057814</pub-id>
</element-citation></ref><ref id="B190-viruses-17-00203"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Alejandro</surname><given-names>B.</given-names></name>
<name><surname>Hetman</surname><given-names>M.</given-names></name>
<name><surname>Hattab</surname><given-names>E.M.</given-names></name>
<name><surname>Joiner</surname><given-names>J.</given-names></name>
<name><surname>Schroten</surname><given-names>H.</given-names></name>
<name><surname>Ishikawa</surname><given-names>H.</given-names></name>
<name><surname>Chung</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Zika Virus Infects Pericytes in the Choroid Plexus and Enters the Central Nervous System through the Blood-Cerebrospinal Fluid Barrier</article-title><source>PLoS Pathog.</source><year>2020</year><volume>16</volume><elocation-id>e1008204</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008204</pub-id><pub-id pub-id-type="pmid">32357162</pub-id>
</element-citation></ref><ref id="B191-viruses-17-00203"><label>191.</label><element-citation publication-type="gov"><person-group person-group-type="author">
<name><surname>Danes</surname><given-names>L.</given-names></name>
<name><surname>Kufner</surname><given-names>J.</given-names></name>
<name><surname>Hruskov&#x000e1;</surname><given-names>V.</given-names></name>
<name><surname>Rychterova</surname><given-names>V.</given-names></name>
</person-group><article-title>The Role of the Olfactory Route on Infection of the Respiratory Tract with Venezuelan Equine Encephalomyelitis Virus in Normal and Operated Macaca Rhesus Monkeys. I. Results of Virological Examination</article-title><comment>Available online: <ext-link xlink:href="https://pubmed.ncbi.nlm.nih.gov/4405396/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/4405396/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-21">(accessed on 21 December 2024)</date-in-citation></element-citation></ref><ref id="B192-viruses-17-00203"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>H.</given-names></name>
<name><surname>Albe</surname><given-names>J.R.</given-names></name>
<name><surname>Gilliland</surname><given-names>T.</given-names></name>
<name><surname>McMillen</surname><given-names>C.M.</given-names></name>
<name><surname>Gardner</surname><given-names>C.L.</given-names></name>
<name><surname>Boyles</surname><given-names>D.A.</given-names></name>
<name><surname>Cottle</surname><given-names>E.L.</given-names></name>
<name><surname>Dunn</surname><given-names>M.D.</given-names></name>
<name><surname>Lundy</surname><given-names>J.D.</given-names></name>
<name><surname>Salama</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Long-Term Persistence of Viral RNA and Inflammation in the CNS of Macaques Exposed to Aerosolized Venezuelan Equine Encephalitis Virus</article-title><source>PLoS Pathog.</source><year>2022</year><volume>18</volume><elocation-id>e1009946</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009946</pub-id><pub-id pub-id-type="pmid">35696423</pub-id>
</element-citation></ref><ref id="B193-viruses-17-00203"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bantle</surname><given-names>C.M.</given-names></name>
<name><surname>Phillips</surname><given-names>A.T.</given-names></name>
<name><surname>Smeyne</surname><given-names>R.J.</given-names></name>
<name><surname>Rocha</surname><given-names>S.M.</given-names></name>
<name><surname>Olson</surname><given-names>K.E.</given-names></name>
<name><surname>Tjalkens</surname><given-names>R.B.</given-names></name>
</person-group><article-title>Infection with Mosquito-Borne Alphavirus Induces Selective Loss of Dopaminergic Neurons, Neuroinflammation and Widespread Protein Aggregation</article-title><source>NPJ Park. Dis.</source><year>2019</year><volume>5</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1038/s41531-019-0090-8</pub-id></element-citation></ref><ref id="B194-viruses-17-00203"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singer</surname><given-names>E.J.</given-names></name>
<name><surname>Valdes-Sueiras</surname><given-names>M.</given-names></name>
<name><surname>Commins</surname><given-names>D.</given-names></name>
<name><surname>Levine</surname><given-names>A.</given-names></name>
</person-group><article-title>Neurologic Presentations of AIDS</article-title><source>Neurol. Clin.</source><year>2010</year><volume>28</volume><fpage>253</fpage><pub-id pub-id-type="doi">10.1016/j.ncl.2009.09.018</pub-id><pub-id pub-id-type="pmid">19932385</pub-id>
</element-citation></ref><ref id="B195-viruses-17-00203"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Castellano</surname><given-names>P.</given-names></name>
<name><surname>Prevedel</surname><given-names>L.</given-names></name>
<name><surname>Eugenin</surname><given-names>E.A.</given-names></name>
</person-group><article-title>HIV-Infected Macrophages and Microglia That Survive Acute Infection Become Viral Reservoirs by a Mechanism Involving Bim</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><elocation-id>12866</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-12758-w</pub-id><pub-id pub-id-type="pmid">28993666</pub-id>
</element-citation></ref><ref id="B196-viruses-17-00203"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pattanaik</surname><given-names>A.</given-names></name>
<name><surname>Bhandarkar</surname><given-names>B.S.</given-names></name>
<name><surname>Lodha</surname><given-names>L.</given-names></name>
<name><surname>Marate</surname><given-names>S.</given-names></name>
</person-group><article-title>SARS-CoV-2 and the Nervous System: Current Perspectives</article-title><source>Arch. Virol.</source><year>2023</year><volume>168</volume><fpage>171</fpage><pub-id pub-id-type="doi">10.1007/s00705-023-05801-x</pub-id><pub-id pub-id-type="pmid">37261613</pub-id>
</element-citation></ref><ref id="B197-viruses-17-00203"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haverty</surname><given-names>R.</given-names></name>
<name><surname>McCormack</surname><given-names>J.</given-names></name>
<name><surname>Evans</surname><given-names>C.</given-names></name>
<name><surname>Purves</surname><given-names>K.</given-names></name>
<name><surname>O&#x02019;Reilly</surname><given-names>S.</given-names></name>
<name><surname>Gautier</surname><given-names>V.</given-names></name>
<name><surname>Rochfort</surname><given-names>K.</given-names></name>
<name><surname>Fabre</surname><given-names>A.</given-names></name>
<name><surname>Fletcher</surname><given-names>N.F.</given-names></name>
</person-group><article-title>SARS-CoV-2 Infects Neurons, Astrocytes, Choroid Plexus Epithelial Cells and Pericytes of the Human Central Nervous System</article-title><source>J. Gen. Virol.</source><year>2024</year><volume>105</volume><fpage>002009</fpage><pub-id pub-id-type="doi">10.1099/jgv.0.002009</pub-id><pub-id pub-id-type="pmid">38995681</pub-id>
</element-citation></ref><ref id="B198-viruses-17-00203"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Steardo</surname><given-names>L.</given-names></name>
<name><surname>Steardo</surname><given-names>L.</given-names></name>
<name><surname>Zorec</surname><given-names>R.</given-names></name>
<name><surname>Verkhratsky</surname><given-names>A.</given-names></name>
</person-group><article-title>Neuroinfection May Contribute to Pathophysiology and Clinical Manifestations of COVID-19</article-title><source>Acta Physiol.</source><year>2020</year><volume>229</volume><fpage>e13473</fpage><pub-id pub-id-type="doi">10.1111/apha.13473</pub-id><pub-id pub-id-type="pmid">32223077</pub-id>
</element-citation></ref><ref id="B199-viruses-17-00203"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kist</surname><given-names>M.</given-names></name>
<name><surname>Vucic</surname><given-names>D.</given-names></name>
</person-group><article-title>Cell Death Pathways: Intricate Connections and Disease Implications</article-title><source>EMBO J.</source><year>2021</year><volume>40</volume><fpage>e106700</fpage><pub-id pub-id-type="doi">10.15252/embj.2020106700</pub-id><pub-id pub-id-type="pmid">33439509</pub-id>
</element-citation></ref><ref id="B200-viruses-17-00203"><label>200.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Said</surname><given-names>S.</given-names></name>
<name><surname>Kang</surname><given-names>M.</given-names></name>
</person-group><source>Viral Encephalitis</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B201-viruses-17-00203"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Houston</surname><given-names>F.</given-names></name>
<name><surname>Andr&#x000e9;oletti</surname><given-names>O.</given-names></name>
</person-group><article-title>Animal Prion Diseases: The Risks to Human Health</article-title><source>Brain Pathol.</source><year>2019</year><volume>29</volume><fpage>248</fpage><pub-id pub-id-type="doi">10.1111/bpa.12696</pub-id><pub-id pub-id-type="pmid">30588682</pub-id>
</element-citation></ref><ref id="B202-viruses-17-00203"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bogovic</surname><given-names>P.</given-names></name>
<name><surname>Strle</surname><given-names>F.</given-names></name>
</person-group><article-title>Tick-Borne Encephalitis: A Review of Epidemiology, Clinical Characteristics, and Management</article-title><source>World J. Clin. Cases WJCC</source><year>2015</year><volume>3</volume><fpage>430</fpage><pub-id pub-id-type="doi">10.12998/wjcc.v3.i5.430</pub-id><pub-id pub-id-type="pmid">25984517</pub-id>
</element-citation></ref><ref id="B203-viruses-17-00203"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Counotte</surname><given-names>M.J.</given-names></name>
<name><surname>Kim</surname><given-names>C.R.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Bernstein</surname><given-names>K.</given-names></name>
<name><surname>Deal</surname><given-names>C.D.</given-names></name>
<name><surname>Broutet</surname><given-names>N.J.N.</given-names></name>
<name><surname>Low</surname><given-names>N.</given-names></name>
</person-group><article-title>Sexual Transmission of Zika Virus and Other Flaviviruses: A Living Systematic Review</article-title><source>PLoS Med.</source><year>2018</year><volume>15</volume><elocation-id>e1002611</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002611</pub-id><pub-id pub-id-type="pmid">30040845</pub-id>
</element-citation></ref><ref id="B204-viruses-17-00203"><label>204.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Simon</surname><given-names>L.V.</given-names></name>
<name><surname>Sandhu</surname><given-names>D.S.</given-names></name>
<name><surname>Goyal</surname><given-names>A.</given-names></name>
<name><surname>Kruse</surname><given-names>B.</given-names></name>
</person-group><source>Japanese Encephalitis</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2022</year></element-citation></ref><ref id="B205-viruses-17-00203"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fares</surname><given-names>M.</given-names></name>
<name><surname>Cochet-Bernoin</surname><given-names>M.</given-names></name>
<name><surname>Gonzalez</surname><given-names>G.</given-names></name>
<name><surname>Montero-Menei</surname><given-names>C.N.</given-names></name>
<name><surname>Blanchet</surname><given-names>O.</given-names></name>
<name><surname>Benchoua</surname><given-names>A.</given-names></name>
<name><surname>Boissart</surname><given-names>C.</given-names></name>
<name><surname>Lecollinet</surname><given-names>S.</given-names></name>
<name><surname>Richardson</surname><given-names>J.</given-names></name>
<name><surname>Haddad</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Pathological Modeling of TBEV Infection Reveals Differential Innate Immune Responses in Human Neurons and Astrocytes That Correlate with Their Susceptibility to Infection</article-title><source>J. Neuroinflammation</source><year>2020</year><volume>17</volume><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/s12974-020-01756-x</pub-id><pub-id pub-id-type="pmid">32127025</pub-id>
</element-citation></ref><ref id="B206-viruses-17-00203"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bl&#x000e1;zquez</surname><given-names>A.-B.</given-names></name>
<name><surname>Saiz</surname><given-names>J.-C.</given-names></name>
</person-group><article-title>Neurological Manifestations of Zika Virus Infection</article-title><source>World J. Virol.</source><year>2016</year><volume>5</volume><fpage>135</fpage><pub-id pub-id-type="doi">10.5501/wjv.v5.i4.135</pub-id><pub-id pub-id-type="pmid">27878100</pub-id>
</element-citation></ref><ref id="B207-viruses-17-00203"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sips</surname><given-names>G.J.</given-names></name>
<name><surname>Wilschut</surname><given-names>J.</given-names></name>
<name><surname>Smit</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Neuroinvasive Flavivirus Infections</article-title><source>Rev. Med. Virol.</source><year>2012</year><volume>22</volume><fpage>69</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1002/rmv.712</pub-id><pub-id pub-id-type="pmid">22086854</pub-id>
</element-citation></ref><ref id="B208-viruses-17-00203"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Turtle</surname><given-names>L.</given-names></name>
<name><surname>Solomon</surname><given-names>T.</given-names></name>
</person-group><article-title>Japanese Encephalitis-the Prospects for New Treatments</article-title><source>Nat. Rev. Neurol.</source><year>2018</year><volume>14</volume><fpage>298</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2018.30</pub-id><pub-id pub-id-type="pmid">29697099</pub-id>
</element-citation></ref><ref id="B209-viruses-17-00203"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Petersen</surname><given-names>L.R.</given-names></name>
<name><surname>Roehrig</surname><given-names>J.T.</given-names></name>
<name><surname>Hughes</surname><given-names>J.M.</given-names></name>
</person-group><article-title>West Nile Virus Encephalitis</article-title><source>N. Engl. J. Med.</source><year>2002</year><volume>347</volume><fpage>1225</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1056/NEJMO020128</pub-id><pub-id pub-id-type="pmid">12270973</pub-id>
</element-citation></ref><ref id="B210-viruses-17-00203"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bogovi&#x0010d;</surname><given-names>P.</given-names></name>
<name><surname>Lusa</surname><given-names>L.</given-names></name>
<name><surname>Korva</surname><given-names>M.</given-names></name>
<name><surname>Pavleti&#x0010d;</surname><given-names>M.</given-names></name>
<name><surname>Rus</surname><given-names>K.R.</given-names></name>
<name><surname>Lotri&#x0010d;-Furlan</surname><given-names>S.</given-names></name>
<name><surname>Av&#x00161;i&#x0010d;-&#x0017e;upanc</surname><given-names>T.</given-names></name>
<name><surname>Strle</surname><given-names>K.</given-names></name>
<name><surname>Strle</surname><given-names>F.</given-names></name>
</person-group><article-title>Inflammatory Immune Responses in the Pathogenesis of Tick-Borne Encephalitis</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><elocation-id>731</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8050731</pub-id><pub-id pub-id-type="pmid">31121969</pub-id>
</element-citation></ref><ref id="B211-viruses-17-00203"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quan</surname><given-names>T.M.</given-names></name>
<name><surname>Thao</surname><given-names>T.T.N.</given-names></name>
<name><surname>Duy</surname><given-names>N.M.</given-names></name>
<name><surname>Nhat</surname><given-names>T.M.</given-names></name>
<name><surname>Clapham</surname><given-names>H.E.</given-names></name>
</person-group><article-title>Estimates of the Global Burden of Japanese Encephalitis and the Impact of Vaccination from 2000&#x02013;2015</article-title><source>Elife</source><year>2020</year><volume>9</volume><fpage>e51027</fpage><pub-id pub-id-type="doi">10.7554/eLife.51027</pub-id><pub-id pub-id-type="pmid">32450946</pub-id>
</element-citation></ref><ref id="B212-viruses-17-00203"><label>212.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Clark</surname><given-names>M.B.</given-names></name>
<name><surname>Schaefer</surname><given-names>T.J.</given-names></name>
</person-group><source>West Nile Virus</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B213-viruses-17-00203"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiffi</surname><given-names>G.</given-names></name>
<name><surname>Grandgirard</surname><given-names>D.</given-names></name>
<name><surname>Leib</surname><given-names>S.L.</given-names></name>
<name><surname>Chrdle</surname><given-names>A.</given-names></name>
<name><surname>R&#x0016f;&#x0017e;ek</surname><given-names>D.</given-names></name>
</person-group><article-title>Tick-Borne Encephalitis: A Comprehensive Review of the Epidemiology, Virology, and Clinical Picture</article-title><source>Rev. Med. Virol.</source><year>2023</year><volume>33</volume><fpage>e2470</fpage><pub-id pub-id-type="doi">10.1002/rmv.2470</pub-id><pub-id pub-id-type="pmid">37392370</pub-id>
</element-citation></ref><ref id="B214-viruses-17-00203"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mu&#x000f1;oz</surname><given-names>L.S.</given-names></name>
<name><surname>Parra</surname><given-names>B.</given-names></name>
<name><surname>Pardo</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Neurological Implications of Zika Virus Infection in Adults</article-title><source>J. Infect. Dis.</source><year>2017</year><volume>216</volume><fpage>S897</fpage><pub-id pub-id-type="doi">10.1093/infdis/jix511</pub-id><pub-id pub-id-type="pmid">29267923</pub-id>
</element-citation></ref><ref id="B215-viruses-17-00203"><label>215.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Fischer</surname><given-names>M.</given-names></name>
<name><surname>Hills</surname><given-names>S.</given-names></name>
<name><surname>Staples</surname><given-names>E.</given-names></name>
<name><surname>Johnson</surname><given-names>B.</given-names></name>
<name><surname>Yaich</surname><given-names>M.</given-names></name>
<name><surname>Solomon</surname><given-names>T.</given-names></name>
</person-group><article-title>Japanese Encephalitis Prevention and Control: Advances, Challenges, and New Initiatives</article-title><source>Emerging Infections 8</source><publisher-name>Wiley Online Library</publisher-name><publisher-loc>Minneapolis, MN, USA</publisher-loc><year>2014</year><fpage>93</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1128/9781555815592.CH6</pub-id></element-citation></ref><ref id="B216-viruses-17-00203"><label>216.</label><element-citation publication-type="gov"><article-title>Clinical Signs and Symptoms of West Nile Virus Disease|West Nile Virus|CDC</article-title><comment>Available online: <ext-link xlink:href="https://www.cdc.gov/west-nile-virus/hcp/clinical-signs/index.html" ext-link-type="uri">https://www.cdc.gov/west-nile-virus/hcp/clinical-signs/index.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-21">(accessed on 21 December 2024)</date-in-citation></element-citation></ref><ref id="B217-viruses-17-00203"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gyure</surname><given-names>K.A.</given-names></name>
</person-group><article-title>West Nile Virus Infections</article-title><source>J. Neuropathol. Exp. Neurol.</source><year>2009</year><volume>68</volume><fpage>1053</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1097/NEN.0b013e3181b88114</pub-id><pub-id pub-id-type="pmid">19918117</pub-id>
</element-citation></ref><ref id="B218-viruses-17-00203"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mandl</surname><given-names>C.W.</given-names></name>
</person-group><article-title>Steps of the Tick-Borne Encephalitis Virus Replication Cycle That Affect Neuropathogenesis</article-title><source>Virus Res.</source><year>2005</year><volume>111</volume><fpage>161</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2005.04.007</pub-id><pub-id pub-id-type="pmid">15871909</pub-id>
</element-citation></ref><ref id="B219-viruses-17-00203"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gelpi</surname><given-names>E.</given-names></name>
<name><surname>Preusser</surname><given-names>M.</given-names></name>
<name><surname>Garzuly</surname><given-names>F.</given-names></name>
<name><surname>Holzmann</surname><given-names>H.</given-names></name>
<name><surname>Heinz</surname><given-names>F.X.</given-names></name>
<name><surname>Budka</surname><given-names>H.</given-names></name>
</person-group><article-title>Visualization of Central European Tick-Borne Encephalitis Infection in Fatal Human Cases</article-title><source>J. Neuropathol. Exp. Neurol.</source><year>2005</year><volume>64</volume><fpage>506</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1093/jnen/64.6.506</pub-id><pub-id pub-id-type="pmid">15977642</pub-id>
</element-citation></ref><ref id="B220-viruses-17-00203"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuwayama</surname><given-names>M.</given-names></name>
<name><surname>Ito</surname><given-names>M.</given-names></name>
<name><surname>Takao</surname><given-names>S.</given-names></name>
<name><surname>Shimazu</surname><given-names>Y.</given-names></name>
<name><surname>Fukuda</surname><given-names>S.</given-names></name>
<name><surname>Miyazaki</surname><given-names>K.</given-names></name>
<name><surname>Kurane</surname><given-names>I.</given-names></name>
<name><surname>Takasaki</surname><given-names>T.</given-names></name>
</person-group><article-title>Japanese Encephalitis Virus in Meningitis Patients, Japan</article-title><source>Emerg. Infect. Dis.</source><year>2005</year><volume>11</volume><fpage>471</fpage><pub-id pub-id-type="doi">10.3201/eid1103.040285</pub-id><pub-id pub-id-type="pmid">15757569</pub-id>
</element-citation></ref><ref id="B221-viruses-17-00203"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Solomon</surname><given-names>T.</given-names></name>
<name><surname>Kneen</surname><given-names>R.</given-names></name>
<name><surname>Dung</surname><given-names>N.M.</given-names></name>
<name><surname>Khanh</surname><given-names>V.C.</given-names></name>
<name><surname>Thuy</surname><given-names>T.T.N.</given-names></name>
<name><surname>Ha</surname><given-names>D.Q.</given-names></name>
<name><surname>Day</surname><given-names>N.P.J.</given-names></name>
<name><surname>Nisalak</surname><given-names>A.</given-names></name>
<name><surname>Vaughn</surname><given-names>D.W.</given-names></name>
<name><surname>White</surname><given-names>N.J.</given-names></name>
</person-group><article-title>Poliomyelitis-like Illness Due to Japanese Encephalitis Virus</article-title><source>Lancet</source><year>1998</year><volume>351</volume><fpage>1094</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(97)07509-0</pub-id><pub-id pub-id-type="pmid">9660579</pub-id>
</element-citation></ref><ref id="B222-viruses-17-00203"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Solomon</surname><given-names>T.</given-names></name>
<name><surname>Dung</surname><given-names>N.M.</given-names></name>
<name><surname>Kneen</surname><given-names>R.</given-names></name>
<name><surname>Gainsborough</surname><given-names>M.</given-names></name>
<name><surname>Vaughn</surname><given-names>D.W.</given-names></name>
<name><surname>Khanh</surname><given-names>V.T.</given-names></name>
</person-group><article-title>Japanese Encephalitis</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2000</year><volume>68</volume><fpage>405</fpage><pub-id pub-id-type="doi">10.1136/jnnp.68.4.405</pub-id><pub-id pub-id-type="pmid">10727474</pub-id>
</element-citation></ref><ref id="B223-viruses-17-00203"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghosh</surname><given-names>D.</given-names></name>
<name><surname>Basu</surname><given-names>A.</given-names></name>
</person-group><article-title>Japanese Encephalitis&#x02014;A Pathological and Clinical Perspective</article-title><source>PLoS Negl. Trop. Dis.</source><year>2009</year><volume>3</volume><elocation-id>e437</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0000437</pub-id><pub-id pub-id-type="pmid">19787040</pub-id>
</element-citation></ref><ref id="B224-viruses-17-00203"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xiang</surname><given-names>J.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.H.</given-names></name>
<name><surname>Tan</surname><given-names>Z.R.</given-names></name>
<name><surname>Huang</surname><given-names>J.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.W.</given-names></name>
</person-group><article-title>Guillain-Barr&#x000e9; Syndrome Associated with Japanese Encephalitis Virus Infection in China</article-title><source>Viral Immunol.</source><year>2014</year><volume>27</volume><fpage>418</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1089/vim.2014.0049</pub-id><pub-id pub-id-type="pmid">25140441</pub-id>
</element-citation></ref><ref id="B225-viruses-17-00203"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Wen</surname><given-names>Y.</given-names></name>
</person-group><article-title>The Underlying Mechanism of Guillain-Barr&#x000e9; Syndrome in a Young Patient Suffered from Japanese Encephalitis Virus Infection: A Case Report</article-title><source>Virol. J.</source><year>2022</year><volume>19</volume><fpage>139</fpage><pub-id pub-id-type="doi">10.1186/s12985-022-01870-7</pub-id><pub-id pub-id-type="pmid">36050705</pub-id>
</element-citation></ref><ref id="B226-viruses-17-00203"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sejvar</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Clinical Manifestations and Outcomes of West Nile Virus Infection</article-title><source>Viruses</source><year>2014</year><volume>6</volume><elocation-id>606</elocation-id><pub-id pub-id-type="doi">10.3390/v6020606</pub-id><pub-id pub-id-type="pmid">24509812</pub-id>
</element-citation></ref><ref id="B227-viruses-17-00203"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beshai</surname><given-names>R.</given-names></name>
<name><surname>Bibawy</surname><given-names>D.</given-names></name>
<name><surname>Bibawy</surname><given-names>J.</given-names></name>
</person-group><article-title>Guillain&#x02013;Barr&#x000e9; Syndrome Secondary to West Nile Virus in New York City</article-title><source>Case Rep. Infect. Dis.</source><year>2020</year><volume>2020</volume><fpage>6501658</fpage><pub-id pub-id-type="doi">10.1155/2020/6501658</pub-id><pub-id pub-id-type="pmid">32774950</pub-id>
</element-citation></ref><ref id="B228-viruses-17-00203"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sejvar</surname><given-names>J.J.</given-names></name>
<name><surname>Bode</surname><given-names>A.V.</given-names></name>
<name><surname>Marfin</surname><given-names>A.A.</given-names></name>
<name><surname>Campbell</surname><given-names>G.L.</given-names></name>
<name><surname>Pape</surname><given-names>J.</given-names></name>
<name><surname>Biggerstaff</surname><given-names>B.J.</given-names></name>
<name><surname>Petersen</surname><given-names>L.R.</given-names></name>
</person-group><article-title>West Nile Virus&#x02013;Associated Flaccid Paralysis Outcome</article-title><source>Emerg. Infect. Dis.</source><year>2006</year><volume>12</volume><fpage>514</fpage><pub-id pub-id-type="doi">10.3201/eid1203.050643</pub-id><pub-id pub-id-type="pmid">16704798</pub-id>
</element-citation></ref><ref id="B229-viruses-17-00203"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Klee</surname><given-names>A.L.</given-names></name>
<name><surname>Maldin</surname><given-names>B.</given-names></name>
<name><surname>Edwin</surname><given-names>B.</given-names></name>
<name><surname>Poshni</surname><given-names>I.</given-names></name>
<name><surname>Mostashari</surname><given-names>F.</given-names></name>
<name><surname>Fine</surname><given-names>A.</given-names></name>
<name><surname>Layton</surname><given-names>M.</given-names></name>
<name><surname>Nash</surname><given-names>D.</given-names></name>
</person-group><article-title>Long-Term Prognosis for Clinical West Nile Virus Infection</article-title><source>Emerg. Infect. Dis.</source><year>2004</year><volume>10</volume><fpage>1405</fpage><pub-id pub-id-type="doi">10.3201/eid1008.030879</pub-id><pub-id pub-id-type="pmid">15496241</pub-id>
</element-citation></ref><ref id="B230-viruses-17-00203"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murray</surname><given-names>K.O.</given-names></name>
<name><surname>Resnick</surname><given-names>M.</given-names></name>
<name><surname>Miller</surname><given-names>V.</given-names></name>
</person-group><article-title>Depression after Infection with West Nile Virus</article-title><source>Emerg. Infect. Dis.</source><year>2007</year><volume>13</volume><fpage>479</fpage><pub-id pub-id-type="doi">10.3201/eid1303.060602</pub-id><pub-id pub-id-type="pmid">17552106</pub-id>
</element-citation></ref><ref id="B231-viruses-17-00203"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carson</surname><given-names>P.J.</given-names></name>
<name><surname>Konewko</surname><given-names>P.</given-names></name>
<name><surname>Wold</surname><given-names>K.S.</given-names></name>
<name><surname>Mariani</surname><given-names>P.</given-names></name>
<name><surname>Goli</surname><given-names>S.</given-names></name>
<name><surname>Bergloff</surname><given-names>P.</given-names></name>
<name><surname>Crosby</surname><given-names>R.D.</given-names></name>
</person-group><article-title>Long-Term Clinical and Neuropsychological Outcomes of West Nile Virus Infection</article-title><source>Clin. Infect. Dis.</source><year>2006</year><volume>43</volume><fpage>723</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1086/506939</pub-id><pub-id pub-id-type="pmid">16912946</pub-id>
</element-citation></ref><ref id="B232-viruses-17-00203"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heckmann</surname><given-names>J.G.</given-names></name>
<name><surname>Vachalov&#x000e1;</surname><given-names>I.</given-names></name>
<name><surname>Gro&#x000df;kopf</surname><given-names>J.</given-names></name>
</person-group><article-title>Tick-Borne Encephalitis Complicated by Guillain-Barr&#x000e9; Syndrome</article-title><source>Acta Neurol. Belg.</source><year>2019</year><volume>119</volume><fpage>649</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1007/s13760-019-01152-0</pub-id><pub-id pub-id-type="pmid">31124012</pub-id>
</element-citation></ref><ref id="B233-viruses-17-00203"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gritsun</surname><given-names>T.S.</given-names></name>
<name><surname>Lashkevich</surname><given-names>V.A.</given-names></name>
<name><surname>Gould</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Tick-Borne Encephalitis</article-title><source>Antivir. Res.</source><year>2003</year><volume>57</volume><fpage>129</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(02)00206-1</pub-id><pub-id pub-id-type="pmid">12615309</pub-id>
</element-citation></ref><ref id="B234-viruses-17-00203"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Acosta-Ampudia</surname><given-names>Y.</given-names></name>
<name><surname>Monsalve</surname><given-names>D.M.</given-names></name>
<name><surname>Castillo-Medina</surname><given-names>L.F.</given-names></name>
<name><surname>Rodr&#x000ed;guez</surname><given-names>Y.</given-names></name>
<name><surname>Pacheco</surname><given-names>Y.</given-names></name>
<name><surname>Halstead</surname><given-names>S.</given-names></name>
<name><surname>Willison</surname><given-names>H.J.</given-names></name>
<name><surname>Anaya</surname><given-names>J.M.</given-names></name>
<name><surname>Ram&#x000ed;rez-Santana</surname><given-names>C.</given-names></name>
</person-group><article-title>Autoimmune Neurological Conditions Associated with Zika Virus Infection</article-title><source>Front. Mol. Neurosci.</source><year>2018</year><volume>11</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00116</pub-id><pub-id pub-id-type="pmid">29695953</pub-id>
</element-citation></ref><ref id="B235-viruses-17-00203"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>S.</given-names></name>
<name><surname>Verma</surname><given-names>A.</given-names></name>
<name><surname>Yadav</surname><given-names>P.</given-names></name>
<name><surname>Dubey</surname><given-names>S.K.</given-names></name>
<name><surname>Azhar</surname><given-names>E.I.</given-names></name>
<name><surname>Maitra</surname><given-names>S.S.</given-names></name>
<name><surname>Dwivedi</surname><given-names>V.D.</given-names></name>
</person-group><article-title>Molecular Pathogenesis of Japanese Encephalitis and Possible Therapeutic Strategies</article-title><source>Arch. Virol.</source><year>2022</year><volume>167</volume><fpage>1739</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1007/s00705-022-05481-z</pub-id><pub-id pub-id-type="pmid">35654913</pub-id>
</element-citation></ref><ref id="B236-viruses-17-00203"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yadav</surname><given-names>P.</given-names></name>
<name><surname>Chakraborty</surname><given-names>P.</given-names></name>
<name><surname>Jha</surname><given-names>N.K.</given-names></name>
<name><surname>Dewanjee</surname><given-names>S.</given-names></name>
<name><surname>Jha</surname><given-names>A.K.</given-names></name>
<name><surname>Panda</surname><given-names>S.P.</given-names></name>
<name><surname>Mishra</surname><given-names>P.C.</given-names></name>
<name><surname>Dey</surname><given-names>A.</given-names></name>
<name><surname>Jha</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases</article-title><source>Viruses</source><year>2022</year><volume>14</volume><elocation-id>2686</elocation-id><pub-id pub-id-type="doi">10.3390/v14122686</pub-id><pub-id pub-id-type="pmid">36560690</pub-id>
</element-citation></ref><ref id="B237-viruses-17-00203"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Trivedi</surname><given-names>S.</given-names></name>
<name><surname>Chakravarty</surname><given-names>A.</given-names></name>
</person-group><article-title>Neurological Complications of Dengue Fever</article-title><source>Curr. Neurol. Neurosci. Rep.</source><year>2022</year><volume>22</volume><fpage>515</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1007/s11910-022-01213-7</pub-id><pub-id pub-id-type="pmid">35727463</pub-id>
</element-citation></ref><ref id="B238-viruses-17-00203"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pustijanac</surname><given-names>E.</given-names></name>
<name><surname>Bur&#x00161;i&#x00107;</surname><given-names>M.</given-names></name>
<name><surname>Talapko</surname><given-names>J.</given-names></name>
<name><surname>&#x00160;krlec</surname><given-names>I.</given-names></name>
<name><surname>Me&#x00161;trovi&#x00107;</surname><given-names>T.</given-names></name>
<name><surname>Li&#x00161;nji&#x00107;</surname><given-names>D.</given-names></name>
</person-group><article-title>Tick-Borne Encephalitis Virus: A Comprehensive Review of Transmission, Pathogenesis, Epidemiology, Clinical Manifestations, Diagnosis, and Prevention</article-title><source>Microorganisms</source><year>2023</year><volume>11</volume><elocation-id>1634</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms11071634</pub-id><pub-id pub-id-type="pmid">37512806</pub-id>
</element-citation></ref><ref id="B239-viruses-17-00203"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>S.</given-names></name>
<name><surname>Mathur</surname><given-names>A.</given-names></name>
<name><surname>Prakash</surname><given-names>V.</given-names></name>
<name><surname>Kulshreshtha</surname><given-names>R.</given-names></name>
<name><surname>Kumar</surname><given-names>R.</given-names></name>
<name><surname>Chaturvedi</surname><given-names>U.C.</given-names></name>
</person-group><article-title>Japanese Encephalitis Virus Latency in Peripheral Blood Lymphocytes and Recurrence of Infection in Children</article-title><source>Clin. Exp. Immunol.</source><year>1991</year><volume>85</volume><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.1991.tb05687.x</pub-id><pub-id pub-id-type="pmid">1649022</pub-id>
</element-citation></ref><ref id="B240-viruses-17-00203"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patabendige</surname><given-names>A.</given-names></name>
<name><surname>Michael</surname><given-names>B.D.</given-names></name>
<name><surname>Craig</surname><given-names>A.G.</given-names></name>
<name><surname>Solomon</surname><given-names>T.</given-names></name>
</person-group><article-title>Brain Microvascular Endothelial-Astrocyte Cell Responses Following Japanese Encephalitis Virus Infection in an in Vitro Human Blood-Brain Barrier Model</article-title><source>Mol. Cell Neurosci.</source><year>2018</year><volume>89</volume><fpage>60</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2018.04.002</pub-id><pub-id pub-id-type="pmid">29635016</pub-id>
</element-citation></ref><ref id="B241-viruses-17-00203"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Filgueira</surname><given-names>L.</given-names></name>
<name><surname>Lannes</surname><given-names>N.</given-names></name>
</person-group><article-title>Review of Emerging Japanese Encephalitis Virus: New Aspects and Concepts about Entry into the Brain and Inter-Cellular Spreading</article-title><source>Pathogens</source><year>2019</year><volume>8</volume><elocation-id>111</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens8030111</pub-id><pub-id pub-id-type="pmid">31357540</pub-id>
</element-citation></ref><ref id="B242-viruses-17-00203"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheeran</surname><given-names>M.C.J.</given-names></name>
<name><surname>Hu</surname><given-names>S.</given-names></name>
<name><surname>Sheng</surname><given-names>W.S.</given-names></name>
<name><surname>Rashid</surname><given-names>A.</given-names></name>
<name><surname>Peterson</surname><given-names>P.K.</given-names></name>
<name><surname>Lokensgard</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Differential Responses of Human Brain Cells to West Nile Virus Infection</article-title><source>J. Neurovirol.</source><year>2005</year><volume>11</volume><fpage>512</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1080/13550280500384982</pub-id><pub-id pub-id-type="pmid">16338745</pub-id>
</element-citation></ref><ref id="B243-viruses-17-00203"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shrestha</surname><given-names>B.</given-names></name>
<name><surname>Gottlieb</surname><given-names>D.</given-names></name>
<name><surname>Diamond</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Infection and Injury of Neurons by West Nile Encephalitis Virus</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>13203</fpage><pub-id pub-id-type="doi">10.1128/JVI.77.24.13203-13213.2003</pub-id><pub-id pub-id-type="pmid">14645577</pub-id>
</element-citation></ref><ref id="B244-viruses-17-00203"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verma</surname><given-names>S.</given-names></name>
<name><surname>Kumar</surname><given-names>M.</given-names></name>
<name><surname>Gurjav</surname><given-names>U.</given-names></name>
<name><surname>Lum</surname><given-names>S.</given-names></name>
<name><surname>Nerurkar</surname><given-names>V.R.</given-names></name>
</person-group><article-title>Reversal of West Nile Virus-Induced Blood-Brain Barrier Disruption and Tight Junction Proteins Degradation by Matrix Metalloproteinases Inhibitor</article-title><source>Virology</source><year>2010</year><volume>397</volume><fpage>130</fpage><pub-id pub-id-type="doi">10.1016/j.virol.2009.10.036</pub-id><pub-id pub-id-type="pmid">19922973</pub-id>
</element-citation></ref><ref id="B245-viruses-17-00203"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Constant</surname><given-names>O.</given-names></name>
<name><surname>Maarifi</surname><given-names>G.</given-names></name>
<name><surname>Barthelemy</surname><given-names>J.</given-names></name>
<name><surname>Martin</surname><given-names>M.F.</given-names></name>
<name><surname>Tinto</surname><given-names>B.</given-names></name>
<name><surname>Savini</surname><given-names>G.</given-names></name>
<name><surname>Van de Perre</surname><given-names>P.</given-names></name>
<name><surname>Nisole</surname><given-names>S.</given-names></name>
<name><surname>Simonin</surname><given-names>Y.</given-names></name>
<name><surname>Salinas</surname><given-names>S.</given-names></name>
</person-group><article-title>Differential Effects of Usutu and West Nile Viruses on Neuroinflammation, Immune Cell Recruitment and Blood&#x02013;Brain Barrier Integrity</article-title><source>Emerg. Microbes Infect.</source><year>2023</year><volume>12</volume><fpage>2156815</fpage><pub-id pub-id-type="doi">10.1080/22221751.2022.2156815</pub-id><pub-id pub-id-type="pmid">36495563</pub-id>
</element-citation></ref><ref id="B246-viruses-17-00203"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghita</surname><given-names>L.</given-names></name>
<name><surname>Breitkopf</surname><given-names>V.</given-names></name>
<name><surname>Mulenge</surname><given-names>F.</given-names></name>
<name><surname>Pavlou</surname><given-names>A.</given-names></name>
<name><surname>Gern</surname><given-names>O.L.</given-names></name>
<name><surname>Dur&#x000e1;n</surname><given-names>V.</given-names></name>
<name><surname>Prajeeth</surname><given-names>C.K.</given-names></name>
<name><surname>Kohls</surname><given-names>M.</given-names></name>
<name><surname>Jung</surname><given-names>K.</given-names></name>
<name><surname>Stangel</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Sequential MAVS and MyD88/TRIF Signaling Triggers Anti-Viral Responses of Tick-Borne Encephalitis Virus-Infected Murine Astrocytes</article-title><source>J. Neurosci. Res.</source><year>2021</year><volume>99</volume><fpage>2478</fpage><lpage>2492</lpage><pub-id pub-id-type="doi">10.1002/jnr.24923</pub-id><pub-id pub-id-type="pmid">34296786</pub-id>
</element-citation></ref><ref id="B247-viruses-17-00203"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pranclova</surname><given-names>V.</given-names></name>
<name><surname>Nedvedova</surname><given-names>L.</given-names></name>
<name><surname>Kotounova</surname><given-names>E.</given-names></name>
<name><surname>Vaclav</surname><given-names>H.</given-names></name>
<name><surname>Dvorakova</surname><given-names>M.</given-names></name>
<name><surname>Davidkova</surname><given-names>M.</given-names></name>
<name><surname>Bily</surname><given-names>T.</given-names></name>
<name><surname>Vancova</surname><given-names>M.</given-names></name>
<name><surname>Ruzek</surname><given-names>D.</given-names></name>
<name><surname>Palus</surname><given-names>M.</given-names></name>
</person-group><article-title>Unraveling the Role of Human Microglia in Tick-Borne Encephalitis Virus Infection: Insights into Neuroinflammation and Viral Pathogenesis</article-title><source>Microbes Infect.</source><year>2024</year><volume>26</volume><fpage>105383</fpage><pub-id pub-id-type="doi">10.1016/j.micinf.2024.105383</pub-id><pub-id pub-id-type="pmid">38942136</pub-id>
</element-citation></ref><ref id="B248-viruses-17-00203"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schultz</surname><given-names>V.</given-names></name>
<name><surname>Barrie</surname><given-names>J.A.</given-names></name>
<name><surname>Donald</surname><given-names>C.L.</given-names></name>
<name><surname>Crawford</surname><given-names>C.L.</given-names></name>
<name><surname>Mullin</surname><given-names>M.</given-names></name>
<name><surname>Anderson</surname><given-names>T.J.</given-names></name>
<name><surname>Solomon</surname><given-names>T.</given-names></name>
<name><surname>Barnett</surname><given-names>S.C.</given-names></name>
<name><surname>Linington</surname><given-names>C.</given-names></name>
<name><surname>Kohl</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Oligodendrocytes Are Susceptible to Zika Virus Infection in a Mouse Model of Perinatal Exposure: Implications for CNS Complications</article-title><source>Glia</source><year>2021</year><volume>69</volume><fpage>2023</fpage><lpage>2036</lpage><pub-id pub-id-type="doi">10.1002/glia.24010</pub-id><pub-id pub-id-type="pmid">33942402</pub-id>
</element-citation></ref><ref id="B249-viruses-17-00203"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mutso</surname><given-names>M.</given-names></name>
<name><surname>John</surname><given-names>J.A.S.</given-names></name>
<name><surname>Ling</surname><given-names>Z.L.</given-names></name>
<name><surname>Burt</surname><given-names>F.J.</given-names></name>
<name><surname>Poo</surname><given-names>Y.S.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>&#x0017d;usinaite</surname><given-names>E.</given-names></name>
<name><surname>Grau</surname><given-names>G.E.</given-names></name>
<name><surname>Hueston</surname><given-names>L.</given-names></name>
<name><surname>Merits</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Basic Insights into Zika Virus Infection of Neuroglial and Brain Endothelial Cells</article-title><source>J. Gen. Virol.</source><year>2020</year><volume>101</volume><fpage>622</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.001416</pub-id><pub-id pub-id-type="pmid">32375993</pub-id>
</element-citation></ref><ref id="B250-viruses-17-00203"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferraris</surname><given-names>P.</given-names></name>
<name><surname>Cochet</surname><given-names>M.</given-names></name>
<name><surname>Hamel</surname><given-names>R.</given-names></name>
<name><surname>Gladwyn-Ng</surname><given-names>I.</given-names></name>
<name><surname>Alfano</surname><given-names>C.</given-names></name>
<name><surname>Diop</surname><given-names>F.</given-names></name>
<name><surname>Garcia</surname><given-names>D.</given-names></name>
<name><surname>Talignani</surname><given-names>L.</given-names></name>
<name><surname>Montero-Menei</surname><given-names>C.N.</given-names></name>
<name><surname>Nougair&#x000e8;de</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Zika Virus Differentially Infects Human Neural Progenitor Cells According to Their State of Differentiation and Dysregulates Neurogenesis through the Notch Pathway</article-title><source>Emerg. Microbes Infect.</source><year>2019</year><volume>8</volume><fpage>1003</fpage><pub-id pub-id-type="doi">10.1080/22221751.2019.1637283</pub-id><pub-id pub-id-type="pmid">31282298</pub-id>
</element-citation></ref><ref id="B251-viruses-17-00203"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garcez</surname><given-names>P.P.</given-names></name>
<name><surname>Nascimento</surname><given-names>J.M.</given-names></name>
<name><surname>De Vasconcelos</surname><given-names>J.M.</given-names></name>
<name><surname>Madeiro Da Costa</surname><given-names>R.</given-names></name>
<name><surname>Delvecchio</surname><given-names>R.</given-names></name>
<name><surname>Trindade</surname><given-names>P.</given-names></name>
<name><surname>Loiola</surname><given-names>E.C.</given-names></name>
<name><surname>Higa</surname><given-names>L.M.</given-names></name>
<name><surname>Cassoli</surname><given-names>J.S.</given-names></name>
<name><surname>Vit&#x000f3;ria</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Zika Virus Disrupts Molecular Fingerprinting of Human Neurospheres</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><elocation-id>srep40780</elocation-id><pub-id pub-id-type="doi">10.1038/srep40780</pub-id><pub-id pub-id-type="pmid">28112162</pub-id>
</element-citation></ref><ref id="B252-viruses-17-00203"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thongtan</surname><given-names>T.</given-names></name>
<name><surname>Thepparit</surname><given-names>C.</given-names></name>
<name><surname>Smith</surname><given-names>D.R.</given-names></name>
</person-group><article-title>The Involvement of Microglial Cells in Japanese Encephalitis Infections</article-title><source>J. Immunol. Res.</source><year>2012</year><volume>2012</volume><fpage>890586</fpage><pub-id pub-id-type="doi">10.1155/2012/890586</pub-id><pub-id pub-id-type="pmid">22919405</pub-id>
</element-citation></ref><ref id="B253-viruses-17-00203"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thongtan</surname><given-names>T.</given-names></name>
<name><surname>Cheepsunthorn</surname><given-names>P.</given-names></name>
<name><surname>Chaiworakul</surname><given-names>V.</given-names></name>
<name><surname>Rattanarungsan</surname><given-names>C.</given-names></name>
<name><surname>Wikan</surname><given-names>N.</given-names></name>
<name><surname>Smith</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Highly Permissive Infection of Microglial Cells by Japanese Encephalitis Virus: A Possible Role as a Viral Reservoir</article-title><source>Microbes Infect.</source><year>2010</year><volume>12</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2009.09.013</pub-id><pub-id pub-id-type="pmid">19786116</pub-id>
</element-citation></ref><ref id="B254-viruses-17-00203"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bai</surname><given-names>F.</given-names></name>
<name><surname>Kong</surname><given-names>K.F.</given-names></name>
<name><surname>Dai</surname><given-names>J.</given-names></name>
<name><surname>Qian</surname><given-names>F.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Brown</surname><given-names>C.R.</given-names></name>
<name><surname>Fikrig</surname><given-names>E.</given-names></name>
<name><surname>Montgomery</surname><given-names>R.R.</given-names></name>
</person-group><article-title>A Paradoxical Role for Neutrophils in the Pathogenesis of West Nile Virus</article-title><source>J. Infect. Dis.</source><year>2010</year><volume>202</volume><fpage>1804</fpage><pub-id pub-id-type="doi">10.1086/657416</pub-id><pub-id pub-id-type="pmid">21050124</pub-id>
</element-citation></ref><ref id="B255-viruses-17-00203"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mladinich</surname><given-names>M.C.</given-names></name>
<name><surname>Schwedes</surname><given-names>J.</given-names></name>
<name><surname>Mackow</surname><given-names>E.R.</given-names></name>
</person-group><article-title>Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells</article-title><source>mBio</source><year>2017</year><volume>8</volume><fpage>e00952-17</fpage><pub-id pub-id-type="doi">10.1128/mBio.00952-17</pub-id><pub-id pub-id-type="pmid">28698279</pub-id>
</element-citation></ref><ref id="B256-viruses-17-00203"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ravi</surname><given-names>V.</given-names></name>
<name><surname>Desai</surname><given-names>A.S.</given-names></name>
<name><surname>Shenoy</surname><given-names>P.K.</given-names></name>
<name><surname>Satishchandra</surname><given-names>P.</given-names></name>
<name><surname>Chandramuki</surname><given-names>A.</given-names></name>
<name><surname>Gourie-Devi</surname><given-names>M.</given-names></name>
</person-group><article-title>Persistence of Japanese Encephalitis Virus in the Human Nervous System</article-title><source>J. Med. Virol.</source><year>1993</year><volume>40</volume><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890400412</pub-id><pub-id pub-id-type="pmid">8228925</pub-id>
</element-citation></ref><ref id="B257-viruses-17-00203"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murray</surname><given-names>K.</given-names></name>
<name><surname>Walker</surname><given-names>C.</given-names></name>
<name><surname>Herrington</surname><given-names>E.</given-names></name>
<name><surname>Lewis</surname><given-names>J.A.</given-names></name>
<name><surname>McCormick</surname><given-names>J.</given-names></name>
<name><surname>Beasley</surname><given-names>D.W.C.</given-names></name>
<name><surname>Tesh</surname><given-names>R.B.</given-names></name>
<name><surname>Fisher-Hoch</surname><given-names>S.</given-names></name>
</person-group><article-title>Persistent Infection with West Nile Virus Years after Initial Infection</article-title><source>J. Infect. Dis.</source><year>2010</year><volume>201</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1086/648731</pub-id><pub-id pub-id-type="pmid">19961306</pub-id>
</element-citation></ref><ref id="B258-viruses-17-00203"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nicholls</surname><given-names>C.M.R.</given-names></name>
<name><surname>Sevvana</surname><given-names>M.</given-names></name>
<name><surname>Kuhn</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Structure-Guided Paradigm Shifts in Flavivirus Assembly and Maturation Mechanisms</article-title><source>Adv. Virus Res.</source><year>2020</year><volume>108</volume><fpage>33</fpage><pub-id pub-id-type="doi">10.1016/BS.AIVIR.2020.08.003</pub-id><pub-id pub-id-type="pmid">33837721</pub-id>
</element-citation></ref><ref id="B259-viruses-17-00203"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chowdhury</surname><given-names>P.</given-names></name>
<name><surname>Khan</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Global Emergence of West Nile Virus: Threat &#x00026; Preparedness in Special Perspective to India</article-title><source>Indian J. Med. Res.</source><year>2021</year><volume>154</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.4103/IJMR.IJMR_642_19</pub-id><pub-id pub-id-type="pmid">34782529</pub-id>
</element-citation></ref><ref id="B260-viruses-17-00203"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Dai</surname><given-names>X.</given-names></name>
</person-group><article-title>The Global Incidence and Trends of Three Common Flavivirus Infections (Dengue, Yellow Fever, and Zika) from 2011 to 2021</article-title><source>Front. Microbiol.</source><year>2024</year><volume>15</volume><elocation-id>1458166</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2024.1458166</pub-id><pub-id pub-id-type="pmid">39206366</pub-id>
</element-citation></ref><ref id="B261-viruses-17-00203"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Liang</surname><given-names>G.</given-names></name>
</person-group><article-title>Epidemiology of Japanese Encephalitis: Past, Present, and Future Prospects</article-title><source>Ther. Clin. Risk Manag.</source><year>2015</year><volume>11</volume><fpage>435</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.2147/TCRM.S51168</pub-id><pub-id pub-id-type="pmid">25848290</pub-id>
</element-citation></ref><ref id="B262-viruses-17-00203"><label>262.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Gole</surname><given-names>S.</given-names></name>
<name><surname>Anand</surname><given-names>A.</given-names></name>
</person-group><source>Autoimmune Encephalitis</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B263-viruses-17-00203"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lancaster</surname><given-names>E.</given-names></name>
</person-group><article-title>Autoantibody Encephalitis: Presentation, Diagnosis, and Management</article-title><source>J. Clin. Neurol.</source><year>2022</year><volume>18</volume><fpage>373</fpage><pub-id pub-id-type="doi">10.3988/jcn.2022.18.4.373</pub-id><pub-id pub-id-type="pmid">35796263</pub-id>
</element-citation></ref><ref id="B264-viruses-17-00203"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zang</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Guo</surname><given-names>J.</given-names></name>
<name><surname>Long</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Cui</surname><given-names>C.</given-names></name>
<name><surname>Song</surname><given-names>D.</given-names></name>
<name><surname>Yu</surname><given-names>B.</given-names></name>
<name><surname>Tang</surname><given-names>F.</given-names></name>
<name><surname>Teng</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Treatment of Severe Japanese Encephalitis Complicated with Hashimoto&#x02019;s Thyroiditis and Guillain-Barr&#x000e9; Syndrome with Protein A Immunoadsorption: A Case Report</article-title><source>Front. Immunol.</source><year>2022</year><volume>12</volume><elocation-id>807937</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.807937</pub-id><pub-id pub-id-type="pmid">35069593</pub-id>
</element-citation></ref><ref id="B265-viruses-17-00203"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karagianni</surname><given-names>P.</given-names></name>
<name><surname>Alexopoulos</surname><given-names>H.</given-names></name>
<name><surname>Sourdi</surname><given-names>A.</given-names></name>
<name><surname>Papadimitriou</surname><given-names>D.</given-names></name>
<name><surname>Dimitrakopoulos</surname><given-names>A.N.</given-names></name>
<name><surname>Moutsopoulos</surname><given-names>H.M.</given-names></name>
</person-group><article-title>West Nile Virus Infection Triggering Autoimmune Encephalitis: Pathophysiological and Therapeutic Implications</article-title><source>Clin. Immunol.</source><year>2019</year><volume>207</volume><fpage>97</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2019.07.007</pub-id><pub-id pub-id-type="pmid">31454696</pub-id>
</element-citation></ref><ref id="B266-viruses-17-00203"><label>266.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Anilkumar</surname><given-names>A.C.</given-names></name>
<name><surname>Foris</surname><given-names>L.A.</given-names></name>
<name><surname>Tadi</surname><given-names>P.</given-names></name>
</person-group><source>Acute Disseminated Encephalomyelitis</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2024</year></element-citation></ref><ref id="B267-viruses-17-00203"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kamel</surname><given-names>M.G.</given-names></name>
<name><surname>Nam</surname><given-names>N.T.</given-names></name>
<name><surname>Han</surname><given-names>N.H.B.</given-names></name>
<name><surname>El-Shabouny</surname><given-names>A.E.</given-names></name>
<name><surname>Makram</surname><given-names>A.E.R.M.</given-names></name>
<name><surname>Abd-Elhay</surname><given-names>F.A.E.</given-names></name>
<name><surname>Dang</surname><given-names>T.N.</given-names></name>
<name><surname>Hieu</surname><given-names>N.L.T.</given-names></name>
<name><surname>Huong</surname><given-names>V.T.Q.</given-names></name>
<name><surname>Tung</surname><given-names>T.H.</given-names></name>
<etal/>
</person-group><article-title>Post-Dengue Acute Disseminated Encephalomyelitis: A Case Report and Meta-Analysis</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005715</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005715</pub-id><pub-id pub-id-type="pmid">28665957</pub-id>
</element-citation></ref><ref id="B268-viruses-17-00203"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karoli</surname><given-names>R.</given-names></name>
<name><surname>Siddiqi</surname><given-names>Z.</given-names></name>
<name><surname>Fatima</surname><given-names>J.</given-names></name>
<name><surname>Maini</surname><given-names>S.</given-names></name>
</person-group><article-title>Was It a Case of Acute Disseminated Encephalomyelitis? A Rare Association Following Dengue Fever</article-title><source>J. Neurosci. Rural. Pract.</source><year>2013</year><volume>4</volume><fpage>318</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.4103/0976-3147.118783</pub-id><pub-id pub-id-type="pmid">24250170</pub-id>
</element-citation></ref><ref id="B269-viruses-17-00203"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alves-Leon</surname><given-names>S.V.</given-names></name>
<name><surname>Lima</surname><given-names>M.D.R.</given-names></name>
<name><surname>Nunes</surname><given-names>P.C.G.</given-names></name>
<name><surname>Chimelli</surname><given-names>L.M.C.</given-names></name>
<name><surname>Rabelo</surname><given-names>K.</given-names></name>
<name><surname>Nogueira</surname><given-names>R.M.R.</given-names></name>
<name><surname>De Bruycker-Nogueira</surname><given-names>F.</given-names></name>
<name><surname>De Azeredo</surname><given-names>E.L.</given-names></name>
<name><surname>Bahia</surname><given-names>P.R.</given-names></name>
<name><surname>Rueda Lopes</surname><given-names>F.C.</given-names></name>
<etal/>
</person-group><article-title>Zika Virus Found in Brain Tissue of a Multiple Sclerosis Patient Undergoing an Acute Disseminated Encephalomyelitis-like Episode</article-title><source>Mult. Scler.</source><year>2019</year><volume>25</volume><fpage>427</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1177/1352458518781992</pub-id><pub-id pub-id-type="pmid">30226115</pub-id>
</element-citation></ref><ref id="B270-viruses-17-00203"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ohtaki</surname><given-names>E.</given-names></name>
<name><surname>Matsuishi</surname><given-names>T.</given-names></name>
<name><surname>Hirano</surname><given-names>Y.</given-names></name>
<name><surname>Maekawa</surname><given-names>K.</given-names></name>
<name><surname>Ohtaki</surname><given-names>J.E.</given-names></name>
<name><surname>Matsuishi</surname><given-names>T.</given-names></name>
<name><surname>Hirano</surname><given-names>Y.</given-names></name>
</person-group><article-title>Acute Disseminated Encephalomyelitis after Treatment with Japanese B Encephalitis Vaccine (Nakayama-Yoken and Beijing Strains)</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>1995</year><volume>59</volume><fpage>316</fpage><pub-id pub-id-type="doi">10.1136/jnnp.59.3.316</pub-id><pub-id pub-id-type="pmid">7673966</pub-id>
</element-citation></ref><ref id="B271-viruses-17-00203"><label>271.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>T.P.</given-names></name>
<name><surname>Taylor</surname><given-names>R.S.</given-names></name>
</person-group><source>Guillain-Barre Syndrome</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B272-viruses-17-00203"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>C.S.</given-names></name>
<name><surname>Kaisbain</surname><given-names>N.</given-names></name>
<name><surname>Lim</surname><given-names>W.J.</given-names></name>
</person-group><article-title>A Rare Combination: Dengue Fever Complicated with Guillain-Barre Syndrome</article-title><source>Cureus</source><year>2023</year><volume>15</volume><fpage>e40957</fpage><pub-id pub-id-type="doi">10.7759/cureus.40957</pub-id><pub-id pub-id-type="pmid">37503499</pub-id>
</element-citation></ref><ref id="B273-viruses-17-00203"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barbi</surname><given-names>L.</given-names></name>
<name><surname>Coelho</surname><given-names>A.V.C.</given-names></name>
<name><surname>de Alencar</surname><given-names>L.C.A.</given-names></name>
<name><surname>Crovella</surname><given-names>S.</given-names></name>
</person-group><article-title>Prevalence of Guillain-Barr&#x000e9; Syndrome among Zika Virus Infected Cases: A Systematic Review and Meta-Analysis</article-title><source>Braz. J. Infect. Dis.</source><year>2018</year><volume>22</volume><fpage>137</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.bjid.2018.02.005</pub-id><pub-id pub-id-type="pmid">29545017</pub-id>
</element-citation></ref><ref id="B274-viruses-17-00203"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Basumatary</surname><given-names>L.J.</given-names></name>
<name><surname>Raja</surname><given-names>D.</given-names></name>
<name><surname>Bhuyan</surname><given-names>D.</given-names></name>
<name><surname>Das</surname><given-names>M.</given-names></name>
<name><surname>Goswami</surname><given-names>M.</given-names></name>
<name><surname>Kayal</surname><given-names>A.K.</given-names></name>
</person-group><article-title>Clinical and Radiological Spectrum of Japanese Encephalitis</article-title><source>J. Neurol. Sci.</source><year>2013</year><volume>325</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2012.11.007</pub-id><pub-id pub-id-type="pmid">23260319</pub-id>
</element-citation></ref><ref id="B275-viruses-17-00203"><label>275.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Shrimanker</surname><given-names>I.</given-names></name>
<name><surname>Tadi</surname><given-names>P.</given-names></name>
<name><surname>Schoo</surname><given-names>C.</given-names></name>
<name><surname>S&#x000e1;nchez-Manso</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Parkinsonism</article-title><source>Encyclopedia of the Neurological Sciences</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2024</year><fpage>820</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-385157-4.00028-2</pub-id></element-citation></ref><ref id="B276-viruses-17-00203"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Poponnikova</surname><given-names>T.V.</given-names></name>
</person-group><article-title>The Clinical Picture of Chronic Tick-Borne Encephalitis in Children</article-title><source>Int. J. Med. Microbiol.</source><year>2008</year><volume>298</volume><fpage>351</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2008.03.007</pub-id></element-citation></ref><ref id="B277-viruses-17-00203"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fulton</surname><given-names>C.D.M.</given-names></name>
<name><surname>Beasley</surname><given-names>D.W.C.</given-names></name>
<name><surname>Bente</surname><given-names>D.A.</given-names></name>
<name><surname>Dineley</surname><given-names>K.T.</given-names></name>
</person-group><article-title>Long-Term, West Nile Virus-Induced Neurological Changes: A Comparison of Patients and Rodent Models</article-title><source>Brain Behav. Immun. Health</source><year>2020</year><volume>7</volume><fpage>100105</fpage><pub-id pub-id-type="doi">10.1016/j.bbih.2020.100105</pub-id><pub-id pub-id-type="pmid">34589866</pub-id>
</element-citation></ref><ref id="B278-viruses-17-00203"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>H.C.</given-names></name>
<name><surname>Chou</surname><given-names>H.P.</given-names></name>
<name><surname>Chiang</surname><given-names>Y.C.</given-names></name>
<name><surname>Chang</surname><given-names>R.</given-names></name>
<name><surname>Chen</surname><given-names>Y.S.</given-names></name>
<name><surname>Juan</surname><given-names>Y.C.</given-names></name>
</person-group><article-title>Neurological or Psychiatric Disorders After Dengue Fever</article-title><source>JAMA Netw. Open</source><year>2024</year><volume>7</volume><fpage>E2410075</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2024.10075</pub-id><pub-id pub-id-type="pmid">38713469</pub-id>
</element-citation></ref><ref id="B279-viruses-17-00203"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rico-Hesse</surname><given-names>R.</given-names></name>
</person-group><article-title>Microevolution and Virulence of Dengue Viruses</article-title><source>Adv. Virus Res.</source><year>2003</year><volume>59</volume><fpage>315</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/S0065-3527(03)59009-1</pub-id><pub-id pub-id-type="pmid">14696333</pub-id>
</element-citation></ref><ref id="B280-viruses-17-00203"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kakde</surname><given-names>U.</given-names></name>
<name><surname>Khatib</surname><given-names>M.N.</given-names></name>
</person-group><article-title>Neurological Complications in Dengue Among Males of the Adult Age Group</article-title><source>Cureus</source><year>2024</year><volume>16</volume><fpage>e51586</fpage><pub-id pub-id-type="doi">10.7759/cureus.51586</pub-id><pub-id pub-id-type="pmid">38313931</pub-id>
</element-citation></ref><ref id="B281-viruses-17-00203"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ireland</surname><given-names>D.D.C.</given-names></name>
<name><surname>Manangeeswaran</surname><given-names>M.</given-names></name>
<name><surname>Lewkowicz</surname><given-names>A.P.</given-names></name>
<name><surname>Engel</surname><given-names>K.</given-names></name>
<name><surname>Clark</surname><given-names>S.M.</given-names></name>
<name><surname>Laniyan</surname><given-names>A.</given-names></name>
<name><surname>Sykes</surname><given-names>J.</given-names></name>
<name><surname>Lee</surname><given-names>H.N.</given-names></name>
<name><surname>McWilliams</surname><given-names>I.L.</given-names></name>
<name><surname>Kelley-Baker</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Long-Term Persistence of Infectious Zika Virus: Inflammation and Behavioral Sequela in Mice</article-title><source>PLoS Pathog.</source><year>2020</year><volume>16</volume><elocation-id>e1008689</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008689</pub-id><pub-id pub-id-type="pmid">33301527</pub-id>
</element-citation></ref><ref id="B282-viruses-17-00203"><label>282.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Swinkels</surname><given-names>H.M.</given-names></name>
<name><surname>Vaillant</surname><given-names>A.A.J.</given-names></name>
<name><surname>Nguyen</surname><given-names>A.D.</given-names></name>
<name><surname>Gulick</surname><given-names>P.G.</given-names></name>
</person-group><article-title>HIV and AIDS</article-title><source>Geriatric Gastroenterology</source><publisher-name>Springer Science &#x00026; Business Media</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2024</year><fpage>659</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1007/978-1-4419-1623-5_71</pub-id></element-citation></ref><ref id="B283-viruses-17-00203"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>J.H.</given-names></name>
<name><surname>Hearps</surname><given-names>A.C.</given-names></name>
<name><surname>Martin</surname><given-names>G.E.</given-names></name>
<name><surname>Williams</surname><given-names>K.C.</given-names></name>
<name><surname>Crowe</surname><given-names>S.M.</given-names></name>
</person-group><article-title>The Importance of Monocytes and Macrophages in HIV Pathogenesis, Treatment, and Cure</article-title><source>AIDS</source><year>2014</year><volume>28</volume><fpage>2175</fpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000408</pub-id><pub-id pub-id-type="pmid">25144219</pub-id>
</element-citation></ref><ref id="B284-viruses-17-00203"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Subra</surname><given-names>C.</given-names></name>
<name><surname>Trautmann</surname><given-names>L.</given-names></name>
</person-group><article-title>Role of T Lymphocytes in HIV Neuropathogenesis</article-title><source>Curr. HIV/AIDS Rep.</source><year>2019</year><volume>16</volume><fpage>236</fpage><pub-id pub-id-type="doi">10.1007/s11904-019-00445-6</pub-id><pub-id pub-id-type="pmid">31062168</pub-id>
</element-citation></ref><ref id="B285-viruses-17-00203"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kincer</surname><given-names>L.P.</given-names></name>
<name><surname>Schnell</surname><given-names>G.</given-names></name>
<name><surname>Swanstrom</surname><given-names>R.</given-names></name>
<name><surname>Miller</surname><given-names>M.B.</given-names></name>
<name><surname>Spudich</surname><given-names>S.</given-names></name>
<name><surname>Eron</surname><given-names>J.J.</given-names></name>
<name><surname>Price</surname><given-names>R.W.</given-names></name>
<name><surname>Joseph</surname><given-names>S.B.</given-names></name>
</person-group><article-title>HIV-1 Is Transported into the Central Nervous System by Trafficking Infected Cells</article-title><source>Pathog. Immun.</source><year>2023</year><volume>7</volume><fpage>131</fpage><pub-id pub-id-type="doi">10.20411/pai.v7i2.524</pub-id><pub-id pub-id-type="pmid">36865569</pub-id>
</element-citation></ref><ref id="B286-viruses-17-00203"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gras</surname><given-names>G.</given-names></name>
<name><surname>Kaul</surname><given-names>M.</given-names></name>
</person-group><article-title>Molecular Mechanisms of Neuroinvasion by Monocytes-Macrophages in HIV-1 Infection</article-title><source>Retrovirology</source><year>2010</year><volume>7</volume><fpage>30</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-7-30</pub-id><pub-id pub-id-type="pmid">20374632</pub-id>
</element-citation></ref><ref id="B287-viruses-17-00203"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burdo</surname><given-names>T.H.</given-names></name>
<name><surname>Lackner</surname><given-names>A.</given-names></name>
<name><surname>Williams</surname><given-names>K.C.</given-names></name>
</person-group><article-title>Monocyte/Macrophages and Their Role in HIV Neuropathogenesis</article-title><source>Immunol. Rev.</source><year>2013</year><volume>254</volume><fpage>102</fpage><pub-id pub-id-type="doi">10.1111/imr.12068</pub-id><pub-id pub-id-type="pmid">23772617</pub-id>
</element-citation></ref><ref id="B288-viruses-17-00203"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cenker</surname><given-names>J.J.</given-names></name>
<name><surname>Stultz</surname><given-names>R.D.</given-names></name>
<name><surname>McDonald</surname><given-names>D.</given-names></name>
</person-group><article-title>Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2017</year><volume>33</volume><fpage>1155</fpage><pub-id pub-id-type="doi">10.1089/aid.2017.0004</pub-id><pub-id pub-id-type="pmid">28486838</pub-id>
</element-citation></ref><ref id="B289-viruses-17-00203"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schnell</surname><given-names>G.</given-names></name>
<name><surname>Joseph</surname><given-names>S.</given-names></name>
<name><surname>Spudich</surname><given-names>S.</given-names></name>
<name><surname>Price</surname><given-names>R.W.</given-names></name>
<name><surname>Swanstrom</surname><given-names>R.</given-names></name>
</person-group><article-title>HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types</article-title><source>PLoS Pathog.</source><year>2011</year><volume>7</volume><elocation-id>e1002286</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002286</pub-id><pub-id pub-id-type="pmid">22007152</pub-id>
</element-citation></ref><ref id="B290-viruses-17-00203"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Churchill</surname><given-names>M.J.</given-names></name>
<name><surname>Wesselingh</surname><given-names>S.L.</given-names></name>
<name><surname>Cowley</surname><given-names>D.</given-names></name>
<name><surname>Pardo</surname><given-names>C.A.</given-names></name>
<name><surname>McArthur</surname><given-names>J.C.</given-names></name>
<name><surname>Brew</surname><given-names>B.J.</given-names></name>
<name><surname>Gorry</surname><given-names>P.R.</given-names></name>
</person-group><article-title>Extensive Astrocyte Infection Is Prominent in Human Immunodeficiency Virus-Associated Dementia</article-title><source>Ann. Neurol.</source><year>2009</year><volume>66</volume><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1002/ana.21697</pub-id><pub-id pub-id-type="pmid">19743454</pub-id>
</element-citation></ref><ref id="B291-viruses-17-00203"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaalund</surname><given-names>S.S.</given-names></name>
<name><surname>Johansen</surname><given-names>A.</given-names></name>
<name><surname>Fabricius</surname><given-names>K.</given-names></name>
<name><surname>Pakkenberg</surname><given-names>B.</given-names></name>
</person-group><article-title>Untreated Patients Dying with AIDS Have Loss of Neocortical Neurons and Glia Cells</article-title><source>Front. Neurosci.</source><year>2020</year><volume>13</volume><elocation-id>507164</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2019.01398</pub-id><pub-id pub-id-type="pmid">32009881</pub-id>
</element-citation></ref><ref id="B292-viruses-17-00203"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eugenin</surname><given-names>E.A.</given-names></name>
<name><surname>Berman</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Cytochrome c Dysregulation Induced by HIV Infection of Astrocytes Results in Bystander Apoptosis of Uninfected Astrocytes by an IP3 and Calcium-Dependent Mechanism</article-title><source>J. Neurochem.</source><year>2013</year><volume>127</volume><fpage>644</fpage><pub-id pub-id-type="doi">10.1111/jnc.12443</pub-id><pub-id pub-id-type="pmid">23992092</pub-id>
</element-citation></ref><ref id="B293-viruses-17-00203"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ash</surname><given-names>M.K.</given-names></name>
<name><surname>Al-Harthi</surname><given-names>L.</given-names></name>
<name><surname>Schneider</surname><given-names>J.R.</given-names></name>
</person-group><article-title>HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>867</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9080867</pub-id><pub-id pub-id-type="pmid">34451992</pub-id>
</element-citation></ref><ref id="B294-viruses-17-00203"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malik</surname><given-names>S.</given-names></name>
<name><surname>Eugenin</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems</article-title><source>Curr. HIV Res.</source><year>2016</year><volume>14</volume><fpage>400</fpage><pub-id pub-id-type="doi">10.2174/1570162X14666160324124558</pub-id><pub-id pub-id-type="pmid">27009098</pub-id>
</element-citation></ref><ref id="B295-viruses-17-00203"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohammadzadeh</surname><given-names>N.</given-names></name>
<name><surname>Chomont</surname><given-names>N.</given-names></name>
<name><surname>Estaquier</surname><given-names>J.</given-names></name>
<name><surname>Cohen</surname><given-names>E.A.</given-names></name>
<name><surname>Power</surname><given-names>C.</given-names></name>
</person-group><article-title>Is the Central Nervous System Reservoir a Hurdle for an HIV Cure?</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>2385</elocation-id><pub-id pub-id-type="doi">10.3390/v15122385</pub-id><pub-id pub-id-type="pmid">38140626</pub-id>
</element-citation></ref><ref id="B296-viruses-17-00203"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Elendu</surname><given-names>C.</given-names></name>
<name><surname>Aguocha</surname><given-names>C.M.</given-names></name>
<name><surname>Okeke</surname><given-names>C.V.</given-names></name>
<name><surname>Okoro</surname><given-names>C.B.</given-names></name>
<name><surname>Peterson</surname><given-names>J.C.</given-names></name>
</person-group><article-title>HIV-Related Neurocognitive Disorders: Diagnosis, Treatment, and Mental Health Implications: A Review</article-title><source>Medicine</source><year>2023</year><volume>102</volume><fpage>E35652</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000035652</pub-id><pub-id pub-id-type="pmid">37904369</pub-id>
</element-citation></ref><ref id="B297-viruses-17-00203"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chan</surname><given-names>P.</given-names></name>
<name><surname>Valcour</surname><given-names>V.</given-names></name>
</person-group><article-title>Neurocognition and the Aging Brain in People with HIV: Implications for Screening</article-title><source>Top. Antivir. Med.</source><year>2021</year><volume>29</volume><fpage>423</fpage></element-citation></ref><ref id="B298-viruses-17-00203"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marquine</surname><given-names>M.J.</given-names></name>
<name><surname>Umlauf</surname><given-names>A.</given-names></name>
<name><surname>Rooney</surname><given-names>A.S.</given-names></name>
<name><surname>Fazeli</surname><given-names>P.L.</given-names></name>
<name><surname>Gouaux</surname><given-names>B.D.</given-names></name>
<name><surname>Woods</surname><given-names>S.P.</given-names></name>
<name><surname>Letendre</surname><given-names>S.L.</given-names></name>
<name><surname>Ellis</surname><given-names>R.J.</given-names></name>
<name><surname>Grant</surname><given-names>I.</given-names></name>
<name><surname>Moore</surname><given-names>D.J.</given-names></name>
</person-group><article-title>The Veterans Aging Cohort Study (VACS) Index Is Associated with Concurrent Risk for Neurocognitive Impairment</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2014</year><volume>65</volume><fpage>190</fpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000008</pub-id><pub-id pub-id-type="pmid">24442225</pub-id>
</element-citation></ref><ref id="B299-viruses-17-00203"><label>299.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Daliparty</surname><given-names>V.M.</given-names></name>
<name><surname>Balasubramanya</surname><given-names>R.</given-names></name>
</person-group><article-title>HIV Encephalitis</article-title><source>Neuroinfections</source><edition>1st ed.</edition><person-group person-group-type="editor">
<name><surname>Gilden</surname><given-names>D.</given-names></name>
</person-group><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc><year>2022</year><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1093/med/9780199926633.003.0004</pub-id></element-citation></ref><ref id="B300-viruses-17-00203"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaul</surname><given-names>M.</given-names></name>
<name><surname>Lipton</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Chemokines and Activated Macrophages in HIV Gp120-Induced Neuronal Apoptosis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>8212</fpage><pub-id pub-id-type="doi">10.1073/pnas.96.14.8212</pub-id><pub-id pub-id-type="pmid">10393974</pub-id>
</element-citation></ref><ref id="B301-viruses-17-00203"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kovalevich</surname><given-names>J.</given-names></name>
<name><surname>Langford</surname><given-names>D.</given-names></name>
</person-group><article-title>Neuronal Toxicity in HIV CNS Disease</article-title><source>Future Virol.</source><year>2012</year><volume>7</volume><fpage>687</fpage><pub-id pub-id-type="doi">10.2217/fvl.12.57</pub-id><pub-id pub-id-type="pmid">23616788</pub-id>
</element-citation></ref><ref id="B302-viruses-17-00203"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Xie</surname><given-names>J.</given-names></name>
<name><surname>Dutta</surname><given-names>D.</given-names></name>
<name><surname>Xiong</surname><given-names>H.</given-names></name>
</person-group><article-title>HIV-1 Envelope Protein Gp120 Modulation of Glutamate Effects on Cortical Neuronal Synapses: Implications for HIV-1-Associated Neuropathogenesis</article-title><source>Int. J. Physiol. Pathophysiol. Pharmacol.</source><year>2023</year><volume>15</volume><fpage>75</fpage><pub-id pub-id-type="pmid">37457651</pub-id>
</element-citation></ref><ref id="B303-viruses-17-00203"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>L.</given-names></name>
<name><surname>Saksena</surname><given-names>N.K.</given-names></name>
</person-group><article-title>HIV Associated Neurocognitive Disorders</article-title><source>Infect. Dis. Rep.</source><year>2013</year><volume>5</volume><fpage>38</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.4081/idr.2013.s1.e8</pub-id></element-citation></ref><ref id="B304-viruses-17-00203"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ben Haij</surname><given-names>N.</given-names></name>
<name><surname>Plan&#x000e8;s</surname><given-names>R.</given-names></name>
<name><surname>Leghmari</surname><given-names>K.</given-names></name>
<name><surname>Serrero</surname><given-names>M.</given-names></name>
<name><surname>Delobel</surname><given-names>P.</given-names></name>
<name><surname>Izopet</surname><given-names>J.</given-names></name>
<name><surname>BenMohamed</surname><given-names>L.</given-names></name>
<name><surname>Bahraoui</surname><given-names>E.</given-names></name>
</person-group><article-title>HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-&#x0039a;B Pathway</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>129425</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0129425</pub-id></element-citation></ref><ref id="B305-viruses-17-00203"><label>305.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Periyasamy</surname><given-names>P.</given-names></name>
<name><surname>Thangaraj</surname><given-names>A.</given-names></name>
<name><surname>Bendi</surname><given-names>V.S.</given-names></name>
<name><surname>Buch</surname><given-names>S.</given-names></name>
</person-group><article-title>HIV-1 Tat-Mediated Microglial Inflammation Involves a Novel MiRNA-34a-NLRC5-NF&#x003ba;B Signaling Axis</article-title><source>Brain Behav. Immun.</source><year>2019</year><volume>80</volume><fpage>227</fpage><pub-id pub-id-type="doi">10.1016/j.bbi.2019.03.011</pub-id><pub-id pub-id-type="pmid">30872089</pub-id>
</element-citation></ref><ref id="B306-viruses-17-00203"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ru</surname><given-names>W.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Bae</surname><given-names>C.</given-names></name>
<name><surname>Shi</surname><given-names>Y.</given-names></name>
<name><surname>Walikonis</surname><given-names>R.</given-names></name>
<name><surname>Chung</surname><given-names>J.M.</given-names></name>
<name><surname>Tang</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Microglia Mediate HIV-1 Gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits</article-title><source>J. Neurosci.</source><year>2019</year><volume>39</volume><fpage>8408</fpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2851-18.2019</pub-id><pub-id pub-id-type="pmid">31471472</pub-id>
</element-citation></ref><ref id="B307-viruses-17-00203"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mangino</surname><given-names>G.</given-names></name>
<name><surname>Percario</surname><given-names>Z.A.</given-names></name>
<name><surname>Fiorucci</surname><given-names>G.</given-names></name>
<name><surname>Vaccari</surname><given-names>G.</given-names></name>
<name><surname>Acconcia</surname><given-names>F.</given-names></name>
<name><surname>Chiarabelli</surname><given-names>C.</given-names></name>
<name><surname>Leone</surname><given-names>S.</given-names></name>
<name><surname>Noto</surname><given-names>A.</given-names></name>
<name><surname>Horenkamp</surname><given-names>F.A.</given-names></name>
<name><surname>Manrique</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>HIV-1 Nef Induces Proinflammatory State in Macrophages through Its Acidic Cluster Domain: Involvement of TNF Alpha Receptor Associated Factor 2</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e22982</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0022982</pub-id><pub-id pub-id-type="pmid">21886773</pub-id>
</element-citation></ref><ref id="B308-viruses-17-00203"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>K.M.</given-names></name>
<name><surname>He</surname><given-names>J.J.</given-names></name>
</person-group><article-title>HIV Nef Expression Down-Modulated GFAP Expression and Altered Glutamate Uptake and Release and Proliferation in Astrocytes</article-title><source>Aging Dis.</source><year>2023</year><volume>14</volume><fpage>152</fpage><pub-id pub-id-type="doi">10.14336/AD.2022.0712</pub-id><pub-id pub-id-type="pmid">36818564</pub-id>
</element-citation></ref><ref id="B309-viruses-17-00203"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>G.</given-names></name>
<name><surname>Makar</surname><given-names>T.</given-names></name>
<name><surname>Gerzanich</surname><given-names>V.</given-names></name>
<name><surname>Kalakonda</surname><given-names>S.</given-names></name>
<name><surname>Ivanova</surname><given-names>S.</given-names></name>
<name><surname>Pereira</surname><given-names>E.F.R.</given-names></name>
<name><surname>Andharvarapu</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Marc Simard</surname><given-names>J.</given-names></name>
<name><surname>Zhao</surname><given-names>R.Y.</given-names></name>
</person-group><article-title>HIV-1 Vpr-Induced Proinflammatory Response and Apoptosis Are Mediated through the Sur1-Trpm4 Channel in Astrocytes</article-title><source>mBio</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1128/mBio.02939-20</pub-id><pub-id pub-id-type="pmid">33293383</pub-id>
</element-citation></ref><ref id="B310-viruses-17-00203"><label>310.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thangaraj</surname><given-names>A.</given-names></name>
<name><surname>Periyasamy</surname><given-names>P.</given-names></name>
<name><surname>Liao</surname><given-names>K.</given-names></name>
<name><surname>Bendi</surname><given-names>V.S.</given-names></name>
<name><surname>Callen</surname><given-names>S.</given-names></name>
<name><surname>Pendyala</surname><given-names>G.</given-names></name>
<name><surname>Buch</surname><given-names>S.</given-names></name>
</person-group><article-title>HIV-1 TAT-Mediated Microglial Activation: Role of Mitochondrial Dysfunction and Defective Mitophagy</article-title><source>Autophagy</source><year>2018</year><volume>14</volume><fpage>1596</fpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1476810</pub-id><pub-id pub-id-type="pmid">29966509</pub-id>
</element-citation></ref><ref id="B311-viruses-17-00203"><label>311.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dubrovsky</surname><given-names>L.</given-names></name>
<name><surname>Brichacek</surname><given-names>B.</given-names></name>
<name><surname>Prashant</surname><given-names>N.M.</given-names></name>
<name><surname>Pushkarsky</surname><given-names>T.</given-names></name>
<name><surname>Mukhamedova</surname><given-names>N.</given-names></name>
<name><surname>Fleetwood</surname><given-names>A.J.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Dragoljevic</surname><given-names>D.</given-names></name>
<name><surname>Fitzgerald</surname><given-names>M.</given-names></name>
<name><surname>Horvath</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Extracellular Vesicles Carrying HIV-1 Nef Induce Long-Term Hyperreactivity of Myeloid Cells</article-title><source>Cell Rep.</source><year>2022</year><volume>41</volume><fpage>111674</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111674</pub-id><pub-id pub-id-type="pmid">36417867</pub-id>
</element-citation></ref><ref id="B312-viruses-17-00203"><label>312.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lv</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Tsao</surname><given-names>L.C.</given-names></name>
<name><surname>Nakagawa</surname><given-names>T.</given-names></name>
<name><surname>Guo</surname><given-names>H.</given-names></name>
<name><surname>Su</surname><given-names>L.</given-names></name>
<name><surname>Xiong</surname><given-names>Y.</given-names></name>
</person-group><article-title>Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication</article-title><source>Mol. Cell</source><year>2018</year><volume>70</volume><fpage>961</fpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.05.007</pub-id><pub-id pub-id-type="pmid">29883611</pub-id>
</element-citation></ref><ref id="B313-viruses-17-00203"><label>313.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Langer</surname><given-names>S.</given-names></name>
<name><surname>Hammer</surname><given-names>C.</given-names></name>
<name><surname>Hopfensperger</surname><given-names>K.</given-names></name>
<name><surname>Klein</surname><given-names>L.</given-names></name>
<name><surname>Hotter</surname><given-names>D.</given-names></name>
<name><surname>Jesus</surname><given-names>P.D.D.</given-names></name>
<name><surname>Herbert</surname><given-names>K.M.</given-names></name>
<name><surname>Pache</surname><given-names>L.</given-names></name>
<name><surname>Smith</surname><given-names>N.</given-names></name>
<name><surname>van der Merwe</surname><given-names>J.A.</given-names></name>
<etal/>
</person-group><article-title>HIV-1 Vpu Is a Potent Transcriptional Suppressor of NF-&#x0039a;B-Elicited Antiviral Immune Responses</article-title><source>Elife</source><year>2019</year><volume>8</volume><fpage>e41930</fpage><pub-id pub-id-type="doi">10.7554/eLife.41930</pub-id><pub-id pub-id-type="pmid">30717826</pub-id>
</element-citation></ref><ref id="B314-viruses-17-00203"><label>314.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>R.Z.</given-names></name>
<name><surname>Kane</surname><given-names>M.</given-names></name>
</person-group><article-title>Insights into the Role of HIV-1 Vpu in Modulation of NF-&#x00138;B Signaling Pathways</article-title><source>mBio</source><year>2023</year><volume>14</volume><elocation-id>e0092023</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.00920-23</pub-id><pub-id pub-id-type="pmid">37409832</pub-id>
</element-citation></ref><ref id="B315-viruses-17-00203"><label>315.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shrikant</surname><given-names>P.</given-names></name>
<name><surname>Benos</surname><given-names>D.J.</given-names></name>
<name><surname>Tang</surname><given-names>L.P.</given-names></name>
<name><surname>Benveniste</surname><given-names>E.N.</given-names></name>
</person-group><article-title>HIV Glycoprotein 120 Enhances Intercellular Adhesion Molecule-1 Gene Expression in Glial Cells. Involvement of Janus Kinase/Signal Transducer and Activator of Transcription and Protein Kinase C Signaling Pathways</article-title><source>J. Immunol.</source><year>1950</year><volume>156</volume><fpage>1307</fpage><lpage>1314</lpage><comment>Available online: <ext-link xlink:href="https://pubmed.ncbi.nlm.nih.gov/8558011/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/8558011/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-23">(accessed on 23 December 2024)</date-in-citation><pub-id pub-id-type="doi">10.4049/jimmunol.156.3.1307</pub-id></element-citation></ref><ref id="B316-viruses-17-00203"><label>316.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pu</surname><given-names>H.</given-names></name>
<name><surname>Tian</surname><given-names>J.</given-names></name>
<name><surname>Flora</surname><given-names>G.</given-names></name>
<name><surname>Lee</surname><given-names>Y.W.</given-names></name>
<name><surname>Nath</surname><given-names>A.</given-names></name>
<name><surname>Hennig</surname><given-names>B.</given-names></name>
<name><surname>Toborek</surname><given-names>M.</given-names></name>
</person-group><article-title>HIV-1 Tat Protein Upregulates Inflammatory Mediators and Induces Monocyte Invasion into the Brain</article-title><source>Mol. Cell. Neurosci.</source><year>2003</year><volume>24</volume><fpage>224</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/S1044-7431(03)00171-4</pub-id><pub-id pub-id-type="pmid">14550782</pub-id>
</element-citation></ref><ref id="B317-viruses-17-00203"><label>317.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duan</surname><given-names>M.</given-names></name>
<name><surname>Yao</surname><given-names>H.</given-names></name>
<name><surname>Hu</surname><given-names>G.</given-names></name>
<name><surname>Chen</surname><given-names>X.M.</given-names></name>
<name><surname>Lund</surname><given-names>A.K.</given-names></name>
<name><surname>Buch</surname><given-names>S.</given-names></name>
</person-group><article-title>HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for MiR-221/-222 in HIV-Associated Cardiomyopathy</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e60170</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0060170</pub-id><pub-id pub-id-type="pmid">23555914</pub-id>
</element-citation></ref><ref id="B318-viruses-17-00203"><label>318.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swingler</surname><given-names>S.</given-names></name>
<name><surname>Brichacek</surname><given-names>B.</given-names></name>
<name><surname>Jacque</surname><given-names>J.M.</given-names></name>
<name><surname>Ulich</surname><given-names>C.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Stevenson</surname><given-names>M.</given-names></name>
</person-group><article-title>HIV-1 Nef Intersects the Macrophage CD40L Signalling Pathway to Promote Resting-Cell Infection</article-title><source>Nature</source><year>2003</year><volume>424</volume><fpage>213</fpage><pub-id pub-id-type="doi">10.1038/nature01749</pub-id><pub-id pub-id-type="pmid">12853962</pub-id>
</element-citation></ref><ref id="B319-viruses-17-00203"><label>319.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fabryova</surname><given-names>H.</given-names></name>
<name><surname>Strebel</surname><given-names>K.</given-names></name>
</person-group><article-title>Vpr and Its Cellular Interaction Partners: R We There Yet?</article-title><source>Cells</source><year>2019</year><volume>8</volume><elocation-id>1310</elocation-id><pub-id pub-id-type="doi">10.3390/cells8111310</pub-id><pub-id pub-id-type="pmid">31652959</pub-id>
</element-citation></ref><ref id="B320-viruses-17-00203"><label>320.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghaly</surname><given-names>M.</given-names></name>
<name><surname>Proulx</surname><given-names>J.</given-names></name>
<name><surname>Borgmann</surname><given-names>K.</given-names></name>
<name><surname>Park</surname><given-names>I.W.</given-names></name>
</person-group><article-title>Novel Role of HIV-1 Nef in Regulating the Ubiquitination of Cellular Proteins</article-title><source>Front. Cell Infect. Microbiol.</source><year>2023</year><volume>13</volume><elocation-id>1106591</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2023.1106591</pub-id><pub-id pub-id-type="pmid">36968110</pub-id>
</element-citation></ref><ref id="B321-viruses-17-00203"><label>321.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Badley</surname><given-names>A.D.</given-names></name>
<name><surname>Pilon</surname><given-names>A.A.</given-names></name>
<name><surname>Landay</surname><given-names>A.</given-names></name>
<name><surname>Lynch</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Mechanisms of HIV-Associated Lymphocyte Apoptosis</article-title><source>Blood</source><year>2000</year><volume>96</volume><fpage>2951</fpage><lpage>2964</lpage><pub-id pub-id-type="doi">10.1182/blood.V96.9.2951</pub-id><pub-id pub-id-type="pmid">11049971</pub-id>
</element-citation></ref><ref id="B322-viruses-17-00203"><label>322.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jabea Ekabe</surname><given-names>C.</given-names></name>
<name><surname>Asaba Clinton</surname><given-names>N.</given-names></name>
<name><surname>Agyei</surname><given-names>E.K.</given-names></name>
<name><surname>Kehbila</surname><given-names>J.</given-names></name>
</person-group><article-title>Role of Apoptosis in HIV Pathogenesis</article-title><source>Adv. Virol.</source><year>2022</year><volume>2022</volume><fpage>8148119</fpage><pub-id pub-id-type="doi">10.1155/2022/8148119</pub-id><pub-id pub-id-type="pmid">35462964</pub-id>
</element-citation></ref><ref id="B323-viruses-17-00203"><label>323.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cummins</surname><given-names>N.W.</given-names></name>
<name><surname>Badley</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Anti-Apoptotic Mechanisms of HIV: Lessons and Novel Approaches to Curing HIV</article-title><source>Cell Mol. Life Sci.</source><year>2012</year><volume>70</volume><fpage>3355</fpage><pub-id pub-id-type="doi">10.1007/s00018-012-1239-3</pub-id><pub-id pub-id-type="pmid">23275944</pub-id>
</element-citation></ref><ref id="B324-viruses-17-00203"><label>324.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Shackelford</surname><given-names>J.M.</given-names></name>
<name><surname>Selliah</surname><given-names>N.</given-names></name>
<name><surname>Shivers</surname><given-names>D.K.</given-names></name>
<name><surname>O&#x02019;Neill</surname><given-names>E.</given-names></name>
<name><surname>Garcia</surname><given-names>J.V.</given-names></name>
<name><surname>Muthumani</surname><given-names>K.</given-names></name>
<name><surname>Weiner</surname><given-names>D.</given-names></name>
<name><surname>Yu</surname><given-names>X.F.</given-names></name>
<name><surname>Gabuzda</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>The HIV-1 Vif Protein Mediates Degradation of Vpr and Reduces Vpr-Induced Cell Cycle Arrest</article-title><source>DNA Cell Biol.</source><year>2008</year><volume>27</volume><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1089/dna.2007.0707</pub-id><pub-id pub-id-type="pmid">18462066</pub-id>
</element-citation></ref><ref id="B325-viruses-17-00203"><label>325.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Q.H.</given-names></name>
<name><surname>Williams</surname><given-names>D.A.</given-names></name>
<name><surname>McManus</surname><given-names>C.</given-names></name>
<name><surname>Baribaud</surname><given-names>F.</given-names></name>
<name><surname>Doms</surname><given-names>R.W.</given-names></name>
<name><surname>Schols</surname><given-names>D.</given-names></name>
<name><surname>De Clercq</surname><given-names>E.</given-names></name>
<name><surname>Kotlikoff</surname><given-names>M.I.</given-names></name>
<name><surname>Collman</surname><given-names>R.G.</given-names></name>
<name><surname>Freedman</surname><given-names>B.D.</given-names></name>
</person-group><article-title>HIV-1 Gp120 and Chemokines Activate Ion Channels in Primary Macrophages through CCR5 and CXCR4 Stimulation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>4832</fpage><pub-id pub-id-type="doi">10.1073/pnas.090521697</pub-id><pub-id pub-id-type="pmid">10758170</pub-id>
</element-citation></ref><ref id="B326-viruses-17-00203"><label>326.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>X.-T.</given-names></name>
</person-group><article-title>HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions</article-title><source>Curr. Drug Targets</source><year>2016</year><volume>17</volume><fpage>4</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.2174/1389450116666150531162212</pub-id><pub-id pub-id-type="pmid">26028040</pub-id>
</element-citation></ref><ref id="B327-viruses-17-00203"><label>327.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shrestha</surname><given-names>J.</given-names></name>
<name><surname>Santerre</surname><given-names>M.</given-names></name>
<name><surname>Allen</surname><given-names>C.N.</given-names></name>
<name><surname>Arjona</surname><given-names>S.P.</given-names></name>
<name><surname>Hooper</surname><given-names>R.</given-names></name>
<name><surname>Mukerjee</surname><given-names>R.</given-names></name>
<name><surname>Kaul</surname><given-names>M.</given-names></name>
<name><surname>Shcherbik</surname><given-names>N.</given-names></name>
<name><surname>Soboloff</surname><given-names>J.</given-names></name>
<name><surname>Sawaya</surname><given-names>B.E.</given-names></name>
</person-group><article-title>HIV-1 Gp120 Protein Promotes HAND through the Calcineurin Pathway Activation</article-title><source>Mitochondrion</source><year>2023</year><volume>70</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1016/j.mito.2023.03.003</pub-id><pub-id pub-id-type="pmid">36925028</pub-id>
</element-citation></ref><ref id="B328-viruses-17-00203"><label>328.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>R.C.</given-names></name>
<name><surname>Mishra</surname><given-names>N.</given-names></name>
<name><surname>Gaur</surname><given-names>R.</given-names></name>
</person-group><article-title>G Protein-Coupled and ATP-Sensitive Inwardly Rectifying Potassium Ion Channels Are Essential for HIV Entry</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><elocation-id>4113</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-40968-x</pub-id><pub-id pub-id-type="pmid">30858482</pub-id>
</element-citation></ref><ref id="B329-viruses-17-00203"><label>329.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferrucci</surname><given-names>A.</given-names></name>
<name><surname>Nonnemacher</surname><given-names>M.R.</given-names></name>
<name><surname>Wigdahl</surname><given-names>B.</given-names></name>
</person-group><article-title>Human Immunodeficiency Virus Viral Protein R as an Extracellular Protein in Neuropathogenesis</article-title><source>Adv. Virus Res.</source><year>2011</year><volume>81</volume><fpage>165</fpage><pub-id pub-id-type="doi">10.1016/B978-0-12-385885-6.00010-9</pub-id><pub-id pub-id-type="pmid">22094081</pub-id>
</element-citation></ref><ref id="B330-viruses-17-00203"><label>330.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ewart</surname><given-names>G.D.</given-names></name>
<name><surname>Sutherland</surname><given-names>T.</given-names></name>
<name><surname>Gage</surname><given-names>P.W.</given-names></name>
<name><surname>Cox</surname><given-names>G.B.</given-names></name>
</person-group><article-title>The Vpu Protein of Human Immunodeficiency Virus Type 1 Forms Cation-Selective Ion Channels</article-title><source>J. Virol.</source><year>1996</year><volume>70</volume><fpage>7108</fpage><pub-id pub-id-type="doi">10.1128/jvi.70.10.7108-7115.1996</pub-id><pub-id pub-id-type="pmid">8794357</pub-id>
</element-citation></ref><ref id="B331-viruses-17-00203"><label>331.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ebenbichler</surname><given-names>C.F.</given-names></name>
<name><surname>Stoiber</surname><given-names>H.</given-names></name>
<name><surname>Schneider</surname><given-names>R.</given-names></name>
<name><surname>Patsch</surname><given-names>J.R.</given-names></name>
<name><surname>Dierich</surname><given-names>M.P.</given-names></name>
</person-group><article-title>The Human Immunodeficiency Virus Type 1 Transmembrane Gp41 Protein Is a Calcium-Binding Protein and Interacts with the Putative Second-Receptor Molecules in a Calcium-Dependent Manner</article-title><source>J. Virol.</source><year>1996</year><volume>70</volume><fpage>1723</fpage><lpage>1728</lpage><pub-id pub-id-type="doi">10.1128/jvi.70.3.1723-1728.1996</pub-id><pub-id pub-id-type="pmid">8627693</pub-id>
</element-citation></ref><ref id="B332-viruses-17-00203"><label>332.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Majeed</surname><given-names>S.</given-names></name>
<name><surname>Dang</surname><given-names>L.</given-names></name>
<name><surname>Islam</surname><given-names>M.M.</given-names></name>
<name><surname>Ishola</surname><given-names>O.</given-names></name>
<name><surname>Borbat</surname><given-names>P.P.</given-names></name>
<name><surname>Ludtke</surname><given-names>S.J.</given-names></name>
<name><surname>Georgieva</surname><given-names>E.R.</given-names></name>
</person-group><article-title>HIV-1 Vpu Protein Forms Stable Oligomers in Aqueous Solution via Its Transmembrane Domain Self-Association</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><elocation-id>14691</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-41873-0</pub-id><pub-id pub-id-type="pmid">37673923</pub-id>
</element-citation></ref><ref id="B333-viruses-17-00203"><label>333.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clark</surname><given-names>E.</given-names></name>
<name><surname>Nava</surname><given-names>B.</given-names></name>
<name><surname>Caputi</surname><given-names>M.</given-names></name>
</person-group><article-title>Tat Is a Multifunctional Viral Protein That Modulates Cellular Gene Expression and Functions</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>27569</fpage><lpage>27581</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.15174</pub-id><pub-id pub-id-type="pmid">28187438</pub-id>
</element-citation></ref><ref id="B334-viruses-17-00203"><label>334.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Bae</surname><given-names>C.</given-names></name>
<name><surname>Gelman</surname><given-names>B.B.</given-names></name>
<name><surname>Chung</surname><given-names>J.M.</given-names></name>
<name><surname>Tang</surname><given-names>S.J.</given-names></name>
</person-group><article-title>A Neuron-to-Astrocyte Wnt5a Signal Governs Astrogliosis during HIV-Associated Pain Pathogenesis</article-title><source>Brain</source><year>2022</year><volume>145</volume><fpage>4108</fpage><pub-id pub-id-type="doi">10.1093/brain/awac015</pub-id><pub-id pub-id-type="pmid">35040478</pub-id>
</element-citation></ref><ref id="B335-viruses-17-00203"><label>335.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mukerji</surname><given-names>J.</given-names></name>
<name><surname>Olivieri</surname><given-names>K.C.</given-names></name>
<name><surname>Misra</surname><given-names>V.</given-names></name>
<name><surname>Agopian</surname><given-names>K.A.</given-names></name>
<name><surname>Gabuzda</surname><given-names>D.</given-names></name>
</person-group><article-title>Proteomic Analysis of HIV-1 Nef Cellular Binding Partners Reveals a Role for Exocyst Complex Proteins in Mediating Enhancement of Intercellular Nanotube Formation</article-title><source>Retrovirology</source><year>2012</year><volume>9</volume><fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-9-33</pub-id><pub-id pub-id-type="pmid">22534017</pub-id>
</element-citation></ref><ref id="B336-viruses-17-00203"><label>336.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buffalo</surname><given-names>C.Z.</given-names></name>
<name><surname>Iwamoto</surname><given-names>Y.</given-names></name>
<name><surname>Hurley</surname><given-names>J.H.</given-names></name>
<name><surname>Ren</surname><given-names>X.</given-names></name>
</person-group><article-title>How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection</article-title><source>J. Virol.</source><year>2019</year><volume>93</volume><fpage>e01322-19</fpage><pub-id pub-id-type="doi">10.1128/JVI.01322-19</pub-id><pub-id pub-id-type="pmid">31578291</pub-id>
</element-citation></ref><ref id="B337-viruses-17-00203"><label>337.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goes</surname><given-names>L.R.</given-names></name>
<name><surname>Sajani</surname><given-names>A.</given-names></name>
<name><surname>Sivro</surname><given-names>A.</given-names></name>
<name><surname>Olowojesiku</surname><given-names>R.</given-names></name>
<name><surname>Ray</surname><given-names>J.C.</given-names></name>
<name><surname>Perrone</surname><given-names>I.</given-names></name>
<name><surname>Yolitz</surname><given-names>J.</given-names></name>
<name><surname>Girard</surname><given-names>A.</given-names></name>
<name><surname>Leyre</surname><given-names>L.</given-names></name>
<name><surname>Wibmer</surname><given-names>C.K.</given-names></name>
<etal/>
</person-group><article-title>The V2 Loop of HIV Gp120 Delivers Costimulatory Signals to CD4+ T Cells through Integrin A4&#x003b2;7 and Promotes Cellular Activation and Infection</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>32566</fpage><lpage>32573</lpage><pub-id pub-id-type="doi">10.1073/pnas.2011501117</pub-id><pub-id pub-id-type="pmid">33288704</pub-id>
</element-citation></ref><ref id="B338-viruses-17-00203"><label>338.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valent&#x000ed;n-Guillama</surname><given-names>G.</given-names></name>
<name><surname>L&#x000f3;pez</surname><given-names>S.</given-names></name>
<name><surname>Kucheryavykh</surname><given-names>Y.V.</given-names></name>
<name><surname>Chorna</surname><given-names>N.E.</given-names></name>
<name><surname>P&#x000e9;rez</surname><given-names>J.</given-names></name>
<name><surname>Ortiz-Rivera</surname><given-names>J.</given-names></name>
<name><surname>Inyushin</surname><given-names>M.</given-names></name>
<name><surname>Makarov</surname><given-names>V.</given-names></name>
<name><surname>Valent&#x000ed;n-Acevedo</surname><given-names>A.</given-names></name>
<name><surname>Quinones-Hinojosa</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>HIV-1 Envelope Protein Gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell</article-title><source>Cancers</source><year>2018</year><volume>10</volume><elocation-id>301</elocation-id><pub-id pub-id-type="doi">10.3390/cancers10090301</pub-id><pub-id pub-id-type="pmid">30200472</pub-id>
</element-citation></ref><ref id="B339-viruses-17-00203"><label>339.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vignoli</surname><given-names>A.L.</given-names></name>
<name><surname>Martini</surname><given-names>I.</given-names></name>
<name><surname>Haglid</surname><given-names>K.H.</given-names></name>
<name><surname>Silvestroni</surname><given-names>L.</given-names></name>
<name><surname>Augusti-Tocco</surname><given-names>G.</given-names></name>
<name><surname>Biagioni</surname><given-names>S.</given-names></name>
</person-group><article-title>Neuronal Glycolytic Pathway Impairment Induced by HIV Envelope Glycoprotein Gp120</article-title><source>Mol. Cell Biochem.</source><year>2000</year><volume>215</volume><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1023/A:1026590916661</pub-id><pub-id pub-id-type="pmid">11204458</pub-id>
</element-citation></ref><ref id="B340-viruses-17-00203"><label>340.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kang</surname><given-names>S.</given-names></name>
<name><surname>Tang</surname><given-names>H.</given-names></name>
</person-group><article-title>HIV-1 Infection and Glucose Metabolism Reprogramming of T Cells: Another Approach Toward Functional Cure and Reservoir Eradication</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>572677</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.572677</pub-id><pub-id pub-id-type="pmid">33117366</pub-id>
</element-citation></ref><ref id="B341-viruses-17-00203"><label>341.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barrero</surname><given-names>C.A.</given-names></name>
<name><surname>Datta</surname><given-names>P.K.</given-names></name>
<name><surname>Sen</surname><given-names>S.</given-names></name>
<name><surname>Deshmane</surname><given-names>S.</given-names></name>
<name><surname>Amini</surname><given-names>S.</given-names></name>
<name><surname>Khalili</surname><given-names>K.</given-names></name>
<name><surname>Merali</surname><given-names>S.</given-names></name>
</person-group><article-title>HIV-1 Vpr Modulates Macrophage Metabolic Pathways: A SILAC-Based Quantitative Analysis</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e68376</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0068376</pub-id><pub-id pub-id-type="pmid">23874603</pub-id>
</element-citation></ref><ref id="B342-viruses-17-00203"><label>342.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sivalingam</surname><given-names>K.</given-names></name>
<name><surname>Cirino</surname><given-names>T.J.</given-names></name>
<name><surname>McLaughlin</surname><given-names>J.P.</given-names></name>
<name><surname>Samikkannu</surname><given-names>T.</given-names></name>
</person-group><article-title>HIV-Tat and Cocaine Impact Brain Energy Metabolism: Redox Modification and Mitochondrial Biogenesis Influence NRF Transcription-Mediated Neurodegeneration</article-title><source>Mol. Neurobiol.</source><year>2021</year><volume>58</volume><elocation-id>490</elocation-id><pub-id pub-id-type="doi">10.1007/s12035-020-02131-w</pub-id><pub-id pub-id-type="pmid">32978730</pub-id>
</element-citation></ref><ref id="B343-viruses-17-00203"><label>343.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>J.</given-names></name>
<name><surname>Shun</surname><given-names>M.C.</given-names></name>
<name><surname>Hao</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Qian</surname><given-names>J.</given-names></name>
<name><surname>Hrecka</surname><given-names>K.</given-names></name>
<name><surname>Delucia</surname><given-names>M.</given-names></name>
<name><surname>Monnie</surname><given-names>C.</given-names></name>
<name><surname>Ahn</surname><given-names>J.</given-names></name>
<name><surname>Skowronski</surname><given-names>J.</given-names></name>
</person-group><article-title>HIV-1 Vpr Reprograms CLR4DCAF1 E3 Ubiquitin Ligase to Antagonize Exonuclease 1-Mediated Restriction of HIV-1 Infection</article-title><source>mBio</source><year>2018</year><volume>9</volume><fpage>10-1128</fpage><pub-id pub-id-type="doi">10.1128/mBio.01732-18</pub-id></element-citation></ref><ref id="B344-viruses-17-00203"><label>344.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wen</surname><given-names>X.</given-names></name>
<name><surname>Klockow</surname><given-names>L.</given-names></name>
<name><surname>Nekorchuk</surname><given-names>M.</given-names></name>
<name><surname>Sharifi</surname><given-names>H.J.</given-names></name>
<name><surname>de Noronha</surname><given-names>C.M.C.</given-names></name>
</person-group><article-title>The HIV1 Protein Vpr Acts to Enhance Constitutive DCAF1-Dependent UNG2 Turnover</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e30939</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0030939</pub-id><pub-id pub-id-type="pmid">22292079</pub-id>
</element-citation></ref><ref id="B345-viruses-17-00203"><label>345.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>X.</given-names></name>
<name><surname>Delucia</surname><given-names>M.</given-names></name>
<name><surname>Hao</surname><given-names>C.</given-names></name>
<name><surname>Hrecka</surname><given-names>K.</given-names></name>
<name><surname>Monnie</surname><given-names>C.</given-names></name>
<name><surname>Skowronski</surname><given-names>J.</given-names></name>
<name><surname>Ahn</surname><given-names>J.</given-names></name>
</person-group><article-title>HIV-1 Vpr Protein Directly Loads Helicase-like Transcription Factor (HLTF) onto the CRL4-DCAF1 E3 Ubiquitin Ligase</article-title><source>J. Biol. Chem.</source><year>2017</year><volume>292</volume><fpage>21117</fpage><lpage>21127</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.798801</pub-id><pub-id pub-id-type="pmid">29079575</pub-id>
</element-citation></ref><ref id="B346-viruses-17-00203"><label>346.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Erdmann</surname><given-names>N.B.</given-names></name>
<name><surname>Whitney</surname><given-names>N.P.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
</person-group><article-title>Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase</article-title><source>Clin. Neurosci. Res.</source><year>2006</year><volume>6</volume><fpage>315</fpage><pub-id pub-id-type="doi">10.1016/j.cnr.2006.09.009</pub-id><pub-id pub-id-type="pmid">18059978</pub-id>
</element-citation></ref><ref id="B347-viruses-17-00203"><label>347.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El-Amine</surname><given-names>R.</given-names></name>
<name><surname>Germini</surname><given-names>D.</given-names></name>
<name><surname>Zakharova</surname><given-names>V.V.</given-names></name>
<name><surname>Tsfasman</surname><given-names>T.</given-names></name>
<name><surname>Sheval</surname><given-names>E.V.</given-names></name>
<name><surname>Louzada</surname><given-names>R.A.N.</given-names></name>
<name><surname>Dupuy</surname><given-names>C.</given-names></name>
<name><surname>Bilhou-Nabera</surname><given-names>C.</given-names></name>
<name><surname>Hamade</surname><given-names>A.</given-names></name>
<name><surname>Najjar</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>HIV-1 Tat Protein Induces DNA Damage in Human Peripheral Blood B-Lymphocytes via Mitochondrial ROS Production</article-title><source>Redox Biol.</source><year>2018</year><volume>15</volume><elocation-id>97</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2017.11.024</pub-id><pub-id pub-id-type="pmid">29220699</pub-id>
</element-citation></ref><ref id="B348-viruses-17-00203"><label>348.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>S.</given-names></name>
<name><surname>Sheng</surname><given-names>W.S.</given-names></name>
<name><surname>Lokensgard</surname><given-names>J.R.</given-names></name>
<name><surname>Peterson</surname><given-names>P.K.</given-names></name>
<name><surname>Rock</surname><given-names>R.B.</given-names></name>
</person-group><article-title>Preferential Sensitivity of Human Dopaminergic Neurons to Gp120-Induced Oxidative Damage</article-title><source>J. Neurovirol.</source><year>2009</year><volume>15</volume><fpage>401</fpage><pub-id pub-id-type="doi">10.3109/13550280903296346</pub-id><pub-id pub-id-type="pmid">20175694</pub-id>
</element-citation></ref><ref id="B349-viruses-17-00203"><label>349.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mangino</surname><given-names>G.</given-names></name>
<name><surname>Famiglietti</surname><given-names>M.</given-names></name>
<name><surname>Capone</surname><given-names>C.</given-names></name>
<name><surname>Veroni</surname><given-names>C.</given-names></name>
<name><surname>Percario</surname><given-names>Z.A.</given-names></name>
<name><surname>Leone</surname><given-names>S.</given-names></name>
<name><surname>Fiorucci</surname><given-names>G.</given-names></name>
<name><surname>L&#x000fc;lf</surname><given-names>S.</given-names></name>
<name><surname>Romeo</surname><given-names>G.</given-names></name>
<name><surname>Agresti</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO<sub>2</sub> Production and Neurotoxic Activity</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0130189</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0130189</pub-id><pub-id pub-id-type="pmid">26066624</pub-id>
</element-citation></ref><ref id="B350-viruses-17-00203"><label>350.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borrajo</surname><given-names>A.</given-names></name>
<name><surname>Spuch</surname><given-names>C.</given-names></name>
<name><surname>Penedo</surname><given-names>M.A.</given-names></name>
<name><surname>Olivares</surname><given-names>J.M.</given-names></name>
<name><surname>Ag&#x000ed;s-Balboa</surname><given-names>R.C.</given-names></name>
</person-group><article-title>Important Role of Microglia in HIV-1 Associated Neurocognitive Disorders and the Molecular Pathways Implicated in Its Pathogenesis</article-title><source>Ann. Med.</source><year>2021</year><volume>53</volume><fpage>43</fpage><pub-id pub-id-type="doi">10.1080/07853890.2020.1814962</pub-id><pub-id pub-id-type="pmid">32841065</pub-id>
</element-citation></ref><ref id="B351-viruses-17-00203"><label>351.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hategan</surname><given-names>A.</given-names></name>
<name><surname>Bianchet</surname><given-names>M.A.</given-names></name>
<name><surname>Steiner</surname><given-names>J.</given-names></name>
<name><surname>Karnaukhova</surname><given-names>E.</given-names></name>
<name><surname>Masliah</surname><given-names>E.</given-names></name>
<name><surname>Fields</surname><given-names>A.</given-names></name>
<name><surname>Lee</surname><given-names>M.H.</given-names></name>
<name><surname>Dickens</surname><given-names>A.M.</given-names></name>
<name><surname>Haughey</surname><given-names>N.</given-names></name>
<name><surname>Dimitriadis</surname><given-names>E.K.</given-names></name>
<etal/>
</person-group><article-title>HIV-Tat Protein and Amyloid &#x003b2; Peptide Form Multifibrillar Structures That Cause Neurotoxicity</article-title><source>Nat. Struct. Mol. Biol.</source><year>2017</year><volume>24</volume><elocation-id>379</elocation-id><pub-id pub-id-type="doi">10.1038/nsmb.3379</pub-id><pub-id pub-id-type="pmid">28218748</pub-id>
</element-citation></ref><ref id="B352-viruses-17-00203"><label>352.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naghavi</surname><given-names>M.H.</given-names></name>
</person-group><article-title>&#x0201c;APP&#x0201d;reciating the Complexity of HIV-Induced Neurodegenerative Diseases</article-title><source>PLoS Pathog.</source><year>2018</year><volume>14</volume><pub-id pub-id-type="doi">10.1371/journal.ppat.1007309</pub-id></element-citation></ref><ref id="B353-viruses-17-00203"><label>353.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raulin</surname><given-names>A.C.</given-names></name>
<name><surname>Doss</surname><given-names>S.V.</given-names></name>
<name><surname>Trottier</surname><given-names>Z.A.</given-names></name>
<name><surname>Ikezu</surname><given-names>T.C.</given-names></name>
<name><surname>Bu</surname><given-names>G.</given-names></name>
<name><surname>Liu</surname><given-names>C.C.</given-names></name>
</person-group><article-title>ApoE in Alzheimer&#x02019;s Disease: Pathophysiology and Therapeutic Strategies</article-title><source>Mol. Neurodegener.</source><year>2022</year><volume>17</volume><fpage>e1007309</fpage><pub-id pub-id-type="doi">10.1186/s13024-022-00574-4</pub-id></element-citation></ref><ref id="B354-viruses-17-00203"><label>354.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwon</surname><given-names>H.S.</given-names></name>
<name><surname>Brent</surname><given-names>M.M.</given-names></name>
<name><surname>Getachew</surname><given-names>R.</given-names></name>
<name><surname>Jayakumar</surname><given-names>P.</given-names></name>
<name><surname>Chen</surname><given-names>L.F.</given-names></name>
<name><surname>Schnolzer</surname><given-names>M.</given-names></name>
<name><surname>McBurney</surname><given-names>M.W.</given-names></name>
<name><surname>Marmorstein</surname><given-names>R.</given-names></name>
<name><surname>Greene</surname><given-names>W.C.</given-names></name>
<name><surname>Ott</surname><given-names>M.</given-names></name>
</person-group><article-title>Human Immunodeficiency Virus Type 1 Tat Protein Inhibits the SIRT1 Deacetylase and Induces T-Cell Hyperactivation</article-title><source>Cell Host Microbe</source><year>2008</year><volume>3</volume><fpage>158</fpage><pub-id pub-id-type="doi">10.1016/j.chom.2008.02.002</pub-id><pub-id pub-id-type="pmid">18329615</pub-id>
</element-citation></ref><ref id="B355-viruses-17-00203"><label>355.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abraham</surname><given-names>L.</given-names></name>
<name><surname>Fackler</surname><given-names>O.T.</given-names></name>
</person-group><article-title>HIV-1 Nef: A Multifaceted Modulator of T Cell Receptor Signaling</article-title><source>Cell Commun. Signal</source><year>2012</year><volume>10</volume><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/1478-811X-10-39</pub-id><pub-id pub-id-type="pmid">23227982</pub-id>
</element-citation></ref><ref id="B356-viruses-17-00203"><label>356.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abbas</surname><given-names>W.</given-names></name>
<name><surname>Herbein</surname><given-names>G.</given-names></name>
</person-group><article-title>T-Cell Signaling in HIV-1 Infection</article-title><source>Open Virol. J.</source><year>2013</year><volume>7</volume><fpage>57</fpage><pub-id pub-id-type="doi">10.2174/1874357920130621001</pub-id><pub-id pub-id-type="pmid">23986795</pub-id>
</element-citation></ref><ref id="B357-viruses-17-00203"><label>357.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reuschl</surname><given-names>A.K.</given-names></name>
<name><surname>Mesner</surname><given-names>D.</given-names></name>
<name><surname>Shivkumar</surname><given-names>M.</given-names></name>
<name><surname>Whelan</surname><given-names>M.V.X.</given-names></name>
<name><surname>Pallett</surname><given-names>L.J.</given-names></name>
<name><surname>Guerra-Assun&#x000e7;&#x000e3;o</surname><given-names>J.A.</given-names></name>
<name><surname>Madansein</surname><given-names>R.</given-names></name>
<name><surname>Dullabh</surname><given-names>K.J.</given-names></name>
<name><surname>Sigal</surname><given-names>A.</given-names></name>
<name><surname>Thornhill</surname><given-names>J.P.</given-names></name>
<etal/>
</person-group><article-title>HIV-1 Vpr Drives a Tissue Residency-like Phenotype during Selective Infection of Resting Memory T Cells</article-title><source>Cell Rep.</source><year>2022</year><volume>39</volume><fpage>110650</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110650</pub-id><pub-id pub-id-type="pmid">35417711</pub-id>
</element-citation></ref><ref id="B358-viruses-17-00203"><label>358.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bauby</surname><given-names>H.</given-names></name>
<name><surname>Ward</surname><given-names>C.C.</given-names></name>
<name><surname>Hugh-White</surname><given-names>R.</given-names></name>
<name><surname>Swanson</surname><given-names>C.M.</given-names></name>
<name><surname>Schulz</surname><given-names>R.</given-names></name>
<name><surname>Goujon</surname><given-names>C.</given-names></name>
<name><surname>Malima</surname><given-names>M.H.</given-names></name>
</person-group><article-title>HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4+ T Cells Early Postinfection</article-title><source>mBio</source><year>2021</year><volume>12</volume><elocation-id>e0136921</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01369-21</pub-id><pub-id pub-id-type="pmid">34154423</pub-id>
</element-citation></ref><ref id="B359-viruses-17-00203"><label>359.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berman</surname><given-names>J.W.</given-names></name>
<name><surname>Carvallo</surname><given-names>L.</given-names></name>
<name><surname>Buckner</surname><given-names>C.M.</given-names></name>
<name><surname>Luers</surname><given-names>A.</given-names></name>
<name><surname>Prevedel</surname><given-names>L.</given-names></name>
<name><surname>Bennett</surname><given-names>M.V.</given-names></name>
<name><surname>Eugenin</surname><given-names>E.A.</given-names></name>
</person-group><article-title>HIV-Tat Alters Connexin43 Expression and Trafficking in Human Astrocytes: Role in NeuroAIDS</article-title><source>J. Neuroinflammation</source><year>2016</year><volume>13</volume><fpage>54</fpage><pub-id pub-id-type="doi">10.1186/s12974-016-0510-1</pub-id><pub-id pub-id-type="pmid">26934876</pub-id>
</element-citation></ref><ref id="B360-viruses-17-00203"><label>360.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaul</surname><given-names>M.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Okamoto</surname><given-names>S.</given-names></name>
<name><surname>Gendelman</surname><given-names>H.E.</given-names></name>
<name><surname>Lipton</surname><given-names>S.A.</given-names></name>
</person-group><article-title>HIV-1 Infection and AIDS: Consequences for the Central Nervous System</article-title><source>Cell Death Differ.</source><year>2005</year><volume>12</volume><issue>(Suppl. 1)</issue><fpage>878</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401623</pub-id><pub-id pub-id-type="pmid">15832177</pub-id>
</element-citation></ref><ref id="B361-viruses-17-00203"><label>361.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guha</surname><given-names>D.</given-names></name>
<name><surname>Wagner</surname><given-names>M.C.E.</given-names></name>
<name><surname>Ayyavoo</surname><given-names>V.</given-names></name>
</person-group><article-title>Human Immunodeficiency Virus Type 1 (HIV-1)-Mediated Neuroinflammation Dysregulates Neurogranin and Induces Synaptodendritic Injury</article-title><source>J. Neuroinflammation</source><year>2018</year><volume>15</volume><fpage>126</fpage><pub-id pub-id-type="doi">10.1186/s12974-018-1160-2</pub-id><pub-id pub-id-type="pmid">29703241</pub-id>
</element-citation></ref><ref id="B362-viruses-17-00203"><label>362.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dahm</surname><given-names>T.</given-names></name>
<name><surname>Rudolph</surname><given-names>H.</given-names></name>
<name><surname>Schwerk</surname><given-names>C.</given-names></name>
<name><surname>Schroten</surname><given-names>H.</given-names></name>
<name><surname>Tenenbaum</surname><given-names>T.</given-names></name>
</person-group><article-title>Neuroinvasion and Inflammation in Viral Central Nervous System Infections</article-title><source>Mediat. Inflamm.</source><year>2016</year><volume>2016</volume><fpage>8562805</fpage><pub-id pub-id-type="doi">10.1155/2016/8562805</pub-id></element-citation></ref><ref id="B363-viruses-17-00203"><label>363.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bryant</surname><given-names>A.K.</given-names></name>
<name><surname>Ellis</surname><given-names>R.J.</given-names></name>
<name><surname>Umlauf</surname><given-names>A.</given-names></name>
<name><surname>Gouaux</surname><given-names>B.</given-names></name>
<name><surname>Soontornniyomkij</surname><given-names>V.</given-names></name>
<name><surname>Letendre</surname><given-names>S.L.</given-names></name>
<name><surname>Achim</surname><given-names>C.L.</given-names></name>
<name><surname>Masliah</surname><given-names>E.</given-names></name>
<name><surname>Grant</surname><given-names>I.</given-names></name>
<name><surname>Moore</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Antiretroviral Therapy Reduces Neurodegeneration in Human Immunodeficiency Virus Infection</article-title><source>AIDS</source><year>2015</year><volume>29</volume><fpage>323</fpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000553</pub-id><pub-id pub-id-type="pmid">25686681</pub-id>
</element-citation></ref><ref id="B364-viruses-17-00203"><label>364.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heaton</surname><given-names>R.K.</given-names></name>
<name><surname>Clifford</surname><given-names>D.B.</given-names></name>
<name><surname>Franklin</surname><given-names>D.R.</given-names></name>
<name><surname>Woods</surname><given-names>S.P.</given-names></name>
<name><surname>Ake</surname><given-names>C.</given-names></name>
<name><surname>Vaida</surname><given-names>F.</given-names></name>
<name><surname>Ellis</surname><given-names>R.J.</given-names></name>
<name><surname>Letendre</surname><given-names>S.L.</given-names></name>
<name><surname>Marcotte</surname><given-names>T.D.</given-names></name>
<name><surname>Atkinson</surname><given-names>J.H.</given-names></name>
<etal/>
</person-group><article-title>HIV-Associated Neurocognitive Disorders Persist in the Era of Potent Antiretroviral Therapy: CHARTER Study</article-title><source>Neurology</source><year>2010</year><volume>75</volume><fpage>2087</fpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e318200d727</pub-id><pub-id pub-id-type="pmid">21135382</pub-id>
</element-citation></ref><ref id="B365-viruses-17-00203"><label>365.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krut</surname><given-names>J.J.</given-names></name>
<name><surname>Mellberg</surname><given-names>T.</given-names></name>
<name><surname>Price</surname><given-names>R.W.</given-names></name>
<name><surname>Hagberg</surname><given-names>L.</given-names></name>
<name><surname>Fuchs</surname><given-names>D.</given-names></name>
<name><surname>Rosengren</surname><given-names>L.</given-names></name>
<name><surname>Nilsson</surname><given-names>S.</given-names></name>
<name><surname>Zetterberg</surname><given-names>H.</given-names></name>
<name><surname>Gissl&#x000e9;n</surname><given-names>M.</given-names></name>
</person-group><article-title>Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e88591</elocation-id><pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0088591</pub-id><pub-id pub-id-type="pmid">24523921</pub-id>
</element-citation></ref><ref id="B366-viruses-17-00203"><label>366.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sacktor</surname><given-names>N.</given-names></name>
</person-group><article-title>Changing Clinical Phenotypes of HIV-Associated Neurocognitive Disorders</article-title><source>J. Neurovirol.</source><year>2018</year><volume>24</volume><fpage>141</fpage><pub-id pub-id-type="doi">10.1007/s13365-017-0556-6</pub-id><pub-id pub-id-type="pmid">28752495</pub-id>
</element-citation></ref><ref id="B367-viruses-17-00203"><label>367.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clifford</surname><given-names>D.B.</given-names></name>
<name><surname>Fagan</surname><given-names>A.M.</given-names></name>
<name><surname>Holtzman</surname><given-names>D.M.</given-names></name>
<name><surname>Morris</surname><given-names>J.C.</given-names></name>
<name><surname>Teshome</surname><given-names>M.</given-names></name>
<name><surname>Shah</surname><given-names>A.R.</given-names></name>
<name><surname>Kauwe</surname><given-names>J.S.K.</given-names></name>
</person-group><article-title>CSF Biomarkers of Alzheimer Disease in HIV-Associated Neurologic Disease</article-title><source>Neurology</source><year>2009</year><volume>73</volume><fpage>1982</fpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3181c5b445</pub-id><pub-id pub-id-type="pmid">19907013</pub-id>
</element-citation></ref><ref id="B368-viruses-17-00203"><label>368.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rubin</surname><given-names>L.H.</given-names></name>
<name><surname>Sundermann</surname><given-names>E.E.</given-names></name>
<name><surname>Moore</surname><given-names>D.J.</given-names></name>
</person-group><article-title>The Current Understanding of Overlap between Characteristics of HIV-Associated Neurocognitive Disorders and Alzheimer&#x02019;s Disease</article-title><source>J. Neurovirol.</source><year>2019</year><volume>25</volume><fpage>661</fpage><pub-id pub-id-type="doi">10.1007/s13365-018-0702-9</pub-id><pub-id pub-id-type="pmid">30671777</pub-id>
</element-citation></ref><ref id="B369-viruses-17-00203"><label>369.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ortega</surname><given-names>M.</given-names></name>
<name><surname>Ances</surname><given-names>B.M.</given-names></name>
</person-group><article-title>Role of HIV in Amyloid Metabolism</article-title><source>J. Neuroimmune Pharmacol.</source><year>2014</year><volume>9</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1007/s11481-014-9546-0</pub-id><pub-id pub-id-type="pmid">24816714</pub-id>
</element-citation></ref><ref id="B370-viruses-17-00203"><label>370.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Howdle</surname><given-names>G.C.</given-names></name>
<name><surname>Quid&#x000e9;</surname><given-names>Y.</given-names></name>
<name><surname>Kassem</surname><given-names>M.S.</given-names></name>
<name><surname>Johnson</surname><given-names>K.</given-names></name>
<name><surname>Rae</surname><given-names>C.D.</given-names></name>
<name><surname>Brew</surname><given-names>B.J.</given-names></name>
<name><surname>Cysique</surname><given-names>L.A.</given-names></name>
</person-group><article-title>Brain Amyloid in Virally Suppressed HIV-Associated Neurocognitive Disorder</article-title><source>Neurol. Neuroimmunol. Neuroinflamm</source><year>2020</year><volume>7</volume><pub-id pub-id-type="doi">10.1212/NXI.0000000000000739</pub-id></element-citation></ref><ref id="B371-viruses-17-00203"><label>371.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sundermann</surname><given-names>E.E.</given-names></name>
<name><surname>Bondi</surname><given-names>M.W.</given-names></name>
<name><surname>Campbell</surname><given-names>L.M.</given-names></name>
<name><surname>Gouaux</surname><given-names>B.</given-names></name>
<name><surname>Moore</surname><given-names>R.C.</given-names></name>
<name><surname>Soontornniyomkij</surname><given-names>V.</given-names></name>
<name><surname>Moore</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Distinguishing Amnestic Mild Cognitive Impairment From HIV-Associated Neurocognitive Disorders</article-title><source>J. Infect. Dis.</source><year>2021</year><volume>224</volume><fpage>435</fpage><pub-id pub-id-type="doi">10.1093/infdis/jiaa760</pub-id><pub-id pub-id-type="pmid">33319235</pub-id>
</element-citation></ref><ref id="B372-viruses-17-00203"><label>372.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mirsattari</surname><given-names>S.M.</given-names></name>
<name><surname>Power</surname><given-names>C.</given-names></name>
<name><surname>Nath</surname><given-names>A.</given-names></name>
</person-group><article-title>Parkinsonism with HIV Infection</article-title><source>Mov. Disord.</source><year>1998</year><volume>13</volume><fpage>684</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1002/mds.870130413</pub-id><pub-id pub-id-type="pmid">9686775</pub-id>
</element-citation></ref><ref id="B373-viruses-17-00203"><label>373.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koutsilieri</surname><given-names>E.</given-names></name>
<name><surname>Sopper</surname><given-names>S.</given-names></name>
<name><surname>Scheller</surname><given-names>C.</given-names></name>
<name><surname>Ter Meulen</surname><given-names>V.</given-names></name>
<name><surname>Riederer</surname><given-names>P.</given-names></name>
</person-group><article-title>Parkinsonism in HIV Dementia</article-title><source>J. Neural Transm.</source><year>2002</year><volume>109</volume><fpage>767</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1007/s007020200063</pub-id><pub-id pub-id-type="pmid">12111466</pub-id>
</element-citation></ref><ref id="B374-viruses-17-00203"><label>374.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>DeVaughn</surname><given-names>S.</given-names></name>
<name><surname>M&#x000fc;ller-Oehring</surname><given-names>E.M.</given-names></name>
<name><surname>Markey</surname><given-names>B.</given-names></name>
<name><surname>Bront&#x000eb;-Stewart</surname><given-names>H.M.</given-names></name>
<name><surname>Schulte</surname><given-names>T.</given-names></name>
</person-group><article-title>Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention&#x02014;A Comparison with Parkinson&#x02019;s Disease</article-title><source>Neuropsychol. Rev.</source><year>2015</year><volume>25</volume><fpage>424</fpage><pub-id pub-id-type="doi">10.1007/s11065-015-9305-x</pub-id><pub-id pub-id-type="pmid">26577508</pub-id>
</element-citation></ref><ref id="B375-viruses-17-00203"><label>375.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dehner</surname><given-names>L.F.</given-names></name>
<name><surname>Spitz</surname><given-names>M.</given-names></name>
<name><surname>Pereira</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Parkinsonism in HIV Infected Patients during Antiretroviral Therapy&#x02014;Data from a Brazilian Tertiary Hospital</article-title><source>Braz. J. Infect. Dis.</source><year>2016</year><volume>20</volume><fpage>499</fpage><pub-id pub-id-type="doi">10.1016/j.bjid.2016.05.008</pub-id><pub-id pub-id-type="pmid">27449286</pub-id>
</element-citation></ref><ref id="B376-viruses-17-00203"><label>376.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amod</surname><given-names>F.</given-names></name>
<name><surname>Holla</surname><given-names>V.V.</given-names></name>
<name><surname>Ojha</surname><given-names>R.</given-names></name>
<name><surname>Pandey</surname><given-names>S.</given-names></name>
<name><surname>Yadav</surname><given-names>R.</given-names></name>
<name><surname>Pal</surname><given-names>P.K.</given-names></name>
</person-group><article-title>A Review of Movement Disorders in Persons Living with HIV</article-title><source>Park. Relat. Disord.</source><year>2023</year><volume>114</volume><fpage>105774</fpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2023.105774</pub-id></element-citation></ref><ref id="B377-viruses-17-00203"><label>377.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cysique</surname><given-names>L.A.</given-names></name>
<name><surname>Brew</surname><given-names>B.J.</given-names></name>
</person-group><article-title>Vascular Cognitive Impairment and HIV-Associated Neurocognitive Disorder: A New Paradigm</article-title><source>J. Neurovirol.</source><year>2019</year><volume>25</volume><fpage>710</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1007/s13365-018-0706-5</pub-id><pub-id pub-id-type="pmid">30635846</pub-id>
</element-citation></ref><ref id="B378-viruses-17-00203"><label>378.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moulignier</surname><given-names>A.</given-names></name>
<name><surname>Moulonguet</surname><given-names>A.</given-names></name>
<name><surname>Pialoux</surname><given-names>G.</given-names></name>
<name><surname>Rozenbaum</surname><given-names>W.</given-names></name>
</person-group><article-title>Reversible ALS-like Disorder in HIV Infection</article-title><source>Neurology</source><year>2001</year><volume>57</volume><fpage>995</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1212/WNL.57.6.995</pub-id><pub-id pub-id-type="pmid">11571323</pub-id>
</element-citation></ref><ref id="B379-viruses-17-00203"><label>379.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bowen</surname><given-names>L.N.</given-names></name>
<name><surname>Tyagi</surname><given-names>R.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Alfahad</surname><given-names>T.</given-names></name>
<name><surname>Smith</surname><given-names>B.</given-names></name>
<name><surname>Wright</surname><given-names>M.</given-names></name>
<name><surname>Singer</surname><given-names>E.J.</given-names></name>
<name><surname>Nath</surname><given-names>A.</given-names></name>
</person-group><article-title>HIV-Associated Motor Neuron Disease: HERV-K Activation and Response to Antiretroviral Therapy</article-title><source>Neurology</source><year>2016</year><volume>87</volume><fpage>1756</fpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000003258</pub-id><pub-id pub-id-type="pmid">27664983</pub-id>
</element-citation></ref><ref id="B380-viruses-17-00203"><label>380.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Spudich</surname><given-names>S.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Scarano</surname><given-names>F.</given-names></name>
</person-group><article-title>HIV-1-Related Central Nervous System Disease: Current Issues in Pathogenesis, Diagnosis, and Treatment</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2012</year><volume>2</volume><fpage>a007120</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a007120</pub-id><pub-id pub-id-type="pmid">22675662</pub-id>
</element-citation></ref><ref id="B381-viruses-17-00203"><label>381.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saylor</surname><given-names>D.</given-names></name>
<name><surname>Dickens</surname><given-names>A.M.</given-names></name>
<name><surname>Sacktor</surname><given-names>N.</given-names></name>
<name><surname>Haughey</surname><given-names>N.</given-names></name>
<name><surname>Slusher</surname><given-names>B.</given-names></name>
<name><surname>Pletnikov</surname><given-names>M.</given-names></name>
<name><surname>Mankowski</surname><given-names>J.L.</given-names></name>
<name><surname>Brown</surname><given-names>A.</given-names></name>
<name><surname>Volsky</surname><given-names>D.J.</given-names></name>
<name><surname>McArthur</surname><given-names>J.C.</given-names></name>
</person-group><article-title>HIV-Associated Neurocognitive Disorder&#x02014;Pathogenesis and Prospects for Treatment</article-title><source>Nat. Rev. Neurol.</source><year>2016</year><volume>12</volume><fpage>234</fpage><pub-id pub-id-type="doi">10.1038/nrneurol.2016.27</pub-id><pub-id pub-id-type="pmid">26965674</pub-id>
</element-citation></ref><ref id="B382-viruses-17-00203"><label>382.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clifford</surname><given-names>D.B.</given-names></name>
</person-group><article-title>HIV Associated Neurocognitive Disorder</article-title><source>Curr. Opin. Infect. Dis.</source><year>2017</year><volume>30</volume><fpage>117</fpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000328</pub-id><pub-id pub-id-type="pmid">27798498</pub-id>
</element-citation></ref><ref id="B383-viruses-17-00203"><label>383.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thakur</surname><given-names>K.T.</given-names></name>
<name><surname>Boubour</surname><given-names>A.</given-names></name>
<name><surname>Saylor</surname><given-names>D.</given-names></name>
<name><surname>Das</surname><given-names>M.</given-names></name>
<name><surname>Bearden</surname><given-names>D.R.</given-names></name>
<name><surname>Birbeck</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Global HIV Neurology: A Comprehensive Review</article-title><source>AIDS</source><year>2019</year><volume>33</volume><fpage>163</fpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001796</pub-id><pub-id pub-id-type="pmid">29547440</pub-id>
</element-citation></ref><ref id="B384-viruses-17-00203"><label>384.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaul</surname><given-names>M.</given-names></name>
</person-group><article-title>HIV-1 Associated Dementia: Update on Pathological Mechanisms and Therapeutic Approaches</article-title><source>Curr. Opin. Neurol.</source><year>2009</year><volume>22</volume><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1097/WCO.0b013e328329cf3c</pub-id><pub-id pub-id-type="pmid">19300249</pub-id>
</element-citation></ref><ref id="B385-viruses-17-00203"><label>385.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lingor</surname><given-names>P.</given-names></name>
<name><surname>Demleitner</surname><given-names>A.F.</given-names></name>
<name><surname>Wolff</surname><given-names>A.W.</given-names></name>
<name><surname>Feneberg</surname><given-names>E.</given-names></name>
</person-group><article-title>SARS-CoV-2 and Neurodegenerative Diseases: What We Know and What We Don&#x02019;t</article-title><source>J. Neural Transm.</source><year>2022</year><volume>129</volume><fpage>1155</fpage><pub-id pub-id-type="doi">10.1007/s00702-022-02500-w</pub-id><pub-id pub-id-type="pmid">35434769</pub-id>
</element-citation></ref><ref id="B386-viruses-17-00203"><label>386.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siow</surname><given-names>I.</given-names></name>
<name><surname>Lee</surname><given-names>K.S.</given-names></name>
<name><surname>Zhang</surname><given-names>J.J.Y.</given-names></name>
<name><surname>Saffari</surname><given-names>S.E.</given-names></name>
<name><surname>Ng</surname><given-names>A.</given-names></name>
</person-group><article-title>Encephalitis as a Neurological Complication of COVID-19: A Systematic Review and Meta-analysis of Incidence, Outcomes, and Predictors</article-title><source>Eur. J. Neurol.</source><year>2021</year><volume>28</volume><fpage>3491</fpage><pub-id pub-id-type="doi">10.1111/ene.14913</pub-id><pub-id pub-id-type="pmid">33982853</pub-id>
</element-citation></ref><ref id="B387-viruses-17-00203"><label>387.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krahel</surname><given-names>W.D.</given-names></name>
<name><surname>Bartak</surname><given-names>M.</given-names></name>
<name><surname>Cymerys</surname><given-names>J.</given-names></name>
</person-group><article-title>Acute and Long-Term SARS-CoV-2 Infection and Neurodegeneration Processes&#x02014;Circulus Vitiosus</article-title><source>Acta Virol.</source><year>2024</year><volume>68</volume><fpage>12765</fpage><pub-id pub-id-type="doi">10.3389/av.2024.12765</pub-id></element-citation></ref><ref id="B388-viruses-17-00203"><label>388.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pandya</surname><given-names>D.</given-names></name>
<name><surname>Johnson</surname><given-names>T.P.</given-names></name>
</person-group><article-title>Chronic and Delayed Neurological Manifestations of Persistent Infections</article-title><source>Curr. Opin. Neurol.</source><year>2023</year><volume>36</volume><fpage>198</fpage><pub-id pub-id-type="doi">10.1097/WCO.0000000000001154</pub-id><pub-id pub-id-type="pmid">37078647</pub-id>
</element-citation></ref><ref id="B389-viruses-17-00203"><label>389.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Choutka</surname><given-names>J.</given-names></name>
<name><surname>Jansari</surname><given-names>V.</given-names></name>
<name><surname>Hornig</surname><given-names>M.</given-names></name>
<name><surname>Iwasaki</surname><given-names>A.</given-names></name>
</person-group><article-title>Unexplained Post-Acute Infection Syndromes</article-title><source>Nat. Med.</source><year>2022</year><volume>28</volume><fpage>911</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01810-6</pub-id><pub-id pub-id-type="pmid">35585196</pub-id>
</element-citation></ref><ref id="B390-viruses-17-00203"><label>390.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meinhardt</surname><given-names>J.</given-names></name>
<name><surname>Radke</surname><given-names>J.</given-names></name>
<name><surname>Dittmayer</surname><given-names>C.</given-names></name>
<name><surname>Franz</surname><given-names>J.</given-names></name>
<name><surname>Thomas</surname><given-names>C.</given-names></name>
<name><surname>Mothes</surname><given-names>R.</given-names></name>
<name><surname>Laue</surname><given-names>M.</given-names></name>
<name><surname>Schneider</surname><given-names>J.</given-names></name>
<name><surname>Br&#x000fc;nink</surname><given-names>S.</given-names></name>
<name><surname>Greuel</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Olfactory Transmucosal SARS-CoV-2 Invasion as a Port of Central Nervous System Entry in Individuals with COVID-19</article-title><source>Nat. Neurosci.</source><year>2020</year><volume>24</volume><fpage>168</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00758-5</pub-id><pub-id pub-id-type="pmid">33257876</pub-id>
</element-citation></ref><ref id="B391-viruses-17-00203"><label>391.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>E.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Israelow</surname><given-names>B.</given-names></name>
<name><surname>Lu-Culligan</surname><given-names>A.</given-names></name>
<name><surname>Prado</surname><given-names>A.V.</given-names></name>
<name><surname>Skriabine</surname><given-names>S.</given-names></name>
<name><surname>Lu</surname><given-names>P.</given-names></name>
<name><surname>Weizman</surname><given-names>O.E.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Dai</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Neuroinvasion of SARS-CoV-2 in Human and Mouse Brain</article-title><source>J. Exp. Med.</source><year>2021</year><volume>218</volume><fpage>e20202135</fpage><pub-id pub-id-type="doi">10.1084/jem.20202135</pub-id><pub-id pub-id-type="pmid">33433624</pub-id>
</element-citation></ref><ref id="B392-viruses-17-00203"><label>392.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>A.C.</given-names></name>
<name><surname>Kern</surname><given-names>F.</given-names></name>
<name><surname>Losada</surname><given-names>P.M.</given-names></name>
<name><surname>Agam</surname><given-names>M.R.</given-names></name>
<name><surname>Maat</surname><given-names>C.A.</given-names></name>
<name><surname>Schmartz</surname><given-names>G.P.</given-names></name>
<name><surname>Fehlmann</surname><given-names>T.</given-names></name>
<name><surname>Stein</surname><given-names>J.A.</given-names></name>
<name><surname>Schaum</surname><given-names>N.</given-names></name>
<name><surname>Lee</surname><given-names>D.P.</given-names></name>
<etal/>
</person-group><article-title>Dysregulation of Brain and Choroid Plexus Cell Types in Severe COVID-19</article-title><source>Nature</source><year>2021</year><volume>595</volume><fpage>565</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03710-0</pub-id><pub-id pub-id-type="pmid">34153974</pub-id>
</element-citation></ref><ref id="B393-viruses-17-00203"><label>393.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>M.H.</given-names></name>
<name><surname>Perl</surname><given-names>D.P.</given-names></name>
<name><surname>Steiner</surname><given-names>J.</given-names></name>
<name><surname>Pasternack</surname><given-names>N.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Maric</surname><given-names>D.</given-names></name>
<name><surname>Safavi</surname><given-names>F.</given-names></name>
<name><surname>Horkayne-Szakaly</surname><given-names>I.</given-names></name>
<name><surname>Jones</surname><given-names>R.</given-names></name>
<name><surname>Stram</surname><given-names>M.N.</given-names></name>
<etal/>
</person-group><article-title>Neurovascular Injury with Complement Activation and Inflammation in COVID-19</article-title><source>Brain</source><year>2022</year><volume>145</volume><fpage>2555</fpage><lpage>2568</lpage><pub-id pub-id-type="doi">10.1093/brain/awac151</pub-id><pub-id pub-id-type="pmid">35788639</pub-id>
</element-citation></ref><ref id="B394-viruses-17-00203"><label>394.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bayat</surname><given-names>A.H.</given-names></name>
<name><surname>Azimi</surname><given-names>H.</given-names></name>
<name><surname>Hassani Moghaddam</surname><given-names>M.</given-names></name>
<name><surname>Ebrahimi</surname><given-names>V.</given-names></name>
<name><surname>Fathi</surname><given-names>M.</given-names></name>
<name><surname>Vakili</surname><given-names>K.</given-names></name>
<name><surname>Mahmoudiasl</surname><given-names>G.R.</given-names></name>
<name><surname>Forouzesh</surname><given-names>M.</given-names></name>
<name><surname>Boroujeni</surname><given-names>M.E.</given-names></name>
<name><surname>Nariman</surname><given-names>Z.</given-names></name>
<etal/>
</person-group><article-title>COVID-19 Causes Neuronal Degeneration and Reduces Neurogenesis in Human Hippocampus</article-title><source>Apoptosis</source><year>2022</year><volume>27</volume><fpage>852</fpage><pub-id pub-id-type="doi">10.1007/s10495-022-01754-9</pub-id><pub-id pub-id-type="pmid">35876935</pub-id>
</element-citation></ref><ref id="B395-viruses-17-00203"><label>395.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kry&#x00144;ska</surname><given-names>K.</given-names></name>
<name><surname>Kuli&#x0015b;</surname><given-names>K.</given-names></name>
<name><surname>Mazurek</surname><given-names>W.</given-names></name>
<name><surname>Gudowska-Sawczuk</surname><given-names>M.</given-names></name>
<name><surname>Zajkowska</surname><given-names>M.</given-names></name>
<name><surname>Mroczko</surname><given-names>B.</given-names></name>
</person-group><article-title>The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological Diseases</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>8715</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25168715</pub-id><pub-id pub-id-type="pmid">39201402</pub-id>
</element-citation></ref><ref id="B396-viruses-17-00203"><label>396.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jarczak</surname><given-names>D.</given-names></name>
<name><surname>Nierhaus</surname><given-names>A.</given-names></name>
</person-group><article-title>Cytokine Storm&#x02014;Definition, Causes, and Implications</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>11740</elocation-id><pub-id pub-id-type="doi">10.3390/ijms231911740</pub-id><pub-id pub-id-type="pmid">36233040</pub-id>
</element-citation></ref><ref id="B397-viruses-17-00203"><label>397.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ningrum</surname><given-names>D.N.A.</given-names></name>
<name><surname>Kung</surname><given-names>W.M.</given-names></name>
</person-group><article-title>Challenges and Perspectives of Neurological Disorders</article-title><source>Brain Sci.</source><year>2023</year><volume>13</volume><elocation-id>676</elocation-id><pub-id pub-id-type="doi">10.3390/brainsci13040676</pub-id><pub-id pub-id-type="pmid">37190641</pub-id>
</element-citation></ref><ref id="B398-viruses-17-00203"><label>398.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feigin</surname><given-names>V.L.</given-names></name>
<name><surname>Vos</surname><given-names>T.</given-names></name>
<name><surname>Nichols</surname><given-names>E.</given-names></name>
<name><surname>Owolabi</surname><given-names>M.O.</given-names></name>
<name><surname>Carroll</surname><given-names>W.M.</given-names></name>
<name><surname>Dichgans</surname><given-names>M.</given-names></name>
<name><surname>Deuschl</surname><given-names>G.</given-names></name>
<name><surname>Parmar</surname><given-names>P.</given-names></name>
<name><surname>Brainin</surname><given-names>M.</given-names></name>
<name><surname>Murray</surname><given-names>C.</given-names></name>
</person-group><article-title>The Global Burden of Neurological Disorders: Translating Evidence into Policy</article-title><source>Lancet Neurol.</source><year>2020</year><volume>19</volume><fpage>255</fpage><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30411-9</pub-id><pub-id pub-id-type="pmid">31813850</pub-id>
</element-citation></ref><ref id="B399-viruses-17-00203"><label>399.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Schependom</surname><given-names>J.</given-names></name>
<name><surname>D&#x02019;haeseleer</surname><given-names>M.</given-names></name>
</person-group><article-title>Advances in Neurodegenerative Diseases</article-title><source>J. Clin. Med.</source><year>2023</year><volume>12</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.3390/jcm12051709</pub-id></element-citation></ref><ref id="B400-viruses-17-00203"><label>400.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dehhaghi</surname><given-names>M.</given-names></name>
<name><surname>Kazemi Shariat Panahi</surname><given-names>H.</given-names></name>
<name><surname>Guillemin</surname><given-names>G.J.</given-names></name>
</person-group><article-title>Microorganisms&#x02019; Footprint in Neurodegenerative Diseases</article-title><source>Front. Cell Neurosci.</source><year>2018</year><volume>12</volume><elocation-id>466</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00466</pub-id><pub-id pub-id-type="pmid">30564101</pub-id>
</element-citation></ref><ref id="B401-viruses-17-00203"><label>401.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Flint</surname><given-names>B.</given-names></name>
<name><surname>Tadi</surname><given-names>P.</given-names></name>
</person-group><source>Physiology, Aging</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B402-viruses-17-00203"><label>402.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ramano&#x000eb;l</surname><given-names>S.</given-names></name>
<name><surname>Hoyau</surname><given-names>E.</given-names></name>
<name><surname>Kauffmann</surname><given-names>L.</given-names></name>
<name><surname>Renard</surname><given-names>F.</given-names></name>
<name><surname>Pichat</surname><given-names>C.</given-names></name>
<name><surname>Boudiaf</surname><given-names>N.</given-names></name>
<name><surname>Krainik</surname><given-names>A.</given-names></name>
<name><surname>Jaillard</surname><given-names>A.</given-names></name>
<name><surname>Baciu</surname><given-names>M.</given-names></name>
</person-group><article-title>Gray Matter Volume and Cognitive Performance during Normal Aging. A Voxel-Based Morphometry Study</article-title><source>Front. Aging Neurosci.</source><year>2018</year><volume>10</volume><elocation-id>350276</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2018.00235</pub-id></element-citation></ref><ref id="B403-viruses-17-00203"><label>403.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Choi</surname><given-names>W.J.</given-names></name>
<name><surname>Wei</surname><given-names>W.</given-names></name>
<name><surname>Song</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>R.K.</given-names></name>
</person-group><article-title>Aging-Associated Changes in Cerebral Vasculature and Blood Flow as Determined by Quantitative Optical Coherence Tomography Angiography</article-title><source>Neurobiol. Aging</source><year>2018</year><volume>70</volume><elocation-id>148</elocation-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.06.017</pub-id><pub-id pub-id-type="pmid">30007164</pub-id>
</element-citation></ref><ref id="B404-viruses-17-00203"><label>404.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costantini</surname><given-names>E.</given-names></name>
<name><surname>D&#x02019;Angelo</surname><given-names>C.</given-names></name>
<name><surname>Reale</surname><given-names>M.</given-names></name>
</person-group><article-title>The Role of Immunosenescence in Neurodegenerative Diseases</article-title><source>Mediat. Inflamm.</source><year>2018</year><volume>2018</volume><fpage>6039171</fpage><pub-id pub-id-type="doi">10.1155/2018/6039171</pub-id></element-citation></ref><ref id="B405-viruses-17-00203"><label>405.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gitler</surname><given-names>A.D.</given-names></name>
<name><surname>Dhillon</surname><given-names>P.</given-names></name>
<name><surname>Shorter</surname><given-names>J.</given-names></name>
</person-group><article-title>Neurodegenerative Disease: Models, Mechanisms, and a New Hope</article-title><source>Dis. Model. Mech.</source><year>2017</year><volume>10</volume><fpage>499</fpage><pub-id pub-id-type="doi">10.1242/dmm.030205</pub-id><pub-id pub-id-type="pmid">28468935</pub-id>
</element-citation></ref><ref id="B406-viruses-17-00203"><label>406.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Erkkinen</surname><given-names>M.G.</given-names></name>
<name><surname>Kim</surname><given-names>M.O.</given-names></name>
<name><surname>Geschwind</surname><given-names>M.D.</given-names></name>
</person-group><article-title>Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2018</year><volume>10</volume><elocation-id>a033118</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a033118</pub-id><pub-id pub-id-type="pmid">28716886</pub-id>
</element-citation></ref><ref id="B407-viruses-17-00203"><label>407.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maiti</surname><given-names>P.</given-names></name>
<name><surname>Manna</surname><given-names>J.</given-names></name>
<name><surname>Dunbar</surname><given-names>G.L.</given-names></name>
<name><surname>Maiti</surname><given-names>P.</given-names></name>
<name><surname>Dunbar</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Current Understanding of the Molecular Mechanisms in Parkinson&#x02019;s Disease: Targets for Potential Treatments</article-title><source>Transl. Neurodegener.</source><year>2017</year><volume>6</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/s40035-017-0099-z</pub-id><pub-id pub-id-type="pmid">29090092</pub-id>
</element-citation></ref><ref id="B408-viruses-17-00203"><label>408.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdelmoaty</surname><given-names>M.M.</given-names></name>
<name><surname>Lu</surname><given-names>E.</given-names></name>
<name><surname>Kadry</surname><given-names>R.</given-names></name>
<name><surname>Foster</surname><given-names>E.G.</given-names></name>
<name><surname>Bhattarai</surname><given-names>S.</given-names></name>
<name><surname>Mosley</surname><given-names>R.L.</given-names></name>
<name><surname>Gendelman</surname><given-names>H.E.</given-names></name>
</person-group><article-title>Clinical Biomarkers for Lewy Body Diseases</article-title><source>Cell Biosci.</source><year>2023</year><volume>13</volume><elocation-id>209</elocation-id><pub-id pub-id-type="doi">10.1186/s13578-023-01152-x</pub-id><pub-id pub-id-type="pmid">37964309</pub-id>
</element-citation></ref><ref id="B409-viruses-17-00203"><label>409.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baizabal-Carvallo</surname><given-names>J.</given-names></name>
<name><surname>Alonso-Juarez</surname><given-names>M.</given-names></name>
</person-group><article-title>The Role of Viruses in the Pathogenesis of Parkinson&#x02019;s Disease</article-title><source>Neural Regen. Res.</source><year>2021</year><volume>16</volume><fpage>1200</fpage><pub-id pub-id-type="doi">10.4103/1673-5374.300437</pub-id><pub-id pub-id-type="pmid">33269775</pub-id>
</element-citation></ref><ref id="B410-viruses-17-00203"><label>410.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olsen</surname><given-names>L.K.</given-names></name>
<name><surname>Dowd</surname><given-names>E.</given-names></name>
<name><surname>McKernan</surname><given-names>D.P.</given-names></name>
</person-group><article-title>A Role for Viral Infections in Parkinson&#x02019;s Etiology?</article-title><source>Neuronal Signal</source><year>2018</year><volume>2</volume><fpage>20170166</fpage><pub-id pub-id-type="doi">10.1042/NS20170166</pub-id></element-citation></ref><ref id="B411-viruses-17-00203"><label>411.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>German</surname><given-names>D.C.</given-names></name>
<name><surname>Manaye</surname><given-names>K.</given-names></name>
<name><surname>Smith</surname><given-names>W.K.</given-names></name>
<name><surname>Woodward</surname><given-names>D.J.</given-names></name>
<name><surname>Saper</surname><given-names>C.B.</given-names></name>
</person-group><article-title>Midbrain Dopaminergic Cell Loss in Parkinson&#x02019;s Disease: Computer Visualization</article-title><source>Ann. Neurol.</source><year>1989</year><volume>26</volume><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1002/ana.410260403</pub-id><pub-id pub-id-type="pmid">2817827</pub-id>
</element-citation></ref><ref id="B412-viruses-17-00203"><label>412.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arai</surname><given-names>H.</given-names></name>
<name><surname>Furuya</surname><given-names>T.</given-names></name>
<name><surname>Mizuno</surname><given-names>Y.</given-names></name>
<name><surname>Mochizuki</surname><given-names>H.</given-names></name>
</person-group><article-title>Inflammation and Infection in Parkinson&#x02019;s Disease</article-title><source>Histol. Histopathol.</source><year>2006</year><volume>21</volume><fpage>673</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.14670/HH-21.673</pub-id><pub-id pub-id-type="pmid">16528677</pub-id>
</element-citation></ref><ref id="B413-viruses-17-00203"><label>413.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Henry</surname><given-names>J.</given-names></name>
<name><surname>Smeyne</surname><given-names>R.J.</given-names></name>
<name><surname>Jang</surname><given-names>H.</given-names></name>
<name><surname>Miller</surname><given-names>B.</given-names></name>
<name><surname>Okun</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Parkinsonism and Neurological Manifestations of Influenza Throughout the 20th and 21st Centuries</article-title><source>Park. Relat. Disord.</source><year>2010</year><volume>16</volume><fpage>566</fpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2010.06.012</pub-id></element-citation></ref><ref id="B414-viruses-17-00203"><label>414.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takahashi</surname><given-names>M.</given-names></name>
<name><surname>Yamada</surname><given-names>T.</given-names></name>
<name><surname>Nakajima</surname><given-names>S.</given-names></name>
<name><surname>Nakajima</surname><given-names>K.</given-names></name>
<name><surname>Yamamoto</surname><given-names>T.</given-names></name>
<name><surname>Okada</surname><given-names>H.</given-names></name>
</person-group><article-title>The Substantia Nigra Is a Major Target for Neurovirulent Influenza A Virus</article-title><source>J. Exp. Med.</source><year>1995</year><volume>181</volume><fpage>2161</fpage><pub-id pub-id-type="doi">10.1084/jem.181.6.2161</pub-id><pub-id pub-id-type="pmid">7760004</pub-id>
</element-citation></ref><ref id="B415-viruses-17-00203"><label>415.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Tan</surname><given-names>C.</given-names></name>
<name><surname>Zhou</surname><given-names>W.</given-names></name>
<name><surname>Jiang</surname><given-names>J.</given-names></name>
<name><surname>Peng</surname><given-names>W.</given-names></name>
<name><surname>Zhou</surname><given-names>X.</given-names></name>
<name><surname>Mo</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>L.</given-names></name>
</person-group><article-title>Bacterial, Viral, and Fungal Infection-related Risk of Parkinson&#x02019;s Disease: Meta-analysis of Cohort and Case&#x02013;Control Studies</article-title><source>Brain Behav.</source><year>2020</year><volume>10</volume><fpage>e01549</fpage><pub-id pub-id-type="doi">10.1002/brb3.1549</pub-id><pub-id pub-id-type="pmid">32017453</pub-id>
</element-citation></ref><ref id="B416-viruses-17-00203"><label>416.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vlajinac</surname><given-names>H.</given-names></name>
<name><surname>Dzoljic</surname><given-names>E.</given-names></name>
<name><surname>Maksimovic</surname><given-names>J.</given-names></name>
<name><surname>Marinkovic</surname><given-names>J.</given-names></name>
<name><surname>Sipetic</surname><given-names>S.</given-names></name>
<name><surname>Kostic</surname><given-names>V.</given-names></name>
</person-group><article-title>Infections as a Risk Factor for Parkinson&#x02019;s Disease: A Case-Control Study</article-title><source>Int. J. Neurosci.</source><year>2013</year><volume>123</volume><fpage>329</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.3109/00207454.2012.760560</pub-id><pub-id pub-id-type="pmid">23270425</pub-id>
</element-citation></ref><ref id="B417-viruses-17-00203"><label>417.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>W.Y.</given-names></name>
<name><surname>Lin</surname><given-names>M.S.</given-names></name>
<name><surname>Weng</surname><given-names>Y.H.</given-names></name>
<name><surname>Yeh</surname><given-names>T.H.</given-names></name>
<name><surname>Lin</surname><given-names>Y.S.</given-names></name>
<name><surname>Fong</surname><given-names>P.Y.</given-names></name>
<name><surname>Wu</surname><given-names>Y.R.</given-names></name>
<name><surname>Lu</surname><given-names>C.S.</given-names></name>
<name><surname>Chen</surname><given-names>R.S.</given-names></name>
<name><surname>Huang</surname><given-names>Y.Z.</given-names></name>
</person-group><article-title>Association of Antiviral Therapy with Risk of Parkinson Disease in Patients with Chronic Hepatitis C Virus Infection</article-title><source>JAMA Neurol.</source><year>2019</year><volume>76</volume><fpage>1019</fpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2019.1368</pub-id><pub-id pub-id-type="pmid">31168563</pub-id>
</element-citation></ref><ref id="B418-viruses-17-00203"><label>418.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jang</surname><given-names>H.</given-names></name>
<name><surname>Boltz</surname><given-names>D.A.</given-names></name>
<name><surname>Webster</surname><given-names>R.G.</given-names></name>
<name><surname>Smeyne</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Viral Parkinsonism</article-title><source>Biochim. Biophys. Acta</source><year>2009</year><volume>1792</volume><elocation-id>714</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbadis.2008.08.001</pub-id><pub-id pub-id-type="pmid">18760350</pub-id>
</element-citation></ref><ref id="B419-viruses-17-00203"><label>419.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sasco</surname><given-names>A.J.</given-names></name>
<name><surname>Paffenbarger</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Measles Infection and Parkinson&#x02019;s Disease</article-title><source>Am. J. Epidemiol.</source><year>1985</year><volume>122</volume><fpage>1017</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a114183</pub-id><pub-id pub-id-type="pmid">4061437</pub-id>
</element-citation></ref><ref id="B420-viruses-17-00203"><label>420.</label><element-citation publication-type="webpage"><article-title>The Lancet: Global Burden of Disease</article-title><comment>Available online: <ext-link xlink:href="https://www.thelancet.com/gbd" ext-link-type="uri">https://www.thelancet.com/gbd</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-22">(accessed on 22 December 2024)</date-in-citation></element-citation></ref><ref id="B421-viruses-17-00203"><label>421.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qiu</surname><given-names>C.</given-names></name>
<name><surname>Kivipelto</surname><given-names>M.</given-names></name>
<name><surname>Von Strauss</surname><given-names>E.</given-names></name>
</person-group><article-title>Epidemiology of Alzheimer&#x02019;s Disease: Occurrence, Determinants, and Strategies toward Intervention</article-title><source>Dialogues Clin. Neurosci.</source><year>2009</year><volume>11</volume><fpage>111</fpage><pub-id pub-id-type="doi">10.31887/DCNS.2009.11.2/cqiu</pub-id><pub-id pub-id-type="pmid">19585947</pub-id>
</element-citation></ref><ref id="B422-viruses-17-00203"><label>422.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andrade-Guerrero</surname><given-names>J.</given-names></name>
<name><surname>Santiago-Balmaseda</surname><given-names>A.</given-names></name>
<name><surname>Jeronimo-Aguilar</surname><given-names>P.</given-names></name>
<name><surname>Vargas-Rodr&#x000ed;guez</surname><given-names>I.</given-names></name>
<name><surname>Cadena-Su&#x000e1;rez</surname><given-names>A.R.</given-names></name>
<name><surname>S&#x000e1;nchez-Garibay</surname><given-names>C.</given-names></name>
<name><surname>Pozo-Molina</surname><given-names>G.</given-names></name>
<name><surname>M&#x000e9;ndez-Catal&#x000e1;</surname><given-names>C.F.</given-names></name>
<name><surname>Cardenas-Aguayo</surname><given-names>M.D.C.</given-names></name>
<name><surname>Diaz-Cintra</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Alzheimer&#x02019;s Disease: An Updated Overview of Its Genetics</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>3754</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24043754</pub-id><pub-id pub-id-type="pmid">36835161</pub-id>
</element-citation></ref><ref id="B423-viruses-17-00203"><label>423.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Brien</surname><given-names>J.T.</given-names></name>
<name><surname>Thomas</surname><given-names>A.</given-names></name>
</person-group><article-title>Vascular Dementia</article-title><source>Lancet</source><year>2015</year><volume>386</volume><fpage>1698</fpage><lpage>1706</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)00463-8</pub-id><pub-id pub-id-type="pmid">26595643</pub-id>
</element-citation></ref><ref id="B424-viruses-17-00203"><label>424.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rom&#x000e1;n</surname><given-names>G.C.</given-names></name>
</person-group><article-title>Vascular Dementia Prevention: A Risk Factor Analysis</article-title><source>Cerebrovasc. Dis.</source><year>2005</year><volume>20</volume><issue>(Suppl. 2)</issue><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1159/000089361</pub-id><pub-id pub-id-type="pmid">16327258</pub-id>
</element-citation></ref><ref id="B425-viruses-17-00203"><label>425.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Emmady</surname><given-names>P.D.</given-names></name>
<name><surname>Schoo</surname><given-names>C.</given-names></name>
<name><surname>Tadi</surname><given-names>P.</given-names></name>
</person-group><source>Major Neurocognitive Disorder (Dementia)</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2022</year></element-citation></ref><ref id="B426-viruses-17-00203"><label>426.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soscia</surname><given-names>S.J.</given-names></name>
<name><surname>Kirby</surname><given-names>J.E.</given-names></name>
<name><surname>Washicosky</surname><given-names>K.J.</given-names></name>
<name><surname>Tucker</surname><given-names>S.M.</given-names></name>
<name><surname>Ingelsson</surname><given-names>M.</given-names></name>
<name><surname>Hyman</surname><given-names>B.</given-names></name>
<name><surname>Burton</surname><given-names>M.A.</given-names></name>
<name><surname>Goldstein</surname><given-names>L.E.</given-names></name>
<name><surname>Duong</surname><given-names>S.</given-names></name>
<name><surname>Tanzi</surname><given-names>R.E.</given-names></name>
<etal/>
</person-group><article-title>The Alzheimer&#x02019;s Disease-Associated Amyloid &#x003b2;-Protein Is an Antimicrobial Peptide</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e9505</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0009505</pub-id><pub-id pub-id-type="pmid">20209079</pub-id>
</element-citation></ref><ref id="B427-viruses-17-00203"><label>427.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morris</surname><given-names>J.C.</given-names></name>
<name><surname>Chang Wong</surname><given-names>E.</given-names></name>
<name><surname>Chang Chui</surname><given-names>H.</given-names></name>
</person-group><article-title>Vascular Cognitive Impairment and Dementia</article-title><source>CONTINUUM Lifelong Learn. Neurol.</source><year>2022</year><volume>28</volume><fpage>750</fpage><pub-id pub-id-type="doi">10.1212/CON.0000000000001124</pub-id></element-citation></ref><ref id="B428-viruses-17-00203"><label>428.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Custodio</surname><given-names>N.</given-names></name>
<name><surname>Montesinos</surname><given-names>R.</given-names></name>
<name><surname>Lira</surname><given-names>D.</given-names></name>
<name><surname>Herrera-P&#x000e9;rez</surname><given-names>E.</given-names></name>
<name><surname>Bardales</surname><given-names>Y.</given-names></name>
<name><surname>Valeriano-Lorenzo</surname><given-names>L.</given-names></name>
</person-group><article-title>Mixed Dementia: A Review of the Evidence</article-title><source>Dement. Neuropsychol.</source><year>2017</year><volume>11</volume><fpage>364</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1590/1980-57642016dn11-040005</pub-id><pub-id pub-id-type="pmid">29354216</pub-id>
</element-citation></ref><ref id="B429-viruses-17-00203"><label>429.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morales</surname><given-names>I.</given-names></name>
<name><surname>Guzm&#x000e1;n-Mart&#x000ed;nez</surname><given-names>L.</given-names></name>
<name><surname>Cerda-Troncoso</surname><given-names>C.</given-names></name>
<name><surname>Far&#x000ed;as</surname><given-names>G.A.</given-names></name>
<name><surname>Maccioni</surname><given-names>R.B.</given-names></name>
</person-group><article-title>Neuroinflammation in the Pathogenesis of Alzheimer&#x02019;s Disease. A Rational Framework for the Search of Novel Therapeutic Approaches</article-title><source>Front. Cell Neurosci.</source><year>2014</year><volume>8</volume><elocation-id>112</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2014.00112</pub-id><pub-id pub-id-type="pmid">24795567</pub-id>
</element-citation></ref><ref id="B430-viruses-17-00203"><label>430.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Streit</surname><given-names>W.J.</given-names></name>
<name><surname>Mrak</surname><given-names>R.E.</given-names></name>
<name><surname>Griffin</surname><given-names>W.S.T.</given-names></name>
</person-group><article-title>Microglia and Neuroinflammation: A Pathological Perspective</article-title><source>J. Neuroinflammation</source><year>2004</year><volume>1</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-1-14</pub-id><pub-id pub-id-type="pmid">15285801</pub-id>
</element-citation></ref><ref id="B431-viruses-17-00203"><label>431.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lima</surname><given-names>M.N.</given-names></name>
<name><surname>Barbosa-Silva</surname><given-names>M.C.</given-names></name>
<name><surname>Maron-Gutierrez</surname><given-names>T.</given-names></name>
</person-group><article-title>Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases</article-title><source>Front. Cell Neurosci.</source><year>2022</year><volume>16</volume><elocation-id>878987</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2022.878987</pub-id><pub-id pub-id-type="pmid">35783096</pub-id>
</element-citation></ref><ref id="B432-viruses-17-00203"><label>432.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Yuan</surname><given-names>M.</given-names></name>
<name><surname>Yang</surname><given-names>E.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Su</surname><given-names>A.</given-names></name>
<name><surname>Wu</surname><given-names>Z.</given-names></name>
</person-group><article-title>Enterovirus 71 Infection Induced Aquaporin-4 Depolarization by Increasing Matrix Metalloproteinase-9 Activity</article-title><source>Neurosci. Lett.</source><year>2021</year><volume>759</volume><fpage>136049</fpage><pub-id pub-id-type="doi">10.1016/j.neulet.2021.136049</pub-id><pub-id pub-id-type="pmid">34126180</pub-id>
</element-citation></ref><ref id="B433-viruses-17-00203"><label>433.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sousa Junior</surname><given-names>I.P.</given-names></name>
<name><surname>Vieira</surname><given-names>T.C.R.G.</given-names></name>
</person-group><article-title>Enterovirus Infection and Its Relationship with Neurodegenerative Diseases</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2023</year><volume>118</volume><fpage>e220252</fpage><pub-id pub-id-type="doi">10.1590/0074-02760220252</pub-id><pub-id pub-id-type="pmid">36946853</pub-id>
</element-citation></ref><ref id="B434-viruses-17-00203"><label>434.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rippee-Brooks</surname><given-names>M.D.</given-names></name>
<name><surname>Wu</surname><given-names>W.</given-names></name>
<name><surname>Dong</surname><given-names>J.</given-names></name>
<name><surname>Pappolla</surname><given-names>M.</given-names></name>
<name><surname>Fang</surname><given-names>X.</given-names></name>
<name><surname>Bao</surname><given-names>X.</given-names></name>
</person-group><article-title>Viral Infections, Are They a Trigger and Risk Factor of Alzheimer&#x02019;s Disease?</article-title><source>Pathogens</source><year>2024</year><volume>13</volume><elocation-id>240</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens13030240</pub-id><pub-id pub-id-type="pmid">38535583</pub-id>
</element-citation></ref><ref id="B435-viruses-17-00203"><label>435.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sait</surname><given-names>A.</given-names></name>
<name><surname>Angeli</surname><given-names>C.</given-names></name>
<name><surname>Doig</surname><given-names>A.J.</given-names></name>
<name><surname>Day</surname><given-names>P.J.R.</given-names></name>
</person-group><article-title>Viral Involvement in Alzheimer&#x02019;s Disease</article-title><source>ACS Chem. Neurosci.</source><year>2021</year><volume>12</volume><fpage>1049</fpage><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00719</pub-id><pub-id pub-id-type="pmid">33687205</pub-id>
</element-citation></ref><ref id="B436-viruses-17-00203"><label>436.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sipil&#x000e4;</surname><given-names>P.N.</given-names></name>
<name><surname>Heikkil&#x000e4;</surname><given-names>N.</given-names></name>
<name><surname>Lindbohm</surname><given-names>J.V.</given-names></name>
<name><surname>Hakulinen</surname><given-names>C.</given-names></name>
<name><surname>Vahtera</surname><given-names>J.</given-names></name>
<name><surname>Elovainio</surname><given-names>M.</given-names></name>
<name><surname>Suominen</surname><given-names>S.</given-names></name>
<name><surname>V&#x000e4;&#x000e4;n&#x000e4;nen</surname><given-names>A.</given-names></name>
<name><surname>Koskinen</surname><given-names>A.</given-names></name>
<name><surname>Nyberg</surname><given-names>S.T.</given-names></name>
<etal/>
</person-group><article-title>Hospital-Treated Infectious Diseases and the Risk of Dementia: A Large, Multicohort, Observational Study with a Replication Cohort</article-title><source>Lancet Infect. Dis.</source><year>2021</year><volume>21</volume><fpage>1557</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(21)00144-4</pub-id><pub-id pub-id-type="pmid">34166620</pub-id>
</element-citation></ref><ref id="B437-viruses-17-00203"><label>437.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Levine</surname><given-names>K.S.</given-names></name>
<name><surname>Leonard</surname><given-names>H.L.</given-names></name>
<name><surname>Blauwendraat</surname><given-names>C.</given-names></name>
<name><surname>Iwaki</surname><given-names>H.</given-names></name>
<name><surname>Johnson</surname><given-names>N.</given-names></name>
<name><surname>Bandres-Ciga</surname><given-names>S.</given-names></name>
<name><surname>Ferrucci</surname><given-names>L.</given-names></name>
<name><surname>Faghri</surname><given-names>F.</given-names></name>
<name><surname>Singleton</surname><given-names>A.B.</given-names></name>
<name><surname>Nalls</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Virus Exposure and Neurodegenerative Disease Risk across National Biobanks</article-title><source>Neuron</source><year>2023</year><volume>111</volume><fpage>1086</fpage><lpage>1093.e2</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2022.12.029</pub-id><pub-id pub-id-type="pmid">36669485</pub-id>
</element-citation></ref><ref id="B438-viruses-17-00203"><label>438.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schnier</surname><given-names>C.</given-names></name>
<name><surname>Janbek</surname><given-names>J.</given-names></name>
<name><surname>Lathe</surname><given-names>R.</given-names></name>
<name><surname>Haas</surname><given-names>J.</given-names></name>
</person-group><article-title>Reduced Dementia Incidence after Varicella Zoster Vaccination in Wales 2013&#x02013;2020</article-title><source>Alzheimer&#x02019;s Dement. Transl. Res. Clin. Interv.</source><year>2022</year><volume>8</volume><fpage>e12293</fpage><pub-id pub-id-type="doi">10.1002/trc2.12293</pub-id></element-citation></ref><ref id="B439-viruses-17-00203"><label>439.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verreault</surname><given-names>R.</given-names></name>
<name><surname>Laurin</surname><given-names>D.</given-names></name>
<name><surname>Lindsay</surname><given-names>J.</given-names></name>
<name><surname>De Serres</surname><given-names>G.</given-names></name>
</person-group><article-title>Past Exposure to Vaccines and Subsequent Risk of Alzheimer&#x02019;s Disease</article-title><source>Can. Med. Assoc. J.</source><year>2001</year><volume>165</volume><fpage>1495</fpage><pub-id pub-id-type="pmid">11762573</pub-id>
</element-citation></ref><ref id="B440-viruses-17-00203"><label>440.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wollebo</surname><given-names>H.S.</given-names></name>
<name><surname>White</surname><given-names>M.K.</given-names></name>
<name><surname>Gordon</surname><given-names>J.</given-names></name>
<name><surname>Berger</surname><given-names>J.R.</given-names></name>
<name><surname>Khalili</surname><given-names>K.</given-names></name>
</person-group><article-title>Persistence and Pathogenesis of the Neurotropic Polyomavirus JC</article-title><source>Ann. Neurol.</source><year>2015</year><volume>77</volume><fpage>560</fpage><pub-id pub-id-type="doi">10.1002/ana.24371</pub-id><pub-id pub-id-type="pmid">25623836</pub-id>
</element-citation></ref><ref id="B441-viruses-17-00203"><label>441.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pietropaolo</surname><given-names>V.</given-names></name>
<name><surname>Prezioso</surname><given-names>C.</given-names></name>
<name><surname>Bagnato</surname><given-names>F.</given-names></name>
<name><surname>Antonelli</surname><given-names>G.</given-names></name>
</person-group><article-title>John Cunningham Virus: An Overview on Biology and Disease of the Etiological Agent of the Progressive Multifocal Leukoencephalopathy</article-title><source>Rev. New Microbiol.</source><year>2018</year><volume>41</volume><fpage>1121</fpage><lpage>7138</lpage></element-citation></ref><ref id="B442-viruses-17-00203"><label>442.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garg</surname><given-names>M.</given-names></name>
<name><surname>Arora</surname><given-names>A.</given-names></name>
<name><surname>Kulkarni</surname><given-names>S.D.</given-names></name>
<name><surname>Hegde</surname><given-names>A.U.</given-names></name>
<name><surname>Shah</surname><given-names>K.N.</given-names></name>
</person-group><article-title>Subacute Sclerosing Panencephalitis (SSPE): Experience from a Tertiary-Care Pediatric Center</article-title><source>J. Neurosci. Rural Pract.</source><year>2022</year><volume>13</volume><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1055/s-0041-1740612</pub-id><pub-id pub-id-type="pmid">35694059</pub-id>
</element-citation></ref><ref id="B443-viruses-17-00203"><label>443.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jafri</surname><given-names>S.K.</given-names></name>
<name><surname>Kumar</surname><given-names>R.</given-names></name>
<name><surname>Ibrahim</surname><given-names>S.</given-names></name>
</person-group><article-title>Subacute Sclerosing Panencephalitis&#x02013;Current Perspectives</article-title><source>Pediatr. Health Med. Ther.</source><year>2018</year><volume>9</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.2147/PHMT.S126293</pub-id></element-citation></ref><ref id="B444-viruses-17-00203"><label>444.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Poli</surname><given-names>S.</given-names></name>
<name><surname>Donisi</surname><given-names>V.</given-names></name>
<name><surname>Mazzi</surname><given-names>M.A.</given-names></name>
<name><surname>Gobbin</surname><given-names>F.</given-names></name>
<name><surname>Giusto</surname><given-names>G.</given-names></name>
<name><surname>Orlandi</surname><given-names>R.</given-names></name>
<name><surname>Schena</surname><given-names>F.</given-names></name>
<name><surname>Del Piccolo</surname><given-names>L.</given-names></name>
<name><surname>das Nair</surname><given-names>R.</given-names></name>
<name><surname>Gajofatto</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Fostering Quality of Life in Young Adults Living with Multiple Sclerosis: A Pilot Study of a Co-Created Integrated Intervention</article-title><source>Front. Psychol.</source><year>2024</year><volume>15</volume><elocation-id>1342166</elocation-id><pub-id pub-id-type="doi">10.3389/fpsyg.2024.1342166</pub-id><pub-id pub-id-type="pmid">38596329</pub-id>
</element-citation></ref><ref id="B445-viruses-17-00203"><label>445.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lassmann</surname><given-names>H.</given-names></name>
</person-group><article-title>Pathogenic Mechanisms Associated with Different Clinical Courses of Multiple Sclerosis</article-title><source>Front. Immunol.</source><year>2019</year><volume>9</volume><elocation-id>3116</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.03116</pub-id><pub-id pub-id-type="pmid">30687321</pub-id>
</element-citation></ref><ref id="B446-viruses-17-00203"><label>446.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miljkovi&#x00107;</surname><given-names>D.</given-names></name>
<name><surname>Spasojevi&#x00107;</surname><given-names>I.</given-names></name>
</person-group><article-title>Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities</article-title><source>Antioxid. Redox Signal</source><year>2013</year><volume>19</volume><fpage>2286</fpage><pub-id pub-id-type="doi">10.1089/ars.2012.5068</pub-id><pub-id pub-id-type="pmid">23473637</pub-id>
</element-citation></ref><ref id="B447-viruses-17-00203"><label>447.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Virtanen</surname><given-names>J.O.</given-names></name>
<name><surname>Jacobson</surname><given-names>S.</given-names></name>
</person-group><article-title>Viruses and Multiple Sclerosis</article-title><source>CNS Neurol. Disord. Drug Targets</source><year>2012</year><volume>11</volume><fpage>528</fpage><pub-id pub-id-type="doi">10.2174/187152712801661220</pub-id><pub-id pub-id-type="pmid">22583435</pub-id>
</element-citation></ref><ref id="B448-viruses-17-00203"><label>448.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koprowski</surname><given-names>H.</given-names></name>
<name><surname>Defreitas</surname><given-names>E.C.</given-names></name>
<name><surname>Harper</surname><given-names>M.E.</given-names></name>
<name><surname>Sandberg-Wollheim</surname><given-names>M.</given-names></name>
<name><surname>Sheremata</surname><given-names>W.A.</given-names></name>
<name><surname>Robert-Guroff</surname><given-names>M.</given-names></name>
<name><surname>Saxinger</surname><given-names>C.W.</given-names></name>
<name><surname>Feinberg</surname><given-names>M.B.</given-names></name>
<name><surname>Wong-Staal</surname><given-names>F.</given-names></name>
<name><surname>Gallo</surname><given-names>R.C.</given-names></name>
</person-group><article-title>Multiple Sclerosis and Human T-Cell Lymphotropic Retroviruses</article-title><source>Nature</source><year>1985</year><volume>318</volume><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1038/318154a0</pub-id><pub-id pub-id-type="pmid">2997627</pub-id>
</element-citation></ref><ref id="B449-viruses-17-00203"><label>449.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koprowski</surname><given-names>H.</given-names></name>
</person-group><article-title>Search for Viruses in Multiple Sclerosis</article-title><source>Neurology</source><year>1976</year><volume>26</volume><fpage>80</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1212/WNL.26.6_Part_2.80</pub-id><pub-id pub-id-type="pmid">179033</pub-id>
</element-citation></ref><ref id="B450-viruses-17-00203"><label>450.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsunoda</surname><given-names>I.</given-names></name>
<name><surname>Fujinami</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Neuropathogenesis of Theiler&#x02019;s Murine Encephalomyelitis Virus Infection, An Animal Model for Multiple Sclerosis</article-title><source>J. Neuroimmune Pharmacol.</source><year>2009</year><volume>5</volume><fpage>355</fpage><pub-id pub-id-type="doi">10.1007/s11481-009-9179-x</pub-id><pub-id pub-id-type="pmid">19894121</pub-id>
</element-citation></ref><ref id="B451-viruses-17-00203"><label>451.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bjornevik</surname><given-names>K.</given-names></name>
<name><surname>Cortese</surname><given-names>M.</given-names></name>
<name><surname>Healy</surname><given-names>B.C.</given-names></name>
<name><surname>Kuhle</surname><given-names>J.</given-names></name>
<name><surname>Mina</surname><given-names>M.J.</given-names></name>
<name><surname>Leng</surname><given-names>Y.</given-names></name>
<name><surname>Elledge</surname><given-names>S.J.</given-names></name>
<name><surname>Niebuhr</surname><given-names>D.W.</given-names></name>
<name><surname>Scher</surname><given-names>A.I.</given-names></name>
<name><surname>Munger</surname><given-names>K.L.</given-names></name>
<etal/>
</person-group><article-title>Longitudinal Analysis Reveals High Prevalence of Epstein-Barr Virus Associated with Multiple Sclerosis</article-title><source>Science</source><year>2022</year><volume>375</volume><fpage>296</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1126/science.abj8222</pub-id><pub-id pub-id-type="pmid">35025605</pub-id>
</element-citation></ref><ref id="B452-viruses-17-00203"><label>452.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thacker</surname><given-names>E.L.</given-names></name>
<name><surname>Mirzaei</surname><given-names>F.</given-names></name>
<name><surname>Ascherio</surname><given-names>A.</given-names></name>
</person-group><article-title>Infectious Mononucleosis and Risk for Multiple Sclerosis: A Meta-Analysis</article-title><source>Ann. Neurol.</source><year>2006</year><volume>59</volume><fpage>499</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1002/ana.20820</pub-id><pub-id pub-id-type="pmid">16502434</pub-id>
</element-citation></ref><ref id="B453-viruses-17-00203"><label>453.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>DeLorenze</surname><given-names>G.N.</given-names></name>
<name><surname>Munger</surname><given-names>K.L.</given-names></name>
<name><surname>Lennette</surname><given-names>E.T.</given-names></name>
<name><surname>Orentreich</surname><given-names>N.</given-names></name>
<name><surname>Vogelman</surname><given-names>J.H.</given-names></name>
<name><surname>Ascherio</surname><given-names>A.</given-names></name>
</person-group><article-title>Epstein-Barr Virus and Multiple Sclerosis: Evidence of Association from a Prospective Study with Long-Term Follow-Up</article-title><source>Arch. Neurol.</source><year>2006</year><volume>63</volume><fpage>839</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1001/archneur.63.6.noc50328</pub-id><pub-id pub-id-type="pmid">16606758</pub-id>
</element-citation></ref><ref id="B454-viruses-17-00203"><label>454.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Brotman</surname><given-names>R.G.</given-names></name>
<name><surname>Moreno-Escobar</surname><given-names>M.C.</given-names></name>
<name><surname>Joseph</surname><given-names>J.</given-names></name>
<name><surname>Munakomi</surname><given-names>S.</given-names></name>
<name><surname>Pawar</surname><given-names>G.</given-names></name>
</person-group><source>Amyotrophic Lateral Sclerosis</source><publisher-name>StatPearls</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2024</year></element-citation></ref><ref id="B455-viruses-17-00203"><label>455.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hardiman</surname><given-names>O.</given-names></name>
<name><surname>Al-Chalabi</surname><given-names>A.</given-names></name>
<name><surname>Chio</surname><given-names>A.</given-names></name>
<name><surname>Corr</surname><given-names>E.M.</given-names></name>
<name><surname>Logroscino</surname><given-names>G.</given-names></name>
<name><surname>Robberecht</surname><given-names>W.</given-names></name>
<name><surname>Shaw</surname><given-names>P.J.</given-names></name>
<name><surname>Simmons</surname><given-names>Z.</given-names></name>
<name><surname>Van Den Berg</surname><given-names>L.H.</given-names></name>
</person-group><article-title>Amyotrophic Lateral Sclerosis</article-title><source>Nat. Rev. Dis. Primers</source><year>2017</year><volume>3</volume><fpage>17071</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2017.71</pub-id><pub-id pub-id-type="pmid">28980624</pub-id>
</element-citation></ref><ref id="B456-viruses-17-00203"><label>456.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>B.</given-names></name>
<name><surname>Pamphlett</surname><given-names>R.</given-names></name>
</person-group><article-title>Environmental Insults: Critical Triggers for Amyotrophic Lateral Sclerosis</article-title><source>Transl. Neurodegener.</source><year>2017</year><volume>6</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s40035-017-0087-3</pub-id><pub-id pub-id-type="pmid">28638596</pub-id>
</element-citation></ref><ref id="B457-viruses-17-00203"><label>457.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xue</surname><given-names>Y.C.</given-names></name>
<name><surname>Feuer</surname><given-names>R.</given-names></name>
<name><surname>Cashman</surname><given-names>N.</given-names></name>
<name><surname>Luo</surname><given-names>H.</given-names></name>
</person-group><article-title>Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis?</article-title><source>Front. Mol. Neurosci.</source><year>2018</year><volume>11</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00063</pub-id><pub-id pub-id-type="pmid">29593492</pub-id>
</element-citation></ref><ref id="B458-viruses-17-00203"><label>458.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>R.</given-names></name>
</person-group><article-title>The Pathogenic Mechanism of TAR DNA-Binding Protein 43 (TDP-43) in Amyotrophic Lateral Sclerosis</article-title><source>Neural Regen. Res.</source><year>2023</year><volume>19</volume><fpage>800</fpage><pub-id pub-id-type="doi">10.4103/1673-5374.382233</pub-id></element-citation></ref><ref id="B459-viruses-17-00203"><label>459.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tyagi</surname><given-names>R.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Parades</surname><given-names>D.</given-names></name>
<name><surname>Bianchet</surname><given-names>M.A.</given-names></name>
<name><surname>Nath</surname><given-names>A.</given-names></name>
</person-group><article-title>Inhibition of Human Endogenous Retrovirus-K by Antiretroviral Drugs</article-title><source>Retrovirology</source><year>2017</year><volume>14</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/s12977-017-0347-4</pub-id><pub-id pub-id-type="pmid">28330477</pub-id>
</element-citation></ref><ref id="B460-viruses-17-00203"><label>460.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belshaw</surname><given-names>R.</given-names></name>
<name><surname>Katzourakis</surname><given-names>A.</given-names></name>
<name><surname>Pa&#x0010d;es</surname><given-names>J.</given-names></name>
<name><surname>Burt</surname><given-names>A.</given-names></name>
<name><surname>Tristem</surname><given-names>M.</given-names></name>
</person-group><article-title>High Copy Number in Human Endogenous Retrovirus Families Is Associated with Copying Mechanisms in Addition to Reinfection</article-title><source>Mol. Biol. Evol.</source><year>2005</year><volume>22</volume><fpage>814</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1093/molbev/msi088</pub-id><pub-id pub-id-type="pmid">15659556</pub-id>
</element-citation></ref><ref id="B461-viruses-17-00203"><label>461.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shin</surname><given-names>W.</given-names></name>
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Son</surname><given-names>S.Y.</given-names></name>
<name><surname>Ahn</surname><given-names>K.</given-names></name>
<name><surname>Kim</surname><given-names>H.S.</given-names></name>
<name><surname>Han</surname><given-names>K.</given-names></name>
</person-group><article-title>Human-Specific HERV-K Insertion Causes Genomic Variations in the Human Genome</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e60605</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0060605</pub-id><pub-id pub-id-type="pmid">23593260</pub-id>
</element-citation></ref><ref id="B462-viruses-17-00203"><label>462.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wildschutte</surname><given-names>J.H.</given-names></name>
<name><surname>Williams</surname><given-names>Z.H.</given-names></name>
<name><surname>Montesion</surname><given-names>M.</given-names></name>
<name><surname>Subramanian</surname><given-names>R.P.</given-names></name>
<name><surname>Kidd</surname><given-names>J.M.</given-names></name>
<name><surname>Coffin</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Discovery of Unfixed Endogenous Retrovirus Insertions in Diverse Human Populations</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>E2326</fpage><lpage>E2334</lpage><pub-id pub-id-type="doi">10.1073/pnas.1602336113</pub-id><pub-id pub-id-type="pmid">27001843</pub-id>
</element-citation></ref><ref id="B463-viruses-17-00203"><label>463.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Villesen</surname><given-names>P.</given-names></name>
<name><surname>Aagaard</surname><given-names>L.</given-names></name>
<name><surname>Wiuf</surname><given-names>C.</given-names></name>
<name><surname>Pedersen</surname><given-names>F.S.</given-names></name>
</person-group><article-title>Identification of Endogenous Retroviral Reading Frames in the Human Genome</article-title><source>Retrovirology</source><year>2004</year><volume>1</volume><fpage>32</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-1-32</pub-id><pub-id pub-id-type="pmid">15476554</pub-id>
</element-citation></ref><ref id="B464-viruses-17-00203"><label>464.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gr&#x000f6;ger</surname><given-names>V.</given-names></name>
<name><surname>Emmer</surname><given-names>A.</given-names></name>
<name><surname>Staege</surname><given-names>M.S.</given-names></name>
<name><surname>Cynis</surname><given-names>H.</given-names></name>
</person-group><article-title>Endogenous Retroviruses in Nervous System Disorders</article-title><source>Pharmaceuticals</source><year>2021</year><volume>14</volume><elocation-id>70</elocation-id><pub-id pub-id-type="doi">10.3390/ph14010070</pub-id><pub-id pub-id-type="pmid">33467098</pub-id>
</element-citation></ref><ref id="B465-viruses-17-00203"><label>465.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mao</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Cong</surname><given-names>Y.S.</given-names></name>
</person-group><article-title>Human Endogenous Retroviruses in Development and Disease</article-title><source>Comput. Struct. Biotechnol. J.</source><year>2021</year><volume>19</volume><elocation-id>5978</elocation-id><pub-id pub-id-type="doi">10.1016/j.csbj.2021.10.037</pub-id><pub-id pub-id-type="pmid">34849202</pub-id>
</element-citation></ref><ref id="B466-viruses-17-00203"><label>466.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pal</surname><given-names>S.</given-names></name>
<name><surname>Tyler</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Epigenetics and Aging</article-title><source>Sci. Adv.</source><year>2016</year><volume>2</volume><fpage>e1600584</fpage><pub-id pub-id-type="doi">10.1126/sciadv.1600584</pub-id><pub-id pub-id-type="pmid">27482540</pub-id>
</element-citation></ref><ref id="B467-viruses-17-00203"><label>467.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Latifi</surname><given-names>T.</given-names></name>
<name><surname>Zebardast</surname><given-names>A.</given-names></name>
<name><surname>Marashi</surname><given-names>S.M.</given-names></name>
</person-group><article-title>The Role of Human Endogenous Retroviruses (HERVs) in Multiple Sclerosis and the Plausible Interplay between HERVs, Epstein&#x02013;Barr Virus Infection, and Vitamin D</article-title><source>Mult. Scler. Relat. Disord.</source><year>2022</year><volume>57</volume><fpage>103318</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2021.103318</pub-id><pub-id pub-id-type="pmid">35158423</pub-id>
</element-citation></ref><ref id="B468-viruses-17-00203"><label>468.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bhetariya</surname><given-names>P.</given-names></name>
<name><surname>Kriesel</surname><given-names>J.</given-names></name>
<name><surname>Fischer</surname><given-names>K.</given-names></name>
</person-group><article-title>Analysis of Human Endogenous Retrovirus Expression in Multiple Sclerosis Plaques</article-title><source>J. Emerg. Dis. Virol.</source><year>2017</year><volume>3</volume><pub-id pub-id-type="doi">10.16966/2473-1846.133</pub-id></element-citation></ref><ref id="B469-viruses-17-00203"><label>469.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arru</surname><given-names>G.</given-names></name>
<name><surname>Mameli</surname><given-names>G.</given-names></name>
<name><surname>Deiana</surname><given-names>G.A.</given-names></name>
<name><surname>Rassu</surname><given-names>A.L.</given-names></name>
<name><surname>Piredda</surname><given-names>R.</given-names></name>
<name><surname>Sechi</surname><given-names>E.</given-names></name>
<name><surname>Caggiu</surname><given-names>E.</given-names></name>
<name><surname>Bo</surname><given-names>M.</given-names></name>
<name><surname>Nako</surname><given-names>E.</given-names></name>
<name><surname>Urso</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Humoral Immunity Response to Human Endogenous Retroviruses K/W Differentiates between Amyotrophic Lateral Sclerosis and Other Neurological Diseases</article-title><source>Eur. J. Neurol.</source><year>2018</year><volume>25</volume><fpage>1076-e84</fpage><pub-id pub-id-type="doi">10.1111/ene.13648</pub-id><pub-id pub-id-type="pmid">29603839</pub-id>
</element-citation></ref><ref id="B470-viruses-17-00203"><label>470.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>W.</given-names></name>
<name><surname>Samimi</surname><given-names>H.</given-names></name>
<name><surname>Gamez</surname><given-names>M.</given-names></name>
<name><surname>Zare</surname><given-names>H.</given-names></name>
<name><surname>Frost</surname><given-names>B.</given-names></name>
</person-group><article-title>Pathogenic Tau-Induced PiRNA Depletion Promotes Neuronal Death through Transposable Element Dysregulation in Neurodegenerative Tauopathies</article-title><source>Nat. Neurosci.</source><year>2018</year><volume>21</volume><fpage>1038</fpage><pub-id pub-id-type="doi">10.1038/s41593-018-0194-1</pub-id><pub-id pub-id-type="pmid">30038280</pub-id>
</element-citation></ref><ref id="B471-viruses-17-00203"><label>471.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Phan</surname><given-names>K.</given-names></name>
<name><surname>He</surname><given-names>Y.</given-names></name>
<name><surname>Fu</surname><given-names>Y.H.</given-names></name>
<name><surname>Dzamko</surname><given-names>N.</given-names></name>
<name><surname>Bhatia</surname><given-names>S.</given-names></name>
<name><surname>Gold</surname><given-names>J.</given-names></name>
<name><surname>Rowe</surname><given-names>D.</given-names></name>
<name><surname>Ke</surname><given-names>Y.D.</given-names></name>
<name><surname>Ittner</surname><given-names>L.M.</given-names></name>
<name><surname>Hodges</surname><given-names>J.R.</given-names></name>
<etal/>
</person-group><article-title>Pathological Manifestation of Human Endogenous Retrovirus K in Frontotemporal Dementia</article-title><source>Commun. Med.</source><year>2021</year><volume>1</volume><fpage>60</fpage><pub-id pub-id-type="doi">10.1038/s43856-021-00060-w</pub-id><pub-id pub-id-type="pmid">35083468</pub-id>
</element-citation></ref><ref id="B472-viruses-17-00203"><label>472.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>A.D.</given-names></name>
<name><surname>Wendt</surname><given-names>G.A.</given-names></name>
<name><surname>Barcellos</surname><given-names>L.F.</given-names></name>
<name><surname>de Smith</surname><given-names>A.J.</given-names></name>
<name><surname>Walsh</surname><given-names>K.M.</given-names></name>
<name><surname>Metayer</surname><given-names>C.</given-names></name>
<name><surname>Costello</surname><given-names>J.F.</given-names></name>
<name><surname>Wiemels</surname><given-names>J.L.</given-names></name>
<name><surname>Francis</surname><given-names>S.S.</given-names></name>
</person-group><article-title>To ERV Is Human: A Phenotype-Wide Scan Linking Polymorphic Human Endogenous Retrovirus-K Insertions to Complex Phenotypes</article-title><source>Front. Genet.</source><year>2018</year><volume>9</volume><elocation-id>298</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2018.00298</pub-id><pub-id pub-id-type="pmid">30154825</pub-id>
</element-citation></ref><ref id="B473-viruses-17-00203"><label>473.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dolei</surname><given-names>A.</given-names></name>
<name><surname>Ibba</surname><given-names>G.</given-names></name>
<name><surname>Piu</surname><given-names>C.</given-names></name>
<name><surname>Serra</surname><given-names>C.</given-names></name>
</person-group><article-title>Expression of HERV Genes as Possible Biomarker and Target in Neurodegenerative Diseases</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>3706</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20153706</pub-id><pub-id pub-id-type="pmid">31362360</pub-id>
</element-citation></ref><ref id="B474-viruses-17-00203"><label>474.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Christensen</surname><given-names>T.</given-names></name>
</person-group><article-title>Human Endogenous Retroviruses in Neurologic Disease</article-title><source>APMIS</source><year>2016</year><volume>124</volume><fpage>116</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1111/apm.12486</pub-id><pub-id pub-id-type="pmid">26818266</pub-id>
</element-citation></ref><ref id="B475-viruses-17-00203"><label>475.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>K&#x000fc;ry</surname><given-names>P.</given-names></name>
<name><surname>Nath</surname><given-names>A.</given-names></name>
<name><surname>Cr&#x000e9;ange</surname><given-names>A.</given-names></name>
<name><surname>Dolei</surname><given-names>A.</given-names></name>
<name><surname>Marche</surname><given-names>P.</given-names></name>
<name><surname>Gold</surname><given-names>J.</given-names></name>
<name><surname>Giovannoni</surname><given-names>G.</given-names></name>
<name><surname>Hartung</surname><given-names>H.P.</given-names></name>
<name><surname>Perron</surname><given-names>H.</given-names></name>
</person-group><article-title>Human Endogenous Retroviruses in Neurological Diseases</article-title><source>Trends Mol. Med.</source><year>2018</year><volume>24</volume><fpage>379</fpage><pub-id pub-id-type="doi">10.1016/j.molmed.2018.02.007</pub-id><pub-id pub-id-type="pmid">29551251</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-17-00203-f001"><label>Figure 1</label><caption><p>Mechanisms of virus entry into the central nervous system (CNS) through the blood&#x02013;brain barrier (BBB). Viruses present in the systemic circulatory system can infiltrate the CNS by breaching the brain endothelial cells through various mechanisms. These include the following: transcellular trafficking without causing cellular damage; endothelial infection with damage; paracellular migration with the direct disruption of cellular junctions by viral proteins and with the participation of pro-inflammatory cytokines produced by activated barrier cells; disruption of the BBB with the involvement of pro-inflammatory cytokines and bioactive mediators that disrupt cell homeostasis, destabilize cellular junctions, and lead to the damage of cells composing the BBB; Trojan horse delivery within infected cells. For each of these mechanisms, viruses that exploit the pathway to infect the CNS are mentioned.</p></caption><graphic xlink:href="viruses-17-00203-g001" position="float"/></fig><fig position="float" id="viruses-17-00203-f002"><label>Figure 2</label><caption><p>Intercellular junctions connecting the capillary endothelial cells of the blood&#x02013;brain barrier. Tight junctions are formed by transmembrane proteins such as claudins, occludins, and junctional adhesion molecules, which are linked to cytoplasmic scaffolding zonula occludens (ZO) proteins that interact directly with actin filaments of the cytoskeleton. Adherens junctions are primarily composed of E-cadherins and &#x003b2;-catenins, the latter of which anchor the junctions to the actin cytoskeleton. Gap junctions are formed by two hemichannels in the plasma membranes of adjacent cells, which are composed of protein subunits called connexins.</p></caption><graphic xlink:href="viruses-17-00203-g002" position="float"/></fig><table-wrap position="float" id="viruses-17-00203-t001"><object-id pub-id-type="pii">viruses-17-00203-t001_Table 1</object-id><label>Table 1</label><caption><p>Neuronal pathways to CNS invasion used by RABV and HSV-1.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RABV</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HSV-1</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cells through which the virus enters the host&#x02019;s body</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Muscle cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epithelial cells</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Method of entry into the peripheral neuron</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Receptor-dependent clathrin-mediated endocytosis [<xref rid="B39-viruses-17-00203" ref-type="bibr">39</xref>,<xref rid="B62-viruses-17-00203" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fusion of virus lipid envelope with host cell membrane [<xref rid="B63-viruses-17-00203" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral proteins responsible for neuron entry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RABV G&#x02014;the only protein exposed on the surface of the viral envelope that can bind to various receptors [<xref rid="B64-viruses-17-00203" ref-type="bibr">64</xref>,<xref rid="B65-viruses-17-00203" ref-type="bibr">65</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At least 12 different surface glycoproteins bind to more than one receptor [<xref rid="B66-viruses-17-00203" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of neuron used on the way to the CNS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Motor neuron</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sensory neuron</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of virus transport in a neuron</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fast dynein- and kinesin-mediated transport on microtubules in endosomes [<xref rid="B67-viruses-17-00203" ref-type="bibr">67</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dynein, dynactin, and kinesin-1-mediated transport on microtubules of the non-enveloped capsid [<xref rid="B68-viruses-17-00203" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reaching the brain and the fate of the host</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The virus always reaches the brain cells, ultimately causing the host&#x02019;s death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">If the virus reaches the brain cells, it may cause severe acute, potentially fatal encephalomyelitis, but this rarely happens</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ability to persist in the brain without causing the host&#x02019;s death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes, in a latent form in the brainstem, as well as in other brain regions until the host&#x02019;s natural death (not explained how it reaches them)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Main factor(s) determining tissue and cell tropism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple&#x02014;high level of receptors on the host cell surface, lower protective immune response of neurons, low immune surveillance over cells, others</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The occurrence of specific receptors on host cells&#x02019; surface</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inflammatory response in the brain during acute infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specific suppression of the host immunity through diverse mechanisms [<xref rid="B46-viruses-17-00203" ref-type="bibr">46</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brain parenchyma inflammation is accompanied by an inflammatory response that may become exaggerated and further increases brain injury [<xref rid="B69-viruses-17-00203" ref-type="bibr">69</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00203-t002"><object-id pub-id-type="pii">viruses-17-00203-t002_Table 2</object-id><label>Table 2</label><caption><p>Viral pathways of neuroinvasion.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Possible Hematogenous Neuroinvasion Through Brain Barriers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Viruses</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1. Transcellular pathway with none or minimal barrier damage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Flaviviridae</italic>: WNV, JEV, TBEV, ZIKV; <italic toggle="yes">Togaviridae</italic>: VEEV, WEEV; <italic toggle="yes">Retroviridae</italic>: HIV-1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.1. Infection with general damage to barrier cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Flaviviridae</italic>,<break/><italic toggle="yes">Paramyxoviridae</italic>: HeV, NiV</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2. Paracellular pathway with direct impairment of intercellular junctions of barrier cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Flaviviridae</italic>: WNV, JEV, DENV<break/><italic toggle="yes">Picornaviridae</italic>: Enterovirus A71</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3. Barrier damage by inflammatory mediators </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Coronaviridae</italic>: SARS-CoV-2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3. Trojan horse mechanism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Flaviviridae</italic>: JEV, WNV, ZIKV<break/><italic toggle="yes">Retroviridae</italic>: HIV-1, Visna virus</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00203-t003"><object-id pub-id-type="pii">viruses-17-00203-t003_Table 3</object-id><label>Table 3</label><caption><p>Viruses responsible for neuropathology and clinical outcomes in humans.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Virus</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Common Way of Entry to the CNS </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Frequent Clinical Presentation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome and Viral Persistence</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Infected CNS Cells</th></tr></thead><tbody><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Family:<break/><italic toggle="yes">Herpesviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV-1, HSV-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anterograde transport from TG (HSV-1) or sacral dorsal ganglion (HSV-2) by sensory neuron projections [<xref rid="B137-viruses-17-00203" ref-type="bibr">137</xref>], via olfactory pathway [<xref rid="B138-viruses-17-00203" ref-type="bibr">138</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe acute necrotizing encephalitis (HSV-1), meningitis (HSV-2) [<xref rid="B139-viruses-17-00203" ref-type="bibr">139</xref>], or asymptomatic presence&#x02014;accumulating data from the autopsy of people deceased without neurological illnesses (2&#x02013;100%) [<xref rid="B140-viruses-17-00203" ref-type="bibr">140</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitis often leads to lifelong brain damage or death.<break/>Virus undergoes latency and persists permanently within neural tissue.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes, microglia, oligodendrocytes [<xref rid="B141-viruses-17-00203" ref-type="bibr">141</xref>]. </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VZV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anterograde transport by neuron projections from dorsal root ganglia and cranial nerve ganglia.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis or encephalitis often without concurrent zoster rash [<xref rid="B142-viruses-17-00203" ref-type="bibr">142</xref>,<xref rid="B143-viruses-17-00203" ref-type="bibr">143</xref>]<break/>or asymptomatic presence&#x02014;data from the autopsy of people with no evidence of neurological disease (1&#x02013;27.5%) [<xref rid="B144-viruses-17-00203" ref-type="bibr">144</xref>,<xref rid="B145-viruses-17-00203" ref-type="bibr">145</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resolution of symptoms with or without neurologic sequelae, encephalitis can result in fatal outcome.<break/>Virus is suspected to persist in the CNS, as it establishes latency in neurons.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes [<xref rid="B146-viruses-17-00203" ref-type="bibr">146</xref>],<break/>oligodendrocytes [<xref rid="B147-viruses-17-00203" ref-type="bibr">147</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EBV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Via infected lymphocytes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis, encephalitis, and CNS-lymphoma.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resolution of symptoms without or with long-term consequences (depending on the host immune status and other factors [<xref rid="B148-viruses-17-00203" ref-type="bibr">148</xref>]), may end with death. <break/>Establishes lifelong infection of the PNS and/or CNS, EBV-infected cells, free virus, and gene products can be found in the CNS [<xref rid="B149-viruses-17-00203" ref-type="bibr">149</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons [<xref rid="B150-viruses-17-00203" ref-type="bibr">150</xref>],<break/>astrocytes, microglia [<xref rid="B151-viruses-17-00203" ref-type="bibr">151</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CMV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Presumably via infected monocytes [<xref rid="B132-viruses-17-00203" ref-type="bibr">132</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis, encephalitis (particularly in immunosuppressed individuals).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In immune-na&#x000ef;ve and immunocompromised persons can cause CNS complications or result in fatal outcome [<xref rid="B152-viruses-17-00203" ref-type="bibr">152</xref>].<break/>Routinely establishes lifelong infection of the PNS and/or CNS [<xref rid="B149-viruses-17-00203" ref-type="bibr">149</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons (debated), astrocytes, microglia, oligodendrocytes, neural progenitor cells [<xref rid="B153-viruses-17-00203" ref-type="bibr">153</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HHV-6A, HHV-6B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Via olfactory pathway [<xref rid="B154-viruses-17-00203" ref-type="bibr">154</xref>], infected lymphocytes, or optic tract [<xref rid="B155-viruses-17-00203" ref-type="bibr">155</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitis or asymptomatic presence&#x02014;data from autopsies of individuals who passed away without neurological disorders (19&#x02013;87.5%) [<xref rid="B145-viruses-17-00203" ref-type="bibr">145</xref>,<xref rid="B155-viruses-17-00203" ref-type="bibr">155</xref>,<xref rid="B156-viruses-17-00203" ref-type="bibr">156</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitis often has devastating sequelae or may cause death [<xref rid="B157-viruses-17-00203" ref-type="bibr">157</xref>].<break/>Viruses establish the lifelong infection of the PNS and/or CNS [<xref rid="B149-viruses-17-00203" ref-type="bibr">149</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes [<xref rid="B158-viruses-17-00203" ref-type="bibr">158</xref>],<break/>microglia [<xref rid="B159-viruses-17-00203" ref-type="bibr">159</xref>],<break/>oligodendrocytes [<xref rid="B160-viruses-17-00203" ref-type="bibr">160</xref>].</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Family:<break/><italic toggle="yes">Picornaviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poliovirus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Via the BBB and motor neurons [<xref rid="B72-viruses-17-00203" ref-type="bibr">72</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paralytic poliomyelitis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe and irreversible damage of motor neurons, among those paralyzed, 5&#x02013;10% die [<xref rid="B161-viruses-17-00203" ref-type="bibr">161</xref>].<break/>It is suggested that the virus may persist in surviving patients [<xref rid="B162-viruses-17-00203" ref-type="bibr">162</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons [<xref rid="B72-viruses-17-00203" ref-type="bibr">72</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enterovirus-A71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hematogenous way&#x02014;transcellular pathway and/or infection of endothelial cells [<xref rid="B163-viruses-17-00203" ref-type="bibr">163</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis, encephalitis, polio-like syndrome, encephalomyelitis (the risk may be associated with younger age) [<xref rid="B164-viruses-17-00203" ref-type="bibr">164</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CNS involvement may entail severe sequelae, death is rarely reported [<xref rid="B165-viruses-17-00203" ref-type="bibr">165</xref>].<break/>The mechanisms and extent of EV-A71 persistence in the human CNS is unknown [<xref rid="B166-viruses-17-00203" ref-type="bibr">166</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons,<break/>astrocytes [<xref rid="B167-viruses-17-00203" ref-type="bibr">167</xref>],<break/>microglia [<xref rid="B168-viruses-17-00203" ref-type="bibr">168</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Family:<break/><italic toggle="yes">Orthomyxoviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Subtypes of influenza A virus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Presumably via olfactory nerve pathway [<xref rid="B169-viruses-17-00203" ref-type="bibr">169</xref>,<xref rid="B170-viruses-17-00203" ref-type="bibr">170</xref>,<xref rid="B171-viruses-17-00203" ref-type="bibr">171</xref>], cranial nerves [<xref rid="B172-viruses-17-00203" ref-type="bibr">172</xref>], via BBB endothelial cells [<xref rid="B173-viruses-17-00203" ref-type="bibr">173</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute encephalitis or influenza-associated encephalopathy.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe onset, often resulting in significant morbidity and high mortality within a matter of days [<xref rid="B173-viruses-17-00203" ref-type="bibr">173</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons [<xref rid="B174-viruses-17-00203" ref-type="bibr">174</xref>], astrocytes [<xref rid="B175-viruses-17-00203" ref-type="bibr">175</xref>].</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Family:<break/><italic toggle="yes">Paramyxoviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mumps virus (MuV)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Through the choroid plexus&#x02014;virus infects choroidal and ependymal epithelial cells [<xref rid="B176-viruses-17-00203" ref-type="bibr">176</xref>], on mononuclear cells transiting the BBB during viremia.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Usually mild or asymptomatic disease with often complete recovery [<xref rid="B177-viruses-17-00203" ref-type="bibr">177</xref>]. Symptomatic CNS infection is less common and rarely fatal [<xref rid="B178-viruses-17-00203" ref-type="bibr">178</xref>].<break/>In rare instances, the virus is believed to persist in the CNS [<xref rid="B179-viruses-17-00203" ref-type="bibr">179</xref>,<xref rid="B180-viruses-17-00203" ref-type="bibr">180</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons [<xref rid="B181-viruses-17-00203" ref-type="bibr">181</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measles virus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hematogenous way&#x02014;infection of brain endothelial cells [<xref rid="B182-viruses-17-00203" ref-type="bibr">182</xref>], in infected CNS infiltrating macrophages [<xref rid="B183-viruses-17-00203" ref-type="bibr">183</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary encephalitis, postinfectious encephalomyelitis, SSPE.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All diseases can lead to severe and permanent brain injury [<xref rid="B184-viruses-17-00203" ref-type="bibr">184</xref>], SSPE is invariably fatal.<break/>Virus may persist in neurons [<xref rid="B185-viruses-17-00203" ref-type="bibr">185</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes, oligodendrocytes [<xref rid="B183-viruses-17-00203" ref-type="bibr">183</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Henipaviruses (HeV, NiV)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directly from the nasal mucosa and in a hematogenous way [<xref rid="B186-viruses-17-00203" ref-type="bibr">186</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Febrile illness or encephalitis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The disease may be fatal, survivors may experience severe neurological sequelae [<xref rid="B187-viruses-17-00203" ref-type="bibr">187</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endothelial cells of the CNS microvasculature, <break/>neurons [<xref rid="B188-viruses-17-00203" ref-type="bibr">188</xref>],<break/>astrocytes, oligodendrocytes [<xref rid="B189-viruses-17-00203" ref-type="bibr">189</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Family:<break/><italic toggle="yes">Rhabdoviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RABV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrograde axonal transport.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Progressive rabies encephalitis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Invariably fatal outcome.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes (field strains) [<xref rid="B53-viruses-17-00203" ref-type="bibr">53</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Family:<break/><italic toggle="yes">Flaviviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitic flaviviruses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Along the peripheral nervous system and axonal transport,<break/>hematogenous route&#x02014;the infection of choroid plexus cells [<xref rid="B190-viruses-17-00203" ref-type="bibr">190</xref>], the infection of BBB cells without cytopathic effect, with the downregulation of junction proteins, or crossing the BBB<break/>in leukocytes [<xref rid="B83-viruses-17-00203" ref-type="bibr">83</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe encephalitides and other neurologic syndromes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitides are often fatal or may lead to transient or permanent neurological deficits [<xref rid="B96-viruses-17-00203" ref-type="bibr">96</xref>].<break/>Viruses may persist in the CNS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes,<break/>microglia, oligodendrocytes (please ref. to Table 5). </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Family:<break/><italic toggle="yes">Togaviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VEEV, WEEV, EEEV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anterograde transport along peripheral nerves,<break/>olfactory route [<xref rid="B191-viruses-17-00203" ref-type="bibr">191</xref>],<break/>hematogenous route&#x02014;transcytosis across intact BBB [<xref rid="B89-viruses-17-00203" ref-type="bibr">89</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mild, febrile illness to severe encephalitis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitides have 1&#x02013;75% fatality rate, depending on the virus strain [<xref rid="B89-viruses-17-00203" ref-type="bibr">89</xref>].<break/>Virus replication and/or genomic RNA may persist in the CNS [<xref rid="B192-viruses-17-00203" ref-type="bibr">192</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes, microglia [<xref rid="B193-viruses-17-00203" ref-type="bibr">193</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Family:<break/><italic toggle="yes">Retroviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In HIV-infected monocytes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HAND.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cognitive, motor and behavioral abnormalities [<xref rid="B194-viruses-17-00203" ref-type="bibr">194</xref>].<break/>Virus persists in the CNS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microglia, astrocytes [<xref rid="B195-viruses-17-00203" ref-type="bibr">195</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Family:<break/><italic toggle="yes">Coronaviridae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SARS-CoV-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Via olfactory epithelium, via optic nerve,<break/>hematogenous pathway&#x02014;by infection of brain endothelial cells [<xref rid="B196-viruses-17-00203" ref-type="bibr">196</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalopathy (in most critically ill COVID-19 patients), PASC.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">With serious or long-term neurological dysfunctions and deficits.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurons, astrocytes, choroid plexus epithelial cells [<xref rid="B197-viruses-17-00203" ref-type="bibr">197</xref>].</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00203-t004"><object-id pub-id-type="pii">viruses-17-00203-t004_Table 4</object-id><label>Table 4</label><caption><p>Encephalitis and other neurological syndromes associated with selected neurotropic flavivirus infections.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">JEV</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">WNV</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TBEV</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Disease transmission
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mosquito bite</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mosquito bite</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tick bite, consumption of unpasteurized milk from infected ruminants (1% of infections) [<xref rid="B202-viruses-17-00203" ref-type="bibr">202</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mosquito bite, placental transmission, sexual transmission [<xref rid="B203-viruses-17-00203" ref-type="bibr">203</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Geographical regions of most encephalitis cases
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asia, Australia, Western Pacific [<xref rid="B204-viruses-17-00203" ref-type="bibr">204</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Europe and North America [<xref rid="B82-viruses-17-00203" ref-type="bibr">82</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Central/Northern Europe and North-Eastern Asia [<xref rid="B205-viruses-17-00203" ref-type="bibr">205</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Africa, South-East Asia, Micronesia, French Polynesia, both Americas [<xref rid="B206-viruses-17-00203" ref-type="bibr">206</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Most frequently encephalitis-bearing patients
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elderly or inmunocompromised individuals [<xref rid="B207-viruses-17-00203" ref-type="bibr">207</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Newborns</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Vaccines available
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
% of people infected with <break/>the virus <break/>who develop encephalitis
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#x02013;1% [<xref rid="B208-viruses-17-00203" ref-type="bibr">208</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67% [<xref rid="B209-viruses-17-00203" ref-type="bibr">209</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02013;25% [<xref rid="B210-viruses-17-00203" ref-type="bibr">210</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Number of encephalitis cases annually
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~100,000 [<xref rid="B211-viruses-17-00203" ref-type="bibr">211</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Few thousand [<xref rid="B212-viruses-17-00203" ref-type="bibr">212</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10,000&#x02013;15,000 [<xref rid="B213-viruses-17-00203" ref-type="bibr">213</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown in newborns, very few cases of adult people [<xref rid="B214-viruses-17-00203" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Encephalitis mortality rate
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20&#x02013;30% [<xref rid="B215-viruses-17-00203" ref-type="bibr">215</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Over 10% [<xref rid="B216-viruses-17-00203" ref-type="bibr">216</xref>], <break/>10&#x02013;20% for WNV meningitis [<xref rid="B217-viruses-17-00203" ref-type="bibr">217</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;40% [<xref rid="B218-viruses-17-00203" ref-type="bibr">218</xref>]&#x02014;<break/>in severe infections, TBE manifests as meningoencephalitis with significant mortality rate [<xref rid="B219-viruses-17-00203" ref-type="bibr">219</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Other neurological syndromes associated with infection
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis [<xref rid="B220-viruses-17-00203" ref-type="bibr">220</xref>],<break/>poliomyelitis-like flaccid paralysis [<xref rid="B221-viruses-17-00203" ref-type="bibr">221</xref>], <break/>Parkinsonian syndrome [<xref rid="B222-viruses-17-00203" ref-type="bibr">222</xref>], neuropsychiatric sequelae,<break/>cognitive and language impairment [<xref rid="B223-viruses-17-00203" ref-type="bibr">223</xref>], <break/>GBS [<xref rid="B224-viruses-17-00203" ref-type="bibr">224</xref>,<xref rid="B225-viruses-17-00203" ref-type="bibr">225</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis, <break/>poliomyelitis [<xref rid="B226-viruses-17-00203" ref-type="bibr">226</xref>], <break/>GBS [<xref rid="B227-viruses-17-00203" ref-type="bibr">227</xref>], <break/>acute flaccid paralysis [<xref rid="B228-viruses-17-00203" ref-type="bibr">228</xref>], <break/>movement disorders, cognitive difficulties [<xref rid="B229-viruses-17-00203" ref-type="bibr">229</xref>], <break/>neuropsychiatric sequelae [<xref rid="B230-viruses-17-00203" ref-type="bibr">230</xref>,<xref rid="B231-viruses-17-00203" ref-type="bibr">231</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningitis, <break/>GBS [<xref rid="B232-viruses-17-00203" ref-type="bibr">232</xref>], <break/>permanent paresis, <break/>postencephalitic syndrome [<xref rid="B210-viruses-17-00203" ref-type="bibr">210</xref>], <break/>epilepsy, <break/>lateral sclerosis, <break/>dispersed sclerosis, <break/>Parkinson-like disease, <break/>mental deterioration leading to severe dementia and/or death [<xref rid="B233-viruses-17-00203" ref-type="bibr">233</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microcephaly and other congenital malformations in newborns, <break/>GBS&#x02014;predominate presentaion in adults [<xref rid="B234-viruses-17-00203" ref-type="bibr">234</xref>], <break/>encephalopathy, <break/>meningitis, <break/>myelitis, <break/>seizures [<xref rid="B214-viruses-17-00203" ref-type="bibr">214</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00203-t005"><object-id pub-id-type="pii">viruses-17-00203-t005_Table 5</object-id><label>Table 5</label><caption><p>Non-neuronal cells infected by flaviviruses in the human CNS.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Flavivirus</bold>
</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Non-neuronal CNS cells that can be infected</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>JEV</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">astrocytes [<xref rid="B82-viruses-17-00203" ref-type="bibr">82</xref>], microglia, BMECs [<xref rid="B240-viruses-17-00203" ref-type="bibr">240</xref>], pericytes [<xref rid="B241-viruses-17-00203" ref-type="bibr">241</xref>], neural progenitor stem cells [<xref rid="B81-viruses-17-00203" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>WNV</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">astrocytes [<xref rid="B242-viruses-17-00203" ref-type="bibr">242</xref>], oligodendrocytes [<xref rid="B243-viruses-17-00203" ref-type="bibr">243</xref>], BMECs [<xref rid="B244-viruses-17-00203" ref-type="bibr">244</xref>], pericytes [<xref rid="B245-viruses-17-00203" ref-type="bibr">245</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>TBEV</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">astrocytes, oligodendrocytes [<xref rid="B205-viruses-17-00203" ref-type="bibr">205</xref>], microglia [<xref rid="B246-viruses-17-00203" ref-type="bibr">246</xref>], BMECs, pericytes [<xref rid="B247-viruses-17-00203" ref-type="bibr">247</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>ZIKV</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">astrocytes, oligodendrocytes [<xref rid="B248-viruses-17-00203" ref-type="bibr">248</xref>], microglia, BMECs [<xref rid="B249-viruses-17-00203" ref-type="bibr">249</xref>], pericytes [<xref rid="B190-viruses-17-00203" ref-type="bibr">190</xref>], neural progenitor cells [<xref rid="B250-viruses-17-00203" ref-type="bibr">250</xref>], glial progenitor cells [<xref rid="B251-viruses-17-00203" ref-type="bibr">251</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00203-t006"><object-id pub-id-type="pii">viruses-17-00203-t006_Table 6</object-id><label>Table 6</label><caption><p>Autoimmune conditions and related flavivirus infections.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Autoimmune<break/>Condition</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Definition</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Onset Time</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Flaviviral Infections Associated with<break/>Autoimmune Condition</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Autoimmune encephalitis, AIE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute to subacute progressive inflammation of the brain, associated with the presence of antibodies against self-antigens expressed in the CNS, often neuronal proteins [<xref rid="B262-viruses-17-00203" ref-type="bibr">262</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Can develop early or during onset of encephalitis, usually during recovery from viral infection or several weeks later [<xref rid="B263-viruses-17-00203" ref-type="bibr">263</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">JEV, WNV [<xref rid="B264-viruses-17-00203" ref-type="bibr">264</xref>,<xref rid="B265-viruses-17-00203" ref-type="bibr">265</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute disseminated encephalomy-elitis, ADEM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute post-infectious progressive inflammatory disorder characterized by brain and spinal cord demyelination and other types of neural damage [<xref rid="B266-viruses-17-00203" ref-type="bibr">266</xref>] can also occur post-vaccination.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Develops during or within days to weeks after CNS infections or after illnesses with CNS involvement.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DENV, ZIKV [<xref rid="B237-viruses-17-00203" ref-type="bibr">237</xref>,<xref rid="B267-viruses-17-00203" ref-type="bibr">267</xref>,<xref rid="B268-viruses-17-00203" ref-type="bibr">268</xref>,<xref rid="B269-viruses-17-00203" ref-type="bibr">269</xref>].<break/>Immunization against JEV [<xref rid="B270-viruses-17-00203" ref-type="bibr">270</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guillain&#x02013;Barre Syndrome, GBS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Post-infectious neuropathy resulting from the autoimmune destruction of nerves in the PNS [<xref rid="B271-viruses-17-00203" ref-type="bibr">271</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Typically begins within a few days to several weeks after a viral infection.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DENV, WNV, JEV, and ZIKV [<xref rid="B224-viruses-17-00203" ref-type="bibr">224</xref>,<xref rid="B227-viruses-17-00203" ref-type="bibr">227</xref>,<xref rid="B272-viruses-17-00203" ref-type="bibr">272</xref>,<xref rid="B273-viruses-17-00203" ref-type="bibr">273</xref>].</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00203-t007"><object-id pub-id-type="pii">viruses-17-00203-t007_Table 7</object-id><label>Table 7</label><caption><p>Neurotoxic effects of HIV proteins in the brain.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Direct injury of neurons</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">gp120, gp41, Tat, Vpr [<xref rid="B300-viruses-17-00203" ref-type="bibr">300</xref>,<xref rid="B301-viruses-17-00203" ref-type="bibr">301</xref>,<xref rid="B302-viruses-17-00203" ref-type="bibr">302</xref>,<xref rid="B303-viruses-17-00203" ref-type="bibr">303</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of pro-inflammatory cytokine expression and release; glial and myeloid cell activation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat, gp120, Nef, Vpr [<xref rid="B122-viruses-17-00203" ref-type="bibr">122</xref>,<xref rid="B304-viruses-17-00203" ref-type="bibr">304</xref>,<xref rid="B305-viruses-17-00203" ref-type="bibr">305</xref>,<xref rid="B306-viruses-17-00203" ref-type="bibr">306</xref>,<xref rid="B307-viruses-17-00203" ref-type="bibr">307</xref>,<xref rid="B308-viruses-17-00203" ref-type="bibr">308</xref>,<xref rid="B309-viruses-17-00203" ref-type="bibr">309</xref>,<xref rid="B310-viruses-17-00203" ref-type="bibr">310</xref>,<xref rid="B311-viruses-17-00203" ref-type="bibr">311</xref>,<xref rid="B312-viruses-17-00203" ref-type="bibr">312</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppression of NF-&#x003ba;B-elicited antiviral immune responses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vpu [<xref rid="B313-viruses-17-00203" ref-type="bibr">313</xref>,<xref rid="B314-viruses-17-00203" ref-type="bibr">314</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of adhesion molecules expression and mediation of adhesion molecules&#x02019; release</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat, gp120, Nef [<xref rid="B315-viruses-17-00203" ref-type="bibr">315</xref>,<xref rid="B316-viruses-17-00203" ref-type="bibr">316</xref>,<xref rid="B317-viruses-17-00203" ref-type="bibr">317</xref>,<xref rid="B318-viruses-17-00203" ref-type="bibr">318</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulation of protein stability through modulation of ubiquitination</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vif, Vpu, Vpx, Vpr, Nef [<xref rid="B319-viruses-17-00203" ref-type="bibr">319</xref>,<xref rid="B320-viruses-17-00203" ref-type="bibr">320</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promotion of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">gp120, Tat, Vpu, Nef [<xref rid="B319-viruses-17-00203" ref-type="bibr">319</xref>,<xref rid="B321-viruses-17-00203" ref-type="bibr">321</xref>,<xref rid="B322-viruses-17-00203" ref-type="bibr">322</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat, Vpr, Nef, Vif [<xref rid="B323-viruses-17-00203" ref-type="bibr">323</xref>,<xref rid="B324-viruses-17-00203" ref-type="bibr">324</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alteration of intracellular ionic homeostasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat, gp120, Nef, Vpr, Vpu, gp41 [<xref rid="B325-viruses-17-00203" ref-type="bibr">325</xref>,<xref rid="B326-viruses-17-00203" ref-type="bibr">326</xref>,<xref rid="B327-viruses-17-00203" ref-type="bibr">327</xref>,<xref rid="B328-viruses-17-00203" ref-type="bibr">328</xref>,<xref rid="B329-viruses-17-00203" ref-type="bibr">329</xref>,<xref rid="B330-viruses-17-00203" ref-type="bibr">330</xref>,<xref rid="B331-viruses-17-00203" ref-type="bibr">331</xref>,<xref rid="B332-viruses-17-00203" ref-type="bibr">332</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disruption of cell&#x02013;cell communication</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat, Nef, gp120 [<xref rid="B333-viruses-17-00203" ref-type="bibr">333</xref>,<xref rid="B334-viruses-17-00203" ref-type="bibr">334</xref>,<xref rid="B335-viruses-17-00203" ref-type="bibr">335</xref>,<xref rid="B336-viruses-17-00203" ref-type="bibr">336</xref>,<xref rid="B337-viruses-17-00203" ref-type="bibr">337</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disruption of metabolic pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">gp120, Tat, Vpr [<xref rid="B338-viruses-17-00203" ref-type="bibr">338</xref>,<xref rid="B339-viruses-17-00203" ref-type="bibr">339</xref>,<xref rid="B340-viruses-17-00203" ref-type="bibr">340</xref>,<xref rid="B341-viruses-17-00203" ref-type="bibr">341</xref>,<xref rid="B342-viruses-17-00203" ref-type="bibr">342</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disruption of DNA repair</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vpr [<xref rid="B343-viruses-17-00203" ref-type="bibr">343</xref>,<xref rid="B344-viruses-17-00203" ref-type="bibr">344</xref>,<xref rid="B345-viruses-17-00203" ref-type="bibr">345</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disruption of neurotransmitter signaling</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B346-viruses-17-00203" ref-type="bibr">346</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of ROS and RNS production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat, Vpr, Vpu, gp120, gp41, Nef [<xref rid="B347-viruses-17-00203" ref-type="bibr">347</xref>,<xref rid="B348-viruses-17-00203" ref-type="bibr">348</xref>,<xref rid="B349-viruses-17-00203" ref-type="bibr">349</xref>,<xref rid="B350-viruses-17-00203" ref-type="bibr">350</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Interaction with A&#x003b2; and/or Tau resulting in their accumulation (disruption of processing, localization, and phagocytosis by microglial cells)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tat, gp120, Vpr, Nef [<xref rid="B351-viruses-17-00203" ref-type="bibr">351</xref>,<xref rid="B352-viruses-17-00203" ref-type="bibr">352</xref>,<xref rid="B353-viruses-17-00203" ref-type="bibr">353</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modulation of infected T cell activation status</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">gp120, Env, Nef, Tat, Vpr [<xref rid="B354-viruses-17-00203" ref-type="bibr">354</xref>,<xref rid="B355-viruses-17-00203" ref-type="bibr">355</xref>,<xref rid="B356-viruses-17-00203" ref-type="bibr">356</xref>,<xref rid="B357-viruses-17-00203" ref-type="bibr">357</xref>,<xref rid="B358-viruses-17-00203" ref-type="bibr">358</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00203-t008"><object-id pub-id-type="pii">viruses-17-00203-t008_Table 8</object-id><label>Table 8</label><caption><p>Endogenous retroviruses implicated in neurodegenerative disorders.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Neurodegenerative Disorder</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HERVs Implicated in Disease</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HERV-W, HERV-K, HERV-H, HERV-E, HERV-<sub>15</sub> [<xref rid="B467-viruses-17-00203" ref-type="bibr">467</xref>,<xref rid="B468-viruses-17-00203" ref-type="bibr">468</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HERV-K, HERV-W [<xref rid="B469-viruses-17-00203" ref-type="bibr">469</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HERV-H, HERV-K, HERV-L, HERV-W [<xref rid="B5-viruses-17-00203" ref-type="bibr">5</xref>,<xref rid="B470-viruses-17-00203" ref-type="bibr">470</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">progressive supranuclear palsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HERV-H, HERV-K, HERV-L [<xref rid="B470-viruses-17-00203" ref-type="bibr">470</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HERV-K [<xref rid="B471-viruses-17-00203" ref-type="bibr">471</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HERV-K [<xref rid="B5-viruses-17-00203" ref-type="bibr">5</xref>,<xref rid="B472-viruses-17-00203" ref-type="bibr">472</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>